Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692121-42721298 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 70.7;Proximal tubular cells: 91.0;Urothelial cells: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 38.7;ASC TERT1: 31.3;RPTEC TERT1: 27.1;TIME: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001141 Uncertain Mitochondria NA NA 22000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 41.5 14.3 6.2 6.1 6.0 4.1 31.3 5.0 8.0 29.6 8.0 30.9 4.5 28.1 3.3 30.6 29.2 4.4 77.0 6.2 5.3 51.3 4.3 26.0 6.8 7.8 5.8 7.8 6.2 1.2 16.7 9.1 5.6 35.1 1.7 0.3 36.1 21.3 19.4 20.8 18.2 6.9 6.0 16.2 26.6 6.2 7.1 1.6 25.1 6.3 5.1 38.1 38.2 6.0 1.2 13.6 0.0 0.0 38.7 31.3 20.1 5.5 5.8 1.2 2.1 4.3 2.2 13.6 9.4 9.7 6.7 1.3 12.9 6.5 0.2 0.0 2.7 0.3 21.1 0.5 11.5 0.0 0.9 18.6 1.8 5.5 0.9 1.8 4.7 0.0 0.1 0.0 5.1 19.0 0.0 0.0 1.6 0.9 3.3 0.0 3.0 1.4 27.1 23.4 0.2 0.0 16.9 0.3 0.0 2.4 10.6 1.6 29.3 0.0 2.6 24.3 7.3 2.8 13.1 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 6.2 6.0 5.0 8.0 6.2 5.3 7.8 5.8 5.6 6.0 7.1 6.0 47.1 0.0 0.5 0.3 1.6 9.2 28.9 70.7 0.0 0.1 4.2 1.5 15.8 1.5 41.2 18.4 0.0 48.7 0.4 0.2 13.7 23.1 0.7 11.1 10.3 43.7 0.0 10.7 0.1 1.1 35.3 43.8 2.6 17.4 1.3 0.2 30.7 0.2 5.3 0.0 0.1 0.0 14.2 1.0 11.8 4.4 46.3 4.0 7.2 7.5 30.0 0.8 0.0 0.5 0.0 3.6 0.0 30.1 0.1 40.1 0.0 91.0 12.1 0.6 39.5 7.6 29.3 0.6 0.6 1.2 8.8 9.4 1.5 19.9 0.1 74.7 ABCC1 "GS-X, MRP, MRP1" ENSG00000103222 "ATP binding cassette subfamily C member 1" P33527 16 15949138-16143257 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Hydrolase, Translocase" "Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002380, HPA076011" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "Cell Junctions" "HPA002380: AB_1844432, HPA076011: " "unprognostic (9.97e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.42e-1)" "unprognostic (3.31e-1)" "unprognostic (4.07e-2)" "unprognostic (9.78e-3)" "unprognostic (7.19e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-2)" 10.4 11.6 0.3 4.0 0.2 3.6 8.6 0.3 0.7 10.4 4.1 16.1 1.1 11.0 0.1 22.8 7.0 3.1 11.2 0.3 0.5 8.0 2.3 15.5 4.4 1.1 0.8 8.9 8.9 3.6 7.2 2.0 0.7 15.2 0.7 0.4 9.2 0.9 21.2 9.7 12.4 6.3 0.5 15.7 15.0 13.1 0.6 4.3 21.0 0.1 1.1 15.4 12.8 0.9 4.3 43.7 0.3 11.7 3.2 4.5 0.5 15.4 19.0 13.1 13.8 6.7 34.8 7.0 79.6 29.6 11.0 12.1 3.4 12.4 4.6 22.2 4.4 16.4 22.0 16.3 25.1 5.9 39.5 15.0 9.0 1.1 2.3 3.8 10.2 28.6 17.8 6.8 0.5 5.4 12.0 0.9 3.5 1.8 8.2 41.9 7.8 5.3 0.7 15.2 6.4 11.8 18.9 17.8 3.6 11.9 6.2 0.8 3.5 0.4 2.0 11.4 11.9 13.5 7.4 3.3 6.6 0.6 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.7 0.3 0.5 1.1 0.8 0.7 0.5 0.6 0.9 8.6 25.6 5.6 10.7 13.1 8.8 8.5 18.2 9.6 3.1 4.4 3.7 6.0 4.3 14.4 5.5 22.9 0.9 9.8 2.7 3.9 9.1 11.0 15.7 12.9 8.6 18.6 16.0 26.6 6.2 3.2 12.3 49.5 17.8 22.1 16.8 8.6 0.4 8.5 5.0 38.5 6.6 14.2 21.4 9.1 14.3 7.5 12.2 3.6 11.2 10.5 1.2 5.2 12.1 15.9 11.2 4.5 6.8 15.7 18.7 0.5 1.1 9.9 8.8 0.0 6.4 5.1 4.9 6.6 18.1 5.1 0.5 17.4 37.1 3.7 11.6 ABCD1 "adrenoleukodystrophy, ALD, ALDP, AMN" ENSG00000101986 "ATP binding cassette subfamily D member 1" P33897 X 153724856-153744755 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4" "Cancer enhanced" "Detected in all" "melanoma: 36.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035214 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 45: Enterocytes - Digestion" "HPA035214: " "unprognostic (1.90e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-3)" "unprognostic (5.57e-3)" "unprognostic (8.81e-3)" "unprognostic (1.54e-1)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (6.14e-3)" "unprognostic (3.40e-2)" "unprognostic (1.41e-1)" "unprognostic (6.17e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.23e-2)" 14.6 33.3 3.1 5.4 3.9 4.7 12.5 3.4 3.8 7.5 2.2 14.7 10.6 33.2 1.7 3.7 9.3 3.4 11.9 2.9 3.4 7.0 13.3 7.6 3.9 4.4 3.6 5.4 11.9 2.1 10.0 4.7 4.8 9.9 1.8 0.5 6.2 5.6 20.5 4.4 17.4 4.8 3.1 13.8 7.2 19.0 5.5 4.3 6.0 4.6 1.7 11.9 6.1 4.2 13.2 4.0 2.6 11.2 7.4 3.2 34.3 6.3 6.8 4.2 7.4 2.6 7.1 3.5 69.7 8.6 11.3 1.7 1.6 1.4 0.5 11.8 2.1 10.3 42.1 34.1 9.8 6.4 22.4 6.2 1.7 4.8 0.4 4.4 6.7 4.7 6.0 12.4 5.9 4.7 4.5 6.1 3.3 3.2 50.0 7.8 6.2 5.7 3.2 1.4 2.8 11.5 16.4 49.2 26.4 3.0 3.7 10.8 7.9 5.5 7.4 14.3 7.0 12.2 5.7 8.4 6.9 21.7 7.8 0.4 3.2 2.5 0.8 3.0 4.0 1.0 1.0 1.2 2.7 0.7 1.1 0.8 1.7 0.7 2.8 1.7 0.3 2.5 3.1 3.9 3.4 3.8 2.9 3.4 4.4 3.6 4.8 3.1 5.5 4.2 5.0 0.0 1.1 3.6 3.8 3.2 1.6 1.6 0.6 2.2 2.7 2.8 2.4 2.8 2.2 3.7 2.1 12.2 4.8 9.5 0.0 3.8 0.7 2.0 3.5 3.4 6.0 3.6 0.5 6.9 19.5 4.5 3.6 4.0 0.0 6.9 5.7 6.8 12.6 8.4 0.9 5.0 2.0 15.9 8.4 2.7 4.1 12.3 1.8 0.0 5.9 2.4 0.0 0.0 1.2 5.0 2.1 5.7 2.4 0.8 39.2 2.8 1.2 0.7 6.6 2.3 2.8 3.8 4.8 0.8 1.3 27.4 4.0 7.8 5.5 1.4 ABHD16A "BAT5, D6S82E, NG26" ENSG00000204427 "Abhydrolase domain containing 16A, phospholipase" O95870 6 31686955-31703356 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 41.2;OE19: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058606 Approved NA NA 37000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 59: Non-specific - Transcription" "HPA058606: AB_2683774" "unprognostic (1.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.26e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (3.14e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (6.17e-3)" "unprognostic (1.97e-3)" "unprognostic (6.02e-2)" "unprognostic (1.30e-2)" "unprognostic (9.35e-2)" "unprognostic (1.81e-1)" "unprognostic (5.11e-3)" "unprognostic (1.60e-3)" 16.2 22.1 1.1 11.7 1.3 6.7 13.3 1.2 4.1 20.5 0.9 20.9 0.0 21.5 19.0 21.1 18.9 9.9 17.4 1.2 1.2 17.0 30.0 16.0 13.0 1.6 2.0 15.0 18.7 5.8 40.0 7.9 1.4 19.6 7.3 6.7 17.4 4.2 35.0 12.9 17.6 0.0 1.5 18.5 21.5 31.6 1.5 4.5 21.3 0.0 0.0 20.7 15.0 1.5 0.0 15.7 0.0 41.2 29.0 11.7 0.0 14.5 16.2 16.5 15.6 0.0 26.1 16.5 33.7 21.2 0.0 0.0 0.0 19.7 9.0 16.0 12.7 0.0 0.0 0.0 34.7 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.3 0.0 0.0 0.0 0.5 0.0 42.4 0.0 0.7 0.0 29.3 21.0 0.0 0.2 20.0 0.9 0.5 0.4 0.0 0.0 0.0 14.9 19.6 14.5 0.0 0.0 10.5 21.1 8.5 13.6 0.1 16.1 2.5 6.8 8.4 4.1 8.9 1.9 2.8 1.2 4.2 6.2 2.8 3.5 2.7 13.3 5.9 0.5 4.1 4.1 6.3 1.1 1.3 1.2 4.1 1.2 1.2 1.6 2.0 1.4 1.5 1.5 1.5 1.2 0.0 8.2 11.4 10.7 0.4 0.3 1.7 15.4 1.2 1.5 1.0 0.5 0.0 1.6 0.0 0.0 3.9 2.2 12.0 3.9 18.3 1.3 1.4 1.7 2.7 12.5 14.9 13.4 13.3 1.5 5.3 12.2 1.2 1.3 0.5 0.7 0.8 3.3 0.0 14.6 9.7 2.0 2.2 2.1 0.4 0.9 8.8 3.6 13.1 8.1 1.0 5.2 15.6 21.1 12.7 16.0 0.4 16.4 0.4 16.5 0.7 1.7 1.4 0.0 0.7 4.9 2.5 1.6 16.8 1.0 5.3 7.6 0.2 12.1 0.3 ABR MDB ENSG00000159842 "ABR activator of RhoGEF and GTPase" Q12979 17 1003518-1229738 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 171.7;Late spermatids: 164.0;Microglial cells: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "basophil: 9.0" "Lineage enriched" "Detected in single" 17 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "Daudi: 31.3;hTERT-RPE1: 38.6;LHCN-M2: 24.6;RPMI-8226: 21.5;TIME: 41.3;U-251 MG: 42.0;U-698: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Nucleoplasm "HPA053618: AB_2682208, HPA054824: AB_2682616" "unprognostic (1.69e-1)" "prognostic favorable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favorable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 22.7 21.7 4.5 5.5 3.1 1.3 20.0 1.2 6.0 27.0 0.0 58.9 1.9 28.5 0.1 42.0 22.9 0.6 40.5 5.1 1.7 9.7 3.0 28.5 1.0 4.2 5.0 14.7 8.6 1.2 22.4 1.6 7.3 18.2 7.0 1.2 28.1 0.4 9.0 25.0 40.5 8.1 6.9 21.0 19.5 13.9 6.7 4.8 10.5 0.0 5.7 22.0 24.7 12.3 1.0 1.3 0.3 0.1 1.3 0.2 1.7 0.2 0.3 0.1 0.0 0.6 0.0 31.3 0.7 0.3 1.7 0.1 4.0 0.1 0.9 11.8 14.5 0.0 0.4 0.1 0.8 2.7 9.5 0.4 0.0 0.3 12.7 38.6 0.0 0.0 0.1 0.0 24.6 1.2 0.1 3.4 0.2 0.7 0.2 0.2 0.0 21.5 0.2 0.4 0.3 0.6 0.1 0.0 1.8 0.1 11.5 3.0 41.3 0.3 0.4 3.0 42.0 0.1 0.6 29.5 1.9 5.1 0.8 9.0 0.2 0.6 0.1 0.5 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.5 0.0 0.2 0.0 0.5 0.0 4.5 3.1 1.2 6.0 5.1 1.7 4.2 5.0 7.3 6.9 6.7 12.3 20.0 32.1 24.6 171.7 9.6 17.1 18.2 19.0 11.4 75.5 11.3 8.3 23.7 22.8 21.0 1.8 2.1 2.4 13.3 61.0 0.0 17.7 37.0 14.3 6.1 22.1 15.0 2.5 80.5 6.3 3.0 13.7 18.8 9.7 19.6 16.3 18.2 0.6 30.4 11.8 67.6 37.2 16.2 31.9 49.4 164.0 13.7 31.0 19.6 146.1 25.5 25.8 34.0 41.7 5.2 48.3 38.4 9.4 4.2 21.8 36.8 7.9 26.7 20.0 39.5 19.9 25.3 2.7 8.3 22.3 16.9 2.2 15.5 0.6 53.2 25.1 ACTN4 FSGS1 ENSG00000130402 "Actinin alpha 4" O43707 19 38647649-38731589 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 626.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 947.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001873, HPA006035" Supported Approved "Nuclear bodies,Actin filaments,Cytosol" NA NA 71000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Actin filaments" Cytosol "HPA001873: AB_1078096, HPA006035: AB_1078095" "unprognostic (1.03e-1)" "unprognostic (6.34e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-2)" "unprognostic (2.37e-1)" "unprognostic (3.34e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.70e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.99e-1)" "prognostic favorable (5.25e-5)" "unprognostic (6.59e-2)" "unprognostic (1.91e-1)" "unprognostic (6.75e-3)" "unprognostic (6.52e-2)" 176.5 160.8 22.9 63.9 42.0 74.2 151.4 42.9 42.2 165.2 58.5 168.5 128.7 269.4 11.8 232.8 163.2 46.8 89.0 19.5 27.8 166.7 85.0 174.7 37.5 45.9 42.4 102.5 90.6 42.2 80.0 85.7 44.8 115.6 42.2 26.0 148.1 59.0 52.2 183.4 150.3 73.1 30.2 118.1 120.9 23.6 38.1 18.5 105.4 18.8 24.2 150.2 181.3 63.4 364.6 947.0 92.9 48.6 37.7 50.6 237.2 198.7 162.5 178.8 143.9 335.9 265.1 99.0 409.1 260.6 117.4 185.1 57.4 203.8 38.3 238.3 69.5 139.7 356.1 240.4 103.4 101.7 145.2 95.3 63.4 157.5 79.6 146.9 116.4 26.3 165.0 71.8 127.5 221.2 27.2 44.1 78.4 197.8 177.3 89.5 109.4 43.8 174.6 396.3 83.0 49.8 366.3 210.5 94.7 64.0 94.5 78.8 309.7 249.3 138.7 135.3 476.1 44.1 84.5 67.8 231.7 90.6 476.7 7.6 8.1 17.8 13.2 7.7 9.8 3.2 5.7 13.2 7.0 3.0 0.9 4.4 16.9 24.8 6.7 10.8 9.5 10.6 22.9 42.0 42.9 42.2 19.5 27.8 45.9 42.4 44.8 30.2 38.1 63.4 315.2 179.5 120.0 21.5 45.8 234.8 266.4 155.1 153.7 25.6 134.0 148.1 9.2 143.0 119.4 152.6 14.6 123.7 150.7 626.1 19.6 413.5 2.5 272.0 145.7 206.2 162.0 59.3 46.0 419.3 256.7 77.3 219.7 346.4 73.5 75.9 130.6 108.5 72.6 23.5 22.6 365.5 73.2 65.9 103.7 4.5 41.3 75.4 46.2 48.7 162.2 122.4 120.5 35.2 83.6 532.3 425.2 71.5 91.2 322.1 315.5 104.0 122.1 32.3 190.7 97.2 251.0 36.2 23.7 189.3 202.7 168.0 119.4 115.3 280.6 284.7 ADM5 "AM5, C19orf76" ENSG00000224420 "Adrenomedullin 5 (putative)" C9JUS6 19 49688664-49690575 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Adipocytes: 29.3;Endothelial cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 18.0" "Secreted to blood" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (2.34e-2)" "unprognostic (2.56e-1)" "unprognostic (3.08e-3)" "unprognostic (5.62e-2)" "unprognostic (2.18e-2)" "unprognostic (2.64e-2)" "unprognostic (1.28e-1)" "unprognostic (2.39e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (1.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.21e-11)" "unprognostic (2.39e-2)" "unprognostic (9.25e-2)" "unprognostic (9.92e-3)" "prognostic favorable (6.74e-4)" 7.8 0.8 1.9 0.7 1.9 1.3 6.0 4.5 2.9 3.7 1.5 2.4 0.8 4.3 0.3 3.3 5.0 0.6 1.8 2.0 1.9 3.5 1.8 4.3 1.0 1.9 1.9 2.0 1.8 0.1 2.7 0.7 2.2 3.9 0.2 1.5 2.6 0.4 3.9 5.0 2.9 0.8 1.8 6.7 2.3 3.0 2.2 0.7 2.6 0.4 0.7 3.6 3.6 1.9 3.4 5.7 3.3 2.3 0.1 0.0 3.9 0.3 0.3 1.1 0.6 6.6 3.1 5.1 1.2 0.2 0.3 1.0 5.9 1.9 0.4 6.0 11.3 5.8 1.6 4.3 0.1 1.7 3.8 0.6 4.2 0.7 0.5 0.8 1.1 5.4 4.2 3.7 0.2 5.4 2.6 18.0 4.4 0.6 1.6 7.4 2.5 5.3 0.5 5.9 2.0 0.9 0.8 1.6 1.6 0.8 3.6 2.5 0.9 1.8 6.6 0.9 1.4 12.6 10.7 5.9 1.2 10.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 4.5 2.9 2.0 1.9 1.9 1.9 2.2 1.8 2.2 1.9 29.3 0.0 1.5 1.3 1.4 6.1 1.4 1.4 6.2 4.3 5.4 6.1 0.1 1.5 1.5 0.0 0.0 0.5 1.0 1.8 0.0 0.5 8.1 3.0 1.9 47.3 1.2 0.0 0.3 1.1 0.5 2.2 1.5 6.0 0.0 0.7 5.0 0.3 0.3 0.0 0.4 1.5 0.0 1.0 4.9 4.3 0.6 1.3 5.4 0.0 0.2 0.9 0.0 0.0 0.9 0.6 0.4 0.7 0.2 1.9 0.3 0.0 1.6 2.4 0.0 2.9 1.5 1.1 1.2 6.2 6.3 0.1 1.3 0.3 1.6 1.1 AGPAT1 LPAAT-alpha ENSG00000204310 "1-acylglycerol-3-phosphate O-acyltransferase 1" Q99943 6 32168212-32178096 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 91.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 47.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048478, HPA073355" Approved Supported "Endoplasmic reticulum,Rods & Rings" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "Endoplasmic reticulum" "Rods & Rings" "HPA048478: AB_2680411, HPA073355: AB_2686596" "prognostic unfavorable (1.93e-4)" "unprognostic (9.35e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (4.79e-2)" "unprognostic (7.05e-2)" "unprognostic (7.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.79e-1)" "unprognostic (4.24e-3)" "unprognostic (1.84e-3)" "unprognostic (1.77e-1)" "unprognostic (6.58e-2)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.92e-3)" "unprognostic (7.00e-2)" 46.6 60.3 3.0 5.9 7.2 6.6 42.6 2.5 47.1 58.2 2.9 61.3 28.2 64.3 42.9 33.9 56.5 18.9 66.9 4.0 25.5 61.6 60.2 44.2 10.9 3.8 9.5 67.2 37.5 9.3 53.8 15.9 4.4 53.2 20.1 12.5 34.1 0.0 67.7 35.1 53.0 1.5 2.5 39.8 58.4 79.3 3.3 18.4 54.1 33.5 12.5 58.2 42.7 4.7 0.0 0.4 51.2 0.3 127.5 85.2 49.4 0.0 0.0 0.0 0.0 104.5 0.0 0.0 46.1 128.0 36.4 13.4 108.5 39.4 0.0 0.4 83.6 0.0 0.0 111.7 0.0 0.0 101.5 51.0 47.6 0.0 46.0 105.9 31.6 86.7 78.5 66.0 109.2 28.8 0.4 26.8 0.0 0.1 18.0 0.6 0.0 0.5 32.8 0.0 0.0 0.1 51.3 16.1 70.4 51.6 63.4 0.0 25.9 0.0 20.3 0.0 0.2 45.9 41.1 18.0 64.3 0.1 0.3 3.4 5.6 12.4 7.6 8.2 7.4 5.3 5.0 8.6 9.3 5.0 4.3 6.4 9.4 8.7 5.8 11.6 7.2 6.9 3.0 7.2 2.5 47.1 4.0 25.5 3.8 9.5 4.4 2.5 3.3 4.7 32.1 16.0 18.6 11.1 14.3 9.1 14.0 20.6 16.5 26.1 26.2 21.6 4.0 14.3 12.0 36.8 12.5 35.2 24.5 28.7 5.9 17.9 63.9 14.1 24.9 21.3 29.4 12.0 13.8 14.3 29.9 19.6 16.3 11.4 12.7 22.7 27.1 31.2 24.7 32.0 17.7 24.3 18.3 22.3 20.6 91.7 13.4 24.9 8.8 11.2 13.0 38.5 21.6 10.1 14.8 17.0 22.3 21.4 16.9 10.2 73.6 29.4 12.9 17.9 0.0 18.3 22.9 44.8 22.1 9.5 3.7 15.3 13.8 21.5 20.8 12.1 AHDC1 "DJ159A19.3, RP1-159A19.1" ENSG00000126705 "AT-hook DNA binding motif containing 1" Q5TGY3 1 27534035-27604431 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 31.3" "Low region specificity" "Detected in all" "HPA028648, HPA028685, HPA028691" Approved Supported Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781" "unprognostic (1.96e-1)" "unprognostic (1.73e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.43e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (5.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.76e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" 12.3 24.3 10.6 3.8 8.4 2.5 12.6 12.5 11.3 23.5 0.0 16.2 2.6 26.8 2.2 35.8 19.5 3.4 18.2 9.1 8.1 11.5 7.6 12.0 3.2 5.5 9.2 22.7 8.5 2.0 18.7 4.6 3.8 12.0 1.1 2.7 16.8 6.9 30.3 31.2 7.8 5.2 3.2 16.6 11.3 9.7 9.0 6.3 20.9 15.5 2.0 15.2 24.2 5.1 10.5 9.5 13.0 6.9 4.1 6.7 13.2 9.6 6.8 6.5 5.3 3.7 9.5 1.6 6.9 6.5 3.9 10.3 1.4 12.5 1.9 3.9 5.0 8.3 9.0 5.0 3.8 2.2 4.1 6.3 5.0 4.6 2.9 6.7 3.4 4.8 10.0 1.1 11.1 5.1 7.2 11.8 9.5 2.6 11.5 31.3 15.7 0.8 4.4 1.4 22.3 8.6 6.8 10.8 2.7 4.4 5.3 1.9 6.6 11.2 9.2 8.4 3.0 3.3 2.4 1.6 9.5 6.5 6.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.1 10.6 8.4 12.5 11.3 9.1 8.1 5.5 9.2 3.8 3.2 9.0 5.1 20.3 6.4 5.2 39.2 5.8 49.5 9.1 25.3 41.5 33.4 37.9 44.4 14.5 4.3 14.4 18.4 0.0 11.5 23.0 10.3 3.9 10.4 0.8 13.2 33.0 19.7 9.7 3.4 26.4 13.7 4.3 24.5 15.8 14.1 0.0 5.5 17.2 11.7 14.2 35.3 19.9 5.5 6.1 3.5 24.8 4.1 51.9 5.8 16.0 16.9 3.6 12.8 14.4 21.6 8.1 16.2 4.5 63.6 5.6 11.6 4.3 4.3 17.7 2.0 39.5 46.2 20.9 4.6 6.8 61.6 56.1 5.6 10.5 67.5 6.6 13.6 AKAP8 "AKAP95, DKFZp586B1222" ENSG00000105127 "A-kinase anchoring protein 8" O43823 19 15353385-15379815 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004776 Supported Supported Nucleoplasm NA NA 10000 "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA004776: AB_1078122" "unprognostic (9.04e-3)" "unprognostic (3.67e-3)" "unprognostic (1.03e-1)" "unprognostic (4.17e-2)" "unprognostic (8.03e-2)" "unprognostic (1.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.17e-2)" "unprognostic (3.34e-3)" "unprognostic (1.27e-1)" "unprognostic (2.82e-1)" "unprognostic (1.78e-3)" "unprognostic (5.04e-3)" "unprognostic (1.22e-2)" "unprognostic (3.57e-1)" "unprognostic (6.06e-2)" "unprognostic (3.83e-2)" 13.6 10.4 0.1 1.5 0.1 3.1 12.3 0.2 1.0 10.2 0.1 11.7 5.4 12.3 0.0 11.6 11.0 0.0 10.0 0.1 0.1 8.8 12.5 10.3 0.3 0.1 0.1 10.9 10.5 1.5 7.5 0.4 0.1 9.5 0.1 0.3 11.2 1.1 23.0 14.6 12.8 0.4 0.0 13.3 10.7 7.4 0.1 1.8 10.1 2.5 0.2 10.7 10.2 0.1 18.2 12.2 8.4 5.6 2.6 2.3 12.2 10.1 7.1 7.2 7.2 19.4 10.6 19.9 10.2 8.9 6.8 8.5 5.1 12.3 0.4 17.9 12.8 21.1 11.7 18.8 4.3 28.0 8.0 4.5 2.7 7.8 0.0 0.6 7.3 11.5 15.1 6.4 2.3 23.7 15.1 5.7 17.8 9.7 15.8 12.1 12.3 16.8 0.0 22.5 10.5 11.4 13.0 9.9 8.9 1.5 4.3 2.2 18.8 12.4 10.1 7.0 21.0 12.9 12.8 21.0 9.8 10.4 11.5 0.0 4.4 0.9 4.4 4.6 4.7 3.8 4.0 4.8 6.5 4.2 2.9 3.6 0.3 4.1 6.3 4.4 5.6 3.0 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 25.6 12.8 28.1 17.0 24.6 19.2 21.0 14.5 19.9 14.7 16.0 14.7 18.0 10.0 22.3 12.9 27.1 30.0 25.9 26.0 5.9 18.9 3.6 22.8 24.1 20.9 10.8 28.2 14.4 21.6 23.9 17.6 20.9 39.9 30.4 14.3 10.4 13.8 13.1 21.9 14.0 21.9 2.0 13.5 16.1 2.7 19.0 19.8 12.4 10.3 21.3 16.5 12.3 12.1 15.3 18.6 13.1 13.9 25.6 16.7 14.8 9.7 22.1 19.5 6.6 26.3 22.5 19.6 23.2 21.3 16.1 40.2 25.6 15.4 22.6 20.9 AL662899.2 ENSG00000263020 "Novel protein" 6 31666102-31673546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Club cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005944, HPA048307" Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "HPA005944: AB_1847290, HPA048307: AB_2680348" "unprognostic (7.19e-2)" "unprognostic (4.75e-1)" "unprognostic (2.65e-1)" "unprognostic (7.07e-3)" "unprognostic (1.09e-2)" "unprognostic (6.32e-2)" "unprognostic (1.37e-3)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (3.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" 7.9 7.0 0.0 0.0 0.0 10.4 7.5 0.1 0.1 8.7 0.0 8.5 0.0 6.2 0.1 8.0 8.7 0.1 7.4 0.0 0.1 7.5 8.2 7.5 0.1 0.0 0.0 9.3 7.0 0.0 6.3 0.0 0.1 8.7 0.1 0.2 6.2 0.0 5.7 13.9 10.7 0.0 0.0 15.1 7.6 7.3 0.0 0.0 7.2 0.3 0.0 6.6 6.4 0.0 0.4 0.3 0.7 0.6 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.5 0.7 0.6 0.3 0.5 0.9 0.5 0.1 1.5 1.7 0.4 1.2 1.2 0.3 0.2 0.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.6 0.2 0.4 1.1 1.2 0.1 0.5 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.5 1.4 0.4 0.3 0.1 0.0 0.3 0.3 0.1 0.7 1.6 0.0 0.0 0.0 0.3 1.4 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ALG6 ENSG00000088035 "ALG6 alpha-1,3-glucosyltransferase" Q9Y672 1 63367575-63438553 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062536, HPA076130" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" "Endoplasmic reticulum" "HPA062536: AB_2684792, HPA076130: " "unprognostic (1.21e-1)" "unprognostic (5.60e-3)" "prognostic favorable (4.86e-4)" "unprognostic (1.59e-1)" "unprognostic (3.45e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (2.07e-1)" "unprognostic (9.81e-3)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (1.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (3.41e-1)" 3.5 4.5 1.1 1.1 1.3 1.4 3.4 1.9 1.4 3.7 1.0 3.8 1.1 2.9 1.4 6.1 3.0 0.8 2.1 1.1 1.2 3.0 4.6 2.7 1.9 1.1 1.2 3.2 3.3 1.4 2.0 1.0 1.1 3.1 1.2 1.2 4.3 0.6 2.8 5.1 4.4 0.6 1.1 5.2 3.2 2.2 1.1 2.0 3.1 0.1 1.6 3.1 4.2 1.4 0.5 1.3 1.3 1.2 1.8 1.3 2.6 0.9 0.2 0.3 0.3 2.0 0.6 2.7 1.4 0.7 1.5 1.0 2.0 1.0 1.4 2.4 4.2 2.2 1.5 2.4 0.6 2.8 2.4 0.9 0.6 0.9 0.6 0.7 2.0 2.3 2.2 1.3 1.0 2.5 1.7 2.4 7.6 1.3 2.3 1.8 1.6 2.1 1.6 2.2 1.5 0.8 2.3 3.2 2.3 2.9 0.9 2.1 0.9 0.6 0.6 1.8 1.5 1.7 1.7 1.7 1.2 3.3 2.4 1.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.6 0.5 0.1 0.4 0.3 0.2 0.3 0.2 1.1 1.3 1.9 1.4 1.1 1.2 1.1 1.2 1.1 1.1 1.1 1.4 9.8 9.6 4.8 9.8 12.1 11.0 8.5 24.6 15.4 6.3 8.5 5.5 3.1 12.8 22.1 3.7 4.2 42.1 10.2 6.1 1.9 12.4 2.4 11.2 7.0 8.7 4.2 9.0 19.1 8.9 28.5 8.6 11.2 10.0 8.9 12.2 8.2 11.5 15.5 6.7 19.4 7.8 22.4 7.1 8.8 2.0 6.8 9.1 16.0 4.7 4.8 5.5 13.4 19.1 16.8 6.0 3.6 4.9 11.4 4.9 8.2 7.3 11.7 5.4 6.6 4.5 6.6 16.2 15.3 18.3 11.1 26.8 15.1 10.0 11.5 7.4 ANKZF1 "FLJ10415, Vms1, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1" Q9H8Y5 2 219229783-219236679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 9.1 9.2 7.8 8.8 8.6 7.8 10.8 9.9 9.8 13.8 9.6 13.1 9.6 10.1 3.2 15.2 13.5 6.1 14.1 7.9 8.0 13.9 14.4 10.7 13.7 10.1 8.5 16.0 15.6 6.4 12.5 5.9 9.3 15.1 5.2 8.2 15.3 5.6 16.9 17.3 15.2 4.6 7.9 18.1 14.2 7.9 8.7 11.9 11.9 8.1 8.3 12.4 15.0 10.5 31.6 6.1 8.1 11.8 10.6 8.8 32.5 10.1 10.0 13.6 17.2 14.9 13.2 6.6 18.0 4.3 15.3 22.7 10.5 17.5 10.0 13.9 11.0 14.6 19.1 13.9 10.6 9.6 13.7 8.9 33.1 10.1 15.9 22.6 9.4 17.0 24.8 14.9 6.9 13.6 14.1 24.1 13.5 13.7 10.9 14.3 9.9 21.4 7.6 7.9 10.3 10.5 11.9 23.9 19.8 19.5 6.4 23.7 10.3 11.4 8.7 10.1 13.3 31.6 19.9 12.9 19.4 13.8 5.1 9.9 9.1 11.0 16.1 9.0 17.4 13.0 16.3 16.2 9.4 13.3 19.0 18.0 12.3 24.4 14.0 9.8 17.1 13.6 7.8 8.6 9.9 9.8 7.9 8.0 10.1 8.5 9.3 7.9 8.7 10.5 10.2 16.0 17.2 24.2 28.0 9.3 14.5 28.9 9.6 39.8 14.4 13.6 9.2 11.5 24.8 12.9 31.3 10.5 32.7 17.3 13.7 20.5 4.4 28.2 9.7 11.8 9.6 19.6 19.0 12.6 27.2 8.9 17.9 13.0 21.6 21.4 8.6 13.1 7.7 32.0 21.0 19.1 20.3 8.2 5.3 4.0 23.9 10.9 10.6 6.5 15.6 18.0 43.3 13.6 25.3 14.2 16.0 16.6 17.7 13.6 25.2 16.5 65.1 55.4 6.6 13.2 12.8 10.1 17.0 8.3 9.9 11.6 30.0 21.3 17.6 11.1 AP5Z1 "KIAA0415, SPG48, zeta" ENSG00000242802 "Adaptor related protein complex 5 subunit zeta 1" O43299 7 4775615-4794397 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035693 Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles" Nucleoplasm "HPA035693: AB_10960687" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (3.01e-3)" "unprognostic (4.24e-2)" "unprognostic (2.43e-3)" "unprognostic (5.19e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.26e-2)" "unprognostic (5.32e-3)" "unprognostic (8.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.95e-2)" "unprognostic (2.22e-1)" 14.8 18.5 7.0 0.7 7.1 1.5 11.8 7.3 10.0 12.4 5.8 13.2 1.1 13.4 1.0 11.0 11.0 0.8 7.7 6.9 5.7 9.2 9.2 12.9 1.8 8.3 6.5 11.8 9.9 0.7 9.8 1.1 7.4 11.7 0.4 0.6 12.4 0.7 8.5 21.8 15.5 0.4 5.9 22.9 12.0 8.6 7.4 0.9 11.2 0.2 0.6 13.4 10.9 7.3 2.8 4.2 0.7 2.4 1.0 0.9 4.3 1.3 1.9 2.0 1.7 5.2 3.5 1.6 1.8 0.9 5.1 5.4 0.7 0.5 0.6 1.8 3.5 2.4 4.5 4.6 3.0 2.5 5.1 2.2 1.6 1.8 1.3 0.7 0.5 2.2 3.4 1.1 1.2 7.7 0.3 15.0 5.9 0.3 4.3 2.9 2.6 4.8 1.0 4.4 1.7 3.0 1.8 8.7 6.4 0.5 6.4 8.9 3.8 2.3 4.4 6.5 1.7 8.5 7.4 2.3 1.7 5.6 3.6 1.9 2.3 2.9 2.4 2.8 1.4 1.9 1.8 2.4 1.2 1.8 2.5 2.2 2.2 2.4 2.5 2.4 1.8 1.3 7.0 7.1 7.3 10.0 6.9 5.7 8.3 6.5 7.4 5.9 7.4 7.3 12.4 9.6 15.0 7.5 18.2 6.9 2.9 8.8 8.0 10.5 5.7 5.8 4.3 15.7 6.6 11.0 4.2 11.5 20.3 20.1 0.0 14.1 2.2 9.9 10.1 11.6 12.0 5.0 12.4 13.6 7.7 9.9 21.4 16.4 17.1 14.3 12.5 8.1 28.7 18.5 10.7 15.1 10.2 12.3 10.7 1.5 13.4 16.3 14.2 13.1 23.4 8.2 21.6 10.6 12.6 20.6 15.9 10.9 19.8 4.9 14.7 6.8 8.3 9.4 0.0 5.8 9.5 8.1 10.8 7.6 11.1 16.6 15.6 12.6 14.1 3.8 APBA3 "mint3, X11L2" ENSG00000011132 "Amyloid beta precursor protein binding family A member 3" O96018 19 3750772-3761692 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045577 Approved Approved Vesicles NA NA "Cluster 35: T-regs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA045577: AB_10964881" "unprognostic (3.47e-2)" "unprognostic (3.58e-2)" "unprognostic (5.00e-2)" "prognostic favorable (5.97e-4)" "unprognostic (1.69e-1)" "prognostic favorable (4.91e-4)" "unprognostic (6.64e-2)" "unprognostic (7.60e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.83e-4)" 6.7 6.7 3.1 3.5 4.0 2.0 7.1 3.8 5.3 8.0 2.8 8.0 3.5 7.9 0.1 7.5 6.9 1.1 7.6 2.9 3.2 8.3 10.3 6.7 3.7 4.4 3.7 9.4 7.9 1.5 7.1 2.0 4.1 7.5 0.6 0.4 8.4 2.5 15.4 7.5 8.4 1.4 3.4 11.2 8.3 3.2 3.7 2.8 8.3 2.7 1.9 7.5 6.8 5.6 8.0 6.0 1.3 2.3 2.4 1.8 6.4 5.1 3.0 2.7 3.7 5.8 2.7 5.4 4.4 2.0 6.3 3.8 1.4 4.3 0.6 20.5 4.5 3.1 4.9 4.6 8.1 1.9 11.2 3.6 5.3 3.4 2.2 2.2 3.7 5.5 5.2 8.4 1.2 4.7 6.1 7.8 3.5 2.6 8.9 6.3 2.6 8.9 1.9 5.0 4.6 4.8 3.2 4.6 7.9 0.8 2.0 4.6 6.4 4.5 4.6 7.9 6.3 17.0 6.8 4.9 4.1 6.2 4.8 11.3 7.3 11.4 13.0 5.6 11.9 9.5 12.9 12.9 8.3 11.6 8.2 10.0 10.2 6.9 5.1 7.8 19.8 8.4 3.1 4.0 3.8 5.3 2.9 3.2 4.4 3.7 4.1 3.4 3.7 5.6 4.9 6.4 5.6 2.9 12.1 4.2 6.5 18.1 4.0 3.9 7.0 6.2 4.7 4.3 7.9 7.3 8.4 10.6 9.0 8.0 7.9 14.2 0.9 2.9 4.8 6.4 4.8 1.3 3.4 9.0 10.0 7.6 13.3 5.4 2.5 5.4 5.3 8.2 8.6 3.3 3.2 9.1 10.2 6.7 9.3 0.5 6.2 5.9 5.4 1.0 16.4 3.3 13.4 3.0 5.2 12.6 5.8 3.0 13.4 9.3 19.5 11.3 3.8 6.4 6.6 4.0 5.1 2.5 6.2 7.7 7.5 15.3 12.4 3.5 7.5 6.4 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568137 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 35.0 25.5 17.9 4.5 18.4 11.0 36.3 19.5 25.2 43.7 13.5 41.2 3.5 43.1 6.2 30.8 47.0 2.9 31.1 17.8 16.4 28.2 22.9 46.3 6.7 15.2 15.6 50.4 29.3 3.7 34.1 6.1 15.3 34.7 4.7 8.6 35.1 4.5 28.4 32.1 42.6 6.3 15.3 40.8 38.2 23.7 16.2 7.0 36.3 7.5 5.7 35.6 37.6 18.2 10.5 9.4 26.0 6.4 9.0 4.6 9.1 10.2 6.5 9.1 6.6 16.8 8.3 21.5 6.1 9.2 8.4 6.9 17.4 9.9 11.4 24.5 12.3 18.8 9.2 11.6 9.3 36.0 8.2 5.0 6.8 6.9 7.2 9.2 8.1 13.0 13.4 11.4 11.4 7.7 16.4 13.9 18.6 23.6 4.0 17.3 19.7 8.9 10.6 7.3 7.0 13.8 9.9 12.7 6.1 17.6 5.8 27.0 9.2 7.5 6.2 5.9 10.0 11.1 14.2 27.4 10.6 15.6 6.7 44.6 24.2 17.2 15.4 17.7 14.1 30.2 13.5 12.1 17.1 32.4 15.3 14.6 45.7 18.8 14.8 34.2 15.7 12.8 17.9 18.4 19.5 25.2 17.8 16.4 15.2 15.6 15.3 15.3 16.2 18.2 342.0 141.1 230.6 198.8 242.0 261.7 268.5 179.3 186.1 222.7 153.9 104.0 88.3 90.1 204.9 114.0 135.5 141.9 329.3 195.3 99.7 120.7 42.0 201.2 308.3 298.1 187.7 160.3 208.8 113.2 137.7 204.7 355.7 290.6 168.7 331.2 280.2 81.5 101.3 304.5 155.6 218.5 148.5 90.7 186.2 34.0 255.1 142.1 128.1 161.1 182.1 223.3 301.8 200.6 367.2 145.0 173.8 217.7 194.9 251.0 153.7 58.6 190.7 271.2 216.9 179.6 196.8 199.8 125.9 164.1 262.3 185.2 257.8 280.7 193.1 316.0 ARHGAP17 "FLJ10308, FLJ13219, NADRIN, RICH1, WBP15" ENSG00000140750 "Rho GTPase activating protein 17" Q68EM7 16 24919389-25015666 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041703, HPA075891" Approved Supported "Plasma membrane,Cytosol" NA NA 21000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cytosol" "HPA041703: AB_10794304, HPA075891: " "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (8.11e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.42e-2)" "unprognostic (3.49e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (3.02e-2)" "unprognostic (6.62e-2)" "unprognostic (8.81e-3)" "unprognostic (4.99e-2)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.76e-4)" 46.0 40.5 8.2 15.2 9.8 9.2 37.2 9.2 10.2 29.9 9.6 32.7 11.3 28.9 7.9 33.6 28.6 11.9 48.1 7.9 9.2 25.9 22.9 31.8 24.9 10.6 9.5 24.8 24.1 9.3 30.3 15.3 10.4 23.6 12.2 2.3 21.3 7.9 41.0 34.3 39.2 11.6 8.7 66.8 28.9 25.5 9.7 12.0 28.2 11.1 20.9 25.6 29.8 11.6 28.5 16.7 21.9 23.1 22.0 23.0 23.7 18.1 19.3 20.9 20.4 25.9 11.5 13.0 12.0 36.4 19.9 7.7 21.8 12.8 22.2 20.0 26.1 10.8 37.8 43.3 25.0 15.5 10.7 29.4 7.7 22.6 16.3 15.0 35.7 11.7 14.3 0.0 23.6 20.8 14.3 19.8 25.2 8.1 13.7 68.1 17.9 5.2 25.9 6.4 14.6 14.5 18.6 20.5 8.2 17.5 11.1 40.2 46.7 15.5 11.9 35.6 15.1 13.0 17.3 7.5 19.1 22.6 14.1 5.6 9.7 9.0 6.3 17.5 5.7 25.3 5.5 6.3 14.6 22.8 6.2 6.1 4.8 6.2 15.8 25.9 8.0 8.1 8.2 9.8 9.2 10.2 7.9 9.2 10.6 9.5 10.4 8.7 9.7 11.6 33.8 9.6 11.0 26.8 46.3 14.5 6.8 8.9 14.2 6.4 11.0 9.7 24.9 7.2 9.1 5.5 10.4 11.1 36.3 49.5 3.9 13.3 6.3 30.6 21.8 32.3 21.0 16.2 28.8 16.0 18.9 16.0 15.3 66.4 7.0 16.9 26.7 6.8 27.1 10.1 33.0 21.8 8.2 30.3 21.7 10.8 13.4 25.2 16.0 59.0 22.8 6.4 14.4 40.2 68.9 17.6 27.2 11.7 11.5 11.1 35.4 5.0 8.5 7.5 26.3 15.5 43.8 7.0 11.7 24.7 24.0 15.7 21.1 15.9 19.7 12.2 ARHGDIA "GDIA1, RHOGDI" ENSG00000141522 "Rho GDP dissociation inhibitor alpha" P52565 17 81867721-81871378 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010005, HPA021407" Approved Supported Cytosol NA NA 21000000 "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "CAB010005: AB_2227516, HPA021407: AB_1856267" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (5.00e-2)" "unprognostic (8.39e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (5.32e-2)" "unprognostic (4.67e-2)" "unprognostic (2.67e-2)" "unprognostic (6.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (3.29e-1)" "unprognostic (6.88e-3)" 274.5 196.2 116.6 154.7 122.9 219.4 227.6 92.6 173.4 215.5 64.6 215.7 177.7 222.0 23.8 265.1 191.2 64.3 181.1 122.2 141.1 236.2 220.7 266.1 116.9 136.3 148.9 174.8 195.2 69.6 187.3 101.9 158.2 206.0 52.9 14.6 180.0 78.7 131.9 198.6 225.6 72.4 105.0 243.9 194.3 92.0 131.4 83.4 173.4 32.8 66.9 203.4 212.2 112.9 472.6 455.1 146.6 233.1 131.8 162.9 167.2 396.0 251.3 292.1 216.0 229.0 173.7 249.4 164.9 299.8 254.9 252.3 160.3 302.6 120.7 192.3 422.2 266.3 267.7 303.0 270.6 418.3 367.4 211.1 137.0 213.5 180.5 147.7 450.1 204.1 221.5 334.8 235.8 285.4 611.3 432.9 173.0 159.8 405.3 274.2 185.4 200.6 193.7 289.5 193.0 568.8 208.5 522.2 386.9 105.3 247.5 335.7 499.7 575.1 494.2 539.3 681.4 292.8 164.9 256.5 497.7 249.9 399.8 39.5 47.9 87.5 64.3 72.5 60.8 35.8 53.6 62.5 47.9 27.4 34.5 42.1 30.2 45.2 101.9 55.3 55.4 60.4 116.6 122.9 92.6 173.4 122.2 141.1 136.3 148.9 158.2 105.0 131.4 112.9 146.0 38.5 59.1 14.0 152.2 127.2 201.5 173.0 63.2 18.3 78.8 65.4 2.9 62.9 86.7 79.1 10.4 130.1 164.6 289.7 135.0 234.2 8.3 66.4 97.5 134.6 134.6 34.9 13.9 265.0 263.4 98.2 120.8 124.1 118.6 76.4 112.1 82.7 243.2 52.2 10.4 173.7 101.7 167.1 157.8 19.5 86.6 167.4 193.9 15.0 243.9 82.6 187.4 9.5 17.5 424.5 286.3 74.1 171.3 183.5 300.7 157.5 46.0 11.9 118.3 70.6 121.4 38.9 44.1 88.5 116.1 221.9 169.3 78.6 156.2 222.2 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070273-21090248 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane, Cytosol" "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 21.0 47.2 9.6 5.3 11.1 1.6 18.5 10.0 9.2 24.8 6.2 14.5 3.7 18.9 12.2 3.5 13.2 14.8 12.3 8.9 11.1 10.1 26.9 14.2 2.3 13.5 10.5 19.3 24.0 10.7 9.0 6.5 10.5 12.3 6.2 2.8 20.2 18.6 10.5 7.4 7.9 9.7 10.1 27.8 9.5 4.3 12.1 3.1 15.8 6.1 1.7 13.8 13.3 12.1 3.3 2.9 30.8 5.8 24.5 37.1 1.1 11.4 28.1 12.1 9.4 1.4 7.5 0.0 1.8 20.9 12.2 5.0 2.6 3.7 4.3 6.6 1.1 4.6 3.4 9.0 3.5 3.0 16.5 15.5 2.4 10.3 3.1 22.6 0.0 0.0 1.4 1.3 9.6 0.3 0.0 8.6 8.1 0.8 0.5 1.0 23.2 1.4 7.6 4.1 0.7 11.6 6.4 0.6 8.9 6.0 2.7 10.1 5.9 25.4 17.5 11.9 5.9 2.6 0.0 0.0 8.8 4.2 7.5 0.0 1.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.4 9.6 11.1 10.0 9.2 8.9 11.1 13.5 10.5 10.5 10.1 12.1 12.1 12.7 6.4 5.0 32.0 2.5 4.8 8.0 5.8 1.8 9.2 6.6 11.3 13.4 47.1 3.2 14.7 0.0 1.4 0.5 10.0 19.6 21.2 1.0 17.6 13.1 11.0 7.8 1.7 0.3 10.2 0.9 20.4 18.3 3.5 38.0 11.6 8.2 31.5 14.1 5.0 6.2 9.1 4.1 46.9 14.6 2.3 24.2 22.0 23.2 17.8 23.6 24.6 1.0 21.1 8.9 16.4 6.6 24.0 3.1 6.3 1.0 7.1 1.7 6.8 26.3 18.6 21.9 3.1 2.8 0.6 4.4 1.2 3.5 14.6 18.7 6.1 ASMTL ENSG00000169093 "Acetylserotonin O-methyltransferase like" O95671 X 1403139-1453762 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 92.5;monocytes: 106.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 131.0" "Low region specificity" "Detected in all" "HPA003630, HPA021865" Supported Enhanced Cytosol NA NA 17000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA003630: AB_1078230, HPA021865: AB_1845099" "unprognostic (3.89e-2)" "unprognostic (1.14e-3)" "unprognostic (2.28e-1)" "unprognostic (1.87e-2)" "unprognostic (7.99e-2)" "unprognostic (9.05e-2)" "unprognostic (8.17e-2)" "unprognostic (5.23e-2)" "unprognostic (8.40e-2)" "unprognostic (1.24e-1)" "unprognostic (1.91e-3)" "unprognostic (7.24e-2)" "unprognostic (3.26e-3)" "unprognostic (9.70e-2)" "unprognostic (8.38e-2)" "unprognostic (2.91e-1)" "unprognostic (2.20e-1)" 28.1 21.8 15.6 15.7 15.1 17.4 26.8 15.1 20.3 29.1 23.0 30.8 11.7 29.4 14.3 15.1 28.6 13.6 34.5 15.7 16.5 23.1 32.1 18.3 21.4 20.4 18.4 33.9 23.6 22.4 31.0 11.2 18.3 26.8 7.8 9.4 24.8 23.4 23.8 27.7 20.6 12.2 15.9 24.1 23.1 13.0 16.6 20.0 29.5 15.3 12.4 25.1 22.9 18.0 14.0 24.0 28.0 21.4 16.5 25.5 38.9 16.3 21.3 18.2 23.2 22.0 16.5 24.6 9.0 21.5 19.7 5.1 7.4 7.9 11.4 36.7 23.9 21.4 17.0 26.6 37.5 10.1 131.0 33.9 13.4 13.9 13.4 20.3 21.7 18.7 11.0 19.3 14.6 52.4 43.5 39.6 33.9 12.9 15.0 35.2 26.7 60.0 12.8 7.6 1.1 13.2 21.9 27.8 20.7 18.9 6.4 13.4 28.6 15.2 16.5 29.0 6.1 24.8 8.0 62.9 19.3 14.5 4.6 45.7 25.5 65.9 28.8 30.9 25.6 24.2 26.1 26.9 22.0 37.7 22.5 17.7 37.2 52.9 22.5 42.1 31.4 23.2 15.6 15.1 15.1 20.3 15.7 16.5 20.4 18.4 18.3 15.9 16.6 18.0 20.6 12.8 9.4 5.2 19.3 18.4 25.3 17.2 23.3 17.7 16.4 17.4 21.3 10.0 9.9 14.7 4.2 33.4 28.8 16.1 27.4 15.2 0.9 8.8 14.3 19.5 14.4 7.4 8.3 17.1 24.1 23.8 14.8 10.4 54.6 27.0 17.9 30.8 20.3 92.5 6.7 17.9 8.2 12.3 31.0 2.8 26.1 18.8 12.4 9.4 106.2 17.1 26.8 5.0 7.1 10.9 18.3 43.2 21.8 22.1 19.9 34.2 11.1 12.6 32.9 21.4 23.2 2.5 8.2 22.3 15.6 66.4 20.4 21.9 20.4 18.4 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli NA NA 46000000 "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 35.0 40.8 7.3 7.4 7.4 29.4 40.3 6.6 9.9 50.2 3.9 46.3 11.9 46.0 16.7 56.6 45.6 11.5 31.2 7.9 9.1 36.7 35.1 35.6 14.2 7.7 7.7 57.1 43.4 14.1 43.0 8.8 7.6 43.7 14.0 8.1 44.9 6.3 22.4 53.3 46.9 8.9 7.1 60.0 45.4 29.3 7.4 16.7 51.1 5.0 17.0 44.3 47.0 7.1 2.5 6.3 18.1 29.7 17.8 18.9 11.5 9.8 13.3 13.7 20.8 25.2 20.9 30.4 26.8 60.1 14.5 17.0 23.5 37.2 8.1 18.3 34.5 11.2 36.1 24.7 28.9 2.9 40.0 17.2 16.1 5.4 31.4 25.5 44.0 47.9 38.0 32.9 39.9 18.3 25.5 17.4 5.1 20.8 5.4 7.5 7.6 20.7 17.5 6.3 1.8 6.4 35.2 13.9 40.5 5.0 39.5 12.5 17.1 3.6 13.0 13.7 15.6 33.8 20.4 17.0 15.5 18.5 21.9 4.2 1.1 0.7 1.9 1.7 1.5 1.6 1.0 0.9 2.3 1.1 0.6 1.4 0.9 2.5 1.5 1.4 1.7 2.2 7.3 7.4 6.6 9.9 7.9 9.1 7.7 7.7 7.6 7.1 7.4 7.1 39.1 12.8 15.2 31.6 72.7 24.9 37.6 83.0 33.6 89.3 31.8 26.0 2.0 50.1 53.1 55.2 95.9 88.4 64.9 52.9 5.9 48.1 3.3 22.0 24.5 40.3 53.5 39.8 29.5 42.8 50.2 29.8 39.8 27.8 16.5 148.5 43.5 18.5 52.8 43.7 29.9 53.9 79.3 55.4 40.5 8.9 70.8 42.0 32.0 28.1 65.4 35.0 124.6 21.6 24.1 37.2 58.6 51.9 40.3 30.6 64.3 14.6 43.5 98.0 59.2 30.5 29.8 64.3 58.6 36.1 25.3 89.2 58.6 49.5 55.7 39.8 ATN1 "B37, D12S755E, DRPLA" ENSG00000111676 "Atrophin 1" P54259 12 6924463-6942321 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031619 Enhanced Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031619: AB_10601667" "unprognostic (3.86e-3)" "unprognostic (2.07e-1)" "unprognostic (1.80e-3)" "unprognostic (5.82e-2)" "unprognostic (1.37e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (1.44e-1)" "unprognostic (6.90e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-2)" "unprognostic (3.19e-1)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-1)" "unprognostic (7.35e-2)" 125.2 148.3 71.7 33.7 60.1 6.9 120.6 94.2 120.0 143.8 14.5 155.4 36.3 146.4 25.5 71.9 148.9 43.2 94.2 66.8 75.7 95.5 42.7 109.0 20.4 81.3 70.6 234.6 79.6 56.7 188.9 43.8 60.0 117.6 21.1 58.8 89.8 59.5 81.9 79.2 82.0 49.4 41.2 74.2 100.4 33.3 71.5 16.3 189.0 34.4 14.0 122.2 108.8 67.4 56.4 72.1 75.9 154.7 69.6 61.7 126.3 65.5 55.4 65.1 45.8 73.6 65.6 15.2 20.4 80.8 54.1 36.8 46.2 63.8 33.3 178.0 46.3 70.6 71.7 35.6 108.3 14.6 103.8 101.8 46.1 82.4 63.6 112.5 64.4 22.4 61.1 29.9 58.2 81.2 31.9 13.5 156.0 26.2 30.1 65.9 40.6 11.2 48.3 78.3 23.4 75.3 66.5 77.2 47.1 73.6 29.5 40.3 85.2 76.7 97.9 61.1 102.2 22.7 8.1 10.7 60.1 18.7 82.3 0.5 0.1 0.7 0.6 0.0 0.5 0.7 0.2 0.3 0.1 0.5 0.3 0.4 0.0 0.1 0.0 0.5 0.3 0.2 71.7 60.1 94.2 120.0 66.8 75.7 81.3 70.6 60.0 41.2 71.5 67.4 66.3 16.0 17.2 76.4 9.1 30.2 13.5 22.9 30.1 26.6 51.5 57.4 16.4 24.3 20.4 29.5 18.8 27.4 11.4 37.4 15.6 20.5 2.3 39.9 61.2 40.7 21.7 4.8 23.8 30.3 15.3 30.9 34.7 51.7 10.1 37.1 39.7 8.0 11.9 25.2 29.7 23.0 8.2 10.9 21.0 3.5 63.6 13.7 21.4 23.4 4.8 17.3 3.1 17.6 18.2 29.9 25.3 52.6 9.5 17.4 24.2 12.1 15.4 23.9 19.7 29.4 39.5 9.7 7.7 22.1 24.9 37.1 10.9 26.2 20.4 17.9 BCAR1 "CAS, CASS1, Crkas, P130Cas" ENSG00000050820 "BCAR1 scaffold protein, Cas family member" P56945 16 75228181-75268053 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000443, HPA042282" Approved Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "CAB000443: , HPA042282: AB_2677929" "unprognostic (5.44e-2)" "unprognostic (2.96e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-2)" "unprognostic (2.17e-1)" "unprognostic (5.43e-3)" "prognostic unfavorable (9.11e-5)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.15e-1)" "unprognostic (3.49e-2)" "unprognostic (5.18e-2)" "unprognostic (1.77e-2)" "prognostic favorable (4.55e-8)" "unprognostic (3.38e-1)" "unprognostic (3.60e-2)" "unprognostic (8.20e-2)" "unprognostic (2.20e-1)" 34.7 22.3 3.5 4.2 5.8 0.0 27.9 16.9 6.6 37.7 6.3 34.4 15.8 39.2 2.6 22.5 25.3 9.4 47.1 2.3 7.9 47.3 34.2 38.8 2.1 3.9 1.9 19.7 32.4 5.9 29.5 14.1 2.3 25.6 3.5 1.3 25.5 5.7 93.8 18.2 33.1 3.8 0.0 33.7 44.6 34.3 4.2 0.9 26.8 6.8 1.1 24.9 26.2 15.8 21.8 36.8 17.5 6.0 6.7 6.3 34.1 29.5 17.1 20.9 16.4 46.5 32.1 1.9 38.2 33.3 23.6 18.2 6.1 34.0 6.0 0.1 20.0 0.0 23.7 37.2 16.7 0.1 15.1 19.1 16.3 25.3 12.5 12.3 57.9 0.0 20.0 1.0 12.6 48.9 0.1 1.3 23.4 16.1 24.0 0.8 7.9 8.2 19.1 27.9 21.4 31.5 28.7 6.6 11.2 8.4 15.0 5.4 53.6 34.4 29.5 8.8 44.2 8.0 4.7 0.7 22.2 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 5.8 16.9 6.6 2.3 7.9 3.9 1.9 2.3 0.0 4.2 15.8 30.1 22.4 6.9 9.4 1.2 28.0 59.7 36.8 12.0 26.5 20.3 14.4 22.9 31.5 21.8 22.0 6.2 46.8 0.7 75.7 27.4 51.9 19.0 13.7 27.9 49.2 34.8 0.0 13.1 61.8 25.7 21.1 71.9 22.5 8.9 15.0 46.8 21.0 6.0 13.5 11.7 42.1 12.2 1.4 6.3 26.8 16.4 2.1 32.0 10.3 0.6 12.9 0.0 19.1 31.2 68.5 59.6 33.4 1.4 58.4 57.4 38.9 13.1 6.8 19.7 8.5 38.5 20.6 17.1 12.5 17.6 36.1 2.2 10.9 33.7 62.7 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.3;Club cells: 2.5;Excitatory neurons: 6.4;granulocytes: 2.5;Inhibitory neurons: 7.5;Oligodendrocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;HMC-1: 1.3;hTERT-RPE1: 1.3;RPTEC TERT1: 2.5;SK-MEL-30: 1.4" "HPA045845, HPA050126, HPA050374" Uncertain Approved Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (6.01e-2)" 10.2 9.5 0.2 0.1 0.0 0.0 9.5 0.4 0.2 10.1 0.0 9.9 0.0 9.7 0.0 8.7 8.6 0.3 8.6 0.1 0.0 9.7 12.4 9.1 0.0 0.0 0.2 10.5 11.7 0.1 9.3 0.0 0.0 8.8 0.2 0.2 9.3 0.0 12.5 9.7 9.9 0.1 0.0 9.4 9.4 3.2 0.1 0.0 9.9 0.0 0.0 9.2 9.2 0.3 0.2 0.0 0.0 0.1 0.0 1.0 0.0 0.4 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 1.3 0.9 0.6 0.7 0.0 0.0 0.1 0.2 0.0 1.3 0.0 0.1 0.3 0.5 1.3 0.3 0.5 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.5 0.5 0.0 0.0 1.4 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BRD2 "BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3" ENSG00000204256 "Bromodomain containing 2" P25440 6 32968594-32981505 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042816 Approved Enhanced "Nuclear speckles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA042816: AB_10794766" "unprognostic (2.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.10e-1)" "unprognostic (4.60e-2)" "unprognostic (1.45e-1)" "unprognostic (9.89e-2)" "unprognostic (5.03e-2)" "unprognostic (2.54e-1)" "unprognostic (6.85e-3)" "unprognostic (1.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.42e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.20e-2)" "unprognostic (1.44e-2)" 64.2 61.8 0.8 22.1 2.1 66.5 62.4 4.7 3.8 67.7 0.2 62.1 19.8 71.3 1.8 67.9 66.6 17.4 51.7 3.0 2.8 68.3 61.9 65.3 22.1 1.5 2.4 81.7 80.4 26.3 71.4 19.4 2.1 60.8 11.6 10.1 66.1 18.2 71.4 69.5 60.8 11.7 1.4 71.2 66.0 82.9 2.3 26.9 77.0 10.4 21.2 61.6 65.0 4.0 45.7 19.5 41.6 41.8 31.8 28.5 38.3 44.6 44.4 48.5 35.8 22.7 22.5 37.3 44.6 37.2 32.4 28.1 39.3 33.2 27.7 49.5 147.7 41.2 18.3 14.6 23.5 60.6 39.2 29.2 28.7 38.2 44.9 27.6 21.3 35.2 44.4 76.0 21.7 12.1 77.0 8.5 24.0 28.9 20.4 76.2 18.7 53.8 13.8 26.6 85.6 28.9 54.5 63.7 52.7 27.8 37.4 39.0 27.5 58.6 32.0 21.5 50.0 61.1 69.5 77.9 23.1 19.7 47.8 9.6 7.6 11.6 14.5 8.8 13.0 9.2 9.4 9.9 10.6 8.7 6.6 10.4 9.7 10.3 9.5 8.5 13.3 11.7 0.8 2.1 4.7 3.8 3.0 2.8 1.5 2.4 2.1 1.4 2.3 4.0 325.8 76.9 121.5 38.2 327.1 212.1 232.7 70.0 478.1 78.6 295.5 383.9 171.7 94.4 80.1 60.7 104.3 91.7 395.7 210.7 21.5 69.2 302.4 201.9 149.3 191.2 259.1 97.6 16.1 91.4 145.0 224.2 249.8 256.6 115.2 103.1 113.2 85.3 79.9 55.5 19.9 247.5 77.3 92.6 209.2 177.9 86.9 194.5 124.5 26.2 94.7 62.8 107.1 15.1 22.1 81.2 137.3 77.1 313.0 211.5 133.7 39.5 84.4 65.1 39.5 240.0 251.3 88.4 137.9 365.0 226.9 205.1 356.7 71.2 179.5 248.4 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405630 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 694.2" "Cell type enhanced" "Detected in many" "Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA017060, HPA073472" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 260000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Vesicles" "HPA017060: AB_1845467, HPA073472: " "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 226.0 509.8 86.7 95.6 87.6 103.7 152.9 84.0 125.7 93.4 81.7 94.1 47.4 58.7 59.5 40.3 248.0 109.4 111.2 85.1 84.5 160.1 227.8 141.4 128.0 101.5 85.9 694.2 26.3 13.8 56.8 203.0 88.4 88.6 33.3 2.0 77.7 105.2 46.1 24.8 109.1 76.0 97.0 238.5 84.1 35.4 91.1 123.5 54.0 50.8 65.8 82.9 88.6 90.8 327.0 0.5 0.9 145.6 0.0 1.0 49.6 1.3 24.9 459.5 615.0 150.5 286.1 252.2 338.2 197.6 14.6 1.3 212.9 23.9 14.3 279.1 1.8 3.6 525.7 149.8 256.7 120.1 304.7 1.3 0.0 153.0 0.1 4.4 119.0 6.0 146.3 603.4 0.0 89.5 57.7 208.6 158.0 0.1 407.9 105.5 0.8 530.7 110.1 1.5 0.6 1.4 325.5 12.3 410.5 12.3 243.1 166.3 1.5 1.9 11.4 0.5 3.3 308.3 439.3 168.0 1.3 470.8 2.2 229.7 345.3 125.3 171.4 385.5 163.0 115.2 143.2 160.0 283.8 146.5 114.8 132.6 113.3 353.2 359.3 421.7 143.3 367.9 86.7 87.6 84.0 125.7 85.1 84.5 101.5 85.9 88.4 97.0 91.1 90.8 1193.2 57.7 13.6 4.9 90.7 33.1 19.6 255.7 48.9 0.2 86.2 168.5 7.0 50.1 68.5 49.7 0.0 7.8 184.2 1.5 37.2 18.7 10.7 27.8 11.2 420.2 1.2 74.0 0.0 1.2 61.5 152.4 14.8 50.1 227.8 260.9 455.8 211.1 388.9 0.0 0.0 2.8 28.5 189.4 187.6 12.0 346.7 220.4 74.7 32.8 214.5 1.3 211.2 0.5 0.3 3.3 4.8 419.4 192.8 10.3 3.7 1.3 27.4 2.1 164.3 30.7 146.3 1.3 1.2 15.5 26.1 13.1 135.8 490.6 5.0 28.6 C6orf47 "D6S53E, G4" ENSG00000204439 "Chromosome 6 open reading frame 47" O95873 6 31658298-31660778 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5;HBEC3-KT: 7.6;HDLM-2: 4.7;HEK 293: 6.1;U-2 OS: 5.5;U-266/84: 5.5" "Low region specificity" "Detected in all" HPA045281 Uncertain Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA045281: AB_10961000" "unprognostic (5.99e-2)" "unprognostic (5.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.09e-1)" "unprognostic (3.24e-2)" "unprognostic (3.27e-1)" "unprognostic (5.04e-2)" "unprognostic (2.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.66e-3)" "unprognostic (6.78e-3)" "unprognostic (2.38e-1)" "unprognostic (7.73e-2)" "unprognostic (3.59e-3)" 11.2 12.9 0.4 0.4 0.5 0.2 10.8 1.1 0.7 11.9 0.2 18.0 0.0 15.1 3.2 21.4 12.1 1.0 17.2 0.4 0.5 15.0 10.9 12.0 1.4 0.7 0.5 11.2 13.1 0.6 11.6 0.8 0.7 12.4 1.0 0.6 13.5 0.0 18.9 17.9 17.6 0.0 0.5 18.1 15.5 4.8 0.6 0.7 11.5 0.0 0.0 16.6 13.1 0.8 0.1 4.5 0.0 0.3 3.2 0.1 0.5 0.0 0.0 0.1 0.0 0.3 0.6 3.0 2.4 3.8 0.0 0.0 0.0 7.6 0.0 4.7 6.1 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.3 0.0 1.2 3.8 0.9 2.6 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.4 5.5 0.0 0.2 3.7 5.5 0.9 1.9 0.0 0.2 0.6 1.5 2.8 2.6 1.0 1.3 1.9 0.7 1.6 1.0 1.4 2.0 0.8 1.8 0.7 0.9 0.6 1.4 1.9 0.4 0.5 1.1 0.7 0.4 0.5 0.7 0.5 0.7 0.5 0.6 0.8 8.7 6.4 10.9 0.0 16.6 25.1 29.1 14.6 18.2 16.0 12.2 6.5 1.5 25.8 11.5 12.9 8.4 20.0 17.7 42.2 25.4 24.2 0.0 4.3 7.8 10.9 6.7 6.1 0.0 28.9 15.1 11.2 11.7 6.1 11.4 12.8 15.4 8.5 18.2 6.7 0.0 21.6 4.1 17.4 18.7 0.0 16.1 17.1 8.8 0.0 19.4 12.5 32.0 0.0 0.0 29.9 29.0 21.8 5.1 25.6 40.9 18.1 5.0 13.5 32.9 13.0 14.2 1.0 5.5 20.9 26.9 23.8 16.1 15.8 26.2 47.0 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590021-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 18.1 18.9 16.9 12.2 18.2 21.3 18.9 15.9 18.5 23.0 15.0 21.6 12.6 23.3 6.5 16.5 22.2 9.3 17.6 16.3 16.2 19.6 21.5 17.2 17.3 18.8 17.2 19.9 21.7 10.1 17.0 7.2 16.9 22.9 7.1 3.8 16.6 9.8 21.9 21.4 18.6 11.1 16.0 27.2 20.0 17.3 17.3 18.5 19.0 10.2 10.9 20.9 17.1 20.4 21.5 17.6 12.0 28.5 19.3 10.7 15.8 12.6 10.9 17.8 10.9 16.5 8.7 25.2 16.0 9.4 33.7 23.3 16.2 11.5 8.1 9.9 23.3 9.4 11.5 17.6 22.5 22.7 29.0 12.4 17.0 10.7 11.2 9.4 19.6 26.7 25.1 18.6 10.7 36.1 19.9 46.9 24.0 10.6 23.2 40.1 9.5 21.5 11.6 18.5 15.7 29.2 12.2 39.9 17.3 12.5 18.3 33.8 14.2 14.7 48.2 16.3 27.9 22.5 23.8 23.8 9.9 24.9 44.3 0.5 1.5 2.2 2.0 1.5 2.6 1.7 2.4 2.6 1.1 1.6 2.4 2.0 1.4 1.6 1.6 2.9 2.7 0.9 16.9 18.2 15.9 18.5 16.3 16.2 18.8 17.2 16.9 16.0 17.3 20.4 12.9 9.6 8.6 11.1 13.7 15.2 8.8 4.6 13.1 7.1 14.2 14.5 6.0 12.8 6.1 1.8 6.2 11.6 23.6 11.8 0.0 8.9 8.2 9.9 12.6 12.8 12.6 4.2 9.5 10.2 10.6 11.2 10.7 8.9 1.3 16.0 12.5 7.4 13.4 5.0 8.3 12.5 8.2 11.3 10.2 3.5 8.1 12.9 7.2 7.5 8.4 6.7 18.6 9.5 13.2 10.2 9.8 8.6 10.9 10.9 8.5 8.0 5.3 6.5 6.6 12.0 14.5 11.9 13.5 11.7 12.8 9.7 17.5 14.0 11.6 7.6 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096217-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Macrophages: 142.0;Pancreatic endocrine cells: 121.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 134.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Mitochondria "HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938" "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 12.2 13.7 2.5 3.7 2.1 3.2 11.3 4.8 4.5 11.5 3.1 14.4 6.1 12.0 2.6 11.0 10.8 5.8 10.3 1.8 3.4 16.2 10.8 10.9 4.0 4.0 2.9 7.9 5.5 6.1 6.6 3.3 4.9 8.7 3.2 0.1 9.4 4.2 14.2 10.8 9.5 4.2 3.6 10.5 12.9 19.1 3.5 3.1 8.7 5.5 2.6 11.5 11.5 5.9 33.0 31.3 4.1 9.2 5.3 10.1 12.9 26.7 13.0 18.2 8.2 7.8 10.6 7.0 18.3 9.5 15.4 56.0 3.3 21.9 1.5 134.9 12.3 12.4 6.5 18.4 21.1 11.2 11.4 23.5 8.1 13.2 5.2 20.0 21.4 6.1 5.7 13.8 12.4 64.7 12.1 30.0 3.6 21.1 70.8 8.2 20.7 29.4 22.9 12.1 9.8 17.3 14.4 6.9 30.6 0.8 15.6 11.6 21.6 9.3 18.6 17.9 8.4 10.4 10.1 1.5 39.0 11.3 32.4 27.8 37.4 23.6 10.2 30.0 10.5 12.6 10.0 10.9 30.6 7.5 9.0 8.9 40.3 18.4 17.3 11.1 21.7 22.4 2.5 2.1 4.8 4.5 1.8 3.4 4.0 2.9 4.9 3.6 3.5 5.9 29.3 22.4 20.9 0.0 14.4 0.0 52.8 0.0 25.6 12.0 81.2 75.6 0.0 27.1 5.6 16.5 16.7 22.9 25.7 27.7 62.6 76.6 49.5 19.4 26.8 34.1 15.8 7.8 0.0 58.1 34.6 26.2 36.2 20.3 30.3 8.2 41.7 13.9 79.0 5.0 0.0 19.8 0.0 41.3 0.0 15.3 45.7 142.0 0.0 0.0 68.3 21.9 17.5 0.0 0.0 121.6 10.3 43.6 15.0 58.7 38.9 61.7 2.2 29.8 59.2 30.4 31.1 98.7 26.4 27.9 0.0 21.6 34.0 8.5 18.6 71.0 CCDC130 MGC10471 ENSG00000104957 "Coiled-coil domain containing 130" P13994 19 13731760-13763296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056977 Approved Approved Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA056977: AB_2683297" "unprognostic (6.54e-2)" "unprognostic (5.72e-3)" "unprognostic (2.13e-3)" "unprognostic (1.27e-3)" "unprognostic (2.71e-1)" "prognostic favorable (7.83e-5)" "unprognostic (7.04e-2)" "unprognostic (1.25e-2)" "unprognostic (2.47e-1)" "unprognostic (9.69e-2)" "prognostic favorable (2.34e-4)" "unprognostic (2.06e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.82e-4)" 24.4 20.9 17.3 20.5 21.1 23.1 26.2 18.3 24.8 30.4 21.2 24.8 17.1 27.3 3.6 22.5 28.9 11.7 26.8 17.3 20.7 26.9 24.7 27.2 23.4 22.9 20.1 37.5 25.8 13.1 28.9 15.0 22.1 27.2 7.5 13.4 24.3 10.6 28.2 26.4 29.6 10.9 17.9 31.3 25.0 20.4 21.2 16.5 32.6 11.6 12.2 25.5 27.1 28.7 14.9 10.1 19.3 19.7 12.5 9.7 11.9 15.6 13.2 14.3 13.5 9.5 10.2 12.6 11.3 12.5 11.4 14.4 8.9 8.0 4.6 21.6 26.2 9.7 34.3 14.5 24.4 9.5 24.9 13.8 17.3 17.6 12.0 15.2 16.6 23.2 9.9 22.9 9.0 11.1 25.8 21.1 13.2 7.7 20.1 22.1 9.4 17.1 11.4 16.8 11.8 15.5 10.0 10.4 25.0 9.7 8.3 22.5 13.7 23.2 9.6 27.9 20.4 36.5 14.8 10.3 20.2 22.6 16.2 18.3 12.9 20.3 13.2 11.3 16.4 15.2 14.2 14.1 13.1 18.0 13.0 14.8 13.5 14.4 15.2 10.8 12.8 11.3 17.3 21.1 18.3 24.8 17.3 20.7 22.9 20.1 22.1 17.9 21.2 28.7 25.5 9.6 17.9 21.5 29.0 13.4 15.4 20.2 15.4 30.3 18.6 18.4 14.5 8.6 18.6 29.5 27.1 17.3 31.4 25.6 7.9 17.6 40.2 22.7 24.8 22.4 18.7 16.0 19.8 15.7 19.1 19.5 53.0 26.9 24.6 34.9 17.5 10.8 18.0 26.9 24.9 18.1 24.4 18.6 33.8 24.4 19.0 21.9 24.9 15.0 24.9 26.0 17.5 14.1 30.3 18.1 25.5 17.0 27.3 12.8 32.1 18.9 23.0 41.7 26.3 16.6 23.6 35.5 20.3 19.2 15.6 35.0 31.0 31.8 17.5 11.0 CCDC71 FLJ12800 ENSG00000177352 "Coiled-coil domain containing 71" Q8IV32 3 49162535-49166331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047547 Uncertain Approved "Nuclear membrane" No No "Cluster 22: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear membrane" "HPA047547: AB_2680083" "unprognostic (1.06e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-3)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (3.68e-2)" "unprognostic (6.71e-3)" "unprognostic (7.20e-3)" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (9.03e-3)" "unprognostic (7.20e-2)" "prognostic favorable (9.65e-9)" "unprognostic (3.53e-2)" "unprognostic (1.53e-1)" "unprognostic (2.00e-2)" "unprognostic (7.14e-2)" 13.0 15.4 5.0 9.6 5.4 7.3 14.5 5.4 6.2 13.6 4.9 9.9 8.3 14.9 9.6 13.8 16.4 9.1 12.2 5.0 5.9 10.6 12.6 11.1 13.5 5.3 5.4 18.2 9.5 13.6 9.6 10.1 5.4 12.0 7.6 3.4 12.5 10.5 14.8 13.0 10.7 10.0 5.3 13.3 10.5 12.2 5.4 13.0 16.1 9.5 9.5 12.9 11.9 5.3 12.6 16.9 19.4 18.8 21.8 15.8 18.6 15.2 21.8 26.1 22.9 17.6 19.8 11.2 13.0 26.2 20.9 13.0 19.3 40.7 9.3 24.9 14.0 22.7 22.0 17.9 25.7 18.3 16.5 26.9 31.4 31.0 23.7 19.4 25.8 26.7 23.1 4.6 21.1 26.9 31.8 11.2 30.2 18.8 18.1 11.5 10.8 10.5 24.8 24.0 9.8 21.3 15.5 16.3 18.5 15.6 21.7 30.2 17.1 18.3 19.4 18.3 20.0 17.5 8.2 15.6 13.3 17.2 20.7 0.0 1.0 0.4 0.9 1.7 1.4 0.5 0.8 1.2 0.9 1.3 1.2 0.8 0.9 4.8 1.3 0.3 1.0 0.6 5.0 5.4 5.4 6.2 5.0 5.9 5.3 5.4 5.4 5.3 5.4 5.3 5.1 6.4 1.5 1.6 7.9 2.7 12.5 23.8 6.8 1.5 7.5 8.5 1.4 5.7 11.2 7.3 0.0 23.3 4.1 8.3 25.4 21.3 9.3 2.4 3.5 8.0 8.4 11.8 2.1 11.8 16.5 7.7 7.1 1.8 2.5 6.5 16.1 9.3 20.1 0.0 2.0 8.4 24.4 5.6 2.1 10.2 11.8 5.3 5.4 6.5 8.8 3.6 12.3 1.0 1.0 15.2 9.3 13.5 9.3 10.8 10.4 14.1 7.1 1.2 13.1 4.1 7.0 10.6 18.4 9.2 2.7 22.4 5.8 6.6 8.2 11.5 CCDC92 FLJ22471 ENSG00000119242 "Coiled-coil domain containing 92" Q53HC0 12 123918660-123972831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 89.2;Excitatory neurons: 123.0;Inhibitory neurons: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038560, HPA057580" Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Centrosome Nucleoplasm "HPA038560: AB_10672717, HPA057580: AB_2683476" "unprognostic (4.77e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "prognostic favorable (7.15e-4)" "unprognostic (4.82e-2)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (5.01e-2)" "unprognostic (5.69e-2)" "unprognostic (7.14e-2)" "prognostic favorable (4.59e-5)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (3.08e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" 56.3 26.7 18.5 3.7 17.4 1.2 47.5 2.9 44.2 39.8 0.0 53.6 5.8 40.4 7.1 20.1 37.7 4.0 77.4 24.3 4.8 39.7 38.4 37.7 3.4 17.6 6.3 35.5 21.1 5.5 58.5 7.0 18.6 36.3 2.7 7.2 24.8 4.7 77.8 17.4 34.3 5.5 4.6 27.0 32.9 74.0 14.3 3.2 40.9 7.6 2.4 37.5 28.7 20.0 4.9 5.5 2.7 4.9 17.5 9.6 4.9 8.1 15.3 4.5 4.8 2.9 1.4 2.4 2.7 10.2 2.5 3.4 3.0 2.1 3.0 15.0 7.0 3.1 2.2 1.8 9.2 0.5 11.3 5.5 9.2 5.7 3.5 13.7 12.6 5.3 3.2 1.1 4.0 3.3 3.0 5.4 1.2 2.4 11.6 3.7 1.5 0.7 6.1 5.1 5.1 7.3 4.0 1.9 5.7 6.3 5.7 2.7 12.6 8.9 1.9 5.8 2.8 3.7 2.1 0.7 7.1 4.2 3.9 1.6 0.4 0.7 0.7 0.2 1.2 0.5 0.9 1.1 0.3 0.5 0.6 0.9 0.4 0.5 0.0 0.4 0.1 0.6 18.5 17.4 2.9 44.2 24.3 4.8 17.6 6.3 18.6 4.6 14.3 20.0 17.6 19.2 28.5 52.5 8.3 3.8 7.5 8.1 4.0 33.6 14.2 11.7 40.8 18.6 8.6 18.4 14.6 4.4 16.4 7.2 7.9 14.7 89.2 15.1 13.0 17.7 4.8 4.4 123.0 10.9 2.7 19.2 10.2 14.5 20.3 31.2 18.9 14.5 18.9 21.9 106.1 6.2 8.2 12.0 6.3 63.9 13.7 14.2 8.8 30.9 9.9 15.0 22.6 50.8 70.0 15.5 2.7 17.3 3.2 9.5 10.0 37.0 9.0 13.6 72.3 15.3 24.6 40.9 10.1 6.3 3.0 5.6 13.7 26.3 7.6 7.5 CCNL2 "ania-6b, CCNM, CCNS, HLA-ISO, PCEE, SB138" ENSG00000221978 "Cyclin L2" Q96S94 1 1385711-1399335 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053137 Supported Supported Nucleoplasm "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053137: AB_2682053" "unprognostic (3.08e-2)" "unprognostic (2.60e-1)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.59e-3)" "unprognostic (2.06e-1)" "unprognostic (3.91e-2)" "unprognostic (1.67e-2)" "unprognostic (1.15e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.61e-2)" "unprognostic (6.17e-2)" "unprognostic (3.71e-1)" "prognostic favorable (1.46e-7)" 65.1 79.9 16.3 29.6 17.5 33.3 74.0 24.1 21.5 101.8 27.8 76.9 36.0 88.7 30.9 67.2 86.6 26.4 57.9 16.9 14.2 65.6 100.5 62.1 32.2 16.9 15.7 104.3 90.2 31.7 73.4 34.4 18.4 76.0 22.8 22.9 78.1 31.9 49.7 73.7 75.8 26.6 15.7 62.1 71.3 31.1 17.0 31.6 91.4 18.4 28.1 77.0 82.5 26.6 30.1 24.5 72.5 29.7 39.2 63.9 37.1 63.8 33.8 32.1 31.6 27.5 57.9 30.6 35.3 42.8 27.7 68.4 26.8 40.9 24.6 14.7 68.9 38.4 142.0 43.8 47.8 19.9 42.8 81.1 29.0 31.4 48.5 94.6 34.9 41.0 37.3 32.4 37.6 32.1 25.1 78.7 23.7 21.2 48.5 48.8 17.6 39.1 56.5 37.1 45.4 63.0 40.7 60.6 37.5 42.8 48.8 30.3 60.1 70.8 32.5 29.4 25.2 64.9 12.1 53.7 35.0 50.7 18.5 5.4 6.1 8.5 7.4 4.6 5.0 7.2 7.2 7.9 7.1 9.0 8.3 7.4 5.8 6.6 7.3 6.7 4.3 2.9 16.3 17.5 24.1 21.5 16.9 14.2 16.9 15.7 18.4 15.7 17.0 26.6 66.4 35.3 107.5 76.7 46.6 45.5 36.6 48.3 50.7 31.7 50.8 56.4 37.2 40.0 58.1 29.5 47.9 43.2 48.7 43.1 21.5 30.6 22.4 49.0 82.1 56.0 50.6 26.5 44.7 26.7 33.8 49.9 78.5 55.2 43.1 81.4 37.5 45.6 24.7 60.6 41.2 41.5 52.9 22.9 34.0 14.6 51.3 31.0 32.0 48.7 27.2 35.5 47.4 31.2 52.5 40.2 40.7 32.7 46.7 31.1 33.9 18.4 58.6 39.4 59.2 56.8 59.9 45.1 30.6 40.3 44.0 63.8 46.4 73.6 34.6 39.0 CCZ1 "C7orf28A, CCZ1A, CGI-43" ENSG00000122674 "CCZ1 homolog, vacuolar protein trafficking and biogenesis associated" P86791 7 5898725-5926550 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (1.91e-1)" "unprognostic (2.97e-3)" "unprognostic (3.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.82e-1)" "unprognostic (5.35e-2)" "unprognostic (3.74e-3)" "unprognostic (4.10e-1)" "unprognostic (9.25e-3)" "unprognostic (7.66e-2)" "unprognostic (6.64e-2)" "unprognostic (2.67e-2)" "unprognostic (5.27e-3)" "unprognostic (3.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-1)" "unprognostic (4.41e-1)" 32.5 55.8 10.7 12.8 10.9 26.9 30.2 12.2 13.7 28.7 12.9 31.1 13.0 29.7 9.4 40.8 25.2 10.3 31.3 11.4 10.5 27.3 27.3 26.0 15.4 10.7 10.4 23.0 27.3 29.9 24.9 12.2 10.6 24.6 16.0 12.6 32.1 11.9 43.2 30.3 26.9 13.9 10.5 31.5 29.0 22.1 11.0 20.5 25.5 13.0 16.2 31.7 28.9 11.6 52.2 29.8 30.3 27.1 41.8 35.4 15.3 15.6 30.1 23.1 25.0 9.1 27.2 42.8 4.8 40.8 61.9 27.8 16.6 26.7 26.5 16.2 37.3 18.1 30.2 16.8 38.0 13.1 7.1 40.5 42.4 15.6 19.5 42.5 57.2 25.4 52.4 29.7 38.8 26.9 16.8 56.9 39.5 26.4 28.3 36.0 13.8 28.9 21.1 38.3 23.9 31.9 15.3 36.6 13.6 57.9 26.1 21.0 27.7 28.8 57.4 18.7 25.7 13.6 24.6 58.0 9.6 30.8 41.6 3.1 1.9 2.7 1.8 2.3 1.4 1.3 2.2 2.2 1.8 1.3 1.5 1.6 3.4 3.0 2.4 1.8 4.6 0.7 10.7 10.9 12.2 13.7 11.4 10.5 10.7 10.4 10.6 10.5 11.0 11.6 30.7 3.2 23.5 15.7 26.3 45.2 30.6 21.2 9.6 59.2 29.5 20.2 11.0 24.3 24.0 31.3 62.6 45.0 47.2 38.0 31.3 61.0 6.5 18.7 18.1 35.0 29.9 26.7 20.2 71.4 35.9 26.7 11.2 21.3 15.8 21.1 76.4 17.6 35.7 23.5 20.5 30.8 50.8 39.0 61.6 4.9 37.9 27.5 46.2 8.4 80.8 41.5 72.1 15.6 28.7 74.0 30.1 36.1 14.3 26.2 40.2 21.9 32.9 69.2 78.9 19.4 32.0 40.6 34.5 11.0 54.1 34.9 32.8 38.2 34.4 33.7 CEBPD "C/EBP-delta, CELF, CRP3, NF-IL6-beta" ENSG00000221869 "CCAAT enhancer binding protein delta" P49716 8 47736913-47738164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 54.9" "Group enriched" "Detected in many" 5 "granulocytes: 54.9;monocytes: 19.9" "Cell line enhanced" "Detected in many" "BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067581 Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA067581: AB_2685865" "prognostic favorable (2.28e-5)" "unprognostic (1.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.74e-2)" "unprognostic (2.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.52e-2)" "unprognostic (2.12e-1)" "unprognostic (6.81e-2)" "unprognostic (5.16e-2)" "unprognostic (5.47e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (4.62e-2)" "unprognostic (3.40e-2)" 251.6 72.0 33.4 62.1 35.2 34.3 168.0 37.2 42.0 99.7 43.9 143.5 26.7 82.8 2.7 85.4 192.0 14.7 136.9 35.8 63.6 106.9 207.8 157.5 8.7 81.5 49.3 265.3 81.9 7.6 117.4 50.0 49.5 151.1 12.1 16.9 89.3 19.4 133.0 106.9 79.6 21.6 46.5 109.7 116.3 14.3 47.4 18.5 103.5 21.6 6.6 168.1 139.9 44.6 9.5 7.4 0.3 0.1 41.5 43.2 51.9 24.1 18.7 6.8 14.4 14.8 14.8 0.1 17.3 6.6 5.8 9.9 1.7 12.9 2.1 0.1 3.9 0.5 6.0 6.3 66.8 4.1 0.0 66.7 33.7 1.6 16.0 4.3 1.4 0.4 4.1 7.3 2.5 2.9 0.1 148.7 2.8 6.2 2.5 0.1 5.1 0.5 20.6 7.8 2.8 1.0 58.7 7.7 6.3 2.6 6.4 33.5 6.2 1.5 3.9 15.6 1.5 0.1 0.1 0.1 7.9 0.1 0.3 2.3 19.9 10.6 2.1 8.4 6.2 0.1 0.3 1.2 7.4 0.6 0.0 0.0 54.9 3.7 3.2 0.2 0.3 2.8 33.4 35.2 37.2 42.0 35.8 63.6 81.5 49.3 49.5 46.5 47.4 44.6 1541.7 102.5 196.3 31.3 14.9 663.5 1435.6 98.7 2487.0 6.0 551.3 617.1 79.2 185.8 76.5 224.3 6.2 189.8 152.8 59.2 217.2 50.7 3.5 287.0 418.9 547.9 23.4 30.3 12.5 77.2 457.9 1377.3 387.3 621.0 5.1 96.4 269.5 157.7 220.3 1.7 2.5 44.3 42.7 520.1 502.0 21.5 435.5 912.6 268.6 29.0 163.5 321.9 150.4 6.0 0.5 53.2 58.4 144.8 34.9 1668.5 127.1 353.4 54.9 17.3 466.8 1386.3 1290.5 3.7 13.9 940.2 817.5 351.9 122.7 85.9 73.2 814.5 CEP89 "CCDC123, FLJ14640" ENSG00000121289 "Centrosomal protein 89" Q96ST8 19 32875925-32971991 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039382, HPA040056" Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Plasma membrane" "HPA039382: AB_2676479, HPA040056: AB_10671048" "unprognostic (4.23e-2)" "unprognostic (7.50e-3)" "unprognostic (1.97e-1)" "unprognostic (1.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.04e-2)" "unprognostic (1.80e-2)" "unprognostic (4.00e-2)" "unprognostic (1.74e-1)" "unprognostic (4.48e-2)" "unprognostic (6.53e-2)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" 6.0 6.0 6.3 5.3 6.7 4.7 6.4 7.7 6.4 9.1 7.7 8.9 4.0 9.8 6.7 6.3 8.9 5.1 6.2 6.6 6.9 8.6 3.3 5.7 6.0 5.8 5.6 10.1 6.1 7.0 9.3 5.3 4.7 12.5 4.4 7.4 6.7 5.9 5.9 6.6 6.7 6.9 4.0 6.4 6.2 4.2 7.3 6.2 7.5 4.3 4.3 8.0 6.8 6.0 19.1 25.7 17.1 14.7 9.1 11.0 9.9 14.7 9.8 25.5 19.4 9.3 11.2 7.6 7.8 15.1 14.4 10.5 16.9 11.9 17.6 20.2 10.4 5.9 18.5 8.9 7.2 8.3 5.7 13.3 16.2 24.1 16.2 10.4 19.5 10.4 9.2 11.0 12.3 14.2 9.4 6.4 7.3 10.4 8.0 10.4 9.2 6.6 11.9 10.3 24.1 17.7 15.1 10.3 8.8 10.3 7.7 6.7 12.6 18.4 16.1 16.0 15.3 5.3 9.1 7.0 15.8 7.8 14.0 12.8 3.1 1.6 2.7 4.6 4.9 3.3 2.9 2.4 1.8 5.7 2.8 3.3 3.7 2.1 2.4 3.7 3.4 1.7 6.3 6.7 7.7 6.4 6.6 6.9 5.8 5.6 4.7 4.0 7.3 6.0 12.7 28.9 16.0 17.3 9.5 5.1 11.5 14.5 8.0 16.3 11.7 11.8 17.5 10.0 19.0 20.2 18.8 9.3 9.6 8.0 11.7 19.1 15.1 49.2 24.9 14.8 9.7 13.3 17.2 16.6 11.2 17.7 10.7 17.3 17.1 21.1 14.6 5.6 11.8 20.2 13.6 9.7 8.2 5.3 5.1 8.5 16.1 8.9 5.4 14.0 9.8 9.6 10.3 9.5 15.9 15.1 5.2 12.8 5.4 6.7 9.9 16.3 48.3 38.6 0.0 17.5 16.1 20.3 13.8 7.5 4.5 4.2 9.0 12.7 8.6 6.6 CHERP "DAN16, ERPROT213-21" ENSG00000085872 "Calcium homeostasis endoplasmic reticulum protein" Q8IWX8 19 16517894-16542437 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (1.74e-1)" "unprognostic (8.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-3)" "unprognostic (2.40e-1)" "unprognostic (2.05e-2)" "unprognostic (9.09e-2)" "unprognostic (3.35e-1)" "unprognostic (3.72e-3)" "unprognostic (4.05e-1)" "unprognostic (7.38e-2)" "unprognostic (6.39e-3)" "unprognostic (9.86e-2)" "unprognostic (1.74e-2)" "unprognostic (4.72e-2)" "unprognostic (6.26e-2)" "unprognostic (9.62e-2)" 16.0 17.4 11.9 12.7 11.8 16.5 17.0 11.9 18.3 18.2 7.0 19.1 13.4 19.9 4.6 18.3 18.8 7.3 16.3 13.0 8.6 15.4 25.7 13.9 14.8 8.9 9.0 22.4 17.6 9.7 17.3 9.2 8.6 18.8 4.7 6.8 17.7 8.3 30.7 19.3 18.2 6.4 7.1 19.6 17.0 20.4 9.8 11.0 17.7 9.0 8.1 19.4 16.5 10.8 47.3 29.8 26.8 26.4 13.4 10.0 75.0 22.7 12.1 20.3 18.0 46.3 41.0 56.6 41.8 12.9 14.5 37.6 30.1 27.4 9.4 46.7 71.4 49.1 28.8 36.4 17.8 49.4 42.3 16.6 20.0 20.4 17.6 10.7 16.1 33.5 72.8 32.3 12.5 61.7 64.9 56.4 84.9 36.5 50.8 69.6 28.4 48.0 18.2 42.4 50.3 52.9 24.1 37.7 30.2 12.3 29.5 39.9 25.2 31.8 26.9 46.0 50.4 56.2 51.6 61.6 28.3 59.6 38.7 1.6 3.3 1.9 4.5 3.9 4.2 3.8 3.5 4.4 3.3 4.0 3.4 3.8 4.5 3.0 2.8 4.4 2.6 4.0 11.9 11.8 11.9 18.3 13.0 8.6 8.9 9.0 8.6 7.1 9.8 10.8 18.1 9.6 12.9 12.4 26.4 21.4 25.3 12.7 17.6 22.3 21.5 22.4 6.3 10.0 11.0 7.3 29.2 22.2 21.5 20.6 1.9 11.1 3.2 21.0 21.3 15.9 20.9 28.6 9.3 12.1 18.4 13.8 16.3 31.9 9.5 22.4 14.3 26.7 14.7 16.8 10.7 20.9 12.2 11.3 9.1 6.8 21.1 14.4 12.4 10.3 13.5 15.3 13.4 6.0 11.5 13.6 19.0 17.0 22.5 27.4 14.7 9.8 10.1 27.9 13.1 19.4 12.7 16.0 22.5 19.7 24.0 20.5 21.7 18.8 21.9 27.6 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403588-2448484 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 158.7;Hepatic stellate cells: 152.8;NK-cells: 368.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 60.1;NB-4: 57.4;U-266/70: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 960000 "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 16.1 13.3 4.5 5.1 3.5 6.1 15.0 7.3 5.0 15.4 0.2 13.7 5.4 17.8 0.6 7.9 15.8 1.2 15.5 9.0 2.6 11.3 7.1 14.5 2.9 9.4 4.7 11.6 11.7 1.4 17.6 2.8 4.6 13.6 0.6 1.2 10.3 2.8 8.3 15.6 10.6 1.4 3.8 24.5 11.1 9.1 5.9 1.4 14.1 0.9 1.0 13.1 13.1 4.3 9.5 9.1 2.7 10.0 3.8 2.3 29.5 17.2 4.2 4.2 5.7 9.0 3.2 8.5 31.6 2.7 10.3 7.1 1.6 2.2 0.8 11.2 17.7 5.9 7.0 9.9 2.6 19.4 60.1 4.8 0.9 3.8 0.5 3.3 4.2 11.5 15.1 25.0 1.2 6.8 19.8 57.4 19.1 1.3 14.4 7.1 7.6 42.1 1.2 3.8 6.8 28.7 8.4 4.5 4.0 2.0 6.6 22.3 13.0 9.6 26.5 20.0 15.2 88.9 37.1 3.9 7.8 8.8 17.9 59.1 10.4 53.2 87.6 9.1 54.4 14.7 30.0 71.4 20.4 18.3 12.6 37.8 3.1 121.6 3.9 64.9 33.0 22.9 4.5 3.5 7.3 5.0 9.0 2.6 9.4 4.7 4.6 3.8 5.9 4.3 36.8 16.0 50.5 9.1 32.8 18.1 35.5 24.3 18.8 45.6 18.0 13.0 8.3 15.7 30.5 18.4 66.7 104.5 158.7 6.2 1.9 22.4 6.7 4.7 21.1 59.4 12.7 37.0 11.0 15.3 15.0 37.0 6.1 6.4 38.0 13.4 152.8 7.2 24.8 47.1 12.3 9.1 24.4 26.4 22.9 5.8 95.7 21.2 21.4 10.3 21.3 15.1 368.7 14.1 9.5 13.3 6.7 67.7 107.8 18.4 16.2 9.5 15.2 50.5 19.7 25.6 17.9 37.8 30.6 9.2 15.3 133.5 93.2 18.4 12.2 13.1 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 41.8;Glandular and luminal cells: 104.9;Pancreatic endocrine cells: 56.2;Prostatic glandular cells: 56.4;Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 16.2 6.0 1.3 8.0 0.5 13.7 5.3 0.0 1.5 13.9 0.9 13.4 1.4 16.6 1.0 4.4 17.1 17.7 8.8 1.0 0.6 19.0 4.2 9.3 5.3 1.4 0.5 6.7 6.5 0.2 6.5 4.2 0.4 7.2 1.7 1.4 9.1 1.8 1.5 2.6 9.4 8.3 0.0 8.1 11.2 1.9 2.1 0.7 9.7 1.9 4.4 18.1 7.6 0.2 15.1 31.4 2.2 9.7 4.2 5.8 0.0 20.9 11.6 14.4 7.0 5.1 40.3 9.1 17.1 26.8 17.5 10.3 0.4 10.7 6.3 0.5 0.3 0.1 23.9 4.0 13.6 1.9 2.4 7.6 2.6 15.0 6.5 27.4 3.1 0.0 3.5 0.4 15.0 12.0 0.1 6.8 8.1 18.9 28.8 0.9 4.8 0.5 22.7 0.8 0.1 1.6 57.8 2.2 1.3 4.4 1.3 2.5 12.5 27.6 11.6 35.4 31.5 2.0 0.1 1.0 35.4 1.8 11.1 0.0 0.9 15.2 10.5 3.4 6.2 10.8 4.8 8.3 1.3 13.8 0.1 3.5 0.3 0.2 10.5 0.0 1.1 3.2 1.3 0.5 0.0 1.5 1.0 0.6 1.4 0.5 0.4 0.0 2.1 0.2 4.2 16.0 4.8 1.3 10.6 3.7 25.9 6.5 1.8 0.0 14.5 2.4 0.8 25.8 9.6 7.3 0.0 0.4 10.0 3.8 1.9 24.0 1.8 41.8 19.4 6.2 1.2 0.0 0.7 11.8 0.6 14.0 5.1 104.9 3.8 2.1 2.9 1.0 1.2 0.0 0.5 2.3 6.1 0.3 10.7 4.7 3.4 6.7 8.8 1.0 6.5 1.7 3.1 0.5 0.1 56.2 14.3 0.0 9.5 56.4 0.2 5.2 1.7 0.3 0.0 32.6 10.4 0.3 0.9 1.6 4.4 0.1 9.7 0.1 1.5 65.2 CLIC1 "CLCNL1, G6, NCC27, p64CLCP" ENSG00000213719 "Chloride intracellular channel 1" O00299 6 31730581-31739763 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020825, CAB040557" Enhanced Supported Cytosol NA NA 22000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "CAB020825: , CAB040557: " "unprognostic (7.26e-2)" "unprognostic (9.32e-2)" "unprognostic (2.78e-3)" "unprognostic (7.29e-2)" "unprognostic (6.93e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (8.90e-7)" "unprognostic (2.58e-2)" "unprognostic (8.51e-2)" "unprognostic (8.71e-3)" "unprognostic (1.19e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (8.11e-5)" "unprognostic (4.51e-2)" "unprognostic (2.89e-1)" "unprognostic (1.35e-2)" "unprognostic (7.31e-2)" 292.8 156.5 6.9 43.4 6.8 64.0 256.7 7.1 11.0 222.2 8.7 291.6 37.0 197.9 20.9 395.9 190.5 43.7 183.7 6.7 10.2 318.5 102.6 330.4 44.1 9.4 7.7 149.8 148.1 20.1 111.5 45.5 8.9 217.0 64.0 2.6 251.3 22.3 47.3 324.8 231.6 32.7 8.9 332.6 247.8 41.0 9.6 35.2 180.8 11.1 58.1 257.7 246.8 8.9 119.5 54.1 87.0 45.6 56.6 118.6 43.3 52.8 105.4 92.6 77.9 125.2 87.2 48.7 73.6 186.0 116.9 70.2 65.8 154.9 124.4 38.9 34.4 93.0 43.4 109.3 73.0 164.3 125.9 74.3 80.5 157.0 148.4 101.7 157.9 44.6 109.4 149.5 181.0 79.2 77.2 213.2 7.7 128.9 78.4 13.5 47.5 115.3 210.2 73.0 16.5 19.5 43.1 49.1 71.5 60.4 33.7 228.3 105.0 128.6 91.2 39.0 166.8 48.3 98.3 66.0 62.4 122.0 136.6 244.3 179.4 239.3 165.6 194.3 135.8 186.1 98.0 155.5 143.8 150.3 30.5 92.3 341.1 176.3 174.3 80.5 149.2 414.2 6.9 6.8 7.1 11.0 6.7 10.2 9.4 7.7 8.9 8.9 9.6 8.9 514.8 70.5 67.0 0.7 382.5 960.8 589.1 869.7 331.2 0.4 274.3 300.5 18.6 296.0 457.7 237.3 0.0 545.5 472.2 730.7 602.6 1096.2 31.8 271.1 212.7 490.1 381.4 208.6 0.0 1008.9 912.5 296.6 370.5 301.3 554.1 431.2 300.9 54.2 1047.6 0.0 0.0 665.6 516.8 533.7 1529.8 17.3 233.9 685.7 524.7 13.1 426.4 86.8 706.5 0.5 0.0 1470.4 997.1 188.1 420.2 851.1 707.7 572.1 473.6 6.9 203.8 136.1 554.0 28.7 16.2 464.1 928.0 572.7 522.2 283.3 675.0 1005.9 CLK2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Nuclear bodies" "HPA055366: AB_2682795, HPA059507: AB_2684044" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.43e-4)" 23.7 25.6 11.6 10.7 11.9 11.4 24.4 14.2 14.4 39.2 14.1 24.1 11.7 29.8 12.7 22.6 28.7 9.6 18.5 11.7 12.7 26.8 29.0 22.0 19.6 12.3 11.7 33.9 23.9 14.0 31.4 13.8 12.4 33.1 8.7 9.4 23.3 11.2 16.2 27.5 24.0 10.9 11.7 40.1 20.8 16.2 12.4 18.6 33.2 8.5 15.9 28.1 29.9 13.2 10.8 10.5 29.8 11.4 17.3 9.1 22.5 8.1 12.3 8.2 7.8 13.1 8.7 23.3 9.7 6.6 4.0 17.0 16.8 13.5 6.3 11.4 17.7 20.4 12.9 15.4 14.6 26.8 20.5 7.6 10.7 11.3 20.3 19.0 13.6 16.9 29.6 15.4 10.5 22.2 12.1 11.3 21.2 27.2 17.6 17.7 21.6 28.0 17.9 25.8 11.8 25.1 4.5 10.9 9.9 21.4 15.9 24.9 9.3 4.3 12.1 9.1 9.1 31.6 28.6 22.9 9.9 19.1 5.9 0.5 0.8 1.9 0.8 0.4 1.6 1.2 1.5 0.8 0.9 0.9 1.6 1.6 0.8 0.5 0.4 0.8 0.9 0.6 11.6 11.9 14.2 14.4 11.7 12.7 12.3 11.7 12.4 11.7 12.4 13.2 9.2 16.0 24.3 9.8 13.7 4.6 5.7 4.2 17.6 5.7 7.8 7.5 14.9 12.8 12.6 7.3 4.2 8.0 7.1 5.4 0.0 6.5 6.5 6.9 15.2 11.1 6.7 8.4 8.3 4.4 8.0 11.3 25.0 9.5 10.1 12.1 7.5 8.4 6.9 5.0 6.8 9.1 2.0 11.4 4.5 6.6 7.8 10.4 3.6 9.4 9.5 5.4 8.2 9.5 8.0 4.9 4.8 3.0 17.1 5.7 5.1 3.2 5.1 7.2 6.6 6.4 12.6 8.6 4.3 14.3 4.5 12.4 11.0 7.4 7.2 5.1 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691514-40725784 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 16.5;Endometrial ciliated cells: 16.4;Theca cells: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 15.1 25.2 10.1 5.7 10.7 5.9 15.3 10.4 12.8 23.4 10.9 19.4 9.7 22.0 2.3 16.0 29.8 7.6 21.9 9.8 10.6 21.0 25.7 16.4 6.0 10.6 10.8 22.5 20.7 8.4 49.3 3.5 10.3 23.2 2.3 1.3 16.9 7.3 14.4 20.2 17.8 3.8 11.2 18.3 23.9 17.3 10.6 8.8 23.3 8.6 3.3 20.3 18.4 10.5 9.9 39.5 7.9 18.5 7.8 6.1 8.5 6.6 7.8 5.6 5.1 15.4 14.3 13.8 20.0 4.3 7.8 9.8 7.0 10.5 2.0 20.0 10.4 11.6 12.7 6.4 12.1 4.1 19.2 8.4 10.6 5.4 5.4 5.2 7.4 13.7 7.7 8.1 6.0 6.4 4.9 5.7 6.4 11.5 3.6 11.5 13.1 12.4 15.7 17.6 15.1 11.0 12.5 20.4 21.0 4.4 22.8 17.1 9.4 5.1 20.6 3.9 5.5 9.4 9.0 7.3 27.8 5.2 9.1 10.2 9.4 8.7 6.7 9.3 8.3 7.1 5.5 7.8 9.9 5.9 4.6 5.1 9.0 6.9 9.2 4.6 4.9 7.3 10.1 10.7 10.4 12.8 9.8 10.6 10.6 10.8 10.3 11.2 10.6 10.5 8.5 12.8 3.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 11.6 8.0 0.0 0.0 2.5 12.9 0.0 11.1 6.8 0.0 11.7 16.5 0.0 16.4 7.8 1.7 0.0 0.0 0.0 10.9 9.8 5.0 0.0 10.3 1.3 11.7 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 9.5 0.0 0.0 1.2 0.0 0.0 13.0 8.7 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.4 3.2 19.8 0.0 0.0 CSNK1D "CKID, CKIdelta, HCKID" ENSG00000141551 "Casein kinase 1 delta" P48730 17 82239023-82273731 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 312.5;Late spermatids: 775.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015410 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" Nucleoplasm "CAB015410: AB_831049" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.38e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.38e-6)" "unprognostic (8.05e-2)" "unprognostic (1.09e-1)" "unprognostic (5.00e-2)" "prognostic favorable (9.62e-5)" "unprognostic (2.23e-3)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.54e-1)" "unprognostic (2.52e-1)" "unprognostic (5.52e-3)" "unprognostic (4.74e-2)" 46.7 57.0 36.9 28.9 36.9 25.9 42.3 34.4 37.9 45.3 30.3 57.1 35.1 56.6 26.7 50.8 45.3 24.8 42.4 39.0 40.2 45.5 40.9 45.3 30.8 37.2 37.6 43.1 47.5 43.1 54.2 30.2 36.3 51.8 20.0 15.1 48.6 36.8 88.9 36.4 50.9 29.0 36.3 56.3 49.3 60.7 42.6 34.0 44.7 38.7 22.8 49.0 37.0 32.9 60.3 70.9 39.5 54.7 50.8 53.9 77.7 85.1 54.4 61.0 56.8 58.6 49.4 55.0 66.3 62.5 64.8 57.1 37.4 88.3 48.9 47.0 90.5 68.5 53.4 63.7 146.9 56.9 50.4 81.9 61.5 41.6 61.3 76.0 90.0 39.5 78.5 28.4 58.5 70.6 73.7 59.3 42.2 71.3 108.6 62.6 48.7 49.7 64.8 93.4 48.5 87.4 100.4 85.5 97.7 54.3 61.5 73.0 95.6 86.9 77.3 76.2 67.0 61.0 32.1 58.4 69.5 48.1 64.7 8.8 20.8 27.4 12.3 21.3 11.8 11.1 9.6 12.1 20.1 9.0 8.1 8.7 50.4 15.3 20.3 9.6 9.2 15.4 36.9 36.9 34.4 37.9 39.0 40.2 37.2 37.6 36.3 36.3 42.6 32.9 65.8 48.1 54.3 36.6 81.1 56.6 116.0 58.3 52.9 46.5 59.8 51.2 19.7 31.5 65.7 42.3 27.1 61.8 101.0 105.2 33.2 71.6 312.5 69.6 54.0 54.2 46.2 32.4 24.4 69.6 95.2 42.8 87.1 93.2 60.1 45.3 42.5 33.6 65.3 95.9 21.2 62.8 67.1 51.5 83.8 775.6 30.1 75.7 28.4 24.4 65.8 28.7 79.3 24.6 21.2 87.7 83.2 40.3 80.9 90.8 94.3 43.8 66.6 54.4 39.5 78.6 57.5 55.1 29.6 44.2 48.3 126.6 87.6 46.7 56.7 118.6 CSNK2B "Ckb1, Ckb2" ENSG00000204435 "Casein kinase 2 beta" P67870 6 31665227-31670343 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004349, HPA005944, CAB013087, CAB016059" Approved NA NA 83000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290" "unprognostic (1.61e-1)" "unprognostic (3.21e-2)" "unprognostic (8.88e-2)" "unprognostic (1.55e-3)" "unprognostic (9.51e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-3)" "unprognostic (1.60e-1)" "unprognostic (7.52e-2)" "unprognostic (1.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (5.88e-2)" "unprognostic (1.72e-1)" "unprognostic (9.67e-2)" "unprognostic (3.72e-2)" 155.8 157.4 15.8 31.9 24.6 62.2 150.2 17.6 54.1 147.9 16.8 142.2 27.8 126.7 183.7 166.6 130.1 33.1 178.9 15.9 16.4 172.1 163.7 133.0 72.5 16.3 17.5 161.2 142.3 69.3 130.0 68.2 17.8 120.3 50.4 41.4 131.9 57.6 232.0 294.2 126.5 66.3 15.4 146.0 146.7 257.9 17.1 56.5 132.4 94.8 30.1 126.2 139.8 17.4 0.9 95.5 2.5 164.9 97.4 158.0 120.8 200.9 350.2 407.6 377.9 0.2 129.3 302.5 127.9 196.8 146.0 0.1 1.0 374.5 409.4 153.1 322.6 4.3 0.6 1.1 260.0 341.5 0.9 257.8 1.5 0.8 0.2 0.2 4.7 208.3 1.7 1.7 0.8 2.9 237.1 2.2 102.0 240.0 0.0 221.1 2.3 247.7 222.3 136.5 1.2 243.0 1.8 0.9 175.8 101.0 7.4 1.3 118.8 210.3 203.9 198.0 1.3 167.3 285.9 267.6 122.3 1.6 196.1 87.3 114.8 121.8 80.1 125.9 80.5 113.7 81.7 85.1 111.0 99.1 71.4 61.9 95.2 90.8 83.2 131.7 113.4 95.0 15.8 24.6 17.6 54.1 15.9 16.4 16.3 17.5 17.8 15.4 17.1 17.4 114.3 51.3 67.0 11.1 124.4 186.1 125.1 196.1 138.9 56.8 135.5 196.3 91.3 105.8 116.5 101.2 12.5 211.8 106.4 185.6 270.1 184.7 452.7 75.1 71.7 122.7 125.7 103.5 14.1 175.2 252.7 118.3 93.3 68.2 129.5 102.3 125.7 126.6 296.2 48.8 14.3 175.4 138.4 204.4 218.5 270.7 153.7 146.2 152.9 8.4 181.1 168.3 121.5 14.6 19.1 182.9 248.1 125.3 152.1 154.3 283.1 397.5 91.3 47.8 138.1 107.9 152.2 485.6 186.5 142.7 186.3 282.1 111.5 116.8 184.3 150.6 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869533 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1" "Group enriched" "Detected in all" 6 "dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" NA NA 100000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favorable (5.76e-4)" "prognostic unfavorable (9.02e-4)" 443.9 304.5 65.6 399.7 71.2 87.0 249.0 65.9 77.2 583.2 101.0 312.4 120.8 379.2 116.9 421.6 368.4 230.6 447.0 64.7 95.5 420.6 497.2 428.9 289.6 100.4 90.8 169.1 135.4 79.6 156.8 253.2 107.4 255.5 159.3 33.6 437.3 156.6 237.4 184.7 260.2 316.1 91.9 521.1 194.3 33.2 204.5 60.9 1150.7 99.3 104.0 431.9 477.8 159.2 66.6 283.4 4.0 94.9 657.3 754.5 128.3 885.0 1607.5 258.4 299.5 10.3 294.4 1.5 32.2 1436.1 419.3 279.5 65.3 157.1 195.6 25.9 52.6 58.8 10.0 397.1 479.2 7.7 73.7 296.4 532.2 327.2 427.3 611.5 33.4 20.2 81.7 260.7 194.6 62.5 6.5 23.1 16.3 839.7 91.3 33.6 39.3 202.7 2.6 121.1 4.9 68.6 165.1 68.6 514.6 110.1 97.8 68.7 922.4 766.5 111.9 129.9 259.3 182.7 178.5 4.8 432.5 22.9 249.4 390.6 610.1 90.6 26.3 467.3 35.4 44.1 79.0 31.5 287.4 38.8 48.3 21.5 97.8 31.3 307.6 410.1 78.7 703.7 65.6 71.2 65.9 77.2 64.7 95.5 100.4 90.8 107.4 91.9 204.5 159.2 87.7 109.0 171.4 17.6 54.8 54.7 441.6 563.2 54.7 55.2 94.1 74.5 320.1 165.8 331.7 114.0 41.7 279.4 122.4 147.9 27.4 294.6 15.6 105.8 240.1 163.0 154.7 210.2 36.2 238.2 341.7 155.0 44.4 183.5 179.4 105.9 204.2 239.5 2744.5 58.9 42.8 94.2 158.7 1774.9 436.5 18.5 76.4 1224.3 161.9 70.3 373.1 117.4 24.7 19.1 12.9 363.9 154.0 92.9 47.3 295.5 198.6 351.8 180.8 40.0 39.5 39.4 149.9 10.8 21.0 160.3 40.5 649.6 56.0 32.1 139.6 321.4 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 1.2;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "A-431: 450.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" NA NA 11000000 "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: AB_2683379" "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (2.19e-6)" "prognostic unfavorable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 91.7 142.5 28.3 15.6 30.0 4.9 82.9 29.7 32.3 112.3 28.5 84.9 28.4 117.8 18.7 131.6 85.0 35.1 106.9 27.7 28.2 109.6 66.9 74.8 9.0 33.2 30.8 112.9 79.5 18.1 94.1 23.9 30.9 101.6 23.8 8.4 92.9 27.0 65.7 104.4 70.9 31.8 29.5 53.3 92.2 62.0 30.3 8.7 89.5 14.5 12.7 88.1 101.2 32.5 450.2 97.2 32.0 37.2 53.2 81.9 52.5 93.8 92.5 80.7 63.4 129.5 110.3 17.5 90.6 121.1 86.3 97.3 38.6 98.7 58.7 35.5 39.1 1.7 73.6 61.1 113.9 0.4 22.6 116.6 68.0 89.4 50.2 84.4 68.8 0.5 51.3 3.3 80.9 122.9 0.9 6.4 35.0 163.4 58.6 0.2 39.3 14.3 90.5 143.7 26.3 44.9 68.3 93.2 158.0 57.2 75.8 1.9 86.8 70.8 45.3 111.2 63.6 7.4 5.2 1.0 141.1 0.4 98.9 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.1 0.4 0.0 6.8 28.3 30.0 29.7 32.3 27.7 28.2 33.2 30.8 30.9 29.5 30.3 32.5 95.3 44.8 51.8 61.7 4.0 151.9 102.8 85.8 46.1 39.4 81.0 57.9 64.1 80.1 95.4 134.3 18.8 83.8 1.6 224.4 64.6 146.5 12.4 86.4 84.8 89.9 74.4 18.9 93.4 221.5 95.6 89.1 76.0 116.1 6.3 117.7 78.9 44.1 10.4 38.7 65.4 123.8 57.0 8.9 34.1 26.1 103.2 38.6 122.7 28.1 5.9 42.5 0.0 40.2 145.8 260.6 177.8 98.9 3.1 153.5 108.4 164.3 89.4 32.5 59.2 61.0 87.5 32.0 47.0 76.7 174.9 106.3 5.4 91.4 111.9 258.1 DAXX DAP6 ENSG00000204209 "Death domain associated protein" Q9UER7 6 33318558-33323016 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002224, HPA008736, HPA008797, CAB025546, HPA065779" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear bodies" "CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558" "prognostic favorable (6.05e-4)" "unprognostic (2.90e-1)" "unprognostic (9.66e-2)" "unprognostic (4.04e-2)" "unprognostic (8.55e-2)" "unprognostic (1.36e-1)" "unprognostic (1.46e-3)" "unprognostic (3.48e-1)" "unprognostic (1.92e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (6.32e-7)" "unprognostic (2.43e-1)" "unprognostic (5.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 27.5 33.6 6.4 4.0 6.2 8.1 25.3 5.0 12.0 28.4 2.9 27.9 8.1 27.8 18.9 30.8 28.6 7.2 22.3 6.8 5.8 23.2 25.0 24.0 8.7 6.9 5.9 23.8 23.1 19.3 22.1 7.9 5.5 25.1 10.8 5.2 24.2 9.3 35.4 28.8 30.4 10.6 4.8 44.3 25.0 36.7 6.7 23.5 24.2 12.5 27.3 27.2 25.9 9.0 20.8 0.1 38.0 15.6 16.0 16.0 30.1 27.4 76.7 61.5 43.6 1.6 11.8 58.5 14.8 33.3 65.5 11.8 0.3 46.1 62.5 29.9 39.6 52.0 29.9 39.9 26.5 37.0 17.0 27.0 32.5 25.8 31.0 22.7 15.5 16.2 39.1 21.2 32.1 23.2 29.7 54.1 1.2 0.2 9.1 35.2 5.6 41.8 11.7 1.6 49.7 20.2 0.0 0.9 22.7 14.8 17.5 0.5 22.9 26.3 29.1 0.5 0.3 35.4 58.3 66.4 23.3 23.0 27.7 24.1 22.5 47.3 55.6 28.9 54.9 58.8 48.3 61.3 28.2 56.8 44.5 49.6 22.9 62.9 35.1 27.0 59.0 70.5 6.4 6.2 5.0 12.0 6.8 5.8 6.9 5.9 5.5 4.8 6.7 9.0 18.4 6.4 22.8 5.2 45.3 58.5 23.5 36.2 48.3 19.2 25.8 19.4 7.9 18.6 27.6 12.9 18.8 25.2 41.3 23.3 23.5 38.5 15.7 14.5 54.8 23.9 21.0 27.1 3.7 38.3 35.9 25.2 16.8 23.6 37.9 12.9 16.4 14.5 24.3 15.2 3.8 21.2 12.2 17.2 42.5 7.6 17.7 19.7 24.9 6.5 48.8 29.9 52.5 5.0 4.6 45.4 21.8 23.3 38.7 31.8 20.3 14.4 15.6 111.1 13.1 18.7 19.9 63.8 41.5 45.9 60.9 24.8 42.8 24.1 22.0 35.7 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048287-94081212 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 80.7 130.5 23.3 3.9 24.2 23.5 75.2 25.9 29.7 80.0 24.5 85.8 3.7 93.1 37.2 48.9 81.4 6.7 114.3 24.3 23.9 61.2 43.4 69.4 10.4 31.2 25.2 87.3 49.8 7.0 109.0 2.8 25.4 69.9 3.8 8.0 53.9 4.9 123.9 67.4 59.6 4.1 23.9 75.9 66.1 114.3 25.2 8.0 73.5 4.2 9.1 80.2 65.9 26.2 6.5 1.8 11.5 7.5 6.8 8.8 2.7 17.6 14.5 22.4 20.0 2.2 4.0 29.8 6.4 3.9 6.7 4.1 11.9 1.1 24.5 13.0 0.7 15.8 4.3 9.9 5.7 23.0 6.8 1.4 6.6 4.1 3.9 7.5 3.7 5.6 8.5 8.2 9.6 18.2 7.0 19.6 7.6 1.9 0.2 9.3 26.6 3.5 17.0 2.4 9.1 8.4 17.3 4.2 8.5 1.8 6.8 8.1 11.3 6.4 4.4 8.2 5.3 3.4 24.8 31.5 9.2 12.3 5.1 9.5 2.1 1.7 3.0 1.7 0.8 1.7 1.6 1.8 1.2 2.3 3.0 3.0 1.5 3.8 1.8 1.9 2.1 3.0 23.3 24.2 25.9 29.7 24.3 23.9 31.2 25.2 25.4 23.9 25.2 26.2 164.7 169.9 160.6 45.4 245.9 182.8 186.6 147.4 171.4 184.7 86.6 94.7 228.3 64.3 146.4 147.1 131.3 94.0 332.8 74.1 272.0 147.0 98.2 244.0 248.2 142.2 97.5 75.5 62.9 98.9 72.6 189.0 95.8 201.0 154.9 251.5 109.6 103.4 85.1 232.2 73.6 89.0 118.0 92.1 147.4 67.4 231.5 143.5 99.6 45.0 158.0 133.4 122.6 31.7 56.1 91.0 67.4 244.8 225.6 116.4 70.7 242.3 160.4 200.5 164.3 185.0 198.0 506.5 435.9 127.6 145.6 157.1 342.1 305.9 74.9 123.7 DDX39B "BAT1, D6S81E, UAP56" ENSG00000198563 "DExD-box helicase 39B" Q13838 6 31530219-31542448 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Transport" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034012, HPA055334, HPA058450" Enhanced Enhanced "Nuclear speckles" NA NA 270000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721" "unprognostic (2.78e-2)" "unprognostic (1.30e-2)" "unprognostic (6.86e-3)" "unprognostic (3.44e-2)" "unprognostic (3.22e-2)" "unprognostic (5.13e-3)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (3.53e-3)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.85e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-2)" "prognostic favorable (1.43e-5)" 130.5 138.3 11.9 23.7 12.3 5.5 125.0 12.8 13.1 147.7 12.0 126.6 3.0 127.6 103.5 105.9 133.9 6.2 141.8 11.4 12.4 123.0 125.9 117.5 34.5 14.4 12.5 173.0 187.5 7.9 125.0 14.6 12.6 141.8 16.6 34.3 103.1 30.3 181.6 104.3 134.1 9.5 13.5 178.1 117.0 59.8 12.0 40.1 133.4 60.4 26.4 118.6 113.2 14.6 9.0 130.9 37.7 19.7 121.4 78.1 24.7 9.6 11.5 28.8 25.4 13.3 17.8 24.3 75.0 145.0 106.3 16.5 42.8 223.1 26.7 8.1 352.9 19.9 14.3 28.7 13.2 35.1 18.8 129.0 117.8 28.9 244.9 131.0 18.3 157.0 255.5 7.1 24.1 6.3 22.7 254.1 17.2 18.3 13.0 17.9 41.6 10.8 143.5 11.8 18.4 151.2 26.3 9.0 15.6 35.7 6.5 36.5 10.3 3.7 13.9 3.6 26.7 68.2 78.9 229.9 2.3 39.5 16.6 2.5 6.4 4.8 4.8 7.6 6.4 4.2 6.9 6.7 9.3 6.2 10.2 8.8 4.3 5.2 4.6 7.7 7.1 5.6 11.9 12.3 12.8 13.1 11.4 12.4 14.4 12.5 12.6 13.5 12.0 14.6 31.5 22.4 36.9 0.0 43.9 14.4 41.9 13.2 35.9 21.3 21.8 15.7 4.0 5.7 22.2 3.7 22.9 13.9 58.1 15.2 5.9 9.7 1.4 23.0 37.8 26.5 17.3 26.3 0.0 8.2 11.8 28.0 64.2 32.4 37.2 58.3 13.2 6.9 9.8 15.2 0.0 11.7 12.2 14.8 14.4 2.6 16.1 34.9 8.8 0.0 17.1 8.5 66.9 0.0 0.0 10.4 11.7 11.7 44.5 23.0 17.5 5.1 31.5 27.2 26.3 57.9 35.2 6.4 6.7 44.2 13.5 17.0 50.3 79.6 12.7 33.9 DELE1 "DELE, KIAA0141" ENSG00000081791 "DAP3 binding cell death enhancer 1" Q14154 5 141923855-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 31.3;Cytotrophoblasts: 26.2;Exocrine glandular cells: 24.3;Granulosa cells: 24.4;Hofbauer cells: 29.1;Syncytiotrophoblasts: 25.7;Theca cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 42.5 54.2 26.5 22.5 29.1 39.7 42.0 30.4 32.9 43.3 33.6 43.8 30.3 41.2 14.6 35.4 38.8 24.9 78.9 26.8 27.7 44.5 53.5 46.2 30.2 29.9 28.6 37.9 42.9 38.1 34.0 29.4 28.9 41.4 31.2 14.0 33.1 24.5 71.1 32.3 39.6 30.1 27.7 65.7 42.4 15.6 29.5 19.3 40.3 49.7 27.1 43.4 38.7 29.6 23.6 31.5 44.7 65.9 34.7 45.5 29.7 29.8 48.8 51.6 56.8 46.0 54.0 55.1 33.2 32.9 29.9 35.1 27.2 62.8 28.4 31.7 24.0 33.4 37.9 34.5 43.8 48.3 63.3 55.8 31.3 45.4 37.0 46.0 54.5 11.5 21.4 72.9 26.9 30.8 13.0 26.8 17.2 28.6 49.9 43.5 29.7 61.8 37.2 33.7 25.0 31.8 35.2 54.0 72.6 28.8 70.3 42.6 44.1 38.9 23.8 20.7 27.0 20.1 23.3 34.0 32.0 38.1 43.4 21.2 43.0 14.8 21.2 56.7 19.7 20.6 16.5 20.7 56.1 19.1 13.8 18.2 18.2 24.7 66.9 22.2 27.2 25.3 26.5 29.1 30.4 32.9 26.8 27.7 29.9 28.6 28.9 27.7 29.5 29.6 31.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 16.0 17.0 0.0 0.0 0.0 11.0 0.0 26.2 13.7 0.0 13.7 12.4 0.0 12.0 13.7 10.9 0.0 0.0 0.0 24.3 13.8 6.3 0.0 12.1 0.0 24.4 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 17.2 0.0 0.0 5.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 25.7 4.8 34.5 0.0 0.0 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol No No "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: AB_2680944" "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favorable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 30.4 20.1 15.7 21.5 17.6 29.1 31.0 22.4 17.8 33.8 23.3 36.3 19.6 38.2 26.8 27.1 36.8 17.5 27.6 15.4 17.2 25.5 24.7 30.9 31.6 16.4 16.4 39.5 24.6 28.5 28.1 24.8 16.6 34.0 19.7 19.9 33.2 24.9 32.5 39.5 36.5 20.9 14.0 35.9 28.8 27.9 17.3 30.8 33.0 22.8 26.9 32.6 31.5 22.2 29.6 22.5 36.7 21.0 18.4 22.6 19.6 21.9 18.5 79.4 22.8 96.4 29.9 29.0 29.4 26.9 46.1 45.2 33.8 42.4 51.1 16.1 22.9 41.9 40.2 69.6 23.5 37.8 41.6 23.3 57.0 27.5 15.4 18.1 22.1 54.6 41.7 25.8 20.5 28.7 76.9 33.1 29.4 35.7 32.2 53.7 47.0 18.5 13.1 26.0 45.2 26.7 43.8 41.9 28.9 21.9 41.8 42.7 27.8 64.3 44.8 21.7 31.5 17.1 11.9 38.2 29.3 18.8 23.7 32.6 7.2 20.2 15.0 9.5 15.9 11.7 13.4 14.8 5.1 9.8 17.6 16.5 10.6 13.8 7.6 10.7 11.8 9.6 15.7 17.6 22.4 17.8 15.4 17.2 16.4 16.4 16.6 14.0 17.3 22.2 24.8 25.6 30.1 37.9 28.4 24.2 35.3 17.8 25.6 25.6 23.1 19.6 27.5 22.8 23.8 25.8 33.3 28.6 49.0 32.3 23.5 18.0 42.8 32.1 26.1 26.2 19.2 21.0 44.9 13.8 15.7 24.2 30.1 34.3 22.8 33.8 20.7 19.6 14.5 38.7 46.0 23.2 14.2 16.8 13.7 13.0 35.1 20.2 21.4 32.8 26.8 16.7 42.2 40.7 47.4 22.2 20.2 33.8 30.0 26.3 25.3 9.6 45.8 23.4 6.6 35.4 23.4 26.1 32.1 26.0 25.6 19.7 32.1 25.6 21.1 34.4 DLG5 "KIAA0583, P-dlg" ENSG00000151208 "Discs large MAGUK scaffold protein 5" Q8TDM6 10 77790791-77926755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 112.5;Glandular and luminal cells: 139.6;Horizontal cells: 186.7;Syncytiotrophoblasts: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001746 Supported "Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "HPA001746: AB_2666418" "unprognostic (1.36e-1)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (6.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (5.38e-4)" "unprognostic (8.48e-2)" "unprognostic (6.41e-2)" "unprognostic (1.68e-2)" "unprognostic (2.02e-2)" "unprognostic (2.60e-1)" "unprognostic (8.00e-2)" "unprognostic (3.06e-1)" "unprognostic (5.13e-1)" "unprognostic (6.00e-2)" "unprognostic (2.74e-2)" 11.9 51.8 8.3 0.5 8.1 0.2 19.4 7.7 8.5 24.4 9.4 28.6 0.3 25.1 16.3 19.7 17.7 1.1 7.4 8.1 8.6 8.8 4.6 8.6 0.4 17.2 9.6 19.5 11.1 6.1 33.9 2.4 10.2 31.2 1.7 4.2 16.8 2.9 26.3 36.3 12.5 2.2 10.1 4.1 16.4 6.2 8.6 1.2 22.3 0.9 1.4 20.3 22.2 10.3 5.7 0.1 4.5 4.9 6.8 2.9 2.9 6.3 3.7 1.1 1.1 0.0 3.8 0.0 6.0 3.2 1.9 6.0 2.3 3.4 4.2 2.0 7.5 1.1 0.0 7.0 6.5 0.4 1.5 3.3 8.1 0.2 9.8 8.2 0.4 0.1 3.0 0.0 3.4 2.0 0.6 1.8 4.3 7.0 20.0 4.1 1.4 0.3 4.8 0.0 1.5 4.2 2.7 5.7 2.2 6.1 2.3 1.1 1.9 1.2 9.2 1.2 5.7 0.0 0.7 0.5 1.2 1.2 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 8.1 7.7 8.5 8.1 8.6 17.2 9.6 10.2 10.1 8.6 10.3 5.2 6.4 5.4 21.2 0.5 29.6 24.2 20.2 12.0 18.3 41.9 28.3 2.8 12.8 13.6 20.2 16.7 112.5 12.1 12.2 0.0 6.7 16.4 55.6 41.7 4.9 2.4 0.0 24.0 5.9 23.6 12.5 8.2 139.6 1.3 49.4 3.3 3.3 13.1 186.7 28.3 10.4 8.2 0.0 3.9 10.2 18.6 1.8 8.8 10.3 0.8 46.4 9.2 19.1 13.6 12.4 7.6 18.4 6.8 25.4 15.2 2.1 34.6 15.3 26.3 24.2 15.1 1.6 7.6 10.8 24.2 171.6 5.5 10.4 10.1 23.5 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363744 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 9.1;Suprabasal keratinocytes: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 13.4;MCF7: 13.2;REH: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Mitochondria Nucleoplasm "HPA062738: AB_2684857" "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 16.4 12.2 2.1 0.9 2.5 0.9 16.4 2.7 3.4 16.0 1.4 16.9 1.1 16.6 0.4 10.0 14.1 0.5 36.5 2.1 2.0 23.0 14.4 12.6 1.0 2.2 2.3 12.1 27.9 0.9 11.4 0.4 2.4 12.5 0.1 0.3 10.1 0.5 23.1 13.8 11.3 0.3 2.0 15.5 13.5 12.0 2.3 0.8 12.5 3.8 0.4 17.3 12.2 2.6 1.7 2.8 0.9 3.3 0.5 0.9 1.8 1.8 1.3 2.3 1.0 3.5 1.9 4.1 9.7 1.8 1.7 3.4 0.6 1.7 0.2 13.4 3.1 1.1 1.3 1.0 1.9 2.2 1.4 1.4 1.7 1.8 1.1 0.6 1.2 2.0 1.7 2.9 1.5 13.2 4.5 2.7 5.2 2.7 7.6 13.4 1.6 5.1 2.9 1.6 4.1 4.7 2.8 1.9 2.9 0.5 2.6 1.4 2.8 4.0 3.5 2.8 4.6 2.7 3.3 3.5 2.6 0.9 3.7 0.7 0.0 0.0 0.4 0.2 0.7 1.3 0.6 0.7 0.1 0.5 0.6 0.6 0.1 0.1 0.1 0.3 0.8 0.0 2.1 2.5 2.7 3.4 2.1 2.0 2.2 2.3 2.4 2.0 2.3 2.6 5.4 0.0 0.0 3.3 6.0 8.4 1.1 0.0 9.1 0.6 4.7 3.9 0.8 0.0 0.7 5.5 0.0 1.0 4.3 1.2 1.9 0.5 0.1 3.0 6.9 3.4 0.0 1.7 2.0 1.1 0.9 3.7 3.6 2.6 0.0 1.0 1.4 1.1 1.0 0.0 2.1 1.2 0.0 0.3 7.5 0.2 1.2 3.0 1.8 1.9 0.6 0.3 2.1 2.5 3.5 0.6 0.3 1.2 7.1 0.6 0.8 3.0 0.1 0.4 0.0 2.5 3.7 1.5 4.8 5.7 9.1 1.1 6.9 1.1 0.9 0.9 DPH1 "DPH2L, DPH2L1, OVCA1" ENSG00000108963 "Diphthamide biosynthesis 1" Q9BZG8 17 2030137-2043898 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069750, HPA073864" Approved Approved "Nucleoplasm,Cell Junctions" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Cell Junctions" "HPA069750: AB_2686188, HPA073864: " "unprognostic (5.54e-2)" "unprognostic (1.99e-1)" "unprognostic (1.62e-1)" "unprognostic (1.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "prognostic favorable (1.78e-5)" "unprognostic (2.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (7.30e-2)" "unprognostic (1.41e-1)" 24.5 32.3 13.1 6.0 12.8 5.3 22.2 16.8 17.7 29.1 10.7 26.8 8.0 28.8 5.6 19.8 31.0 9.1 19.2 13.7 11.9 28.0 36.3 16.6 7.5 10.3 10.9 26.6 32.0 14.2 59.3 8.5 10.3 36.2 6.2 12.4 23.7 11.0 42.3 29.3 20.8 8.9 10.1 24.3 27.0 20.3 11.7 6.7 28.6 13.7 6.0 24.2 22.3 11.5 15.4 24.9 6.3 16.0 22.2 14.2 18.7 19.3 26.8 29.7 18.7 24.1 11.6 29.0 23.6 52.5 11.2 11.6 20.7 21.1 15.9 9.0 52.4 6.3 10.5 13.1 19.4 8.3 10.2 20.3 20.3 22.7 19.0 20.5 13.9 16.8 23.4 11.2 11.9 18.2 14.7 4.8 6.5 17.3 25.9 16.6 5.7 22.0 13.3 8.0 13.1 15.2 17.4 17.9 17.2 6.9 25.9 6.8 10.1 19.4 10.1 26.2 16.7 10.3 8.3 6.8 20.3 10.8 8.5 0.8 4.5 0.8 8.0 6.1 8.9 8.8 6.5 7.4 7.7 7.2 9.6 6.9 0.3 6.7 4.5 5.5 10.2 5.2 13.1 12.8 16.8 17.7 13.7 11.9 10.3 10.9 10.3 10.1 11.7 11.5 0.9 3.2 9.2 1.3 9.3 0.4 0.9 0.5 19.4 2.1 0.8 0.8 1.5 0.0 2.7 0.0 2.1 1.4 0.9 0.6 0.0 0.5 1.2 1.5 1.2 1.7 0.0 9.0 4.0 0.6 0.9 4.5 21.4 0.8 2.5 1.0 0.7 0.0 0.6 1.7 3.7 0.8 0.0 0.0 0.8 1.5 0.6 3.9 0.0 1.0 0.4 0.9 2.1 1.5 1.4 0.0 0.2 0.4 12.0 0.5 0.5 0.5 3.0 2.8 0.0 1.3 3.2 1.2 0.5 13.0 0.3 1.4 5.4 1.3 0.4 0.6 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-aminoacyl-tRNA deacylase 1" Q8TEA8 20 18587942-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 350000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 23.5 21.1 7.0 3.7 7.0 4.5 21.5 7.2 7.6 18.9 7.1 15.6 2.7 19.7 4.8 26.6 18.6 3.2 17.5 7.1 7.6 25.6 10.8 16.0 4.1 7.3 6.9 17.6 20.4 7.7 33.8 3.4 7.4 13.7 4.2 6.6 21.9 3.1 29.1 27.4 13.7 4.0 7.2 15.3 16.2 19.1 7.3 2.1 19.3 6.7 4.5 17.1 19.4 7.3 10.1 15.7 15.8 16.2 8.8 12.2 9.1 4.3 12.3 10.5 11.3 10.0 11.4 0.1 4.1 13.6 13.9 5.3 13.1 25.0 10.4 6.8 3.2 10.2 4.0 18.7 22.8 9.4 8.2 10.2 22.4 11.8 42.1 8.7 16.5 3.0 7.0 22.5 15.3 24.9 1.7 23.8 11.0 13.5 9.9 0.0 16.6 11.1 16.6 8.2 16.6 13.0 4.4 20.4 23.6 7.1 12.3 9.2 10.2 14.3 3.8 17.7 14.5 5.5 10.2 4.6 8.6 13.9 11.1 1.7 0.7 0.4 1.8 1.0 0.8 1.1 0.6 1.0 1.5 0.7 0.5 0.5 0.9 1.4 1.0 0.2 0.4 0.6 7.0 7.0 7.2 7.6 7.1 7.6 7.3 6.9 7.4 7.2 7.3 7.3 35.5 35.3 24.0 32.0 26.8 23.6 40.9 48.3 22.2 42.4 27.9 33.0 18.8 28.6 23.1 42.3 2.1 26.7 24.7 9.9 43.0 71.9 38.4 16.2 33.1 36.4 23.3 22.1 41.9 87.4 37.8 29.9 13.7 17.8 42.5 24.6 35.7 11.2 47.8 43.7 60.6 23.5 28.5 23.5 35.9 21.8 18.0 27.1 42.7 12.2 42.8 58.2 38.1 53.3 52.2 90.6 19.1 19.5 24.6 50.6 9.3 73.8 22.8 34.9 0.0 30.1 27.5 93.5 124.2 33.2 35.7 12.4 35.5 42.7 26.8 31.9 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554051-1572271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.6 2.1 3.5 0.2 3.0 1.0 6.0 0.3 8.1 5.1 0.0 11.3 0.0 8.4 0.6 1.4 8.7 0.5 17.0 5.0 0.1 5.4 3.6 9.5 0.3 1.9 0.4 2.4 15.7 0.2 25.5 0.1 0.1 5.1 0.3 1.6 6.1 0.2 13.3 4.3 6.8 1.2 0.3 3.1 8.3 3.1 0.7 0.2 3.7 0.0 0.1 3.6 4.2 2.0 0.6 0.3 0.4 0.0 0.0 0.0 1.1 0.1 0.4 0.1 0.6 0.6 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.1 0.3 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 1.4 1.7 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.8 0.3 0.8 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.3 8.1 5.0 0.1 1.9 0.4 0.1 0.3 0.7 2.0 14.9 3.2 1.1 0.0 6.3 9.8 8.1 2.7 2.8 113.6 32.1 24.3 6.0 14.3 3.2 12.9 47.9 0.3 11.1 57.8 1.9 7.7 0.3 31.5 24.7 6.5 42.3 0.0 11.1 11.3 0.5 4.3 8.6 65.6 0.0 0.4 1.4 0.6 0.5 90.9 11.3 32.6 6.1 0.0 3.4 0.2 0.6 4.7 5.4 2.8 1.0 22.3 1.0 3.0 5.2 11.0 22.4 0.4 4.7 17.4 19.1 1.6 2.8 35.5 6.6 8.0 15.1 0.8 0.6 2.2 4.8 5.9 10.5 0.7 25.0 14.2 DVL2 ENSG00000004975 "Dishevelled segment polarity protein 2" O14641 17 7225342-7234517 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009312, HPA021611, HPA022914, HPA064732" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear bodies" "CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338" "unprognostic (7.63e-3)" "unprognostic (6.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.34e-6)" "unprognostic (5.66e-2)" "unprognostic (8.01e-2)" "unprognostic (8.97e-2)" "prognostic favorable (3.85e-4)" "unprognostic (8.90e-2)" "unprognostic (1.28e-1)" "unprognostic (3.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.80e-1)" "unprognostic (5.45e-2)" 18.2 20.7 15.1 11.4 17.2 14.8 18.1 15.6 17.9 31.7 15.2 22.6 12.9 29.6 10.5 23.0 22.3 14.1 13.8 14.7 14.9 16.3 10.6 15.0 16.7 17.1 16.3 33.9 12.8 17.6 26.0 14.7 16.2 24.7 8.6 14.4 17.8 18.0 16.5 28.8 16.7 18.1 15.0 16.1 14.4 16.4 16.1 22.2 20.1 11.5 13.0 22.1 25.9 19.0 31.0 43.9 52.2 52.0 39.0 35.0 22.5 21.1 38.1 50.0 63.7 37.5 25.6 43.8 31.3 23.5 39.0 43.5 43.5 28.6 19.0 43.6 50.3 28.5 46.0 40.0 68.0 16.0 23.7 52.5 48.2 47.2 25.7 35.0 20.9 50.5 24.6 20.0 30.6 28.9 61.6 16.1 17.8 20.7 17.1 89.5 33.8 26.8 27.8 26.9 22.9 46.4 38.3 18.9 46.7 23.5 27.4 22.1 17.6 28.0 25.1 52.8 39.6 31.1 28.0 20.4 32.6 23.8 44.4 13.5 4.2 10.2 10.0 4.9 8.3 8.5 7.0 9.0 5.0 9.3 8.0 8.5 1.9 7.2 4.9 7.0 4.5 6.2 15.1 17.2 15.6 17.9 14.7 14.9 17.1 16.3 16.2 15.0 16.1 19.0 11.7 9.6 12.1 12.4 13.1 17.5 22.6 20.9 21.6 15.7 13.2 14.4 7.7 5.7 15.0 18.4 25.0 21.3 11.8 11.2 5.9 11.3 0.9 8.8 12.9 10.5 13.2 6.5 11.2 10.4 15.9 15.7 7.7 13.5 14.7 18.4 9.7 4.9 14.6 10.1 9.4 14.3 24.4 6.0 9.4 1.9 26.1 7.6 10.6 2.8 9.3 13.1 14.4 10.6 10.4 7.2 9.9 22.2 5.9 17.1 10.8 5.5 9.3 30.0 13.1 16.0 14.9 18.4 34.2 21.7 19.2 36.5 11.5 18.4 19.6 15.0 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964573-102056443 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease variant, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol NA NA 490000 "Cluster 11: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 22.4 19.3 7.8 4.9 7.2 9.2 18.2 16.1 10.9 17.2 0.0 29.1 3.6 24.6 5.0 18.5 17.5 4.0 29.7 9.2 1.1 12.6 9.4 19.9 4.4 5.2 4.3 21.0 15.8 2.0 20.9 3.0 9.0 14.5 3.1 13.2 19.9 2.9 53.1 27.6 19.2 3.1 0.6 14.2 19.7 13.0 2.1 2.0 17.6 1.2 2.4 23.4 18.0 9.2 3.3 6.6 5.0 4.6 3.0 5.0 3.2 3.0 1.8 5.1 4.5 2.6 4.5 4.2 3.4 5.4 4.9 4.0 8.2 5.3 3.6 3.4 3.5 4.1 15.1 3.3 2.7 3.6 6.4 6.4 6.3 14.1 4.9 3.2 3.9 8.0 3.0 8.9 4.5 4.2 5.6 4.1 5.1 2.1 10.2 4.6 3.3 1.6 5.2 7.6 8.4 2.8 3.2 2.2 3.4 4.9 2.5 1.5 11.5 6.8 4.1 11.5 5.1 4.3 7.6 4.9 9.1 2.9 3.0 1.3 0.6 0.8 0.6 0.4 0.5 0.4 0.4 0.4 0.6 0.5 0.3 0.5 1.2 0.4 0.6 0.6 0.4 0.3 7.8 7.2 16.1 10.9 9.2 1.1 5.2 4.3 9.0 0.6 2.1 9.2 102.1 125.0 84.7 83.9 55.9 52.4 46.4 75.0 51.2 126.4 63.1 55.5 182.9 31.5 89.1 77.3 139.7 49.6 106.3 94.2 13.7 112.6 14.8 123.6 131.0 93.7 71.3 38.1 127.3 81.2 42.9 86.5 86.6 134.6 33.5 117.9 46.1 36.7 40.2 183.4 131.0 68.0 75.3 52.7 123.6 16.8 70.5 90.7 71.2 51.5 99.2 63.3 73.2 51.8 93.3 131.3 73.6 71.5 100.0 47.6 82.6 48.5 90.7 115.4 85.5 81.4 106.1 87.1 72.2 59.2 64.1 37.4 91.3 86.1 64.4 46.5 E4F1 E4F ENSG00000167967 "E4F transcription factor 1" Q66K89 16 2223580-2235742 "Enzymes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052042, HPA069007, HPA071325, HPA072309" Enhanced Enhanced Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: " "unprognostic (3.05e-1)" "prognostic favorable (9.13e-4)" "unprognostic (7.31e-2)" "unprognostic (4.57e-3)" "unprognostic (2.89e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.16e-2)" "unprognostic (4.23e-2)" "unprognostic (3.08e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (8.49e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.85e-1)" "unprognostic (1.03e-1)" "unprognostic (5.12e-1)" "unprognostic (8.93e-3)" 13.5 16.0 7.9 6.6 8.6 11.3 15.1 10.2 13.5 17.5 4.8 16.5 6.2 18.7 1.9 16.1 15.2 3.3 15.3 8.1 7.0 16.1 19.0 13.4 6.8 10.2 8.1 15.9 15.2 4.4 19.0 5.3 10.0 21.3 1.8 3.0 16.0 5.5 19.0 23.6 15.0 2.7 6.1 20.5 14.8 14.4 8.3 6.4 22.6 4.3 2.8 16.1 16.4 9.4 10.9 20.2 8.3 16.4 4.8 4.4 20.0 14.8 6.6 10.0 6.7 32.7 16.2 15.8 15.8 5.7 5.6 14.6 6.8 7.6 1.8 17.2 25.6 11.2 36.1 18.0 9.3 14.2 19.1 6.6 8.5 9.0 4.1 5.6 6.9 13.5 26.7 10.6 3.8 30.1 18.8 30.6 18.7 6.6 18.8 34.7 9.1 27.9 6.2 7.6 21.4 15.5 18.4 21.9 10.7 3.0 19.4 20.0 12.3 12.0 15.7 12.0 12.4 20.7 10.9 32.0 5.0 10.0 12.3 6.8 8.1 11.7 10.2 9.8 8.8 8.2 8.4 9.7 8.8 8.0 9.0 8.4 11.4 6.9 11.8 5.2 11.4 7.5 7.9 8.6 10.2 13.5 8.1 7.0 10.2 8.1 10.0 6.1 8.3 9.4 9.1 16.0 8.2 8.5 14.4 7.1 7.9 12.2 9.1 13.8 12.3 10.8 4.9 5.7 13.9 11.0 37.5 20.4 18.5 26.5 11.7 11.1 19.6 12.6 10.2 10.3 25.8 6.5 8.1 10.5 17.2 8.7 31.1 11.6 2.5 12.3 6.8 10.5 12.6 30.3 7.2 19.8 20.3 7.3 7.8 5.0 11.5 7.3 7.2 10.3 9.1 11.3 13.4 5.0 5.5 11.1 14.5 16.1 13.2 9.7 15.4 8.0 12.0 15.7 13.1 9.6 11.2 19.0 16.1 7.6 8.9 13.4 11.8 12.6 15.3 6.4 EEFSEC "EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153481-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 71.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 13.5 8.2 0.2 0.2 0.2 0.1 12.5 0.2 0.6 14.2 0.1 11.3 0.0 15.6 0.0 12.3 13.9 0.1 25.5 0.2 0.3 14.3 21.8 9.6 2.2 0.4 0.2 12.3 11.7 3.0 8.8 1.6 0.3 12.1 0.6 0.5 9.7 1.9 24.0 16.5 10.7 0.0 0.2 13.4 11.0 19.3 0.4 0.1 9.9 0.0 1.2 12.7 12.3 0.2 0.5 0.1 4.1 1.7 0.1 0.2 0.5 0.0 0.3 0.2 0.2 0.3 6.9 15.2 0.1 3.8 12.3 1.1 0.4 0.1 0.1 0.3 0.3 0.0 0.1 0.1 5.7 0.3 0.3 0.1 0.1 4.0 0.1 0.2 0.3 0.0 0.1 0.2 3.5 0.2 7.9 0.4 0.4 0.1 0.1 0.3 0.2 1.0 0.0 0.0 0.3 10.4 0.0 17.7 15.4 0.3 9.6 0.7 0.0 0.1 0.0 0.2 0.2 0.4 0.7 0.4 0.1 0.4 0.2 0.4 6.3 6.1 5.0 6.0 3.9 5.4 4.4 4.4 8.7 3.9 4.0 5.0 0.0 7.5 4.8 3.7 5.7 4.3 0.2 0.2 0.2 0.6 0.2 0.3 0.4 0.2 0.3 0.2 0.4 0.2 9.4 0.0 6.0 15.0 17.2 6.4 9.3 9.1 7.4 7.8 6.9 8.6 10.1 8.6 4.4 16.5 2.1 22.3 15.7 6.4 15.6 7.9 27.7 3.1 12.5 8.2 11.4 5.9 25.3 7.1 18.3 10.0 10.2 4.5 28.5 10.0 8.9 14.8 14.6 13.5 36.6 11.7 18.3 7.9 8.2 71.6 13.1 11.4 12.4 28.1 9.8 9.3 17.5 45.8 27.1 5.6 2.7 8.6 17.1 9.4 8.6 25.7 2.7 8.2 26.3 9.0 9.1 27.9 16.9 10.8 9.9 29.7 13.7 11.9 10.6 6.0 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164595-32168281 "Metabolic proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Granulosa cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.2;SK-MEL-30: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Nuclear speckles" "HPA061173: AB_2684443" "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 13.3 7.2 3.8 0.5 3.5 1.1 13.6 3.6 5.7 23.4 4.1 19.8 0.6 10.0 0.8 12.3 16.3 3.0 14.2 3.9 3.9 16.3 7.4 9.4 0.3 3.8 3.9 31.2 5.1 0.4 8.2 2.9 3.7 16.9 0.5 0.0 7.9 1.4 3.8 12.8 8.8 0.3 3.8 7.9 10.2 4.4 4.1 0.6 8.7 2.5 0.2 13.5 17.2 3.8 0.2 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.5 0.0 0.3 3.2 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.2 0.7 0.5 0.0 0.0 0.6 1.0 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 3.4 0.0 1.0 0.7 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 5.7 3.9 3.9 3.8 3.9 3.7 3.8 4.1 3.8 1.2 6.4 4.1 0.0 0.3 1.5 0.6 0.3 4.6 1.5 0.5 0.3 0.1 0.0 1.6 1.8 2.1 0.8 0.6 0.2 0.0 0.4 0.1 1.0 1.9 1.7 0.0 1.7 0.0 0.2 0.4 1.5 4.6 1.3 0.0 10.4 3.3 0.3 0.2 0.0 0.0 1.1 0.0 0.6 1.6 0.2 3.7 0.7 0.0 0.0 0.0 0.9 3.1 0.0 0.0 0.3 0.2 1.2 2.1 0.7 0.4 0.1 1.6 1.5 0.0 2.0 1.5 0.5 0.4 4.0 2.3 0.8 0.9 1.5 1.3 0.5 EHMT2 "BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a" ENSG00000204371 "Euchromatic histone lysine methyltransferase 2" Q96KQ7 6 31879759-31897687 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050550, HPA060259" Supported Supported "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Nucleoplasm "HPA050550: AB_2681170, HPA060259: AB_2684234" "unprognostic (3.11e-2)" "unprognostic (2.72e-1)" "unprognostic (4.39e-2)" "unprognostic (1.92e-2)" "unprognostic (5.44e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.89e-2)" "unprognostic (1.88e-1)" "unprognostic (9.78e-3)" "unprognostic (8.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.25e-1)" "unprognostic (9.03e-2)" 8.6 9.6 0.5 0.3 0.4 1.0 8.7 0.4 0.5 15.1 0.2 12.9 2.4 19.8 1.7 10.1 12.8 0.0 5.7 0.4 0.4 7.1 4.6 7.3 1.0 0.4 0.5 16.1 7.8 0.6 12.8 0.7 0.4 10.3 0.3 0.6 9.5 1.3 5.5 9.3 10.5 1.4 0.4 11.5 9.4 12.6 0.5 1.5 10.3 0.4 1.0 13.1 11.3 0.4 0.0 4.5 7.8 0.0 3.4 1.8 5.0 3.5 2.8 3.9 3.2 0.0 0.0 0.0 7.6 5.7 4.0 0.0 0.0 8.6 1.8 5.4 11.8 0.0 0.0 0.1 0.0 13.3 0.0 4.6 1.4 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 9.4 0.0 19.3 0.0 0.0 8.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.3 6.5 3.1 0.0 0.0 3.8 4.1 3.1 6.9 0.0 11.0 16.1 3.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.4 0.4 0.5 0.4 0.4 0.4 0.5 0.4 0.4 0.5 0.4 16.9 16.0 12.0 22.9 20.3 8.4 6.3 11.9 26.2 60.6 15.9 17.8 6.6 17.2 18.9 25.8 41.7 24.6 13.4 9.2 7.9 15.7 41.5 10.1 19.1 16.1 22.6 19.3 16.6 12.2 15.0 16.0 13.3 11.8 14.5 33.8 22.1 7.5 16.3 38.7 24.4 16.4 12.2 12.9 7.3 60.0 27.4 12.1 19.6 9.4 19.9 26.8 25.7 20.1 23.9 10.8 9.1 23.0 16.5 6.2 12.5 10.1 10.8 48.2 26.3 16.3 15.0 20.8 33.7 23.5 11.1 5.6 18.3 19.9 19.0 5.2 EMC2 "KIAA0103, TTC35" ENSG00000104412 "ER membrane protein complex subunit 2" Q15006 8 108443601-108489196 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 190.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022838 Approved NA NA 11000 "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA022838: AB_2670967" "prognostic unfavorable (2.64e-4)" "unprognostic (1.45e-1)" "unprognostic (3.52e-1)" "unprognostic (1.33e-2)" "unprognostic (1.54e-1)" "unprognostic (6.64e-2)" "unprognostic (1.10e-1)" "unprognostic (7.87e-2)" "unprognostic (4.36e-1)" "unprognostic (5.46e-2)" "unprognostic (5.76e-2)" "unprognostic (5.53e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-1)" "unprognostic (1.68e-1)" "unprognostic (2.22e-1)" "unprognostic (4.15e-3)" 40.8 38.2 20.1 5.3 21.4 3.5 36.7 20.7 25.3 33.9 19.7 42.9 6.0 27.7 10.1 39.8 31.0 6.7 49.0 19.3 20.4 40.1 34.6 35.5 6.2 21.9 20.2 29.5 41.0 9.6 32.3 9.3 21.3 27.2 8.5 10.2 33.0 7.5 57.3 30.9 27.6 7.3 21.0 26.6 35.1 38.7 20.0 4.6 30.2 10.9 6.1 33.7 33.8 26.3 10.5 5.8 5.0 6.0 9.0 10.1 4.5 4.1 6.5 7.1 6.5 4.8 6.7 4.9 8.7 6.8 5.2 4.6 9.8 10.7 9.0 10.4 9.7 7.9 12.0 7.0 13.7 4.6 4.8 10.7 13.2 6.1 12.0 10.9 9.3 5.6 7.3 5.2 9.4 11.8 6.4 7.0 4.6 17.1 9.9 2.8 6.0 8.0 16.0 5.6 5.4 3.4 4.8 1.3 10.0 7.4 8.3 7.7 5.4 5.0 4.4 9.2 5.4 5.3 11.8 4.9 12.6 10.8 7.7 11.6 6.1 10.4 9.0 5.9 8.1 6.3 8.1 10.7 6.3 6.0 9.6 9.6 7.9 6.9 6.8 10.3 8.5 5.6 20.1 21.4 20.7 25.3 19.3 20.4 21.9 20.2 21.3 21.0 20.0 26.3 47.3 32.1 49.5 50.9 22.8 27.5 52.5 157.7 27.3 17.9 18.6 20.8 66.8 37.1 98.7 36.8 14.6 57.2 25.8 19.8 86.1 52.0 72.8 48.4 28.4 37.4 21.1 9.9 30.9 46.5 47.6 43.9 17.3 28.7 35.5 20.8 32.9 24.7 47.7 18.5 37.8 23.6 93.6 20.5 16.1 24.6 36.7 21.3 32.0 24.4 38.6 57.9 16.5 44.7 102.1 34.2 27.5 37.2 27.6 31.4 40.3 102.4 98.6 30.5 65.7 39.3 64.6 190.8 71.6 20.5 27.3 73.5 24.4 45.9 22.2 42.5 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379273-154381523 "Disease related genes, Human disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 240000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 32.8 32.5 27.4 15.4 27.4 26.5 33.2 27.8 31.8 46.6 26.6 45.7 14.7 58.2 16.0 35.0 56.2 11.2 46.2 26.0 30.1 48.7 30.6 33.3 13.8 28.5 28.6 63.9 50.5 21.3 42.6 15.5 28.2 36.5 11.1 12.9 33.5 21.8 80.3 36.3 27.2 19.9 29.2 26.9 38.5 17.3 29.7 13.0 40.6 29.7 15.4 51.2 36.1 31.4 121.3 42.4 29.0 32.7 26.3 50.6 54.7 58.1 58.2 68.5 72.4 37.9 22.6 99.6 92.2 56.2 143.5 65.5 55.8 67.4 29.5 60.6 116.8 43.7 58.4 22.5 67.9 42.9 46.8 44.1 53.2 60.4 75.0 46.5 48.3 37.5 37.0 39.0 47.9 49.2 74.4 78.1 51.3 66.3 128.9 62.1 45.9 92.4 38.4 21.9 37.9 47.8 29.8 47.6 74.2 27.8 33.6 31.2 43.5 35.7 69.6 80.2 84.2 131.4 100.6 179.3 42.3 70.9 38.1 35.5 29.5 46.4 45.2 37.3 41.8 37.8 43.1 43.6 24.8 37.0 37.7 37.7 31.0 28.7 28.1 54.9 43.3 30.6 27.4 27.4 27.8 31.8 26.0 30.1 28.5 28.6 28.2 29.2 29.7 31.4 30.3 32.1 39.5 8.1 93.1 71.8 74.8 60.9 84.2 35.1 53.4 60.1 22.3 35.8 40.4 27.6 12.5 60.7 87.4 16.6 70.5 43.5 16.3 46.5 51.8 36.2 23.9 46.7 9.6 55.0 66.4 52.9 53.5 64.4 55.1 40.9 27.1 38.8 52.2 30.3 8.8 37.0 28.5 25.2 93.0 15.4 40.7 69.4 67.6 10.3 50.2 46.9 34.0 5.5 10.8 47.7 31.3 44.8 125.8 86.4 30.9 49.5 27.9 32.6 26.3 49.5 60.1 25.4 36.2 99.3 77.0 125.1 92.7 42.3 30.4 68.3 EME2 "FLJ00151, SLX2B" ENSG00000197774 "Essential meiotic structure-specific endonuclease subunit 2" A4GXA9 16 1772810-1781708 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 3.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.1;Gastric mucus-secreting cells: 15.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.5;REH: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045770 Uncertain NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA045770: AB_2679447" "unprognostic (2.67e-2)" "unprognostic (1.77e-1)" "unprognostic (2.07e-1)" "unprognostic (2.94e-1)" "unprognostic (5.83e-2)" "prognostic favorable (2.86e-4)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (6.76e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "prognostic favorable (6.32e-5)" 0.7 1.1 0.5 0.5 0.7 0.2 0.8 0.4 0.9 0.8 0.2 0.9 0.6 1.1 0.1 1.2 0.9 0.0 0.4 0.8 0.2 0.8 0.4 0.7 0.2 0.9 0.3 0.5 0.8 0.1 3.9 0.1 0.9 2.1 0.0 0.0 1.0 0.4 0.4 0.9 1.2 0.0 0.0 1.1 1.1 0.9 0.3 0.1 1.7 0.0 0.0 0.9 0.8 0.1 0.5 0.1 0.0 0.4 0.1 0.0 1.1 1.8 0.0 0.1 0.1 0.4 0.8 1.8 1.1 0.0 0.0 1.9 0.0 0.0 0.0 2.4 7.5 0.4 0.8 0.1 0.0 0.9 2.1 0.0 0.3 0.0 0.0 0.0 0.2 0.7 2.4 0.1 0.0 0.2 0.5 0.6 1.0 0.1 1.0 4.1 0.3 2.1 0.1 0.1 3.4 0.6 1.7 0.8 0.2 0.0 1.2 0.7 1.2 0.2 1.1 0.5 0.9 2.5 0.8 2.1 0.0 0.4 0.5 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.2 0.3 0.2 0.2 0.5 0.7 0.4 0.9 0.8 0.2 0.9 0.3 0.9 0.0 0.3 0.1 2.8 3.2 8.2 0.3 4.5 2.7 1.2 2.4 2.2 14.1 4.3 3.9 1.3 0.0 6.0 3.7 8.4 2.1 3.3 8.9 0.0 1.6 2.1 2.7 2.8 2.2 6.7 0.8 0.0 2.2 1.2 2.7 15.3 3.1 0.0 4.2 2.5 2.7 3.6 5.0 0.0 3.6 0.0 5.5 2.3 1.4 1.2 4.6 3.6 0.0 4.4 2.4 3.1 0.0 0.1 3.6 1.7 1.5 2.7 2.0 5.6 1.5 3.0 7.1 0.0 4.0 2.4 1.5 1.9 4.6 2.8 2.5 3.6 8.5 6.7 1.4 EPHB4 "HTK, Tyro11" ENSG00000196411 "EPH receptor B4" P54760 7 100802565-100827523 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Angiogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 2.0;neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB013537 Uncertain NA NA 1400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "CAB013537: " "prognostic unfavorable (8.56e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.33e-1)" "unprognostic (5.23e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.84e-1)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (9.51e-3)" "unprognostic (6.63e-2)" "unprognostic (3.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (8.84e-4)" 26.4 49.8 5.0 8.0 4.3 5.6 32.6 4.6 4.8 45.6 6.8 20.7 8.3 61.5 3.8 24.7 27.1 18.0 26.1 4.1 4.1 28.3 33.3 28.2 5.8 5.5 5.1 36.0 26.8 10.1 6.3 35.5 5.3 28.9 10.2 0.3 24.2 22.4 7.7 35.8 17.5 22.2 5.1 47.9 21.4 12.3 6.3 3.1 17.6 13.3 4.9 17.3 28.1 4.8 37.7 33.1 32.5 94.2 20.4 13.0 94.7 14.1 31.2 22.3 29.0 27.4 28.3 4.8 63.6 15.3 31.3 38.2 14.3 38.3 11.9 6.2 25.6 1.3 19.0 43.2 11.8 0.7 0.9 15.3 56.7 14.2 33.1 24.8 84.0 1.5 71.9 1.8 18.4 66.4 0.7 15.0 54.7 56.3 47.5 51.4 15.6 8.9 28.6 19.9 0.2 27.4 22.0 10.4 22.1 45.1 26.1 6.7 71.3 27.6 42.6 51.3 21.4 0.2 0.8 1.7 4.0 12.0 51.2 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.3 0.0 0.1 0.1 0.0 0.7 5.0 4.3 4.6 4.8 4.1 4.1 5.5 5.1 5.3 5.1 6.3 4.8 47.1 9.6 12.6 1.6 1.9 20.5 10.3 13.9 15.9 0.1 22.0 19.7 5.7 7.2 8.5 5.5 0.0 68.5 1.1 9.1 0.0 12.3 28.5 4.8 21.8 51.2 3.0 10.8 0.3 6.6 11.2 6.5 12.8 8.0 1.3 10.7 113.2 22.4 9.0 0.0 0.2 17.4 8.2 4.1 3.4 9.9 8.1 1.3 3.6 1.9 1.5 1.7 0.0 0.0 1.0 20.6 7.6 4.1 1.4 13.3 1.3 4.0 4.2 0.2 6.6 5.7 6.3 1.4 10.2 12.1 17.8 206.5 1.2 2.9 19.9 8.0 ERCC3 "BTF2, RAD25, XPB" ENSG00000163161 "ERCC excision repair 3, TFIIH core complex helicase subunit" P19447 2 127257290-127294166 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037153, HPA046077" Approved Enhanced Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "CAB037153: AB_796181, HPA046077: AB_2679527" "unprognostic (2.31e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-3)" "unprognostic (1.05e-1)" "unprognostic (8.85e-2)" "prognostic unfavorable (1.62e-7)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (9.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.30e-6)" "unprognostic (3.71e-1)" "unprognostic (8.50e-2)" "unprognostic (5.73e-2)" "unprognostic (3.92e-2)" 24.4 25.9 15.0 14.5 16.0 19.8 24.4 15.1 16.5 32.2 19.6 28.9 9.6 27.0 11.6 22.7 28.9 14.2 23.4 16.6 14.9 22.8 22.2 22.1 21.6 15.7 14.8 29.5 23.8 26.3 33.8 13.6 16.0 27.4 13.8 4.4 23.2 16.8 35.3 27.7 24.3 21.5 15.1 32.6 23.7 29.8 15.6 26.6 25.0 25.6 22.4 27.2 26.4 15.2 45.9 30.8 37.8 40.6 40.6 27.8 46.4 41.3 52.9 65.1 62.5 48.1 32.9 34.5 33.2 37.8 41.7 40.2 57.7 43.3 56.1 54.4 51.4 43.6 35.8 51.0 30.5 38.1 45.4 28.9 39.8 75.7 32.4 41.5 42.4 44.3 43.0 22.1 41.7 45.1 54.8 42.2 55.0 29.2 47.3 44.5 42.7 28.8 36.4 42.2 45.2 49.2 35.3 52.6 55.0 42.4 28.7 43.0 34.1 39.2 45.2 35.8 49.7 39.2 81.5 54.0 34.3 18.0 42.8 8.0 11.5 8.8 18.2 12.0 18.4 13.7 13.1 15.7 16.9 12.7 17.7 12.2 3.5 25.0 9.9 13.6 20.5 15.5 15.0 16.0 15.1 16.5 16.6 14.9 15.7 14.8 16.0 15.1 15.6 15.2 12.2 22.4 14.6 24.8 17.7 7.6 9.5 20.6 21.1 0.0 13.0 11.6 13.0 5.7 25.4 7.3 0.0 18.6 18.9 6.1 1.9 13.7 9.0 22.9 13.9 12.2 6.1 3.8 22.3 14.9 12.2 16.6 18.8 13.1 10.1 17.1 15.4 8.6 14.6 0.0 23.5 10.0 14.2 12.5 7.6 5.1 16.4 10.7 8.8 10.3 12.3 0.0 14.4 18.1 22.4 15.5 7.3 12.8 16.4 7.4 6.3 8.5 45.2 0.0 13.1 17.6 13.3 41.1 31.0 11.3 9.5 14.6 15.7 12.3 10.6 8.5 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247569-42255128 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 157.0;Suprabasal keratinocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 38.2 31.8 21.1 21.9 23.7 15.2 35.1 16.5 24.3 35.8 10.4 37.1 34.4 48.2 17.4 25.6 49.9 50.1 37.8 19.5 23.9 37.5 43.4 41.6 20.0 22.3 22.5 43.0 29.1 21.0 40.3 18.5 19.5 30.9 10.0 14.6 26.4 17.2 11.6 33.5 34.4 19.9 17.5 31.4 29.8 32.8 21.9 24.2 38.7 18.0 15.6 29.7 31.3 37.7 57.6 136.4 57.7 65.8 12.7 32.4 16.4 53.3 37.4 53.5 54.0 63.2 65.1 47.4 32.9 49.3 48.0 61.7 42.1 124.4 39.2 23.5 29.1 28.5 82.9 80.1 34.3 33.2 45.5 37.1 41.3 41.4 45.5 69.6 45.0 37.9 62.0 38.4 29.8 115.8 38.0 25.0 48.5 54.4 29.3 46.6 21.0 20.1 33.5 49.1 26.6 54.2 59.4 43.4 61.8 39.1 43.6 58.7 54.2 78.4 112.9 27.4 100.0 43.2 53.1 39.0 76.9 35.3 108.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 21.1 23.7 16.5 24.3 19.5 23.9 22.3 22.5 19.5 17.5 21.9 37.7 63.3 3.2 1.7 7.8 25.0 157.0 30.2 19.8 77.4 14.1 95.0 57.9 7.3 25.8 6.3 9.2 22.9 7.2 21.7 21.6 7.9 19.1 9.4 35.1 20.5 43.7 26.4 7.8 4.2 15.8 4.9 27.2 13.7 23.4 11.4 10.0 41.4 30.2 11.7 10.1 1.5 22.9 2.0 14.5 58.6 4.1 11.1 22.9 55.2 7.5 7.3 19.0 3.1 3.5 8.5 15.3 27.2 10.1 11.2 18.8 34.6 23.3 11.9 12.3 13.1 61.0 39.8 3.0 16.2 37.9 109.7 14.8 25.5 10.2 21.7 17.6 EVA1B "C1orf78, FAM176B, FLJ10647" ENSG00000142694 "Eva-1 homolog B" Q9NVM1 1 36322031-36324154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 143.9;Extravillous trophoblasts: 250.3;Syncytiotrophoblasts: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.3;BJ: 29.0;BJ hTERT+: 22.4;HSkMC: 20.4;NB-4: 41.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041928, HPA043537" Approved Approved Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol "HPA041928: AB_2677752, HPA043537: AB_2678538" "prognostic favorable (4.58e-4)" "unprognostic (5.66e-3)" "unprognostic (1.04e-3)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.45e-1)" "unprognostic (8.33e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.87e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" 26.8 19.4 5.5 3.4 5.4 2.0 35.8 5.5 6.4 41.8 7.5 19.8 2.5 34.0 0.6 12.2 21.9 1.3 19.9 5.0 5.9 39.2 8.5 26.1 1.9 6.8 6.4 30.2 7.8 1.9 9.4 9.0 6.0 29.0 0.4 0.0 28.7 2.9 5.7 24.0 15.8 1.6 7.0 37.6 14.2 7.5 6.6 0.5 33.9 1.0 0.5 22.0 30.1 5.7 0.7 2.7 1.6 3.0 7.9 23.3 6.8 29.0 22.4 5.4 6.3 0.2 2.1 0.0 8.5 9.2 1.0 0.2 0.2 1.1 1.1 3.3 6.0 3.6 0.6 1.3 17.4 0.1 0.6 20.4 0.0 6.9 0.3 0.9 8.7 0.1 1.4 1.0 3.6 0.2 0.1 41.7 1.7 0.0 10.4 1.5 0.3 7.1 4.6 0.0 0.1 3.9 2.8 1.1 13.3 1.1 0.0 2.7 12.7 7.9 0.0 10.5 2.7 0.3 0.0 0.1 2.9 1.8 7.1 4.0 0.9 0.0 0.2 0.3 0.6 0.0 0.3 0.5 0.5 0.0 0.0 0.0 1.7 1.6 0.1 0.0 1.2 0.1 5.5 5.4 5.5 6.4 5.0 5.9 6.8 6.4 6.0 7.0 6.6 5.7 82.8 0.0 0.0 2.3 6.2 16.2 19.3 7.3 0.0 0.0 143.9 90.6 2.2 1.5 5.1 7.3 0.0 54.7 8.4 0.3 1.9 20.2 7.1 9.4 88.4 53.9 0.0 0.8 0.0 15.2 250.3 56.6 0.0 15.2 4.5 15.7 84.9 0.9 48.7 0.0 0.0 0.1 6.1 41.3 28.8 24.8 50.7 30.4 12.4 5.6 10.2 14.1 4.1 0.0 0.1 28.9 1.1 48.5 7.9 56.6 0.4 7.7 5.6 0.9 26.3 7.8 98.4 8.4 3.3 0.7 12.4 161.3 9.7 58.2 0.5 30.3 EXD3 "FLJ20433, LOC54932, mut-7, Nbr" ENSG00000187609 "Exonuclease 3'-5' domain containing 3" Q8N9H8 9 137306896-137423211 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 73.2;Paneth cells: 178.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.4" "Low region specificity" "Detected in all" HPA047395 Approved Approved "Actin filaments,Focal adhesion sites" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Focal adhesion sites" "Actin filaments" "HPA047395: AB_10962864" "unprognostic (2.91e-1)" "unprognostic (5.67e-2)" "unprognostic (1.75e-3)" "prognostic favorable (4.30e-4)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (1.37e-1)" "unprognostic (2.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "unprognostic (7.99e-3)" "unprognostic (2.05e-1)" "unprognostic (8.67e-2)" "unprognostic (5.05e-2)" 9.4 10.1 6.2 3.5 6.8 3.5 10.8 5.9 11.0 11.5 6.6 16.0 9.4 9.9 1.5 11.6 12.3 4.2 11.2 6.5 5.8 12.2 8.1 10.2 3.8 7.2 6.1 10.7 9.8 3.7 13.5 3.4 6.4 14.5 3.6 0.8 10.1 3.7 9.5 10.2 11.3 1.4 5.5 14.8 12.3 4.8 6.1 1.1 11.4 2.6 2.3 10.9 11.2 6.3 8.3 7.0 3.3 9.5 2.8 4.0 7.8 4.0 4.5 3.5 5.3 4.8 17.5 3.5 9.1 3.1 8.7 14.5 1.0 4.4 1.1 8.2 8.1 2.6 13.0 7.9 8.5 1.9 29.4 4.8 6.0 3.1 2.8 10.2 11.9 0.0 7.0 6.4 3.0 22.3 0.1 6.9 3.8 18.1 4.7 6.3 2.6 25.3 7.1 4.7 4.5 7.7 4.0 8.4 3.8 3.8 13.6 9.3 15.0 4.8 4.4 7.5 6.2 8.1 4.1 3.0 8.7 6.4 7.4 10.7 3.4 7.8 2.2 4.5 2.7 2.6 4.0 2.1 3.9 2.4 3.1 2.5 0.8 4.1 4.4 2.5 6.1 2.3 6.2 6.8 5.9 11.0 6.5 5.8 7.2 6.1 6.4 5.5 6.1 6.3 17.6 0.0 6.3 24.2 5.3 5.9 10.0 8.9 13.6 14.6 13.5 17.0 5.2 10.0 11.2 7.3 14.6 9.9 8.1 46.4 9.8 6.8 17.9 11.5 6.5 14.1 7.3 5.0 21.6 11.3 3.3 7.3 19.4 13.1 61.7 10.5 17.2 7.2 9.2 21.9 24.1 27.6 16.2 5.4 7.3 73.2 5.9 6.9 3.6 13.1 6.2 10.0 12.3 26.2 14.6 6.4 178.2 7.9 6.6 10.0 31.3 11.9 9.3 10.4 13.1 5.5 9.9 2.3 8.9 9.9 8.9 4.0 6.4 19.5 39.0 9.2 FAAP100 "C17orf70, FLJ22175" ENSG00000185504 "FA core complex associated protein 100" Q0VG06 17 81539885-81553961 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023954, HPA024626, HPA026532" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.91e-1)" "unprognostic (1.85e-2)" "unprognostic (4.87e-3)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-2)" "unprognostic (1.05e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (9.85e-2)" "unprognostic (4.24e-1)" 14.7 16.8 6.7 13.8 7.0 10.1 15.9 14.7 9.5 18.6 6.8 15.8 12.0 17.3 3.1 16.2 18.8 9.5 16.3 6.7 6.4 21.2 22.7 16.0 15.9 8.1 6.5 19.5 26.6 7.8 22.4 7.2 6.3 20.7 4.9 3.7 14.6 7.8 13.2 16.1 18.8 6.9 5.1 38.1 15.5 13.3 7.3 8.8 24.1 6.0 7.3 17.9 15.5 8.8 11.7 21.3 9.4 26.8 11.0 11.5 14.6 11.2 5.9 14.3 8.9 14.5 14.0 21.0 8.6 15.5 13.8 15.0 4.9 14.5 3.3 6.1 13.9 13.5 23.3 20.0 11.6 15.4 16.0 14.0 10.7 10.4 11.7 17.6 27.0 22.0 20.7 16.5 7.0 23.0 24.4 25.8 11.3 13.6 7.7 22.1 9.4 19.3 10.4 21.1 20.5 17.1 8.5 24.4 10.4 9.7 26.2 20.7 22.8 30.6 18.8 8.3 18.9 18.3 1.5 10.7 8.0 9.9 14.3 0.0 3.0 1.2 2.4 2.8 1.9 3.0 1.6 1.6 2.9 2.0 1.5 1.2 0.4 2.4 1.4 3.2 1.6 2.2 6.7 7.0 14.7 9.5 6.7 6.4 8.1 6.5 6.3 5.1 7.3 8.8 11.4 3.2 7.5 0.0 7.5 0.0 3.5 0.0 4.6 10.3 9.8 10.9 8.9 10.0 2.5 14.7 4.2 6.1 8.5 7.1 3.9 8.2 1.9 4.5 7.3 7.5 7.3 11.8 0.0 6.9 4.8 8.3 15.8 6.8 0.0 14.9 6.8 11.7 8.4 6.7 0.0 6.2 0.0 14.1 0.0 3.0 5.0 7.0 0.0 0.0 8.9 6.2 4.1 0.0 0.0 8.9 4.4 5.3 6.6 5.3 12.7 6.8 1.5 4.9 0.0 7.4 6.4 7.3 7.5 9.5 0.0 3.1 6.2 10.7 7.3 3.6 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "FA core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 337.5;Proximal tubular cells: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 39.3 57.5 18.1 3.2 18.9 5.6 41.2 20.8 28.0 52.5 20.5 48.5 4.6 50.0 1.3 38.8 37.8 1.5 50.0 14.5 19.6 64.8 52.1 37.9 3.6 24.6 18.9 45.3 38.7 5.1 75.5 3.2 19.6 61.1 1.8 3.7 30.7 7.1 26.4 42.7 31.8 1.8 20.2 45.0 47.3 54.8 26.9 2.9 52.9 4.0 3.1 43.7 40.7 18.9 27.7 4.4 5.8 7.3 3.6 4.7 34.8 30.4 11.0 9.6 12.9 6.7 18.0 31.7 43.7 4.8 9.0 13.5 4.2 4.6 4.9 68.3 61.0 26.5 6.8 14.4 13.5 18.7 24.8 8.1 9.8 5.8 6.3 5.9 11.9 24.6 37.1 7.6 6.7 11.6 27.0 57.6 20.8 5.4 55.6 36.0 18.1 30.7 4.6 4.5 47.4 63.5 19.8 8.6 58.5 5.3 8.5 7.5 25.6 15.1 35.8 18.7 17.4 68.9 39.9 48.2 28.0 11.4 6.4 9.8 16.4 63.4 18.4 16.9 18.1 28.3 16.5 19.8 17.0 25.7 22.2 18.6 20.6 10.8 15.6 42.4 16.2 10.6 18.1 18.9 20.8 28.0 14.5 19.6 24.6 18.9 19.6 20.2 26.9 18.9 71.7 6.4 11.9 0.0 82.3 0.0 97.7 0.0 79.6 29.1 120.9 138.2 22.1 62.9 6.8 97.5 4.2 119.7 83.6 14.5 170.2 128.5 102.7 44.3 77.2 62.1 43.7 36.8 0.0 110.8 144.1 65.3 64.7 49.9 7.6 74.8 84.6 94.5 134.0 15.2 0.0 56.0 0.0 110.8 0.0 337.5 86.0 82.3 0.0 0.0 178.9 84.7 91.6 0.0 0.0 141.1 40.8 82.8 60.9 152.8 56.2 290.1 8.0 29.5 65.7 63.3 68.8 101.5 38.3 88.4 0.0 89.8 62.4 102.5 42.2 113.2 FAM120B "CCPG, KIAA1838, PGCC1, SAN1" ENSG00000112584 "Family with sequence similarity 120B" Q96EK7 6 170290703-170407067 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 556.1;Late spermatids: 1847.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037518, HPA037519" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA037518: AB_10671626, HPA037519: AB_10696935" "unprognostic (7.99e-3)" "unprognostic (7.81e-2)" "unprognostic (2.01e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (6.02e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-1)" "unprognostic (9.87e-2)" "prognostic unfavorable (1.60e-4)" "prognostic favorable (2.70e-4)" "unprognostic (1.41e-1)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (2.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" 12.3 12.2 9.3 5.7 8.7 4.5 12.5 11.2 11.2 11.6 9.9 11.5 6.2 12.1 8.9 10.0 12.2 6.1 10.7 7.7 9.0 8.3 8.8 9.4 7.1 10.0 9.8 11.0 9.6 7.1 11.4 6.6 10.3 11.0 8.6 9.2 13.8 6.2 17.4 12.3 10.1 7.6 7.7 10.1 10.2 14.4 9.1 7.4 9.8 6.8 6.6 10.9 10.4 10.5 7.0 7.1 8.7 12.7 15.4 14.2 6.2 6.4 13.4 8.5 7.2 6.4 5.2 8.0 5.2 14.2 9.2 8.2 11.0 13.1 13.0 9.0 5.2 10.5 6.5 8.4 10.5 10.5 6.5 14.0 11.2 9.2 12.2 14.6 15.7 6.3 9.5 7.8 17.0 13.7 6.3 11.8 5.3 12.5 4.8 6.5 9.8 10.3 10.3 6.2 6.0 9.6 6.2 8.7 2.9 13.0 7.0 20.6 13.4 4.2 6.3 11.3 6.4 6.6 7.3 9.9 11.6 7.4 15.9 16.5 5.9 7.5 5.4 6.4 6.3 4.4 5.1 6.1 6.4 5.3 6.4 5.3 10.0 11.9 10.1 3.5 6.6 6.7 9.3 8.7 11.2 11.2 7.7 9.0 10.0 9.8 10.3 7.7 9.1 10.5 17.8 22.4 17.6 36.9 13.2 3.6 5.2 11.1 16.5 16.7 13.7 13.6 15.7 11.5 13.0 14.7 33.3 10.5 7.3 11.8 0.0 8.4 556.1 18.8 16.7 15.4 9.6 11.1 48.8 9.1 7.6 13.1 14.3 22.5 10.1 14.1 10.4 10.7 11.0 6.7 53.2 12.5 12.2 9.8 5.6 1847.0 19.3 10.2 19.6 40.3 8.8 7.7 8.2 50.3 62.6 9.2 6.5 14.3 12.0 9.3 10.1 5.4 19.9 14.2 32.9 12.9 10.1 18.4 12.7 10.8 5.8 13.4 13.9 11.2 8.8 6.4 FAM156A "PRO0659, TMEM29" ENSG00000268350 "Family with sequence similarity 156 member A" Q8NDB6 X 52926402-52995472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Astrocytes: 16.0;Excitatory neurons: 9.6;Gastric mucus-secreting cells: 11.2;Inhibitory neurons: 11.1;Microglial cells: 8.4;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056640, HPA056643" Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 59: Non-specific - Transcription" "HPA056640: AB_2683200, HPA056643: AB_2683201" "unprognostic (1.80e-1)" "unprognostic (5.58e-2)" "unprognostic (6.36e-3)" "unprognostic (2.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-3)" "unprognostic (6.60e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (8.49e-5)" "unprognostic (1.32e-1)" "unprognostic (3.54e-13)" "unprognostic (6.42e-2)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (6.90e-2)" 36.1 35.1 13.3 10.6 10.4 9.7 33.2 14.6 16.7 35.6 9.6 28.6 11.9 29.6 6.0 22.8 34.1 4.1 23.2 10.6 13.1 26.5 24.8 27.5 5.9 13.0 11.9 34.6 25.9 11.4 61.3 20.6 12.4 32.4 7.3 6.7 21.2 9.1 12.1 44.8 26.6 8.2 6.5 37.3 24.8 22.5 10.7 6.8 34.2 3.7 6.6 27.3 28.5 16.1 16.8 22.6 13.1 19.5 5.9 24.6 66.8 26.4 11.4 21.5 11.7 13.3 6.9 22.3 11.8 19.7 9.3 27.2 11.8 15.4 9.1 21.1 24.4 14.5 71.9 23.9 8.9 13.6 9.4 15.2 5.8 19.0 5.9 10.1 7.1 17.9 14.0 6.3 17.3 27.1 14.7 24.1 11.2 8.4 31.7 20.8 18.5 21.6 6.6 16.8 12.6 14.1 23.2 12.2 7.4 12.9 25.5 8.3 5.6 18.1 17.9 45.5 9.8 34.2 42.0 17.0 24.1 18.8 16.6 0.0 8.5 1.4 5.5 5.8 4.5 4.3 4.6 4.7 13.8 4.4 7.6 3.4 2.4 7.2 6.5 7.8 3.8 5.3 13.3 10.4 14.6 16.7 10.6 13.1 13.0 11.9 12.4 6.5 10.7 16.1 0.2 0.0 1.1 16.0 2.1 0.0 0.2 0.0 4.6 0.4 0.2 0.0 4.3 0.0 0.6 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.8 0.0 1.3 9.6 0.0 0.7 1.5 11.2 0.1 0.0 0.2 0.0 0.0 0.3 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 8.4 0.3 0.3 0.0 11.1 11.0 0.1 0.0 0.0 2.9 0.1 0.5 0.0 0.0 0.5 0.0 0.4 0.7 0.0 0.1 3.3 0.1 4.4 1.3 0.2 0.1 0.1 FAM189B "C1orf2, cote1" ENSG00000160767 "Family with sequence similarity 189 member B" P81408 1 155247205-155255483 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006659, HPA050674" Uncertain Supported Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA006659: AB_1078339, HPA050674: AB_2681213" "unprognostic (1.56e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.59e-5)" "unprognostic (1.46e-2)" "unprognostic (4.86e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.70e-2)" "unprognostic (3.49e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.43e-7)" "unprognostic (4.16e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-3)" "unprognostic (3.25e-2)" 12.1 14.5 7.3 3.6 5.1 1.7 11.1 6.8 14.9 13.5 0.2 22.0 5.3 17.1 0.6 17.5 12.3 1.9 11.3 5.9 4.6 11.3 8.6 10.6 2.2 12.5 4.8 12.0 9.2 4.5 14.0 3.2 15.7 13.9 1.3 1.4 11.1 4.1 28.4 13.5 11.4 3.3 5.9 8.9 15.6 13.1 14.9 1.4 9.8 5.7 1.4 21.1 14.1 6.3 22.4 18.9 9.2 31.1 9.6 14.8 4.2 20.9 10.5 10.9 9.8 21.5 13.6 21.9 27.0 11.2 7.8 21.2 12.1 16.7 2.4 27.5 39.6 17.3 12.3 11.0 16.4 4.7 18.4 16.5 10.3 10.5 6.4 11.4 15.3 14.7 13.3 7.2 8.8 14.0 19.9 8.3 20.6 13.0 39.2 21.3 14.5 24.7 7.2 8.9 19.9 30.1 8.9 25.5 23.8 4.9 27.5 16.7 17.4 14.5 18.3 15.4 21.7 16.1 17.4 10.5 17.1 9.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.3 5.1 6.8 14.9 5.9 4.6 12.5 4.8 15.7 5.9 14.9 6.3 10.1 3.2 2.2 7.5 6.1 6.0 12.8 10.0 17.6 18.0 10.8 9.7 12.2 8.6 5.3 12.9 18.8 12.9 3.9 8.0 1.9 13.7 3.7 4.8 9.2 13.3 6.7 9.2 14.8 10.5 15.1 9.2 8.2 8.0 5.7 13.9 13.6 7.5 8.0 40.4 14.5 10.2 12.2 11.2 4.7 8.0 9.6 6.0 7.2 4.7 6.0 7.5 8.2 8.0 8.5 11.9 5.2 9.1 4.3 19.2 12.3 5.9 6.0 19.3 0.0 8.5 9.6 23.2 13.6 13.3 8.2 14.4 4.3 12.6 9.6 12.6 FAM86B2 ENSG00000145002 "Family with sequence similarity 86 member B2" P0C5J1 8 12425614-12436343 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.2;Early spermatids: 1.6;Granulosa cells: 2.7;Late spermatids: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTERT-HME1: 5.3;RPMI-8226: 12.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA "Cluster 35: T-regs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (3.75e-2)" "unprognostic (1.87e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (3.26e-2)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.48e-1)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (6.04e-4)" "unprognostic (9.37e-2)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.13e-2)" 0.3 0.4 0.1 0.1 0.2 0.0 0.4 0.1 0.3 0.6 0.1 0.3 0.1 0.5 0.0 0.9 1.4 0.1 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.2 0.3 0.6 0.6 0.4 1.0 0.0 0.1 0.4 0.1 0.1 0.3 0.4 0.1 0.3 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 0.9 0.0 0.0 0.4 0.4 0.1 0.2 0.6 0.1 0.0 0.2 1.1 1.3 0.2 0.6 0.4 1.0 0.4 1.1 0.7 0.0 1.2 0.3 0.2 0.9 1.5 0.0 0.0 0.0 0.2 0.9 0.0 1.0 0.0 0.0 0.3 1.3 1.3 5.3 0.0 0.0 0.0 1.1 0.2 0.0 0.3 0.0 0.3 1.0 1.9 0.4 0.1 0.1 12.5 0.0 0.9 1.6 0.0 0.4 1.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.2 0.1 0.3 0.2 0.2 0.2 0.3 0.1 0.0 0.2 0.1 0.1 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 2.7 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 FDFT1 SQS ENSG00000079459 "Farnesyl-diphosphate farnesyltransferase 1" P37268 8 11795573-11839304 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 479.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Daudi: 133.1;RPMI-8226: 361.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008874 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" "HPA008874: AB_1078844" "unprognostic (2.33e-1)" "unprognostic (2.60e-1)" "prognostic favorable (4.92e-5)" "unprognostic (1.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.71e-1)" "unprognostic (8.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (2.45e-1)" "unprognostic (2.31e-3)" "unprognostic (2.57e-1)" "prognostic favorable (6.59e-9)" "unprognostic (2.28e-1)" "unprognostic (4.06e-2)" "unprognostic (3.86e-1)" "unprognostic (2.06e-1)" 69.1 126.7 8.2 6.7 14.9 15.0 69.5 13.1 11.6 93.3 7.4 113.4 6.7 80.2 2.9 165.7 59.4 3.2 62.9 10.0 11.7 71.3 118.3 88.0 6.0 29.9 14.1 66.9 58.6 2.0 51.2 4.2 23.1 64.5 5.8 5.4 141.7 3.1 160.3 129.0 92.2 4.9 15.4 50.4 113.2 118.7 15.3 3.2 45.9 6.9 4.5 70.4 107.8 31.9 19.1 8.1 28.8 19.4 3.8 5.7 10.9 19.2 10.6 7.4 8.6 8.1 14.1 133.1 3.9 3.2 34.6 17.8 10.6 24.7 8.2 13.1 17.2 9.6 11.1 21.7 7.4 5.5 13.0 11.2 6.0 13.2 4.7 5.3 2.1 24.5 12.1 60.0 4.6 11.1 16.7 12.9 27.1 9.0 5.3 14.9 11.3 361.0 11.9 61.5 9.6 11.2 4.3 11.2 35.9 12.3 11.6 6.8 11.3 5.1 21.6 3.1 5.8 17.0 30.2 26.3 7.5 18.7 19.7 52.1 19.5 25.5 23.1 23.6 20.7 60.5 25.3 24.5 29.1 45.6 25.7 23.3 22.3 26.7 15.1 27.9 45.7 43.9 8.2 14.9 13.1 11.6 10.0 11.7 29.9 14.1 23.1 15.4 15.3 31.9 31.1 54.5 164.1 67.6 78.0 52.5 94.0 479.6 87.6 17.7 79.6 49.8 78.5 101.5 325.8 79.1 14.6 266.2 49.4 134.8 88.0 165.6 294.4 55.0 20.9 45.2 79.1 113.2 29.3 284.4 153.3 37.1 64.2 68.1 57.0 86.2 22.1 221.8 94.1 11.8 25.6 117.4 284.8 41.9 32.2 228.8 77.0 54.3 101.4 38.4 97.1 61.9 55.6 30.2 95.6 163.6 108.4 53.4 50.0 101.3 87.0 74.9 142.6 21.0 52.6 13.8 74.4 215.5 76.1 112.5 88.8 175.0 55.7 131.4 100.4 167.2 FKBP1C bA184C23.2 ENSG00000198225 "FKBP prolyl isomerase 1C" 6 63211446-63213024 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 9.9;Cardiomyocytes: 11.7;Langerhans cells: 12.0;Melanocytes: 8.8;Suprabasal keratinocytes: 15.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.0;granulocytes: 4.4;monocytes: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051798 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 48: Smooth muscle cells - ECM organization" "HPA051798: AB_2681615" "unprognostic (6.64e-2)" "unprognostic (1.25e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.19e-1)" "unprognostic (4.91e-5)" "unprognostic (4.78e-2)" "unprognostic (3.58e-1)" "unprognostic (1.98e-1)" "unprognostic (9.79e-2)" "unprognostic (8.54e-2)" "unprognostic (9.95e-2)" "unprognostic (9.46e-2)" "unprognostic (3.48e-1)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" 1.5 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.4 0.0 0.7 0.0 0.8 0.0 0.8 0.5 0.0 0.9 0.0 0.0 0.8 0.4 1.3 0.0 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.7 0.6 0.5 0.0 0.0 0.8 0.6 0.2 0.0 0.0 1.0 0.0 0.0 0.5 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.2 0.8 0.0 0.1 0.1 0.4 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 1.3 3.3 4.4 0.4 5.1 0.4 0.6 0.5 0.5 3.0 0.6 0.6 0.7 2.7 0.7 4.7 1.2 1.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.3 9.9 3.1 3.4 0.0 0.0 0.1 0.0 11.7 1.5 0.9 1.8 0.0 1.5 0.0 1.0 0.0 0.1 1.2 0.2 0.5 6.1 0.0 0.0 0.0 0.0 3.3 3.3 0.0 0.3 1.3 0.1 3.3 0.6 3.9 0.0 0.0 0.0 6.1 3.1 12.0 1.8 0.9 1.5 8.8 0.0 1.4 0.0 1.0 0.0 0.0 0.2 2.4 0.4 0.0 2.0 0.5 0.6 2.5 0.0 0.0 1.0 3.9 3.0 2.1 0.0 15.9 0.8 0.6 0.3 0.4 2.0 FKRP "FKTR, LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 10.5 9.1 8.5 8.1 8.2 8.8 9.9 3.7 11.5 11.4 4.5 13.3 4.8 15.2 5.0 8.8 12.6 6.0 15.8 8.5 10.4 12.0 11.9 10.4 7.4 10.1 7.3 12.7 11.1 7.5 16.8 10.1 8.8 13.5 4.3 5.7 11.1 7.4 19.6 7.2 10.5 5.8 6.1 14.7 10.9 9.3 9.4 5.6 13.6 9.8 4.9 13.0 10.5 8.7 12.7 26.5 17.8 12.5 15.4 16.9 15.8 31.7 21.0 12.6 19.9 17.0 21.4 11.7 17.0 18.2 20.9 13.0 6.6 14.8 11.5 21.9 22.2 11.7 14.4 10.7 13.3 9.3 19.8 19.4 12.5 15.6 15.2 14.6 16.7 6.0 12.2 11.0 12.7 5.8 6.8 22.8 17.2 7.8 6.5 18.3 11.1 4.0 8.0 26.4 12.0 23.1 15.8 7.6 10.6 11.7 8.9 7.3 16.8 18.4 19.8 6.7 25.7 11.6 15.4 11.0 15.0 7.5 25.6 1.3 1.8 0.8 1.5 1.0 0.9 1.7 1.1 1.7 1.1 2.4 1.2 1.6 2.2 2.0 1.1 1.9 0.6 1.2 8.5 8.2 3.7 11.5 8.5 10.4 10.1 7.3 8.8 6.1 9.4 8.7 4.7 9.6 7.4 6.8 3.9 0.8 4.8 3.0 1.2 9.8 5.3 5.2 15.5 4.3 5.6 5.5 6.2 9.6 9.1 4.5 5.9 4.2 12.0 7.9 7.3 6.0 7.8 7.8 6.8 2.4 5.9 6.6 3.6 5.1 1.3 6.7 11.4 16.6 7.6 3.3 8.2 4.2 2.0 10.0 1.2 13.2 5.6 4.3 5.4 3.7 6.1 7.8 2.1 8.0 6.2 4.1 4.7 4.1 3.6 4.3 4.2 8.2 9.7 11.0 6.6 7.2 7.0 12.2 4.0 2.4 1.6 18.7 4.3 4.5 4.0 4.3 FLCN "BHD, DENND8B, MGC17998, MGC23445" ENSG00000154803 Folliculin Q8NFG4 17 17212212-17237188 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 79.2;Erythroid cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015158, HPA028760" Supported Supported "Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol "Plasma membrane" "CAB015158: AB_2231645, HPA028760: AB_10601323" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.74e-1)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.73e-2)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (3.90e-1)" "prognostic favorable (4.49e-4)" "unprognostic (6.45e-3)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.65e-1)" 21.8 19.0 19.0 10.7 25.9 17.7 18.9 27.3 31.6 42.5 18.3 43.7 23.3 37.0 14.5 13.8 25.2 17.0 29.2 31.9 14.0 15.3 28.9 26.8 12.4 21.3 15.2 35.3 15.2 13.1 28.6 13.1 22.0 27.1 10.2 7.2 16.4 13.7 42.7 19.3 26.8 14.5 14.0 29.2 22.4 21.0 19.3 8.6 23.8 18.4 8.0 28.2 25.5 28.3 12.0 30.4 11.5 14.9 36.4 20.6 15.8 11.8 19.1 18.0 24.3 24.3 10.4 6.3 13.8 14.0 40.2 14.4 14.0 7.3 9.3 10.9 12.2 12.4 9.1 13.9 33.6 4.9 33.5 30.3 24.0 27.6 20.8 16.4 14.8 9.2 17.7 16.4 17.6 17.5 8.3 8.4 11.2 17.8 8.1 16.9 52.7 7.3 11.0 14.1 13.6 8.8 11.6 7.5 19.3 70.7 11.1 8.8 15.7 40.6 16.6 56.5 14.1 7.7 7.4 5.7 26.0 10.8 16.6 2.4 2.8 1.6 1.6 3.7 2.2 3.6 1.9 1.4 1.4 3.2 2.1 1.9 6.0 2.8 1.4 1.4 2.9 1.8 19.0 25.9 27.3 31.6 31.9 14.0 21.3 15.2 22.0 14.0 19.3 28.3 8.4 25.6 12.6 17.0 9.2 18.4 12.7 5.7 2.8 20.7 13.2 6.5 23.7 14.3 6.2 7.3 79.2 10.9 5.3 25.0 1.9 12.3 14.5 16.8 11.3 12.5 25.7 81.7 31.3 8.3 7.4 20.6 9.7 15.2 1.3 10.3 27.8 24.1 16.6 47.1 23.7 11.0 16.2 21.6 19.2 20.4 28.0 13.2 10.6 18.7 12.2 13.3 6.2 17.1 32.4 9.8 15.6 20.3 4.4 11.6 36.8 6.1 9.1 18.5 19.7 24.8 11.1 6.3 10.8 5.3 18.2 33.8 10.0 16.3 12.6 13.0 FLOT1 ENSG00000137312 "Flotillin 1" O75955 6 30727709-30742732 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 314.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 423.3;hTERT-RPE1: 242.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001393, CAB007766" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA 160000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Vesicles, Plasma membrane" "CAB007766: AB_562116, HPA001393: AB_1078892" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (3.41e-3)" "unprognostic (2.68e-3)" "unprognostic (1.86e-1)" "unprognostic (2.65e-1)" "prognostic favorable (3.06e-4)" "unprognostic (1.81e-2)" "unprognostic (9.36e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (6.43e-3)" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (2.46e-2)" 141.7 239.5 49.3 27.9 54.6 41.7 129.8 49.4 60.9 111.1 56.8 150.3 28.7 108.9 8.4 81.8 95.8 23.1 234.5 55.1 57.9 146.1 127.3 136.8 22.1 50.9 51.5 84.1 88.5 41.4 102.5 35.0 57.4 109.6 17.7 6.3 99.1 45.8 190.0 51.7 87.1 33.0 45.8 129.6 96.9 65.0 53.6 24.9 111.7 83.1 17.0 134.5 96.9 48.8 54.3 18.3 46.4 62.0 49.1 71.0 1.3 59.7 67.5 82.8 79.3 19.4 30.0 13.0 29.0 101.3 423.3 41.8 35.0 20.1 28.6 36.1 1.3 41.1 17.5 19.1 119.2 12.2 67.0 75.4 30.6 40.9 71.3 242.7 65.9 37.9 21.7 52.7 77.9 22.9 38.0 14.5 15.1 29.4 15.7 20.2 48.4 38.0 30.3 13.0 16.4 17.2 33.7 28.7 164.6 30.4 43.8 10.1 44.0 199.5 37.6 20.6 120.6 18.6 19.7 28.8 26.2 42.6 122.7 179.3 76.9 132.0 35.0 38.9 24.1 28.0 21.3 30.4 58.9 23.0 23.7 27.4 314.3 79.9 26.3 59.2 3.9 58.3 49.3 54.6 49.4 60.9 55.1 57.9 50.9 51.5 57.4 45.8 53.6 48.8 175.4 89.8 77.0 26.1 38.1 28.7 111.5 44.9 80.2 14.7 72.1 73.4 90.6 62.9 59.2 84.6 6.2 82.2 57.7 103.2 123.3 77.6 60.2 73.9 50.1 141.6 68.8 41.7 41.3 85.9 70.7 67.6 55.5 75.2 143.3 41.4 154.9 59.7 130.6 20.2 40.2 66.6 57.0 61.3 84.9 144.1 61.8 89.4 71.2 28.1 99.2 64.7 68.0 27.2 22.7 65.7 112.0 38.0 60.4 69.5 89.0 172.1 80.7 18.1 52.6 58.1 65.9 80.2 26.7 63.7 26.9 61.6 51.2 29.1 83.2 99.4 FLT4 "PCL, VEGFR-3, VEGFR3" ENSG00000037280 "Fms related receptor tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 31 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 20000000 290000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 17.2 11.3 3.5 4.7 4.6 0.8 14.7 2.6 3.4 9.0 2.6 4.9 2.8 8.0 3.0 4.4 9.8 3.8 9.7 5.1 2.6 20.1 6.2 16.9 5.5 3.4 3.0 4.5 2.0 2.3 7.8 6.4 3.6 5.6 1.3 0.3 2.0 2.5 4.7 4.0 7.2 4.1 2.8 17.6 3.5 3.1 4.2 1.0 25.7 4.1 1.4 5.6 5.5 2.7 0.1 2.5 3.2 10.1 0.0 0.0 12.4 0.3 0.1 0.0 0.0 0.4 0.3 0.3 0.9 0.1 0.6 0.4 3.4 0.2 0.3 0.1 15.6 1.2 0.5 0.5 0.1 9.5 0.3 0.2 0.1 0.2 0.4 0.3 9.9 12.3 0.4 0.4 2.1 5.6 0.1 0.5 7.0 0.3 0.6 8.2 0.1 0.1 0.1 0.3 0.3 1.1 0.1 0.2 0.1 3.1 14.6 0.3 15.7 0.2 6.9 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.5 0.0 3.8 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 3.5 4.6 2.6 3.4 5.1 2.6 3.4 3.0 3.6 2.8 4.2 2.7 27.4 0.0 1.7 0.7 0.7 0.9 0.2 0.0 1.2 0.2 1.4 1.4 4.5 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 27.1 0.0 0.0 0.2 0.0 37.1 0.8 0.0 0.1 2.5 2.4 64.6 0.6 1.2 0.0 0.1 0.0 0.0 3.3 0.8 0.7 0.3 0.6 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.7 0.7 0.1 5.2 0.1 1.1 1.0 1.8 0.2 0.0 0.1 FNBP4 KIAA1014 ENSG00000109920 "Formin binding protein 4" Q8N3X1 11 47716494-47767443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039485, HPA040029" Supported Enhanced "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA039485: AB_2676536, HPA040029: AB_2676808" "unprognostic (2.49e-2)" "unprognostic (3.95e-1)" "unprognostic (5.50e-2)" "unprognostic (2.78e-1)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (7.33e-5)" "unprognostic (5.58e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.60e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (6.35e-4)" "prognostic unfavorable (1.91e-8)" "unprognostic (3.54e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-1)" "prognostic favorable (7.23e-5)" 38.0 34.4 5.8 12.1 6.1 19.6 36.6 9.9 7.4 46.7 8.4 35.4 8.9 38.9 9.4 33.8 40.6 8.2 29.9 5.7 6.8 29.5 31.3 39.1 15.9 5.9 6.2 48.8 39.2 7.5 29.2 9.6 5.8 36.3 8.8 14.9 32.7 8.2 51.0 40.5 42.8 9.0 5.3 50.6 31.6 16.5 6.4 14.0 42.8 7.0 14.2 34.2 40.2 7.8 10.6 8.5 17.7 12.5 10.0 11.6 12.0 12.3 12.7 11.1 12.9 8.4 14.0 23.2 6.0 14.0 9.3 21.2 15.8 10.0 16.4 18.2 24.1 17.5 28.1 14.3 14.1 19.5 16.6 14.2 16.4 9.7 22.0 16.2 13.1 14.1 19.2 19.2 10.7 9.7 30.0 22.6 16.7 9.4 7.8 21.2 16.8 12.9 10.9 12.8 7.9 13.1 18.5 15.2 10.5 13.2 12.3 9.1 14.4 13.1 13.8 19.0 17.3 18.6 13.4 26.1 9.5 11.9 9.1 3.8 2.1 3.4 3.7 1.5 2.9 5.1 2.6 2.6 1.3 5.4 2.7 2.9 2.0 1.8 2.2 5.6 3.9 0.9 5.8 6.1 9.9 7.4 5.7 6.8 5.9 6.2 5.8 5.3 6.4 7.8 65.0 51.3 71.7 82.6 114.7 70.9 112.5 45.9 112.7 95.1 57.0 49.0 38.2 27.1 63.6 25.8 108.4 48.9 122.0 46.1 5.9 39.9 5.5 94.3 121.9 59.7 36.5 59.1 86.7 37.8 37.4 70.6 89.2 165.4 57.6 95.5 48.2 27.0 28.4 67.3 93.6 46.5 34.6 37.2 58.3 8.0 89.5 59.2 39.2 71.2 62.1 28.1 83.4 100.5 108.3 50.8 39.4 62.1 102.4 120.8 36.6 11.3 60.5 103.2 46.0 70.5 61.6 37.3 28.1 96.0 69.9 82.9 105.7 93.4 42.6 168.0 FRG1 "FRG1A, FSG1" ENSG00000109536 "FSHD region gene 1" Q14331 4 189940870-189963202 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing" "Actin-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA075683 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "HPA075683: " "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-1)" "unprognostic (5.56e-2)" "unprognostic (7.14e-2)" "unprognostic (5.62e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-3)" "unprognostic (2.83e-3)" "unprognostic (2.55e-1)" "unprognostic (2.42e-1)" "unprognostic (3.84e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.01e-1)" 36.8 25.7 6.0 6.4 6.0 16.6 33.9 6.1 13.0 29.5 6.1 35.0 6.6 32.9 9.6 30.7 27.6 5.9 31.9 6.0 6.1 29.2 24.8 23.5 7.9 6.0 6.0 32.0 30.6 13.1 18.5 5.9 6.0 21.7 7.7 3.6 24.9 7.5 31.1 28.6 26.7 8.6 6.0 29.0 30.0 19.8 6.0 13.0 23.4 9.4 8.4 28.8 28.3 6.1 12.2 8.5 21.5 19.0 11.0 16.4 14.6 18.0 13.4 23.3 15.6 6.1 20.1 21.9 8.5 13.5 8.8 7.3 20.3 13.8 24.6 13.3 9.6 39.4 9.3 4.3 18.8 28.9 14.9 12.1 15.5 12.9 4.2 15.8 15.5 19.1 25.4 42.4 19.0 6.9 38.6 42.7 4.4 5.4 12.8 27.2 4.9 14.4 16.3 6.9 15.8 15.7 11.4 13.0 21.1 11.8 6.7 20.3 15.4 8.8 11.6 6.5 13.4 15.4 12.8 17.6 15.7 18.7 13.1 30.7 13.4 19.7 13.6 18.0 13.8 16.9 16.0 15.1 12.1 15.4 13.6 14.8 13.3 16.9 19.1 13.4 20.1 13.6 6.0 6.0 6.1 13.0 6.0 6.1 6.0 6.0 6.0 6.0 6.0 6.1 69.3 80.1 52.9 6.5 61.9 33.4 42.5 62.9 18.2 43.1 47.6 56.9 70.6 64.3 52.9 33.1 16.7 77.0 82.2 45.6 131.0 106.0 50.4 42.4 51.4 61.1 44.9 94.1 12.5 121.9 65.2 50.9 18.8 40.9 84.2 34.8 83.6 133.8 68.1 32.0 11.6 53.9 50.8 92.6 46.7 20.4 76.1 57.4 21.4 4.7 107.6 61.1 124.6 12.5 17.0 88.4 48.9 72.6 41.9 20.7 60.8 126.2 51.7 52.0 52.6 50.7 84.6 75.9 70.6 27.5 28.1 53.5 64.6 42.8 52.9 32.4 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 150.5;Excitatory neurons: 58.7;Inhibitory neurons: 68.1;Oligodendrocyte precursor cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 6.3;HEL: 6.4;U-2 OS: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 64: Astrocytes - Nervous system maintenance" Centrosome "HPA050483: AB_2681140, HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavorable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 20.4 18.0 10.2 2.4 10.9 2.8 20.7 6.4 9.6 45.3 0.0 33.6 0.2 42.8 0.0 14.5 39.0 0.9 28.4 3.9 0.0 16.9 4.7 20.6 2.0 0.3 2.0 40.7 10.4 1.1 30.8 1.3 0.0 34.3 0.5 0.5 16.3 4.2 6.1 19.2 20.2 1.4 0.0 39.0 18.5 7.9 6.1 0.2 22.8 0.0 1.2 25.3 31.6 0.0 2.4 0.0 1.5 6.3 0.7 1.6 1.6 1.6 0.7 1.4 0.4 1.9 0.1 1.1 1.5 0.0 0.3 2.0 0.7 0.0 0.0 5.9 2.6 6.4 3.7 0.0 0.9 0.2 3.1 0.0 0.0 1.2 0.0 1.8 0.8 3.3 5.5 0.0 0.2 1.5 0.6 0.1 0.4 0.0 0.9 2.9 0.6 0.1 0.2 0.0 0.4 1.0 0.4 0.0 2.6 0.4 1.2 0.9 3.6 2.5 6.2 0.2 3.1 5.4 0.6 0.0 1.4 2.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 10.2 10.9 6.4 9.6 3.9 0.0 0.3 2.0 0.0 0.0 6.1 0.0 16.8 12.8 20.2 150.5 10.6 11.9 6.2 4.7 10.2 30.6 13.4 17.7 13.9 1.5 10.7 3.7 0.0 0.3 5.7 0.8 0.0 1.4 4.7 1.3 30.6 17.0 7.2 5.7 58.7 0.9 0.2 16.0 1.5 1.9 7.6 14.6 22.5 0.3 1.1 23.5 68.1 4.7 2.0 5.9 18.3 3.1 15.2 14.4 0.0 19.7 11.0 9.8 0.0 72.4 16.3 1.7 1.6 25.6 0.7 7.6 0.1 1.0 1.1 17.3 13.1 12.5 18.8 1.2 2.7 5.3 11.1 0.5 5.9 6.7 1.5 2.8 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042682, CAB045975" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "CAB045975: AB_10584474, HPA042682: AB_2678113" "prognostic favorable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavorable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favorable (1.10e-5)" 66.6 89.2 3.1 31.8 3.2 8.0 64.6 2.8 4.7 80.4 2.5 100.4 15.0 63.4 11.7 41.2 64.4 22.7 21.4 2.5 4.6 27.3 27.7 89.7 26.2 8.8 5.1 60.5 7.5 27.9 13.8 8.1 5.7 54.6 18.4 0.5 34.6 20.6 53.8 55.4 62.0 31.8 3.7 51.1 46.0 9.0 6.4 9.3 21.1 16.5 15.9 83.8 65.4 4.0 5.4 0.1 0.0 0.0 19.1 12.5 1.9 2.1 17.0 2.1 6.8 0.0 5.0 0.0 20.3 14.0 14.8 0.7 0.0 0.1 1.3 25.9 0.0 0.1 3.1 1.3 2.6 0.5 0.9 14.1 0.0 5.1 0.0 9.3 18.1 0.0 0.3 0.4 7.4 0.0 0.0 4.3 0.0 4.6 0.1 0.0 7.5 0.0 3.7 21.6 0.0 0.2 7.4 1.5 0.1 0.5 0.1 1.0 13.9 2.7 0.1 3.1 1.5 14.0 0.0 0.0 6.9 0.1 0.1 19.1 31.4 10.9 34.4 42.8 43.3 4.7 32.4 32.9 11.6 3.4 24.3 25.4 139.4 26.7 77.8 0.6 79.1 32.5 3.1 3.2 2.8 4.7 2.5 4.6 8.8 5.1 5.7 3.7 6.4 4.0 35.4 25.6 34.3 0.7 21.5 46.5 123.5 24.9 18.2 0.2 56.1 30.4 4.1 27.1 27.1 18.4 0.0 40.2 47.7 41.9 0.0 113.9 35.7 59.6 39.7 60.5 10.2 8.2 0.6 73.2 51.2 41.2 18.3 152.4 47.4 2.5 28.2 30.5 33.2 0.0 1.1 15.7 8.2 84.5 29.4 33.3 4.7 81.1 8.8 14.0 60.6 0.5 110.2 1.5 0.1 73.2 25.9 8.6 17.3 80.3 128.3 12.2 27.5 0.2 19.7 81.9 45.2 1.8 4.6 24.9 61.8 57.7 81.8 33.3 15.3 87.0 GGT5 "GGT-REL, GGTLA1" ENSG00000099998 "Gamma-glutamyltransferase 5" P36269 22 24219654-24245108 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glutathione biosynthesis, Leukotriene biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endothelial cells: 42.8;Fibroblasts: 58.3;Leydig cells: 36.4;Sertoli cells: 184.1;Smooth muscle cells: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.3;eosinophil: 4.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 164.9;ASC TERT1: 124.4;HHSteC: 234.7;HSkMC: 271.7;TIME: 110.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008121, CAB032489" Uncertain Approved "Nucleoli fibrillar center" "Intracellular and membrane" NA NA 22000000 "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoli fibrillar center" "CAB032489: AB_2111010, HPA008121: AB_1078965" "unprognostic (8.14e-2)" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (9.94e-2)" "unprognostic (8.13e-2)" "unprognostic (8.21e-2)" "unprognostic (2.33e-2)" "unprognostic (2.90e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-1)" "unprognostic (8.37e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (6.36e-5)" "prognostic unfavorable (4.06e-4)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.79e-1)" "unprognostic (8.33e-2)" 137.6 60.5 39.0 18.6 39.3 1.4 90.6 37.6 41.7 73.2 32.8 27.8 19.4 54.4 12.9 19.6 70.6 37.2 93.4 35.0 45.1 78.2 55.2 37.7 48.0 52.2 46.3 26.6 25.8 13.2 41.1 11.9 46.9 49.3 12.0 2.1 37.1 20.9 23.1 40.1 40.8 32.2 41.9 36.1 40.0 9.6 45.3 10.4 110.2 16.6 18.3 45.1 64.2 38.2 0.0 1.8 0.6 0.0 164.9 124.4 1.1 2.9 0.2 0.1 0.0 0.1 0.1 0.2 3.4 0.2 0.3 0.3 0.1 0.1 0.0 2.2 0.9 6.7 1.0 24.1 234.7 3.0 6.4 271.7 0.1 3.4 3.2 0.4 45.8 0.7 0.4 1.2 44.1 0.4 0.0 22.4 3.6 1.1 0.0 0.1 4.0 1.0 6.1 0.0 0.4 5.9 0.1 7.3 0.1 22.7 1.0 1.7 110.8 0.1 2.3 0.1 0.0 0.3 1.5 0.2 3.9 5.7 0.2 2.3 0.5 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.2 39.0 39.3 37.6 41.7 35.0 45.1 52.2 46.3 46.9 41.9 45.3 38.2 27.2 3.2 16.0 1.0 0.3 7.0 3.3 3.2 0.0 0.0 7.2 4.2 4.4 0.0 17.9 0.0 0.0 0.2 0.4 0.0 0.0 0.6 0.8 0.3 8.3 42.8 0.0 2.7 0.1 0.2 0.2 58.3 1.1 0.4 1.3 0.0 33.5 0.1 2.1 0.0 0.1 0.0 0.0 1.0 12.5 3.3 36.4 1.8 3.6 22.5 3.3 0.3 0.0 0.5 0.0 0.4 0.0 23.7 0.3 2.2 0.0 0.1 2.2 1.0 184.1 33.9 85.6 0.6 0.4 0.3 4.4 0.3 1.1 2.1 0.0 1.4 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" NA NA 2100000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favorable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-4)" 42.7 36.8 25.0 17.4 26.3 9.0 40.3 24.0 25.7 53.3 17.3 44.5 17.3 57.8 22.4 30.9 46.7 20.4 50.5 24.7 27.5 42.6 25.6 38.2 16.3 27.0 29.0 69.0 58.1 34.3 38.9 24.9 25.2 37.5 18.7 20.3 36.1 24.9 53.8 35.2 36.4 29.9 25.0 35.1 36.3 40.6 29.5 20.0 43.1 16.4 18.9 42.3 40.8 30.0 38.4 52.2 44.7 43.3 113.7 113.2 42.8 45.0 64.2 48.6 68.3 34.4 116.0 22.8 59.8 102.9 35.8 71.1 30.1 62.1 80.1 10.3 26.1 17.9 37.8 54.3 70.5 29.3 12.6 68.0 32.8 63.6 66.3 91.3 100.8 54.8 19.0 24.9 44.2 70.0 14.1 26.0 34.7 81.2 20.6 33.9 32.6 59.5 31.6 17.1 15.8 23.3 87.3 24.9 25.0 47.7 28.2 36.5 79.1 46.1 40.9 48.2 30.3 47.4 51.2 41.1 86.3 22.5 46.6 3.2 16.7 13.3 19.1 15.7 19.2 11.6 23.8 20.9 18.5 10.1 28.2 22.6 7.3 15.4 19.9 18.4 21.0 19.0 25.0 26.3 24.0 25.7 24.7 27.5 27.0 29.0 25.2 25.0 29.5 30.0 52.8 64.1 50.7 114.3 46.4 27.1 27.2 33.0 55.8 68.5 35.6 35.6 79.5 77.2 39.7 51.5 146.0 78.0 75.6 33.5 7.9 39.9 39.7 49.2 79.3 62.0 38.6 25.0 133.4 42.5 43.6 101.4 38.7 58.0 3.8 91.0 75.3 40.7 50.1 70.7 155.3 31.9 24.4 68.8 42.1 28.1 96.9 44.4 42.7 62.8 64.8 59.6 111.2 97.5 137.3 40.8 28.8 114.3 100.2 33.6 47.8 44.2 44.3 57.9 92.1 84.6 59.9 89.2 87.9 30.5 21.6 75.2 72.4 72.4 32.9 26.4 GLI4 "HKR4, ZNF928" ENSG00000250571 "GLI family zinc finger 4" P10075 8 143267433-143276931 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023131 Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytokinetic bridge" "HPA023131: AB_2671080" "unprognostic (4.98e-2)" "unprognostic (2.69e-1)" "unprognostic (5.64e-3)" "unprognostic (1.65e-1)" "unprognostic (9.07e-2)" "unprognostic (2.71e-2)" "unprognostic (1.00e-2)" "unprognostic (4.57e-2)" "unprognostic (2.22e-1)" "unprognostic (2.65e-1)" "unprognostic (7.45e-3)" "unprognostic (5.03e-1)" "unprognostic (6.88e-3)" "unprognostic (4.61e-2)" "unprognostic (1.23e-1)" "unprognostic (3.21e-2)" "unprognostic (3.71e-3)" 11.6 6.6 8.8 4.7 8.2 5.8 10.7 8.3 15.4 12.3 3.3 10.8 6.4 10.3 2.1 12.8 10.2 2.7 13.0 9.6 7.1 13.7 12.0 6.9 5.6 7.4 6.8 13.4 12.6 4.6 9.3 2.0 7.5 13.4 3.7 2.5 9.2 3.9 9.2 12.9 10.4 1.8 5.1 11.6 11.5 10.4 7.5 5.5 10.1 2.0 4.8 11.3 11.1 7.2 6.7 13.5 6.2 9.9 9.9 4.1 7.0 3.9 2.3 2.9 3.5 3.9 19.1 8.7 7.2 6.5 4.2 8.7 3.4 4.3 1.9 15.3 10.3 13.4 7.1 4.6 7.1 4.2 4.3 12.9 2.3 4.0 8.5 6.7 6.4 13.2 7.2 14.1 8.0 18.5 19.7 3.5 5.8 12.8 19.0 11.9 2.9 8.8 7.0 15.0 6.0 7.0 11.7 5.0 8.2 5.7 22.1 1.9 3.6 4.3 12.1 6.2 4.1 18.6 9.7 7.0 7.0 8.0 7.3 0.0 0.3 0.0 0.3 0.3 0.6 0.4 0.4 0.2 0.1 0.3 0.6 0.2 0.3 1.1 0.0 1.1 0.6 0.2 8.8 8.2 8.3 15.4 9.6 7.1 7.4 6.8 7.5 5.1 7.5 7.2 9.5 0.0 0.0 13.1 11.2 7.4 12.7 1.3 13.6 14.6 10.9 12.2 2.0 12.8 1.1 12.9 20.9 5.0 20.6 15.4 25.4 2.6 6.3 8.2 10.6 6.8 11.5 5.9 7.2 4.0 4.5 9.5 11.7 7.3 4.5 15.8 8.9 7.7 7.2 6.7 8.4 7.6 2.0 10.1 5.7 4.3 16.1 9.9 8.8 12.2 6.9 11.9 13.4 4.5 15.5 3.6 17.9 16.6 8.8 9.4 16.4 20.1 2.3 11.9 6.6 11.2 10.6 13.4 14.7 15.8 10.7 2.9 11.9 14.6 13.7 9.9 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 22.1;Peritubular cells: 33.8;Proximal tubular cells: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062755, HPA065406" Enhanced Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA062755: , HPA065406: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 16.3 23.4 4.4 2.5 4.1 0.1 11.4 5.2 3.9 22.3 3.3 19.2 1.5 20.9 0.7 4.9 17.3 5.6 30.9 3.1 3.8 41.5 3.2 30.6 1.6 5.6 5.6 27.5 13.2 2.3 18.9 4.4 4.3 21.7 0.4 0.7 9.8 4.0 3.0 7.1 7.4 3.3 4.4 4.5 11.9 5.3 5.5 0.2 19.4 0.4 0.5 20.2 11.4 2.5 6.1 12.3 2.0 4.8 1.5 7.2 4.3 6.1 5.3 2.3 1.6 3.2 5.1 0.0 10.8 6.0 2.2 3.7 1.2 5.6 0.1 8.9 0.3 0.0 10.9 1.9 6.9 0.0 0.9 4.1 1.2 1.9 0.9 2.6 1.9 0.1 0.5 2.0 1.3 4.0 0.0 1.2 4.6 0.7 2.2 11.7 2.6 6.7 0.4 0.0 0.9 4.6 6.1 2.9 1.7 0.6 8.2 1.0 3.2 3.2 6.0 36.8 1.9 1.4 0.9 1.5 1.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 4.1 5.2 3.9 3.1 3.8 5.6 5.6 4.3 4.4 5.5 2.5 4.8 16.0 9.8 8.5 0.0 5.6 5.4 8.7 1.8 10.6 3.5 2.4 5.9 15.7 5.6 12.9 4.2 0.9 0.1 0.0 19.6 11.8 0.2 1.8 9.0 6.9 0.0 0.0 2.1 8.3 0.9 18.3 0.5 2.1 0.0 2.6 6.8 0.7 0.4 6.7 3.2 0.2 2.0 0.3 6.1 0.9 22.1 0.8 3.6 5.6 1.0 10.4 0.0 4.0 1.3 10.3 0.0 33.8 0.0 5.1 0.0 21.7 3.1 7.3 0.0 8.2 14.6 0.2 3.4 0.7 2.8 1.1 0.7 0.1 0.0 2.8 GNB1L "GY2, WDR14" ENSG00000185838 "G protein subunit beta 1 like" Q9BYB4 22 19783223-19854939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 66.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034627, HPA034628" Approved Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "HPA034627: AB_10600662, HPA034628: AB_10600440" "unprognostic (2.14e-1)" "unprognostic (5.56e-3)" "unprognostic (4.54e-3)" "unprognostic (2.58e-1)" "unprognostic (3.03e-1)" "unprognostic (3.34e-2)" "unprognostic (8.68e-4)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (2.46e-1)" "unprognostic (2.99e-2)" "unprognostic (3.64e-5)" "unprognostic (9.80e-3)" "unprognostic (8.04e-2)" "unprognostic (2.88e-1)" "unprognostic (9.86e-2)" 3.5 2.2 1.4 2.8 1.8 1.7 3.5 1.0 3.7 3.8 0.6 4.0 4.1 4.1 0.4 4.9 3.9 1.0 2.7 1.8 0.8 2.6 2.8 3.1 2.3 1.3 0.7 3.5 3.9 0.4 2.2 1.4 0.9 3.4 0.3 0.3 3.3 1.3 3.7 5.9 3.7 0.6 0.6 5.3 2.7 2.4 0.9 4.0 3.0 0.6 1.3 4.2 4.2 1.3 13.5 10.2 2.9 8.9 0.9 1.7 8.0 9.1 2.5 4.4 4.1 18.3 5.2 18.1 5.8 2.1 2.1 25.5 2.0 4.3 0.6 11.7 34.0 10.9 13.6 9.1 2.7 12.6 2.9 1.4 2.0 3.9 1.5 1.0 1.7 8.1 66.6 6.8 0.8 19.3 28.1 18.1 5.0 3.9 17.1 14.6 8.1 4.1 0.4 5.4 5.9 6.4 3.5 8.8 15.5 0.5 2.3 3.2 4.2 9.8 11.8 16.1 9.3 8.8 7.8 9.6 10.6 11.1 3.4 7.3 6.0 15.9 13.2 7.9 12.7 9.4 12.6 10.0 9.8 11.9 12.1 11.0 6.1 12.0 5.9 13.3 17.0 7.5 1.4 1.8 1.0 3.7 1.8 0.8 1.3 0.7 0.9 0.6 0.9 1.3 2.4 3.2 4.4 3.6 6.9 22.0 6.3 11.8 5.2 8.5 4.7 5.5 1.6 2.8 5.7 0.0 12.5 15.2 5.2 4.6 3.9 5.6 28.3 2.9 3.3 4.6 0.0 4.0 6.7 3.3 13.8 4.3 2.0 4.1 12.7 7.8 2.2 2.8 10.3 0.0 4.1 4.6 8.2 7.3 15.5 6.5 3.4 4.6 14.2 1.9 4.9 3.0 6.2 4.5 4.3 5.9 2.6 4.9 5.4 8.8 6.3 4.9 1.9 4.7 6.6 2.8 4.4 13.8 10.2 5.1 16.2 4.7 7.9 2.7 5.2 5.3 GNB2 ENSG00000172354 "G protein subunit beta 2" P62879 7 100673567-100679174 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010032, HPA040736" Approved Supported "Plasma membrane" NA NA 940000 "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "CAB010032: AB_2263466, HPA040736: AB_2677106" "unprognostic (1.55e-1)" "unprognostic (5.76e-2)" "unprognostic (1.01e-3)" "unprognostic (2.76e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (3.68e-3)" "unprognostic (3.52e-1)" "unprognostic (6.58e-2)" "unprognostic (2.54e-1)" "unprognostic (9.79e-3)" "unprognostic (1.70e-1)" "unprognostic (3.75e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-1)" "unprognostic (5.29e-2)" "unprognostic (2.98e-1)" 198.4 211.0 131.4 128.3 137.3 207.5 188.0 112.3 179.6 209.4 103.8 168.0 103.2 182.4 63.7 328.4 179.8 105.5 175.9 130.2 138.1 186.1 185.8 210.1 107.9 140.3 130.1 175.3 184.8 98.9 203.3 107.4 123.6 183.0 83.6 20.1 190.8 113.6 175.9 295.5 143.5 113.5 126.3 225.9 172.4 92.9 137.6 90.2 144.8 90.2 105.7 165.2 217.7 120.7 358.6 268.6 222.7 272.5 169.8 199.9 194.3 208.4 288.4 294.3 241.7 205.3 333.7 157.7 216.0 311.3 332.2 243.0 177.7 312.6 103.0 216.9 152.1 120.8 198.7 171.3 282.4 157.7 254.5 259.5 291.1 304.2 244.6 237.6 343.6 132.5 228.6 303.3 270.4 980.0 249.5 450.3 173.5 225.1 290.1 234.3 136.3 253.8 235.4 291.3 241.0 380.1 278.0 449.2 201.3 125.3 192.4 192.1 325.8 313.8 346.8 619.2 266.6 88.8 111.9 240.9 237.1 349.7 443.6 27.6 28.6 70.9 17.5 42.7 16.2 13.6 17.9 15.4 28.1 18.1 11.8 12.4 117.2 15.4 35.9 23.8 23.5 12.5 131.4 137.3 112.3 179.6 130.2 138.1 140.3 130.1 123.6 126.3 137.6 120.7 138.1 57.7 97.0 16.0 104.1 151.8 159.3 72.9 148.0 10.4 105.4 106.0 35.0 100.1 55.5 84.6 4.2 172.4 89.4 285.4 162.4 163.7 32.6 133.5 106.8 136.5 180.4 127.7 12.7 218.7 312.1 117.6 135.1 127.2 44.4 97.6 126.0 69.9 264.4 72.3 10.8 211.2 75.3 198.6 198.8 20.1 144.8 193.5 140.5 15.9 160.8 128.2 96.8 5.0 6.9 257.1 285.6 130.1 122.5 226.5 162.3 107.0 68.3 8.5 65.7 62.0 162.2 34.3 69.6 240.7 194.8 293.9 117.8 88.1 192.2 259.5 GRK5 GPRK5 ENSG00000198873 "G protein-coupled receptor kinase 5" P34947 10 119207571-119459745 "Enzymes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025579, HPA046838" Approved Supported "Nuclear membrane,Nuclear speckles,Plasma membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "Nuclear membrane, Nuclear speckles" "Plasma membrane" "CAB025579: , HPA046838: AB_2679833" "unprognostic (1.09e-1)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.02e-2)" "unprognostic (6.56e-2)" "unprognostic (3.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.69e-1)" "unprognostic (4.11e-1)" "unprognostic (1.06e-1)" "unprognostic (3.70e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.38e-7)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" 38.4 18.0 4.2 5.9 5.0 2.7 24.6 5.0 4.6 18.8 3.5 26.3 10.0 21.1 3.5 12.6 19.6 5.7 48.8 4.0 5.1 14.2 12.9 65.6 7.8 3.9 3.6 35.0 4.7 21.3 13.3 8.3 3.9 14.1 4.9 1.0 7.8 4.0 11.9 11.5 25.8 7.3 3.3 37.0 27.5 4.1 4.9 6.2 19.6 9.7 6.8 19.4 18.1 3.5 3.7 2.3 5.4 5.7 11.8 11.0 1.6 7.1 32.1 4.1 2.3 1.7 5.4 3.9 1.6 11.1 7.5 0.9 2.3 7.7 2.7 15.4 2.0 0.7 4.6 7.0 8.2 0.2 2.0 1.5 1.1 8.5 1.2 5.2 24.9 2.4 0.4 3.7 1.5 0.7 3.8 3.5 0.8 25.8 5.2 1.3 0.8 0.9 0.6 1.5 1.8 4.9 2.4 1.1 7.0 3.0 0.1 0.9 7.8 2.3 1.6 14.6 2.8 0.9 4.4 2.4 4.9 4.4 2.4 0.4 1.5 2.9 2.0 1.4 0.1 3.8 3.0 1.6 0.9 4.0 4.5 2.0 2.1 0.1 0.5 0.0 4.0 1.7 4.2 5.0 5.0 4.6 4.0 5.1 3.9 3.6 3.9 3.3 4.9 3.5 32.6 57.7 3.7 3.6 19.7 1.7 0.7 0.5 1.2 3.9 2.3 2.0 19.4 0.0 1.3 3.7 0.0 3.7 13.3 0.4 0.0 1.1 18.7 0.4 5.1 28.4 4.8 0.0 17.7 3.1 15.8 35.7 18.8 1.0 4.5 7.8 24.7 2.2 4.4 1.7 36.5 0.8 6.1 15.5 6.3 4.9 4.4 14.2 7.2 56.2 3.6 0.0 19.6 14.1 5.7 2.4 1.2 4.5 10.2 0.7 4.9 0.6 0.8 0.9 59.2 18.2 46.5 1.3 2.1 0.7 2.4 13.1 14.1 4.6 0.5 0.9 GTF2H2 "BTF2, BTF2P44, p44, T-BTF2P44, TFIIH" ENSG00000145736 "General transcription factor IIH subunit 2" Q13888 5 71032670-71067689 "Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 18.5;RPTEC TERT1: 19.1" HPA047001 Supported "Nuclear speckles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear speckles" "HPA047001: AB_2679899" "unprognostic (7.40e-3)" "unprognostic (4.71e-1)" "unprognostic (6.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.62e-1)" "unprognostic (3.07e-1)" "unprognostic (1.29e-2)" "unprognostic (4.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.22e-3)" "unprognostic (3.74e-1)" "unprognostic (3.06e-1)" "unprognostic (3.67e-2)" "unprognostic (3.93e-2)" "unprognostic (2.43e-1)" "unprognostic (1.87e-3)" "unprognostic (1.62e-1)" 3.1 2.9 0.6 1.1 0.7 1.1 2.8 1.1 1.7 3.9 0.4 4.6 0.2 3.8 2.0 2.6 3.4 1.2 2.7 0.6 0.9 3.6 3.4 2.8 4.8 0.8 0.9 3.4 4.3 1.1 2.6 0.9 1.0 2.3 1.0 1.7 2.8 0.6 3.5 1.9 2.9 5.1 0.6 2.8 2.9 3.7 0.9 1.4 3.5 0.0 0.3 2.6 3.0 1.2 4.8 0.0 4.2 0.0 11.0 12.8 13.9 0.5 0.2 0.3 0.7 12.0 0.4 18.5 8.4 10.2 6.1 3.1 0.6 0.1 0.3 15.0 14.0 8.7 0.2 0.9 12.3 0.4 0.0 0.0 2.7 0.4 0.0 2.4 0.0 0.1 0.2 3.3 0.0 7.3 5.6 6.0 0.1 0.1 0.0 6.6 2.6 11.1 19.1 0.0 0.4 4.6 12.1 1.4 11.5 0.3 7.7 8.0 4.2 5.3 1.1 0.7 8.7 0.2 0.8 4.7 0.1 0.8 10.1 0.2 0.5 0.2 0.6 0.3 0.2 0.5 0.7 0.5 0.3 0.8 0.7 0.5 2.1 0.3 0.3 0.3 0.0 0.3 0.6 0.7 1.1 1.7 0.6 0.9 0.8 0.9 1.0 0.6 0.9 1.2 6.9 16.0 27.0 6.8 17.6 16.6 23.5 17.5 7.4 23.3 14.9 8.1 16.7 28.6 18.7 12.9 39.6 37.3 9.6 8.4 46.9 19.1 5.4 17.0 17.7 12.6 12.0 15.2 10.0 20.5 17.5 14.6 7.1 17.7 6.3 25.5 14.6 12.5 15.0 25.2 10.2 5.9 14.2 15.0 9.9 7.0 24.2 11.0 14.2 4.7 7.9 10.6 9.2 9.0 11.0 16.7 7.5 13.2 14.6 23.7 8.9 22.5 22.7 39.7 26.3 14.1 12.5 60.3 55.9 6.9 12.5 9.6 15.3 15.5 9.1 18.7 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;dendritic cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 31.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 18.1 28.8 24.2 9.9 24.4 16.6 16.7 21.5 32.6 31.2 40.5 21.2 8.8 26.7 7.8 65.2 24.6 11.5 38.5 24.6 21.8 25.4 21.7 20.3 12.2 20.4 20.8 24.4 35.3 18.6 47.8 11.0 19.6 40.4 9.7 18.3 24.9 12.6 50.2 51.0 18.5 15.5 17.0 21.3 24.7 26.6 22.2 18.6 34.6 20.8 11.2 19.7 35.1 21.7 27.8 60.1 43.3 50.7 37.8 30.4 24.6 29.5 33.0 40.2 34.0 45.0 25.6 30.5 42.3 36.4 30.6 30.3 55.4 37.6 32.9 13.7 53.1 25.2 49.8 63.8 21.3 29.1 32.2 37.5 28.0 49.5 21.8 26.9 40.2 34.6 31.7 24.2 32.0 67.6 32.5 34.8 58.4 15.1 28.3 59.7 53.4 31.4 25.2 28.7 54.4 36.5 29.8 24.9 18.6 34.4 44.8 21.8 43.2 40.2 24.0 25.6 30.7 25.6 24.8 30.2 16.6 31.7 30.2 2.6 3.4 3.5 31.9 3.2 23.0 3.1 3.6 15.8 4.3 2.2 3.7 10.0 2.5 12.2 3.3 6.6 4.0 6.9 24.2 24.4 21.5 32.6 24.6 21.8 20.4 20.8 19.6 17.0 22.2 21.7 16.9 19.2 23.9 29.7 10.8 18.4 7.3 14.3 23.3 45.5 10.6 11.9 27.4 10.0 17.2 12.9 93.8 7.8 86.2 18.4 5.9 11.8 2.8 40.4 37.3 18.0 30.0 7.2 30.2 11.5 4.3 22.5 19.9 22.3 19.0 26.1 13.9 13.7 10.9 26.9 33.9 17.6 18.3 10.3 7.7 4.5 19.3 12.9 3.6 14.0 10.0 15.0 52.5 17.1 23.4 15.8 9.3 15.8 29.6 13.9 10.2 9.0 30.8 35.1 13.1 16.4 15.1 17.2 18.2 34.8 20.6 4.2 32.7 25.7 12.2 6.7 H2AW "HIST3H2A, MGC3165" ENSG00000181218 "H2A.W histone" Q7L7L0 1 228456979-228457873 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 35.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 8.2;Cytotrophoblasts: 14.1;dendritic cells: 13.8;Extravillous trophoblasts: 10.8;Hofbauer cells: 28.4;Syncytiotrophoblasts: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 29.7;U-266/70: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (3.65e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.73e-4)" "unprognostic (1.84e-3)" "unprognostic (2.49e-2)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-2)" "unprognostic (3.20e-2)" "unprognostic (1.96e-1)" "unprognostic (6.67e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" 6.0 35.9 6.3 0.8 6.1 5.9 6.8 13.4 6.9 27.9 9.9 5.9 3.2 5.4 1.6 19.2 7.2 1.2 17.8 5.8 6.7 4.4 1.1 4.4 1.2 5.0 4.9 14.1 3.9 3.7 12.9 1.0 5.3 11.1 0.9 4.9 10.3 0.4 1.0 18.0 5.5 0.3 5.0 13.0 6.3 5.8 6.9 1.8 2.1 0.7 0.9 5.4 24.2 5.5 5.9 3.1 4.0 5.6 3.3 3.3 4.8 2.9 2.8 8.2 5.7 3.1 4.8 2.7 3.4 0.6 0.0 14.3 2.9 1.4 1.9 4.2 29.7 4.2 4.0 0.0 7.6 3.0 8.1 7.3 8.4 1.5 3.5 3.3 3.5 5.4 15.0 0.0 0.0 8.4 3.9 0.0 6.2 3.5 7.5 0.0 0.0 22.9 1.4 3.5 24.7 17.4 10.2 8.9 20.7 0.6 15.7 2.2 1.3 0.0 0.1 11.0 2.6 29.4 22.4 0.0 2.9 3.0 2.1 4.4 1.4 0.0 5.8 2.8 4.3 2.7 5.5 4.3 3.0 2.1 4.2 4.1 0.6 6.5 7.0 0.5 10.4 3.4 6.3 6.1 13.4 6.9 5.8 6.7 5.0 4.9 5.3 5.0 6.9 5.5 0.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 14.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 53.8 2.4 0.0 0.0 0.0 H2BC18 HIST2H2BF ENSG00000203814 "H2B clustered histone 18" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 1.4;Fibroblasts: 1.3;Hofbauer cells: 8.5;Syncytiotrophoblasts: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 14 "neutrophil: 30.8" "Lineage enriched" "Detected in many" 14 "granulocytes: 30.8" "Cell line enriched" "Detected in many" 7 "U-266/70: 49.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 10.2 6.7 4.2 1.3 5.0 3.0 5.3 10.0 3.7 36.5 13.1 6.5 0.6 1.1 2.5 9.6 9.7 1.0 7.4 3.4 7.0 8.9 7.2 28.0 0.9 6.0 7.4 35.3 4.7 0.3 5.6 2.2 6.7 30.2 0.9 2.9 6.9 0.9 0.7 17.8 3.3 0.6 5.4 15.8 12.9 3.7 5.5 2.8 6.1 0.5 0.7 6.1 34.7 7.9 0.7 1.0 0.5 1.0 0.6 0.1 0.5 1.0 0.2 0.8 1.0 0.5 1.3 0.7 0.4 0.2 0.8 2.1 0.2 0.0 0.1 2.1 0.7 0.7 3.0 0.1 0.4 0.4 2.7 1.2 0.0 0.4 0.5 0.4 0.1 0.5 1.8 3.8 0.0 1.5 5.2 3.1 0.7 3.6 1.5 0.5 1.7 1.2 0.2 0.2 2.7 0.9 6.6 0.3 0.5 1.0 2.0 0.4 0.0 0.7 0.0 1.1 0.6 49.7 1.7 2.0 1.0 0.5 0.2 0.0 1.4 0.3 0.8 0.5 0.8 0.7 1.1 0.4 0.9 2.1 0.5 0.4 30.8 0.7 0.6 0.8 0.2 0.2 4.2 5.0 10.0 3.7 3.4 7.0 6.0 7.4 6.7 5.4 5.5 7.9 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 H2BC5 "H2B/b, H2BFB, HIST1H2BD" ENSG00000158373 "H2B clustered histone 5" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 151.7" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 22.4;Syncytiotrophoblasts: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 117.9;U-266/84: 134.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol NA Yes "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 25.4 13.4 17.8 7.6 21.9 53.8 18.5 48.7 19.2 151.7 41.8 34.6 11.0 6.3 27.7 37.6 53.5 15.3 31.4 17.9 29.7 67.2 62.9 36.8 9.2 22.2 23.7 101.8 15.7 2.1 30.5 9.3 28.0 144.0 17.1 9.7 28.9 3.6 18.5 44.1 23.3 4.3 27.5 35.4 26.1 11.3 23.8 35.2 25.2 7.3 4.1 17.9 95.5 33.9 17.9 39.7 12.0 6.8 91.2 8.3 3.6 15.5 8.9 19.6 12.3 13.3 14.5 8.1 95.2 18.5 21.8 27.9 6.8 6.6 9.2 36.6 16.9 5.4 33.7 14.5 9.8 7.2 14.7 59.7 10.3 5.5 7.7 7.6 4.9 7.5 57.1 43.3 3.6 64.2 16.4 18.1 12.6 76.1 18.2 6.5 7.6 54.4 18.7 12.8 38.1 16.1 96.8 25.1 15.9 23.1 63.4 2.6 3.0 24.4 63.4 9.9 3.3 117.9 134.9 20.5 3.1 33.2 5.0 35.3 2.3 16.9 8.1 5.1 10.4 13.4 12.3 13.5 5.6 20.0 11.4 8.7 24.8 10.5 6.9 19.3 8.9 2.4 17.8 21.9 48.7 19.2 17.9 29.7 22.2 23.7 28.0 27.5 23.8 33.9 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 7.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 39.4 0.3 0.0 0.0 0.0 HNRNPA2B1 HNRPA2B1 ENSG00000122566 "Heterogeneous nuclear ribonucleoprotein A2/B1" P22626 7 26171151-26201529 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport" "Ribonucleoprotein, RNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001666, HPA005812, CAB012403, HPA065537" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 11000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507" "unprognostic (1.19e-1)" "unprognostic (4.45e-1)" "unprognostic (2.33e-1)" "unprognostic (6.39e-2)" "unprognostic (5.64e-2)" "unprognostic (8.04e-3)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.25e-2)" "unprognostic (9.12e-3)" "unprognostic (4.35e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.12e-4)" "prognostic unfavorable (8.01e-5)" "unprognostic (6.74e-2)" "unprognostic (3.36e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" 367.0 421.3 101.3 151.4 105.4 77.6 314.1 110.9 140.3 403.5 106.4 381.8 124.8 404.3 116.1 417.6 376.3 62.4 463.6 99.7 106.4 530.8 388.5 364.9 184.1 106.4 105.0 527.8 350.2 80.8 337.6 118.9 108.2 300.8 127.5 131.1 325.1 79.2 764.9 280.5 419.0 84.2 102.3 447.5 353.4 370.5 105.4 174.8 367.2 92.0 172.5 339.9 360.8 111.7 202.5 101.8 491.6 312.7 110.7 117.5 249.6 255.8 110.7 149.6 183.6 159.8 338.5 210.2 104.2 180.1 218.8 300.0 196.3 268.7 288.5 74.9 191.2 232.6 309.9 212.1 72.9 374.6 359.4 123.6 192.4 156.3 253.3 194.6 161.1 273.9 210.9 250.4 280.4 229.1 216.5 817.2 320.7 81.7 117.7 239.5 122.1 159.3 287.0 335.8 190.7 245.6 203.5 291.8 127.7 393.6 326.3 359.7 222.0 193.2 265.6 184.6 253.7 367.0 296.0 308.7 149.9 453.8 316.5 0.0 1.7 1.3 4.8 1.0 4.0 2.7 3.0 0.8 0.8 0.8 2.7 2.6 0.6 3.3 0.8 1.6 1.0 0.5 101.3 105.4 110.9 140.3 99.7 106.4 106.4 105.0 108.2 102.3 105.4 111.7 717.8 487.2 591.0 194.6 667.5 738.5 797.7 793.2 560.5 469.4 361.0 361.3 702.1 316.0 665.8 343.9 298.2 971.6 707.7 435.1 461.8 568.0 128.2 465.8 640.8 600.5 491.4 683.2 123.3 452.2 939.9 602.7 449.6 591.1 644.7 680.5 333.4 382.8 613.1 312.9 147.2 533.1 496.4 388.5 681.9 150.0 411.0 640.3 393.1 157.4 572.0 545.4 484.1 198.0 320.6 438.2 438.7 390.0 751.0 520.4 428.4 506.8 608.0 547.0 440.4 599.4 726.5 596.9 490.6 573.8 600.5 1082.8 701.7 652.2 541.4 632.1 HSF1 HSTF1 ENSG00000185122 "Heat shock transcription factor 1" Q00613 8 144291591-144314720 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 248.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004239, HPA008888" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "CAB004239: AB_627753, HPA008888: AB_1079088" "unprognostic (7.08e-2)" "unprognostic (1.89e-2)" "unprognostic (6.07e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (1.55e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.69e-3)" "unprognostic (1.05e-1)" "unprognostic (4.35e-2)" "unprognostic (1.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" 51.7 55.7 20.0 14.7 19.2 18.0 47.9 18.2 24.0 48.6 17.0 70.6 14.1 51.7 7.4 48.1 52.1 12.4 133.5 18.6 19.1 50.2 46.0 49.5 14.5 22.3 21.4 57.3 68.7 18.7 48.1 17.0 20.2 53.2 10.8 7.6 39.8 17.1 125.1 49.2 39.7 15.3 18.6 42.8 57.8 107.8 21.7 14.7 45.7 32.2 12.6 58.7 46.2 18.0 40.8 53.8 22.9 19.6 37.6 35.0 37.9 29.7 26.6 28.8 25.0 36.3 34.6 46.7 42.5 41.5 28.2 28.9 35.2 42.7 18.3 29.9 40.7 58.4 51.8 50.1 59.1 17.1 43.4 34.2 39.3 40.6 74.2 30.6 39.4 41.9 39.6 27.1 29.4 82.0 58.0 26.2 29.4 52.6 154.2 37.2 19.9 59.2 20.6 40.5 34.3 27.9 45.4 35.9 52.8 23.8 40.5 34.5 40.2 29.5 66.3 46.8 49.5 18.8 15.4 39.9 41.8 31.4 28.8 14.2 23.2 26.3 16.7 24.9 17.2 19.2 17.8 21.1 24.6 17.3 17.1 15.9 9.7 16.3 32.2 12.6 22.9 19.2 20.0 19.2 18.2 24.0 18.6 19.1 22.3 21.4 20.2 18.6 21.7 18.0 46.5 6.4 11.2 8.5 40.4 51.4 73.8 53.8 39.9 67.8 37.0 30.5 46.4 22.8 34.7 29.5 62.6 69.9 38.2 43.3 150.6 39.2 248.7 35.1 20.5 44.4 40.9 120.8 12.1 41.1 80.6 34.7 44.9 34.6 37.5 51.1 40.7 63.8 49.5 69.0 14.7 36.8 42.7 25.7 45.6 106.7 37.3 32.7 33.8 12.2 59.7 24.9 34.0 6.0 12.9 45.3 49.3 42.9 40.4 76.6 63.8 34.9 25.9 33.1 59.2 41.3 39.2 84.4 47.7 36.3 45.5 111.0 39.0 105.9 45.8 76.4 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 242.2 88.5 53.0 20.2 43.1 9.0 141.3 50.1 57.1 125.7 60.9 136.7 78.4 116.0 4.7 340.4 146.3 35.0 291.9 45.3 56.8 218.1 154.1 204.7 14.0 69.3 56.0 66.8 42.4 8.1 167.8 45.7 62.3 202.5 26.4 5.1 58.5 149.6 53.8 129.6 154.3 12.2 53.3 79.7 162.5 16.4 79.1 5.9 266.8 37.8 6.2 351.1 206.9 47.1 76.1 245.3 2.7 49.3 31.2 14.1 187.6 314.1 12.6 56.9 6.2 130.5 111.4 0.6 509.6 84.3 67.2 500.2 40.1 17.9 8.6 6.2 25.6 41.5 229.2 425.3 42.3 0.9 2.2 57.4 69.7 0.3 4.3 93.5 35.0 27.6 94.0 2.3 110.4 99.8 11.4 1.8 172.7 336.5 515.3 0.9 200.8 4.2 11.1 206.1 93.5 87.4 261.3 91.9 2.4 128.8 57.0 7.6 188.5 151.3 300.0 49.0 216.1 5.6 6.3 5.2 176.2 39.5 21.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.1 0.1 0.2 0.0 0.0 0.1 53.0 43.1 50.1 57.1 45.3 56.8 69.3 56.0 62.3 53.3 79.1 47.1 1667.3 237.2 171.7 88.2 25.1 102.3 992.2 1443.4 406.3 2.7 98.6 114.3 35.1 112.9 685.1 228.1 4.2 129.9 46.3 594.3 37.2 584.1 5.7 794.1 450.1 907.7 572.7 49.9 0.6 535.5 493.7 195.3 675.3 707.6 22.2 8.9 2131.4 109.1 25.6 0.0 0.5 557.4 321.4 72.2 52.4 8.7 28.6 38.9 90.7 92.8 8.2 85.0 1.0 4.0 0.3 257.4 924.9 0.4 26.7 519.7 579.8 7.1 168.1 8.3 13.1 229.7 206.1 3.2 53.7 455.8 87.9 89.1 39.8 15.9 389.1 591.6 ID3 "bHLHb25, HEIR-1" ENSG00000117318 "Inhibitor of DNA binding 3, HLH protein" Q02535 1 23557926-23559501 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Myogenesis, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1710.3;Basal respiratory cells: 1091.1;Hepatic stellate cells: 1508.2;Ionocytes: 1210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 318.8;naive B-cell: 306.1" "Group enriched" "Detected in many" 39 "B-cells: 318.8;T-cells: 177.0" "Cell line enhanced" "Detected in many" "U-698: 598.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021353, HPA024677" Approved Supported Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "CAB021353: , HPA024677: AB_2671647" "unprognostic (6.73e-2)" "unprognostic (2.48e-1)" "unprognostic (5.19e-2)" "prognostic favorable (1.27e-5)" "unprognostic (5.58e-3)" "unprognostic (1.46e-1)" "unprognostic (8.98e-2)" "unprognostic (7.76e-2)" "unprognostic (3.89e-2)" "unprognostic (6.47e-3)" "unprognostic (2.42e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (4.37e-3)" "unprognostic (8.36e-2)" 163.4 49.5 42.5 22.7 37.4 6.9 114.1 38.6 51.6 81.6 39.6 89.2 29.8 84.2 15.5 42.9 134.1 39.1 177.1 39.2 70.3 93.2 31.6 99.6 26.3 59.3 52.2 106.1 41.0 8.3 120.4 51.0 49.5 110.3 22.3 10.1 39.8 108.1 41.3 62.9 76.3 20.9 48.2 41.9 89.0 6.9 53.7 34.8 195.9 52.1 13.3 131.6 90.3 42.9 24.1 152.6 57.2 199.1 27.2 2.8 53.0 154.2 16.8 105.0 14.5 8.9 1.2 150.2 168.2 80.3 21.7 216.1 77.7 25.1 12.3 1.2 68.8 2.4 227.5 89.6 77.9 0.2 0.4 80.1 141.9 2.8 1.5 104.0 91.7 67.1 0.9 2.0 107.8 59.9 21.0 0.6 41.9 140.0 37.6 189.5 82.1 5.6 1.3 66.3 78.3 55.0 148.4 155.8 12.7 49.9 38.1 5.2 162.3 151.5 72.4 69.4 92.2 47.4 45.9 598.1 34.4 1.8 79.0 0.6 1.3 0.3 3.8 1.8 1.3 318.8 69.8 13.9 5.0 306.1 113.3 45.6 3.6 0.7 2.1 6.2 177.0 36.9 42.5 37.4 38.6 51.6 39.2 70.3 59.3 52.2 49.5 48.2 53.7 42.9 1710.3 115.4 62.6 77.7 211.6 205.2 340.3 1091.1 583.4 4.1 128.3 187.3 35.8 20.0 337.1 209.7 10.4 193.4 27.8 384.8 23.5 216.6 1.9 555.2 270.3 988.8 432.3 41.0 0.1 441.5 931.4 496.5 384.3 562.4 15.2 394.7 1508.2 7.0 70.6 5.0 0.2 560.1 1210.5 71.7 254.9 3.7 41.0 91.1 249.1 62.8 21.0 378.5 1.0 0.5 3.1 88.4 388.8 0.7 67.1 168.4 223.1 7.9 110.6 17.7 519.4 266.4 780.2 0.9 2.8 577.6 189.5 279.2 86.7 19.5 323.3 116.5 IDUA "MPS1, MPSI" ENSG00000127415 Alpha-L-iduronidase P35475 4 986997-1004564 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025901, HPA046979, HPA054254" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 170000 "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429" "unprognostic (3.62e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (7.23e-2)" "unprognostic (1.45e-1)" "unprognostic (2.31e-2)" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.43e-2)" "unprognostic (1.89e-3)" "unprognostic (2.64e-2)" "unprognostic (4.61e-3)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "prognostic favorable (8.04e-5)" 13.5 17.6 3.4 2.2 3.4 2.9 16.1 9.2 7.5 17.5 2.9 10.3 3.6 15.4 2.4 9.9 16.3 3.7 11.6 3.8 1.5 15.9 13.6 13.9 3.5 3.2 2.1 17.0 21.0 2.8 17.2 1.7 2.4 18.5 1.8 1.8 16.6 4.5 3.7 8.9 14.3 2.0 1.0 18.9 17.1 5.6 2.9 3.4 17.0 0.7 1.3 12.0 13.9 2.6 1.8 0.4 0.0 1.1 12.7 3.6 5.3 10.7 8.5 1.2 1.7 0.6 6.4 0.8 10.7 5.0 1.0 0.5 0.1 0.3 0.4 6.1 0.6 1.0 0.8 0.1 5.8 0.8 4.6 9.3 3.1 0.6 0.0 3.4 1.0 0.7 0.6 0.0 1.6 0.0 2.2 2.5 0.8 11.9 5.5 2.7 0.0 1.1 3.5 0.9 0.1 3.3 0.3 0.0 5.7 1.3 1.2 2.3 9.3 9.0 1.6 2.6 1.2 29.0 1.4 0.4 7.8 3.3 1.8 0.0 1.5 0.0 1.4 1.2 1.8 0.1 1.1 0.9 1.8 0.2 1.3 0.7 0.0 1.5 1.7 1.1 0.6 0.5 3.4 3.4 9.2 7.5 3.8 1.5 3.2 2.1 2.4 1.0 2.9 2.6 8.7 6.4 5.0 4.9 5.2 3.6 11.5 1.1 8.6 2.0 8.5 9.1 2.6 1.5 1.5 7.3 4.2 0.4 4.3 5.0 0.0 1.6 0.9 4.1 9.0 4.9 10.7 1.3 4.4 2.4 1.7 13.4 16.8 6.0 2.5 8.2 6.1 2.6 6.5 0.0 2.9 4.2 0.0 5.0 3.6 0.9 19.6 7.3 5.4 1.0 1.6 1.1 4.1 5.5 3.3 1.4 6.9 10.5 15.7 7.7 6.9 1.4 1.4 2.1 0.0 5.5 4.4 3.7 1.6 4.7 1.8 0.4 5.6 4.7 4.3 7.9 IER3 "DIF-2, IEX-1, IEX-1L, PRG1" ENSG00000137331 "Immediate early response 3" P46695 6 30743199-30744548 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 2626.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 155.9;EFO-21: 55.6;HBEC3-KT: 189.9;RPTEC TERT1: 203.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043847 Approved NA NA "Cluster 35: T-regs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "HPA043847: AB_2678699" "unprognostic (2.83e-3)" "unprognostic (9.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.78e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (5.57e-4)" "prognostic unfavorable (6.36e-5)" "unprognostic (1.38e-3)" "unprognostic (1.69e-1)" "unprognostic (9.28e-2)" "unprognostic (1.53e-3)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.10e-7)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.71e-2)" "unprognostic (8.77e-2)" 153.6 102.5 0.0 14.4 0.0 0.0 48.2 0.0 0.4 176.4 0.0 81.3 0.0 40.5 3.4 257.9 56.5 0.0 167.9 0.0 0.0 257.1 101.1 158.3 0.0 0.0 0.0 32.5 98.5 0.0 32.3 0.0 0.0 59.4 0.0 1.1 90.2 0.0 12.9 88.8 40.8 0.0 0.0 67.4 157.7 6.3 0.0 0.0 32.3 0.0 1.0 50.9 199.7 0.0 155.9 0.0 0.0 18.0 4.4 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 55.6 9.9 16.2 0.0 0.0 189.9 0.0 0.6 7.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 203.4 24.3 0.0 0.5 0.0 0.4 0.7 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.1 1.3 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.4 208.3 142.4 2.6 47.9 457.7 865.5 557.8 905.5 1.8 735.2 929.2 8.5 175.8 321.4 101.2 0.0 40.3 179.1 634.3 82.2 1141.6 1.4 889.8 539.8 400.7 147.9 3.6 2.9 710.7 58.1 824.8 431.2 2626.8 124.9 5.8 69.7 19.6 329.5 3.3 2.0 656.2 105.8 110.1 711.5 3.6 9.9 914.8 236.5 35.6 295.3 16.0 10.3 1.0 0.6 802.4 671.0 6.8 52.7 658.9 85.3 18.4 85.0 3.3 26.3 331.4 552.5 0.3 2.2 1251.9 329.2 83.0 92.2 35.5 434.9 644.5 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 177.5;Breast myoepithelial cells: 110.2;dendritic cells: 121.9;Endometrial stromal cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 24.7;SiHa: 34.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 21.4 10.6 3.7 1.2 4.7 0.4 10.7 3.5 7.3 39.4 2.1 9.4 0.8 13.9 2.1 9.4 16.6 1.9 21.6 3.3 4.1 27.2 14.6 13.1 0.7 6.2 4.1 18.9 4.8 0.6 10.7 1.4 4.8 12.3 0.4 0.5 7.5 3.3 3.5 7.5 5.7 1.0 3.7 6.3 9.1 4.7 4.6 0.3 12.4 0.9 0.3 16.2 19.5 4.8 8.6 24.7 6.9 13.3 5.0 7.9 20.9 12.6 1.1 1.9 1.9 1.3 13.8 0.2 4.9 2.9 5.5 18.6 0.3 1.5 0.3 1.2 1.8 0.0 5.7 2.4 3.8 0.3 0.2 8.6 1.9 1.4 0.2 10.8 0.9 0.2 0.7 4.4 0.3 22.1 0.3 1.1 0.6 2.2 12.9 1.2 0.5 3.8 7.6 1.2 3.1 4.1 34.8 11.1 15.7 2.8 3.4 2.2 5.1 11.7 7.0 7.9 18.3 2.4 1.7 0.3 14.9 2.5 5.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.7 4.7 3.5 7.3 3.3 4.1 6.2 4.1 4.8 3.7 4.6 4.8 177.5 16.0 1.7 12.7 25.5 6.8 9.2 11.1 27.9 6.1 52.7 110.2 1.6 25.8 10.7 47.8 0.0 3.9 121.9 34.7 9.8 14.5 0.7 87.1 218.9 42.6 10.7 0.8 13.1 27.1 11.8 41.4 19.9 102.7 0.0 2.2 30.0 11.7 31.0 3.3 4.3 20.6 26.4 17.0 17.2 1.6 10.8 64.7 14.2 15.0 7.4 13.9 0.0 2.0 1.4 20.0 12.5 7.2 11.2 9.8 8.4 17.3 13.4 2.8 26.3 41.8 99.0 0.1 3.6 37.6 4.5 8.1 55.1 3.9 15.4 7.7 IFITM2 "1-8D, DSPA2c" ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 303655-309397 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 920.0;NK-cells: 1350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 6 "neutrophil: 23410.9" "Lineage enriched" "Detected in all" 11 "granulocytes: 23410.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2" "HPA004337, HPA044731" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA 450000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" "Cell Junctions" Nucleoplasm "HPA004337: AB_1851427, HPA044731: " "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 1086.2 307.0 90.3 258.0 90.2 177.0 681.0 89.6 116.6 785.6 101.4 358.6 40.9 702.8 52.1 237.2 903.8 97.4 619.6 92.0 97.9 703.1 1288.5 1069.9 99.9 94.4 89.4 650.1 211.1 112.0 200.6 145.3 94.9 406.1 41.8 27.0 228.9 102.5 195.9 236.7 305.6 200.4 92.8 1402.1 304.3 123.0 95.4 29.8 437.7 132.8 105.8 493.1 496.6 95.1 32.2 65.4 313.1 2.9 137.2 358.3 0.9 106.8 65.1 27.0 63.3 1.7 206.9 2.7 126.6 424.6 0.4 68.5 1.1 9.3 9.0 1.8 41.1 75.1 102.6 117.6 547.7 124.1 494.9 710.9 2.3 5.2 3.3 64.4 51.2 22.5 5.2 210.5 11.6 129.9 2.5 603.3 36.4 5.3 229.4 101.0 29.9 1.1 181.6 0.4 0.8 7.0 65.4 74.9 34.5 5.3 86.7 69.8 338.3 5.7 26.8 36.1 1.4 4.5 5.0 3.3 14.5 485.2 18.1 2706.4 537.4 3789.5 666.6 1421.9 480.8 846.9 590.1 639.5 612.5 799.2 511.7 510.3 23410.9 1225.0 2199.0 279.0 411.7 1376.6 90.3 90.2 89.6 116.6 92.0 97.9 94.4 89.4 94.9 92.8 95.4 95.1 920.0 307.7 540.0 5.9 301.1 104.4 251.1 161.4 215.1 0.3 59.7 66.5 51.8 154.4 209.2 248.3 0.0 8.3 814.7 22.5 487.2 433.0 7.8 67.1 468.6 828.4 9.6 100.7 0.0 256.7 16.9 515.8 30.5 78.5 530.5 68.8 752.1 684.1 223.4 0.0 0.0 39.4 24.4 372.8 255.9 31.5 507.6 645.9 209.9 12.2 177.3 80.5 1350.1 0.0 0.1 161.9 149.2 223.8 123.0 126.3 4.7 45.3 104.8 1.5 315.5 442.5 568.4 8.4 10.4 22.8 83.0 23.4 667.2 61.8 44.3 102.4 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33403413-33479348 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" Receptor "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Prostatic glandular cells: 433.1;Urothelial cells: 602.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 661.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 72.9 41.1 5.9 8.6 7.0 46.6 65.6 2.4 8.2 48.3 7.9 46.8 14.2 31.2 3.4 67.4 37.8 11.6 46.4 7.0 11.2 53.1 43.1 61.8 10.6 8.8 6.4 38.8 32.0 5.6 37.8 18.6 7.6 48.2 7.9 1.0 64.5 6.3 30.0 53.3 51.6 8.6 10.0 80.8 35.8 29.5 12.2 8.1 52.3 10.3 11.9 46.4 56.8 14.0 10.1 10.2 5.9 9.7 16.6 28.2 13.1 30.4 30.0 8.9 13.8 11.3 7.7 15.6 19.8 23.8 24.2 8.6 10.9 25.6 3.1 76.3 44.9 6.0 5.0 12.2 11.0 19.5 17.7 21.4 17.0 14.7 16.6 15.9 20.1 9.9 33.4 11.9 10.2 4.4 5.0 23.2 18.1 15.8 48.0 20.2 14.1 19.6 8.5 10.8 7.9 15.5 19.3 1.9 38.4 1.5 7.1 17.7 30.8 10.1 22.0 8.9 8.8 24.6 28.2 25.4 8.5 23.3 44.7 221.7 283.8 181.7 0.9 281.2 1.2 145.6 16.4 1.7 104.0 158.2 37.7 16.3 661.8 3.5 314.8 31.9 19.2 198.5 5.9 7.0 2.4 8.2 7.0 11.2 8.8 6.4 7.6 10.0 12.2 14.0 72.2 41.7 20.5 9.1 101.4 72.0 225.1 164.8 147.4 9.0 69.3 39.2 18.4 38.6 58.2 27.6 8.4 33.6 11.2 185.3 27.4 117.8 44.6 32.1 51.0 55.1 51.6 17.7 18.7 55.7 86.1 66.8 62.7 50.4 60.3 52.1 40.0 29.6 167.6 15.2 18.9 56.2 57.0 154.5 146.7 60.8 42.0 190.8 56.9 45.0 246.6 8.7 6.2 15.6 5.0 138.6 150.3 32.7 67.9 433.1 151.9 50.1 25.4 8.4 13.1 61.3 33.7 13.4 2.8 90.5 70.0 17.4 16.9 3.4 41.3 602.7 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324687 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 39.7 40.8 26.0 24.0 28.6 29.0 39.0 37.2 40.1 64.7 27.7 70.6 32.8 66.6 26.4 43.9 61.1 24.1 54.9 27.2 28.4 40.4 45.7 35.6 31.8 30.3 27.2 63.6 53.6 28.9 40.0 28.2 30.6 52.9 20.8 13.0 38.3 27.6 90.3 47.2 44.9 26.7 24.5 45.4 52.4 76.0 28.0 29.6 40.7 44.2 25.1 67.5 50.6 33.6 58.4 56.2 31.5 62.1 52.4 41.7 34.1 31.2 49.9 67.6 50.1 53.2 71.0 63.2 43.6 60.7 40.6 41.4 46.3 67.7 29.9 60.3 60.5 49.8 79.7 70.2 80.2 39.1 52.5 72.1 35.9 61.7 91.7 38.2 71.7 59.7 59.5 56.3 34.2 50.8 77.6 52.1 39.1 53.6 60.1 61.0 30.8 93.1 47.6 31.3 45.0 42.1 31.9 83.8 91.7 23.4 45.5 57.0 54.5 43.6 39.6 50.8 40.0 87.3 101.8 85.1 60.4 68.7 22.0 66.5 69.6 48.0 65.2 82.1 68.9 50.3 56.4 59.8 81.2 44.0 52.2 50.2 33.2 64.8 101.7 52.9 78.7 81.0 26.0 28.6 37.2 40.1 27.2 28.4 30.3 27.2 30.6 24.5 28.0 33.6 36.4 38.5 33.7 0.0 9.5 0.0 0.0 0.0 0.0 0.0 32.6 33.9 0.0 0.0 13.0 18.4 0.0 77.3 24.1 0.0 31.3 56.4 0.0 27.1 27.2 14.0 0.0 0.0 0.0 53.9 63.9 18.7 0.0 23.2 10.1 40.4 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 36.2 0.0 0.0 0.0 0.0 54.8 0.0 0.0 6.8 0.0 0.0 34.4 14.6 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 77.0 12.7 49.8 0.0 0.0 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728050-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 14.3 18.7 1.7 10.8 2.0 2.9 14.7 0.5 3.2 16.8 0.9 16.1 4.2 18.3 13.4 12.1 20.7 9.7 13.0 2.2 2.1 15.9 11.8 14.9 8.6 2.7 0.9 23.3 13.0 8.2 17.8 9.6 1.3 11.9 6.5 3.6 12.1 11.3 14.9 12.2 12.9 9.4 0.0 13.2 16.7 12.8 4.4 6.7 15.3 8.3 7.7 13.6 14.4 1.5 26.2 15.8 14.0 19.2 21.3 17.4 19.1 18.2 8.7 21.7 17.4 8.5 24.5 21.3 37.8 24.2 11.8 27.0 28.0 18.7 10.2 24.6 23.0 15.4 37.7 3.8 13.8 18.8 20.5 12.3 7.5 9.5 11.7 17.5 14.4 13.8 19.2 14.6 9.0 8.5 18.6 10.0 23.6 25.5 26.8 24.5 6.4 13.1 8.1 24.7 11.8 15.5 18.9 39.7 11.4 18.4 13.3 25.3 6.1 22.7 6.7 18.1 18.1 17.1 13.7 19.5 24.9 8.9 11.3 0.0 0.8 0.9 0.9 0.5 0.8 0.3 0.3 0.5 1.2 0.3 0.2 0.5 0.8 0.7 2.9 0.3 0.5 0.2 1.7 2.0 0.5 3.2 2.2 2.1 2.7 0.9 1.3 0.0 4.4 1.5 29.1 22.4 22.8 59.7 11.9 10.5 9.5 10.4 15.9 23.7 20.2 22.4 4.6 10.0 11.7 31.3 20.9 13.9 11.6 9.2 0.0 11.9 13.1 39.3 29.4 21.5 12.1 10.9 30.8 8.4 13.4 16.3 23.9 38.8 5.7 32.9 26.7 13.9 12.2 21.9 26.1 16.5 8.2 9.1 22.0 7.6 9.6 14.6 7.2 30.0 17.6 15.4 14.4 27.2 29.7 9.9 14.9 12.0 11.6 10.6 9.8 13.3 25.9 22.4 26.3 11.2 16.5 10.2 12.2 13.9 10.2 10.3 10.0 20.2 14.0 12.2 IRF2BPL "C14orf4, EAP1, KIAA1865" ENSG00000119669 "Interferon regulatory factor 2 binding protein like" Q9H1B7 14 77024543-77028708 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050862, HPA061333" Approved Enhanced Nucleoplasm NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA050862: AB_2681258, HPA061333: AB_2684481" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.99e-3)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.78e-3)" "unprognostic (1.57e-2)" "unprognostic (2.70e-1)" "unprognostic (1.81e-1)" "unprognostic (5.74e-2)" "unprognostic (2.53e-2)" "unprognostic (2.51e-3)" "unprognostic (5.39e-2)" "unprognostic (1.03e-3)" "unprognostic (2.55e-1)" "unprognostic (9.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" 26.1 25.3 12.2 9.2 13.9 5.6 28.5 13.4 12.0 20.1 12.8 32.4 6.9 25.8 5.1 13.3 33.7 6.5 22.6 14.1 21.1 28.7 19.1 20.9 6.2 15.2 14.8 32.4 17.5 19.8 22.6 7.9 10.9 18.4 3.3 7.3 19.2 10.1 16.8 25.2 15.1 8.0 12.6 19.0 18.8 13.5 19.0 9.7 18.7 4.2 3.3 26.4 18.2 9.4 15.4 13.2 32.2 36.3 9.6 8.8 45.8 15.9 13.0 4.4 5.9 6.2 24.8 5.4 11.3 13.6 12.4 23.6 5.6 11.8 3.7 25.8 19.1 6.9 13.0 8.5 12.5 1.9 29.7 11.8 9.1 7.8 6.8 34.8 6.0 10.9 10.4 59.4 5.7 42.2 21.0 14.5 14.5 6.6 68.2 4.4 9.1 13.0 15.6 22.4 24.9 36.0 22.5 23.2 42.5 8.6 16.1 3.4 10.4 20.2 19.5 6.8 10.3 22.9 26.3 9.0 31.3 4.7 25.8 1.7 1.4 1.3 2.8 1.9 2.7 1.4 2.5 2.6 1.3 1.6 2.0 2.3 9.0 5.9 2.3 10.7 2.6 0.8 12.2 13.9 13.4 12.0 14.1 21.1 15.2 14.8 10.9 12.6 19.0 9.4 71.4 22.4 14.3 5.9 40.2 73.7 32.5 22.5 115.5 57.1 54.6 41.5 19.5 32.9 11.6 64.4 29.2 22.8 58.9 10.8 37.2 19.6 1.3 25.3 26.0 44.0 47.6 10.8 8.2 19.0 49.7 47.8 12.2 25.6 26.6 15.2 55.6 60.5 33.3 10.1 8.6 14.7 16.2 54.7 78.9 4.0 30.1 26.6 35.6 9.4 10.0 57.8 38.1 8.5 4.8 17.8 7.0 34.3 21.1 30.0 6.7 23.1 13.8 10.4 39.5 56.4 83.2 1.6 50.5 54.2 50.6 46.0 39.0 27.5 12.8 20.6 ITGA1 "CD49a, VLA1" ENSG00000213949 "Integrin subunit alpha 1" P56199 5 52787916-52959209 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 36.6" "Cell type enhanced" "Detected in many" "Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042555 Uncertain NA NA 6300000 "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA042555: AB_10794281" "unprognostic (1.48e-1)" "unprognostic (1.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (1.38e-1)" "unprognostic (9.89e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (1.79e-3)" "unprognostic (1.50e-2)" "unprognostic (2.62e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.13e-3)" "unprognostic (2.06e-2)" "unprognostic (1.07e-2)" "unprognostic (1.62e-2)" 13.9 22.4 0.6 1.0 0.8 0.0 10.2 0.7 0.9 5.1 0.4 36.6 1.1 16.3 2.5 5.7 9.9 2.2 10.6 0.5 0.8 11.0 17.1 22.1 0.8 0.8 0.8 3.6 3.1 2.1 2.3 5.8 0.8 12.6 2.7 0.1 2.3 7.2 4.6 2.3 12.5 5.8 0.8 27.9 16.6 0.8 0.8 0.2 9.7 2.5 0.4 17.9 5.1 0.9 0.0 0.0 0.3 0.0 1.4 0.4 0.1 0.3 1.3 0.3 0.7 0.7 0.0 0.0 0.1 4.5 0.5 0.2 0.1 0.4 0.2 0.0 0.4 0.0 0.3 0.3 4.5 0.0 0.0 0.7 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.7 0.5 0.0 0.0 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.7 0.9 0.5 0.8 0.8 0.8 0.8 0.8 0.8 0.9 264.1 54.5 26.8 2.9 1.7 3.2 4.7 1.5 2.8 1.8 3.6 13.8 12.6 5.7 8.7 5.5 2.1 1.5 2.9 5.5 1.9 3.0 21.3 7.7 41.8 120.5 16.4 5.3 3.6 5.4 16.8 40.2 6.1 22.1 10.1 1.0 77.1 110.5 2.2 0.0 19.5 14.0 0.0 7.2 8.2 6.1 9.3 5.6 7.2 63.7 9.1 0.4 0.0 1.5 4.2 19.6 7.7 8.2 2.9 3.2 6.5 15.1 6.3 2.0 98.6 18.6 143.9 0.9 1.1 0.5 3.1 3.4 46.0 13.6 14.0 2.3 KAT2A "GCN5, GCN5L2, PCAF-b" ENSG00000108773 "Lysine acetyltransferase 2A" Q92830 17 42113111-42121367 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048958 Uncertain NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "HPA048958: AB_2680571" "unprognostic (1.71e-1)" "unprognostic (9.08e-2)" "unprognostic (1.66e-1)" "unprognostic (2.31e-1)" "unprognostic (3.41e-1)" "unprognostic (9.07e-2)" "unprognostic (1.91e-3)" "unprognostic (3.87e-2)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "prognostic favorable (3.57e-4)" "unprognostic (2.78e-2)" "prognostic unfavorable (1.41e-8)" "unprognostic (3.97e-2)" "unprognostic (2.90e-1)" "unprognostic (1.89e-1)" "unprognostic (2.29e-3)" 14.1 20.8 11.3 6.5 11.9 4.2 13.2 7.7 18.9 20.3 3.1 15.4 6.7 17.2 1.7 14.7 21.0 3.1 10.1 10.8 12.7 13.1 15.7 9.7 5.3 10.8 10.4 28.4 16.9 5.8 14.4 4.6 10.0 16.9 4.0 1.0 10.0 4.3 11.8 15.9 13.5 3.4 5.3 17.4 13.0 10.8 14.0 4.7 14.6 2.1 4.6 15.5 16.4 12.4 24.7 46.6 6.8 25.3 9.3 7.6 29.7 15.7 8.3 34.0 16.7 31.9 19.5 48.1 38.6 12.1 25.6 36.0 27.9 25.0 12.1 27.0 58.0 12.0 29.8 28.8 9.7 32.3 30.8 9.0 20.8 19.1 11.9 9.2 13.8 11.9 30.7 8.9 9.1 26.4 77.7 23.5 14.5 60.9 0.0 18.3 13.3 31.9 9.2 24.4 32.4 14.2 16.8 36.2 13.2 5.1 26.9 15.3 10.7 17.1 17.4 25.1 28.2 23.8 24.5 26.9 12.5 27.5 9.7 0.0 0.1 0.0 0.2 0.0 0.4 0.5 0.5 0.6 0.4 0.3 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.2 11.3 11.9 7.7 18.9 10.8 12.7 10.8 10.4 10.0 5.3 14.0 12.4 21.5 12.8 11.5 84.5 19.0 12.2 12.6 6.8 26.2 16.5 18.9 22.7 7.1 18.6 6.6 18.4 10.4 25.1 10.7 7.9 3.9 9.2 1.3 5.9 11.3 18.4 15.7 6.7 39.6 8.0 20.5 12.1 17.3 8.2 11.4 25.8 22.5 20.2 12.1 10.1 41.0 10.1 6.1 10.9 6.8 3.7 32.6 9.8 7.2 32.8 5.2 3.7 5.2 41.7 28.3 6.7 7.3 29.0 7.2 10.9 4.0 4.1 5.4 7.8 13.1 15.1 10.8 5.2 18.2 18.7 13.9 11.2 7.8 26.4 20.2 9.1 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153598 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7" "Cell line enhanced" "Detected in all" "T-47d: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071568 Supported Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA071568: " "prognostic favorable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.74e-4)" "prognostic favorable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 12.4 19.4 7.8 8.9 9.4 13.5 16.8 15.8 10.0 23.4 5.1 14.7 6.6 18.4 6.7 17.0 20.2 4.7 16.0 9.3 5.3 10.4 21.2 12.5 11.7 9.2 7.3 17.8 13.7 6.6 18.4 9.5 7.5 25.6 2.9 14.7 14.1 7.4 32.2 21.7 13.8 4.9 4.7 22.1 12.6 16.1 8.8 8.8 29.4 8.3 7.2 13.4 18.2 11.9 16.1 5.5 12.8 15.4 7.3 7.2 25.7 7.9 5.8 6.8 8.5 9.6 4.4 22.4 8.2 9.1 5.5 8.9 7.8 9.3 4.2 10.1 19.9 7.5 9.9 8.0 13.6 7.6 16.7 11.2 9.9 5.6 4.7 12.3 9.3 12.4 18.7 13.3 6.2 8.3 8.8 11.5 11.3 5.8 13.6 14.7 9.7 19.0 6.8 10.5 23.7 18.1 10.3 11.2 12.5 12.3 61.5 19.7 13.5 10.1 5.7 12.5 8.0 36.5 16.4 17.1 20.0 15.1 6.0 1.5 0.6 1.9 0.3 0.2 0.2 4.2 0.2 0.2 0.3 5.1 0.4 0.5 4.7 0.8 0.3 1.7 0.4 0.3 7.8 9.4 15.8 10.0 9.3 5.3 9.2 7.3 7.5 4.7 8.8 11.9 15.3 6.4 10.4 18.9 73.2 7.4 14.1 10.8 7.4 72.5 36.1 22.2 15.3 10.0 9.4 7.3 98.0 25.7 25.5 15.3 7.9 10.5 17.0 25.4 18.7 16.4 8.4 9.4 33.6 7.6 26.2 14.6 26.5 30.2 8.2 34.3 15.4 30.9 9.0 74.0 30.6 16.7 16.2 14.2 7.8 12.1 18.3 15.8 10.6 27.2 17.0 23.5 19.6 29.7 28.7 18.0 14.1 23.3 23.9 19.3 7.4 6.6 11.7 69.2 6.6 23.1 13.7 25.2 9.1 14.1 15.3 24.1 13.9 29.7 9.5 12.9 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 22.4;Endothelial cells: 11.9;Enteroendocrine cells: 7.7;Hepatic stellate cells: 13.9;Horizontal cells: 18.5;Spermatogonia: 8.1" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 30.6;MCF7: 24.9;NTERA-2: 20.8;REH: 18.8;SCLC-21H: 19.2;SH-SY5Y: 39.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: AB_2679856, HPA060346: AB_2684259" "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 5.0 2.3 2.1 0.7 1.3 2.0 4.6 0.5 1.5 5.0 3.0 2.6 0.4 2.4 0.2 1.4 2.6 0.4 5.7 0.8 1.4 3.8 0.6 2.2 0.3 1.3 1.3 4.1 5.7 0.3 2.9 1.8 1.4 0.8 0.4 0.1 1.0 0.8 2.9 2.8 1.9 0.4 0.9 4.2 1.8 2.8 1.8 0.2 1.5 1.0 0.1 2.0 2.1 0.5 0.0 1.7 1.0 3.9 0.0 0.0 6.7 0.3 0.0 0.0 0.0 3.1 0.0 0.0 5.3 0.0 0.7 2.5 3.1 0.0 0.0 0.0 4.9 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 6.7 0.0 0.0 0.0 24.9 0.0 0.0 20.8 0.2 2.0 18.8 7.9 2.0 0.0 0.0 19.2 39.3 4.4 0.6 0.0 2.5 0.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.3 0.5 1.5 0.8 1.4 1.3 1.3 1.4 0.9 1.8 0.5 22.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.3 0.1 3.2 0.0 0.0 1.8 0.0 1.0 0.0 1.3 1.9 0.7 0.4 0.2 4.4 11.9 7.7 4.8 0.5 0.2 0.8 2.1 0.0 0.2 0.0 0.4 13.9 0.2 2.6 18.5 0.7 2.6 0.0 0.3 1.1 0.1 0.0 0.1 1.8 3.7 0.0 0.2 0.0 0.0 0.1 0.2 1.0 0.7 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.7 0.2 8.1 1.2 1.7 0.4 0.1 0.3 2.8 0.0 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171598-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 128.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 28.8" "Group enriched" "Detected in many" 10 "granulocytes: 28.8;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 29.1 128.7 13.5 5.6 14.0 6.1 24.9 9.4 14.8 20.2 24.8 56.1 7.2 26.2 10.6 31.1 26.5 16.7 70.5 12.4 21.2 16.3 12.6 17.3 9.9 12.4 14.2 70.1 9.4 10.4 10.1 12.3 16.1 16.9 3.6 2.3 14.1 13.5 29.6 28.1 14.0 14.2 11.6 13.2 16.7 15.5 19.1 4.3 26.6 13.4 6.8 29.4 22.5 10.3 2.5 5.5 22.4 11.4 13.5 8.0 6.9 8.4 4.7 8.2 6.6 3.6 7.4 0.0 4.6 14.0 2.3 0.1 5.6 5.1 2.1 4.6 1.5 15.1 15.2 9.6 25.6 0.0 8.5 13.3 23.9 10.6 0.8 18.4 21.2 5.3 23.7 0.2 6.3 0.7 1.6 16.7 7.4 1.3 13.1 2.3 2.1 0.7 6.1 1.3 0.9 25.2 6.7 0.2 17.0 4.7 6.8 7.3 9.3 6.2 17.1 11.2 2.6 2.1 0.7 0.3 4.5 0.0 3.1 0.0 5.4 28.8 1.0 8.0 0.4 0.0 0.5 0.7 0.5 0.1 1.8 1.0 9.7 0.0 8.3 0.8 0.2 2.4 13.5 14.0 9.4 14.8 12.4 21.2 12.4 14.2 16.1 11.6 19.1 10.3 14.1 9.6 10.9 5.9 0.9 7.6 11.5 16.4 10.8 2.2 10.8 9.0 60.7 11.5 14.3 7.3 2.1 10.9 2.4 1.0 17.6 14.3 7.2 6.8 6.9 20.5 6.7 6.5 3.8 5.9 8.5 22.3 2.6 3.3 1.3 7.7 37.1 7.5 41.7 0.0 4.6 3.0 18.3 12.0 2.2 7.7 15.2 10.5 12.4 6.5 2.5 29.4 0.0 3.5 0.7 8.6 1.7 14.3 0.6 8.3 0.7 13.4 4.0 2.7 98.6 28.3 31.1 9.2 8.6 15.5 9.8 49.8 1.5 55.5 1.7 7.9 LDLRAD2 ENSG00000187942 "Low density lipoprotein receptor class A domain containing 2" Q5SZI1 1 21812265-21825225 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 2.2;Granulosa cells: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 1.2;THP-1: 1.0;TIME: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "basal ganglia: 4.0;midbrain: 5.9" HPA030478 Approved "Secreted - unknown location" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "HPA030478: AB_10601541" "unprognostic (4.16e-2)" "unprognostic (1.22e-1)" "unprognostic (4.13e-2)" "unprognostic (4.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.22e-3)" "unprognostic (1.35e-2)" "unprognostic (4.85e-2)" "unprognostic (7.52e-2)" "unprognostic (3.80e-2)" "unprognostic (5.34e-2)" "unprognostic (5.38e-2)" "unprognostic (1.04e-3)" "unprognostic (7.39e-3)" "unprognostic (3.14e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" 3.7 2.8 0.4 0.8 0.3 1.0 3.0 0.2 0.1 2.7 0.4 4.3 1.6 3.5 0.0 1.7 2.7 0.5 6.8 0.7 1.1 2.2 0.7 1.6 0.7 2.4 3.3 1.1 2.0 0.0 1.5 0.1 1.7 3.7 0.1 0.0 7.2 0.0 1.2 1.3 2.4 0.1 1.7 2.7 3.7 1.4 1.4 0.0 2.2 0.0 0.3 3.9 2.4 0.3 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.0 2.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.4 0.3 0.2 0.1 0.7 1.1 2.4 3.3 1.7 1.7 1.4 0.3 2.2 0.0 0.6 0.0 0.6 0.5 0.1 0.4 0.6 0.0 0.1 0.1 0.7 0.0 0.2 1.8 0.0 0.2 0.3 0.0 0.0 0.2 1.7 0.3 1.2 1.6 0.0 1.3 0.2 0.0 0.6 1.3 0.0 0.9 0.0 4.9 0.7 0.2 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.0 1.0 0.5 0.0 0.0 0.0 0.2 0.3 0.1 0.0 1.3 0.5 0.0 0.0 0.8 0.0 0.0 1.2 0.7 0.6 1.2 0.1 0.4 0.3 0.4 0.4 0.0 0.0 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1 regulator of NFKB signaling" O95751 X 141111605-141177129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 123.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9" "Region enriched" "Detected in many" 5 "cerebellum: 19.2" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 32.3 34.0 4.7 0.9 5.5 0.1 28.0 2.9 8.5 45.8 0.2 18.8 0.9 53.9 1.8 21.4 48.5 1.6 15.1 6.2 5.8 33.2 4.8 19.6 0.8 5.3 5.0 46.8 19.3 10.5 123.3 0.0 5.0 34.3 0.3 3.4 55.1 5.9 5.5 31.5 12.5 2.0 1.2 14.2 18.4 10.8 5.0 0.9 53.7 0.4 0.7 33.1 30.6 6.0 0.0 24.7 3.0 8.4 5.0 6.2 0.0 5.0 5.8 6.3 8.8 0.0 8.0 0.0 4.2 7.7 6.1 10.4 3.4 7.1 4.5 0.0 6.6 0.0 11.7 0.0 2.0 0.0 1.9 10.9 3.6 5.5 2.9 5.1 5.7 0.0 0.1 0.0 5.7 31.9 0.0 0.0 3.3 0.0 34.3 0.0 2.7 0.0 7.7 4.7 0.0 3.2 0.0 4.0 0.0 1.6 5.1 0.0 11.9 0.0 6.8 0.0 21.9 0.0 0.0 0.0 3.5 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.8 0.9 2.5 0.8 0.2 2.1 2.2 1.4 0.0 6.4 0.0 1.4 2.6 1.0 4.7 5.5 2.9 8.5 6.2 5.8 5.3 5.0 5.0 1.2 5.0 6.0 8.6 0.0 5.3 4.2 4.9 6.0 16.8 4.6 16.5 29.3 23.8 20.2 2.2 30.0 8.2 23.9 8.4 2.8 5.7 0.1 43.0 13.8 0.7 7.8 13.5 12.8 5.4 0.8 9.4 14.0 1.8 16.1 3.6 6.0 2.5 8.8 12.8 0.1 0.9 20.2 9.9 0.4 8.2 0.3 1.8 1.1 22.1 1.0 3.6 7.5 0.3 21.2 5.2 7.1 15.0 13.7 0.2 38.7 0.9 11.9 0.0 43.8 4.6 13.0 13.1 15.3 26.2 0.9 7.6 16.7 6.8 1.5 5.2 13.5 0.3 15.0 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 98.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 4.0;HaCaT: 5.7;HDLM-2: 3.6;HSkMC: 2.1;LHCN-M2: 3.1;U-87 MG: 4.1;WM-115: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favorable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favorable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 8.2 8.9 0.2 0.0 0.3 0.1 8.1 0.5 0.3 9.3 0.0 9.4 0.0 8.8 0.2 6.6 9.5 0.0 12.0 0.1 0.2 9.1 8.3 7.1 0.0 0.3 0.3 10.3 10.1 0.1 8.6 0.0 0.9 8.8 0.2 0.2 7.2 0.1 15.2 7.4 8.4 0.0 0.3 11.2 10.0 14.7 0.3 0.1 8.3 0.0 0.1 9.5 7.5 0.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 2.2 0.0 0.6 1.1 0.4 0.5 0.6 0.4 0.9 0.7 0.5 0.6 0.6 0.5 0.8 0.7 0.0 0.4 0.4 0.1 0.2 0.3 0.5 0.3 0.1 0.2 0.3 0.3 0.9 0.3 0.3 0.5 28.8 19.2 8.8 2.3 31.4 20.6 22.1 28.6 11.4 10.1 15.2 14.5 7.8 17.2 17.6 18.4 0.0 27.5 30.9 33.7 23.5 21.5 98.8 23.6 18.6 24.2 27.0 17.7 1.1 28.4 14.6 18.3 10.7 17.6 54.6 15.3 29.3 17.0 30.6 6.7 1.2 27.2 34.6 21.8 23.9 15.6 22.4 22.3 21.4 0.0 26.9 19.4 51.5 1.5 4.7 26.1 28.0 15.1 18.0 15.6 35.9 38.2 26.4 15.6 39.5 14.5 24.8 37.3 31.2 10.8 21.5 42.8 38.7 21.3 18.8 16.7 LMAN1L "ERGIC-53L, ERGL" ENSG00000140506 "Lectin, mannose binding 1 like" Q9HAT1 15 74812716-74825757 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 31.7;lymphoid tissue: 25.7;prostate: 60.9;salivary gland: 20.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Late spermatids: 2.6;Prostatic glandular cells: 10.9;Spermatocytes: 7.3;Spermatogonia: 2.4" "Cancer enriched" "Detected in single" 45 "prostate cancer: 2.2" "Region enhanced" "Detected in many" "cerebellum: 13.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 1.4" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 35: Glandular cells - Unknown function" "unprognostic (4.51e-1)" "unprognostic (2.44e-1)" "unprognostic (4.26e-2)" "unprognostic (3.09e-1)" 0.0 1.8 0.0 0.2 0.8 0.0 0.0 13.3 0.5 0.1 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 31.7 0.2 0.1 0.0 0.0 0.0 0.3 2.3 0.7 0.0 0.0 0.0 0.2 0.0 2.1 60.9 0.1 4.2 20.7 0.0 0.1 0.1 0.3 0.0 2.1 25.7 4.6 1.2 0.3 0.1 0.0 0.0 0.1 0.1 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 13.3 0.5 0.2 0.1 2.3 0.7 2.1 2.1 0.3 3.5 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 0.0 1.3 0.0 0.0 0.4 7.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 LRFN3 "FIGLER1, MGC2656, SALM4" ENSG00000126243 "Leucine rich repeat and fibronectin type III domain containing 3" Q9BTN0 19 35935358-35946624 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048923 Approved NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA048923: AB_2680558" "unprognostic (1.88e-1)" "unprognostic (7.22e-3)" "unprognostic (1.82e-1)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (7.37e-2)" "unprognostic (8.14e-2)" "unprognostic (2.34e-3)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (3.49e-3)" "unprognostic (1.74e-1)" "prognostic favorable (8.46e-7)" "unprognostic (6.84e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-2)" "unprognostic (1.03e-1)" 6.2 6.8 3.6 1.7 3.4 0.1 6.4 4.1 6.0 9.2 0.0 6.8 3.1 10.5 1.0 7.0 7.5 1.9 6.4 3.9 1.2 6.2 8.2 5.1 1.2 2.5 1.5 11.7 8.0 3.4 12.9 1.6 1.3 8.0 1.6 2.0 6.8 3.3 8.1 6.0 6.3 2.9 0.2 5.6 6.5 4.9 2.1 1.0 6.1 1.9 1.1 7.4 7.9 2.0 8.8 10.4 5.4 7.8 10.9 5.8 2.0 3.8 5.7 4.3 4.3 1.9 4.3 5.6 7.3 5.3 5.2 3.2 2.3 5.0 2.5 9.8 3.7 0.6 2.1 1.9 4.0 0.3 7.8 6.2 6.7 2.5 2.7 5.2 5.0 6.7 1.5 8.1 3.9 6.4 4.1 0.2 3.5 7.4 4.5 5.6 3.0 0.1 3.0 3.5 6.1 7.3 5.6 4.3 3.2 2.8 3.2 2.5 5.7 8.9 7.0 7.6 6.0 2.7 3.1 0.2 7.8 3.0 6.2 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.4 0.5 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 3.6 3.4 4.1 6.0 3.9 1.2 2.5 1.5 1.3 0.2 2.1 2.0 5.3 0.0 0.0 0.7 0.9 1.1 3.2 1.9 1.8 7.5 2.0 2.3 11.0 1.5 0.9 3.7 2.1 0.4 0.7 5.9 0.0 3.9 0.5 2.1 2.7 3.0 3.0 0.0 4.3 4.3 2.0 4.0 4.6 2.5 0.0 5.7 8.9 4.6 2.1 8.4 4.2 3.5 4.1 1.0 0.5 1.5 4.4 0.5 0.0 2.8 0.3 4.9 2.1 4.0 1.7 4.3 6.6 7.5 0.6 3.9 6.7 2.5 1.0 5.5 6.6 4.0 3.0 0.2 1.7 1.9 1.1 0.1 1.8 3.3 3.6 2.0 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favorable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 8.6 13.1 10.4 6.4 9.9 7.5 9.7 14.9 11.8 15.6 3.1 15.0 7.5 16.2 5.8 14.1 13.1 5.7 10.9 11.8 7.1 11.8 11.9 9.8 9.3 9.9 9.0 12.9 16.2 8.3 16.0 4.9 9.4 19.4 5.3 3.3 12.0 8.1 11.4 13.1 13.3 5.6 9.1 14.5 14.2 11.7 9.1 7.1 16.8 5.0 6.6 14.6 12.2 10.8 18.2 36.2 9.7 15.8 10.2 8.3 13.8 15.9 6.8 12.6 10.8 15.9 21.6 14.5 16.5 11.9 7.7 19.4 15.3 15.8 5.7 19.7 34.8 21.9 42.7 6.9 9.5 9.3 17.3 10.1 13.3 12.7 6.2 10.4 10.9 16.6 29.2 17.1 12.4 22.3 34.9 12.2 7.9 15.8 51.8 29.6 8.0 20.9 7.6 15.6 26.4 14.7 24.2 19.3 11.2 5.7 29.8 10.3 11.8 21.4 37.6 19.0 23.7 9.5 6.0 18.2 20.1 21.4 13.4 1.6 7.2 1.6 8.3 6.8 8.0 7.8 6.2 7.8 7.2 7.9 6.7 5.6 3.8 11.4 6.0 8.4 6.7 8.0 10.4 9.9 14.9 11.8 11.8 7.1 9.9 9.0 9.4 9.1 9.1 10.8 6.3 6.4 3.1 6.5 10.9 6.4 5.0 3.4 9.1 11.5 9.8 9.5 4.6 14.3 6.0 9.2 2.1 6.9 6.9 10.3 5.9 5.4 2.8 6.3 6.8 7.3 5.4 8.4 3.8 8.2 6.6 5.8 10.2 6.4 7.0 11.2 8.9 9.8 7.7 11.8 2.8 8.1 2.0 6.0 4.0 3.9 7.5 4.4 1.8 8.4 7.4 9.5 9.2 6.6 3.3 7.3 4.9 7.9 11.1 8.3 6.0 7.4 7.5 7.4 6.6 5.0 6.7 29.3 22.0 6.6 5.8 5.5 9.4 16.8 11.9 3.9 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303616 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 133.1;Syncytiotrophoblasts: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Nuclear bodies" Nucleoplasm "HPA051941: AB_2681669" "unprognostic (1.57e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 37.7 43.5 30.4 19.1 31.1 20.0 36.7 29.1 32.7 45.0 28.0 41.4 22.7 50.7 29.0 44.3 45.9 30.9 36.7 31.7 31.4 33.4 36.0 33.7 20.7 31.9 30.2 48.5 41.6 44.1 44.3 34.0 29.8 43.3 19.8 19.4 37.6 41.4 55.3 43.3 29.4 35.4 30.4 28.5 35.1 32.7 30.9 29.9 38.7 33.2 22.7 44.8 39.5 32.6 42.2 30.2 51.1 55.8 67.7 84.0 48.1 42.7 78.6 60.8 40.6 25.7 13.7 26.7 55.5 102.0 81.4 32.0 50.5 60.5 30.7 32.5 54.7 43.5 34.3 37.7 94.6 27.1 22.1 103.8 80.1 56.9 68.2 87.0 78.6 49.3 43.7 26.7 67.5 26.8 36.2 36.0 76.9 27.4 29.3 29.6 26.4 43.4 68.4 50.9 47.4 54.0 57.8 56.6 69.5 78.3 33.5 80.9 52.4 53.0 23.9 44.8 41.5 43.5 21.8 11.8 49.7 20.6 37.6 30.6 32.7 15.5 21.1 30.8 22.6 18.7 22.9 24.0 46.4 22.0 24.9 19.3 3.3 32.7 21.7 26.4 24.4 30.2 30.4 31.1 29.1 32.7 31.7 31.4 31.9 30.2 29.8 30.4 30.9 32.6 19.0 19.2 22.7 17.0 17.9 28.4 36.6 40.4 17.1 23.7 28.6 24.8 11.3 28.6 32.0 35.0 25.0 83.1 20.2 27.4 39.2 42.0 28.2 57.5 36.2 22.0 36.6 24.0 19.8 30.0 48.7 34.8 23.9 133.1 7.0 42.4 25.7 28.0 36.5 47.1 21.1 30.4 30.5 20.6 22.8 19.3 34.8 20.7 10.6 11.2 23.5 25.4 20.6 18.6 22.3 30.1 24.2 33.1 26.5 36.7 38.0 32.7 23.4 27.4 39.5 40.4 32.1 46.6 45.8 21.2 29.0 142.6 18.8 37.7 30.0 34.7 LSM2 "C6orf28, G7b, YBL026W" ENSG00000204392 "LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y333 6 31797396-31806966 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052805, HPA066718" Supported Enhanced Nucleoplasm NA NA 97000 "Cluster 32: T-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA052805: , HPA066718: AB_2685710" "unprognostic (1.69e-1)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.24e-1)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (6.14e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-3)" "unprognostic (1.51e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (5.59e-9)" "unprognostic (2.23e-1)" "unprognostic (8.48e-2)" "unprognostic (4.49e-2)" "unprognostic (9.59e-2)" 38.6 34.3 19.0 19.3 21.8 32.7 37.9 20.6 21.4 44.8 17.4 43.0 23.6 45.0 19.3 39.0 36.9 18.1 32.3 19.4 19.1 43.8 27.6 31.6 36.6 22.8 19.6 37.6 37.2 20.5 30.1 22.5 21.7 29.7 27.8 7.2 25.2 16.3 43.9 37.0 33.6 27.7 24.5 43.5 34.6 26.7 22.9 45.1 30.1 20.9 39.3 39.9 35.6 23.7 91.1 42.5 84.9 103.7 43.8 61.9 58.4 50.1 38.5 85.2 75.1 56.9 37.6 50.3 66.8 50.1 79.8 36.2 109.3 101.1 76.9 72.4 85.0 83.6 27.3 60.1 55.7 80.6 39.7 47.1 47.3 78.6 80.4 40.6 90.3 102.0 127.5 63.0 60.7 73.3 132.3 168.4 56.8 75.0 77.6 73.4 40.5 123.4 69.5 31.6 66.6 55.6 56.0 58.8 101.7 44.7 61.6 68.7 20.1 47.6 74.5 54.1 85.1 53.2 109.9 88.2 26.8 123.3 76.7 29.1 31.3 15.9 36.9 37.7 45.2 3.7 51.6 33.6 35.4 4.1 45.6 30.1 8.7 13.8 25.1 30.9 29.9 57.5 19.0 21.8 20.6 21.4 19.4 19.1 22.8 19.6 21.7 24.5 22.9 23.7 82.9 22.4 23.6 4.6 95.2 58.2 63.7 104.9 56.3 30.9 108.2 177.2 14.9 60.1 48.5 55.2 6.2 143.5 58.5 36.5 113.5 104.5 20.1 38.8 61.2 90.2 54.0 121.8 5.9 137.1 218.8 58.0 46.9 49.2 82.6 119.9 72.8 59.7 143.2 30.3 6.0 93.9 73.2 67.9 76.8 26.0 49.7 56.6 92.5 3.7 99.3 53.3 109.2 9.5 19.8 94.0 55.7 49.2 91.5 78.2 40.8 113.3 24.2 28.3 46.0 70.7 71.4 66.9 176.5 90.8 64.2 69.0 77.8 101.3 113.6 58.6 LTBP3 LTBP2 ENSG00000168056 "Latent transforming growth factor beta binding protein 3" Q9NS15 11 65538559-65558930 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Amelogenesis imperfecta, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 61.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 293.8;U-87 MG: 157.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 2200000 "Cluster 43: B-cells - Humoral immune response" "Cluster 72: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (8.50e-3)" "unprognostic (4.01e-2)" "unprognostic (1.04e-1)" "unprognostic (1.59e-1)" "unprognostic (2.24e-2)" "unprognostic (9.22e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-2)" "unprognostic (4.52e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" 65.4 80.1 44.0 21.4 46.1 11.2 68.0 42.0 56.1 120.0 42.2 103.7 16.8 130.8 36.7 36.7 112.6 39.9 131.2 37.6 41.4 84.5 48.8 72.2 24.7 57.0 49.0 155.5 70.1 44.7 111.0 25.5 45.4 109.0 8.5 12.8 64.2 56.3 54.6 39.6 55.8 35.7 51.7 58.1 62.0 20.3 46.9 17.6 114.0 31.0 12.1 84.9 88.0 54.0 16.5 65.9 8.7 43.2 60.7 97.0 8.5 64.7 43.6 8.2 5.3 25.3 85.5 2.0 53.6 64.2 20.4 71.9 11.8 12.2 3.7 9.5 26.4 15.9 25.2 26.2 40.3 2.2 13.4 109.9 4.9 12.1 1.5 293.8 31.9 5.2 4.9 12.7 6.0 39.4 10.9 5.9 7.6 14.6 81.2 29.3 1.1 32.1 6.7 5.5 2.9 41.8 17.3 24.9 35.3 3.7 46.0 5.8 107.0 24.8 32.2 42.5 17.6 13.9 27.1 1.4 157.8 2.6 52.3 0.2 7.3 2.9 8.8 11.2 14.1 61.2 12.6 10.4 8.9 47.6 10.5 11.2 2.9 10.8 13.2 17.8 14.2 7.8 44.0 46.1 42.0 56.1 37.6 41.4 57.0 49.0 45.4 51.7 46.9 54.0 47.1 12.8 11.7 64.0 26.8 73.8 27.7 22.0 50.7 55.7 42.2 43.1 16.7 35.8 16.2 40.5 2.1 24.7 24.4 19.7 21.5 28.1 1.1 19.3 37.5 29.8 30.6 11.2 21.3 12.0 10.5 86.1 14.8 25.3 24.1 92.5 37.5 61.6 20.7 28.6 17.9 15.1 8.2 11.0 34.4 4.3 86.6 14.6 30.2 17.8 11.5 71.4 24.7 29.7 20.2 18.1 15.0 123.8 20.9 35.8 25.3 15.7 8.2 14.3 39.5 89.4 44.0 9.5 37.5 46.9 79.3 16.3 24.4 26.0 20.4 26.5 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "granulocytes: 327.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 20.2;eosinophil: 63.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 63.1" "Cell line enriched" "Detected in some" 11 "HMC-1: 102.0" "Low region specificity" "Detected in many" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 8.9 6.9 1.1 0.5 0.8 2.3 5.5 1.5 1.3 4.2 0.7 3.3 0.7 5.7 0.0 3.1 11.8 0.3 12.4 1.0 1.4 7.1 1.9 7.7 0.2 2.1 1.5 5.7 2.0 0.2 3.5 0.4 1.4 4.8 0.2 0.0 4.3 0.8 1.0 3.1 3.2 0.4 2.9 6.1 3.0 1.5 2.6 0.0 5.9 0.0 0.1 4.8 4.0 4.7 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.9 8.9 0.2 0.4 0.3 0.6 102.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.2 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 1.0 0.1 20.2 0.5 63.1 0.8 0.6 3.0 0.3 2.1 1.5 8.6 0.2 0.4 1.0 0.3 4.7 0.0 0.4 0.2 0.6 1.1 0.8 1.5 1.3 1.0 1.4 2.1 1.5 1.4 2.9 2.6 4.7 32.3 0.0 3.2 2.9 2.3 9.9 9.6 11.2 14.8 0.4 26.4 38.6 0.0 14.3 6.2 14.7 0.0 10.4 5.0 0.6 1.9 5.9 0.3 4.0 1.5 49.5 3.0 2.1 0.8 2.4 1.9 8.3 3.1 5.6 327.4 0.5 72.1 0.9 41.5 0.0 0.7 1.7 0.0 20.8 46.3 0.9 16.4 53.9 1.8 28.1 2.0 0.1 2.1 1.0 1.5 1.9 0.5 47.4 10.0 3.7 2.2 54.8 5.8 0.5 0.0 0.8 1.6 0.1 0.7 5.2 7.0 3.0 10.0 1.5 3.1 10.0 LY6G5B "C6orf19, G5b" ENSG00000240053 "Lymphocyte antigen 6 family member G5B" Q8NDX9 6 31670167-31673776 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA048307 Approved "Secreted to blood" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA048307: AB_2680348" "unprognostic (2.69e-2)" "unprognostic (1.52e-1)" "unprognostic (8.53e-2)" "unprognostic (1.44e-2)" "unprognostic (5.80e-2)" "unprognostic (9.85e-3)" "unprognostic (5.04e-3)" "unprognostic (8.34e-3)" "unprognostic (5.45e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-4)" "unprognostic (7.27e-3)" "unprognostic (1.98e-5)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (3.00e-2)" "unprognostic (3.98e-4)" 30.1 13.5 3.0 9.5 3.4 29.9 25.9 7.4 7.2 26.3 3.1 25.6 6.9 24.9 11.1 15.8 25.0 6.3 15.0 3.2 3.9 15.5 15.0 27.8 12.1 3.5 3.3 33.2 14.5 2.8 20.8 8.2 3.6 22.1 11.4 11.3 20.3 7.4 15.4 44.6 27.8 9.4 2.7 30.6 19.2 13.0 3.8 7.7 24.7 3.3 13.1 21.1 20.4 3.7 5.4 5.8 11.4 15.5 2.6 5.5 14.5 10.4 3.3 7.3 7.2 7.1 6.8 12.9 2.8 13.0 4.7 8.6 2.7 13.7 11.6 5.2 18.0 12.4 8.1 5.7 2.2 15.6 9.9 11.8 7.9 10.7 5.0 10.3 3.9 9.7 7.7 7.8 5.0 4.9 8.4 12.0 6.4 1.5 2.6 11.8 3.5 5.7 3.4 14.7 8.0 12.9 4.7 1.8 3.6 13.9 4.7 10.3 7.6 14.2 7.5 6.6 2.6 13.6 10.1 11.5 5.1 14.6 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 7.4 7.2 3.2 3.9 3.5 3.3 3.6 2.7 3.8 3.7 0.3 3.2 0.0 0.0 1.4 1.0 1.2 0.7 0.0 1.1 0.7 0.3 0.1 1.5 0.2 0.0 0.0 0.4 0.8 0.6 0.0 0.1 0.0 0.4 0.8 0.5 1.2 0.0 0.5 0.2 0.4 0.9 1.1 1.1 0.0 1.2 0.4 0.4 0.5 0.0 0.6 0.9 0.0 0.0 2.2 0.0 0.6 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.6 1.1 1.8 0.0 0.1 2.3 0.0 1.5 0.8 0.1 0.3 0.4 1.3 0.5 1.4 0.4 1.0 0.8 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982269-20999032 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol No No "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 18.4 15.2 9.0 8.9 9.7 6.0 17.3 8.9 10.1 20.1 7.2 20.1 9.9 23.3 4.4 12.6 18.5 9.4 13.4 9.1 9.1 15.8 12.0 16.0 7.3 10.3 9.5 19.5 12.4 11.5 24.7 9.8 10.8 16.2 6.4 3.4 13.0 8.6 14.7 13.6 15.9 11.3 8.1 18.3 13.9 8.2 8.9 6.5 18.8 8.0 5.7 18.1 15.8 9.3 10.3 8.4 12.2 15.0 27.6 18.9 9.6 20.8 14.6 11.6 15.8 4.9 4.2 11.0 7.6 23.4 10.7 13.7 9.3 17.1 4.7 20.5 21.0 11.8 11.8 7.4 14.6 6.4 14.9 17.5 8.5 14.7 10.6 18.4 22.9 10.0 49.8 18.5 13.4 6.3 11.5 6.0 3.8 12.6 9.1 13.4 17.8 4.4 9.2 13.9 11.9 17.9 11.3 19.5 12.4 7.4 9.1 11.7 20.6 27.0 13.3 12.3 11.5 8.0 7.4 3.2 12.2 6.2 13.5 0.0 0.5 0.0 0.7 0.7 0.4 0.4 0.3 0.8 0.4 0.1 0.4 0.3 0.0 0.3 1.0 0.3 0.1 0.5 9.0 9.7 8.9 10.1 9.1 9.1 10.3 9.5 10.8 8.1 8.9 9.3 12.4 12.8 8.6 20.5 7.9 2.2 1.8 3.7 4.0 9.5 7.5 7.6 11.7 5.7 5.2 9.2 6.2 4.1 11.9 10.7 1.9 7.0 0.9 5.5 12.7 10.1 9.1 2.5 14.2 4.9 4.0 10.9 11.2 8.4 5.7 14.7 12.1 8.5 7.7 3.3 13.2 10.0 6.1 8.8 3.5 1.6 8.7 7.1 7.2 14.0 5.0 5.6 5.2 8.0 17.6 6.1 8.9 9.8 9.2 2.3 7.0 7.6 7.3 9.8 0.0 7.0 11.6 4.5 1.5 5.9 3.7 3.6 7.7 10.1 6.7 1.4 MAEA "EMP, GID9, HLC-10, p44EMLP" ENSG00000090316 "Macrophage erythroblast attacher, E3 ubiquitin ligase" Q7L5Y9 4 1289887-1340147 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036886, HPA058185" Approved Enhanced Nucleoplasm Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA036886: , HPA058185: AB_2683633" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.11e-1)" "unprognostic (2.03e-2)" "prognostic favorable (5.34e-4)" "unprognostic (3.10e-3)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (6.94e-3)" "unprognostic (4.65e-3)" "prognostic favorable (1.90e-4)" "unprognostic (1.17e-2)" "unprognostic (2.49e-1)" "unprognostic (1.97e-1)" "unprognostic (4.51e-2)" 28.5 44.2 21.9 23.5 21.3 18.3 28.8 19.8 24.0 32.6 25.9 39.7 33.5 34.4 10.9 46.7 29.2 17.5 38.6 21.1 27.2 40.9 32.3 24.0 24.3 25.7 23.0 34.9 35.4 30.7 38.9 17.2 26.3 29.2 14.2 8.8 35.7 21.5 37.1 41.2 35.7 14.9 18.1 40.0 37.1 26.8 23.2 20.7 33.9 19.2 15.7 30.7 33.5 20.0 58.1 66.9 47.6 47.7 31.5 31.1 61.4 57.4 30.6 47.1 42.2 70.5 73.5 52.5 43.6 42.4 85.5 42.0 46.1 72.2 19.1 42.4 52.2 49.2 74.1 68.1 37.1 55.8 50.9 38.8 38.6 37.8 23.6 31.8 38.0 50.4 70.4 41.6 41.3 61.5 84.2 86.5 62.2 63.4 72.9 81.0 38.1 47.8 50.3 68.2 84.7 57.8 51.1 39.3 41.5 26.3 71.5 48.4 52.8 85.9 36.0 39.0 96.1 50.5 83.4 58.1 59.0 51.3 48.2 74.9 49.9 70.9 59.2 52.6 83.5 47.6 47.1 56.4 47.1 38.1 41.4 42.5 117.9 45.5 77.3 33.0 59.8 59.1 21.9 21.3 19.8 24.0 21.1 27.2 25.7 23.0 26.3 18.1 23.2 20.0 22.0 19.2 25.0 28.4 21.6 18.7 15.7 33.9 8.0 28.1 22.5 25.3 35.5 14.3 24.3 16.5 20.9 48.2 29.7 41.2 46.9 43.4 8.0 21.9 25.2 24.4 20.4 26.3 19.6 30.3 46.4 25.0 25.5 25.0 10.8 30.4 19.6 15.0 39.6 21.9 23.2 33.1 30.5 29.2 15.9 9.8 35.4 23.2 28.4 14.0 46.3 22.3 28.8 22.6 20.0 40.3 31.3 37.2 23.5 22.7 30.4 36.4 17.9 19.1 13.1 24.9 27.9 36.6 44.0 19.3 19.9 95.2 29.7 59.6 38.1 21.8 MAML1 "KIAA0200, Mam-1" ENSG00000161021 "Mastermind like transcriptional coactivator 1" Q92585 5 179732822-179777283 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 11.2;hTCEpi: 11.3;SK-MEL-30: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037687, HPA057531" Approved Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA037687: AB_10672604, HPA057531: AB_2683458" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (3.01e-2)" "unprognostic (5.41e-3)" "unprognostic (5.79e-2)" "unprognostic (2.45e-1)" "unprognostic (1.75e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (3.44e-1)" "unprognostic (6.05e-2)" "unprognostic (1.06e-1)" "unprognostic (6.69e-2)" 14.6 15.8 0.4 2.5 0.6 4.9 14.0 0.6 0.8 17.2 0.4 17.7 3.3 17.8 5.1 15.3 16.9 0.0 12.2 0.3 0.3 11.1 11.0 13.9 1.6 0.5 0.4 20.2 15.2 0.0 12.7 3.0 0.4 15.7 2.6 1.5 13.4 0.0 12.5 16.5 14.7 3.7 0.3 16.2 13.9 9.7 0.4 0.0 14.4 3.7 0.0 15.8 15.4 0.5 0.0 0.0 0.0 0.0 9.3 9.1 0.0 5.9 10.8 11.2 8.1 0.0 0.0 7.1 8.2 0.0 0.0 0.3 0.0 0.0 7.1 0.0 0.0 0.0 8.7 0.0 8.2 0.0 0.1 0.0 11.3 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.7 0.2 0.1 0.0 0.0 0.2 19.8 10.1 8.9 0.0 9.0 0.1 1.4 0.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.4 0.2 0.1 0.7 0.2 0.3 0.1 0.5 0.2 0.2 0.7 0.2 0.5 0.2 0.1 0.3 0.4 0.6 0.6 0.8 0.3 0.3 0.5 0.4 0.4 0.3 0.4 0.5 15.0 16.0 9.3 11.8 14.0 25.0 12.1 12.1 20.5 12.5 13.9 15.2 7.2 15.7 7.5 9.2 18.8 10.1 20.8 12.0 1.9 6.4 2.4 10.1 15.6 26.4 9.0 16.2 18.1 6.5 12.0 11.6 13.7 13.9 56.0 14.4 33.5 9.9 13.0 21.9 18.2 11.6 12.2 24.2 26.7 2.3 17.4 16.6 5.4 9.4 19.6 7.9 13.4 18.6 14.8 6.7 6.4 25.2 14.0 12.6 7.7 3.9 6.1 9.4 13.1 11.6 14.1 6.1 10.0 19.7 29.8 9.3 17.1 9.7 12.3 16.0 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368612 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 110000 "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 49.3 66.1 20.2 23.9 21.1 37.6 49.3 17.7 28.8 52.1 18.6 41.8 25.5 49.3 12.1 29.9 50.5 16.4 55.6 20.0 17.8 52.8 50.0 50.3 20.3 22.8 18.1 58.5 49.1 26.3 56.6 21.1 20.9 49.4 14.9 14.8 37.3 19.5 58.5 36.8 41.6 18.6 17.5 54.7 46.0 34.8 19.8 17.1 64.8 24.5 12.7 45.7 41.5 22.0 11.0 25.5 21.3 15.7 23.8 20.4 27.1 25.3 23.5 12.9 10.9 20.3 38.3 5.7 14.6 18.6 11.8 33.0 11.7 17.1 8.4 30.8 26.1 34.0 58.5 18.1 35.3 23.1 5.7 25.3 17.0 12.3 15.3 27.3 30.9 16.9 20.5 27.4 10.7 22.1 11.9 25.2 9.0 13.2 11.8 16.0 11.0 34.6 16.8 49.8 13.2 22.7 16.4 23.9 11.5 15.6 26.1 26.1 61.5 27.1 18.7 19.0 25.5 27.9 7.1 9.3 17.6 25.9 27.6 4.0 19.8 3.5 9.2 23.0 9.1 3.2 6.9 6.8 22.6 2.6 9.5 6.9 2.2 6.0 18.9 9.2 10.2 14.3 20.2 21.1 17.7 28.8 20.0 17.8 22.8 18.1 20.9 17.5 19.8 22.0 34.1 22.4 51.7 29.0 12.5 13.5 15.2 13.0 11.4 30.7 18.2 16.3 2.8 5.7 19.2 9.2 54.2 17.2 17.2 22.4 3.9 11.4 10.4 10.1 18.3 23.2 34.2 7.6 28.9 8.7 10.9 20.4 39.3 12.7 31.7 46.8 32.5 22.4 20.4 28.6 23.8 19.5 12.2 29.8 20.2 14.0 23.3 26.3 16.0 15.0 31.4 17.3 19.6 18.1 19.5 11.2 20.0 12.4 12.9 16.0 27.9 15.9 19.3 52.4 26.3 25.6 16.3 21.1 10.4 14.9 8.5 21.2 16.2 17.0 24.0 15.3 MANBA ENSG00000109323 "Mannosidase beta" O00462 4 102630770-102760994 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Macrophages: 74.0;Microglial cells: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 16.6" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1" "Cell line enhanced" "Detected in many" "ASC diff: 15.5;hTCEpi: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053478 Approved Supported Vesicles NA NA 15000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 57: B-cells - Immune response" Vesicles "HPA053478: AB_2682165" "unprognostic (2.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.80e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (1.32e-1)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (7.78e-2)" "unprognostic (1.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (7.12e-2)" "unprognostic (4.81e-2)" "unprognostic (2.13e-1)" 7.1 12.4 1.9 1.5 2.4 7.0 6.4 4.7 2.2 6.5 2.2 6.7 1.6 6.1 0.2 3.8 6.3 1.3 6.6 1.1 2.1 4.8 4.7 10.5 2.1 3.8 2.9 8.8 8.3 3.0 5.0 3.7 4.7 4.3 1.1 2.7 8.9 2.0 3.0 4.5 8.5 2.4 3.0 12.0 9.1 1.6 3.5 1.2 7.1 0.1 2.0 8.1 5.8 3.7 2.9 1.4 0.6 1.6 15.5 12.1 0.9 1.1 6.9 1.8 4.1 1.7 1.0 3.6 1.4 2.7 3.9 1.0 3.0 2.2 1.1 2.2 0.7 3.0 1.1 0.7 2.7 2.8 8.2 3.7 13.7 7.6 3.4 8.9 3.0 1.2 3.6 2.0 3.4 1.4 2.0 2.3 1.3 1.9 1.1 1.9 1.6 0.6 3.4 2.3 1.4 0.5 1.4 1.9 1.5 5.4 4.5 1.8 0.2 2.0 1.3 9.3 1.2 1.3 5.8 0.5 3.1 1.5 1.6 4.0 6.8 16.6 0.4 6.1 0.7 1.7 0.0 0.7 5.3 2.1 0.4 0.6 6.1 1.8 9.1 1.2 0.5 3.1 1.9 2.4 4.7 2.2 1.1 2.1 3.8 2.9 4.7 3.0 3.5 3.7 6.4 32.1 35.6 24.5 45.4 5.9 8.4 13.2 12.0 6.2 11.6 8.1 14.6 14.3 13.5 9.2 6.2 42.3 14.3 5.1 1.9 8.1 2.8 6.9 6.9 8.1 1.8 19.7 36.4 2.7 7.3 13.8 25.5 12.8 34.8 5.5 10.4 17.7 43.6 6.7 66.5 10.5 2.0 58.5 29.6 1.6 9.0 74.0 0.0 111.5 52.8 5.2 17.5 31.2 66.8 5.5 17.3 19.9 17.5 7.5 5.2 9.8 5.8 7.5 0.0 10.8 6.7 0.2 1.4 12.6 4.5 22.6 16.9 12.6 11.2 9.7 MBD3 ENSG00000071655 "Methyl-CpG binding domain protein 3" O95983 19 1573596-1592865 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013265 Supported Supported Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "CAB013265: " "unprognostic (1.41e-1)" "unprognostic (2.12e-2)" "unprognostic (3.44e-2)" "prognostic favorable (5.08e-4)" "unprognostic (1.85e-1)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (2.50e-1)" "unprognostic (3.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (4.42e-2)" "unprognostic (5.89e-2)" "unprognostic (3.17e-1)" "unprognostic (4.24e-2)" 40.1 46.1 12.7 7.0 11.3 12.8 36.2 18.2 16.5 41.5 7.2 45.8 7.6 46.2 7.6 42.4 40.6 6.6 60.3 13.7 9.0 45.3 59.3 38.3 9.6 12.9 11.7 48.9 32.8 7.4 50.0 9.0 10.7 54.8 6.4 4.1 30.4 7.0 74.0 40.2 34.6 7.4 10.1 49.8 39.0 43.4 12.2 9.0 45.3 4.7 9.1 41.1 33.8 13.0 26.4 56.3 22.5 34.9 21.6 15.0 20.8 20.9 13.5 21.5 19.5 44.9 15.6 49.9 12.1 26.7 7.5 35.8 37.8 23.7 13.0 41.2 36.8 24.6 77.4 27.9 17.6 28.2 24.5 20.3 23.1 35.6 17.4 14.2 25.2 25.7 55.8 34.2 17.6 56.6 32.7 30.5 29.4 12.6 25.5 31.1 23.3 21.2 14.1 50.0 64.5 36.8 25.2 18.3 12.6 12.2 23.5 21.1 20.0 28.9 15.5 65.5 42.1 31.8 39.8 38.6 21.2 37.0 27.7 0.7 0.4 0.1 0.3 0.4 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.3 0.5 0.3 0.2 0.5 0.1 0.2 12.7 11.3 18.2 16.5 13.7 9.0 12.9 11.7 10.7 10.1 12.2 13.0 21.6 12.8 24.3 14.4 10.6 10.8 8.9 9.4 5.2 22.6 23.8 20.6 20.8 12.8 11.0 11.0 14.6 46.4 17.4 48.1 5.9 15.0 3.1 9.8 20.5 19.8 14.9 14.9 8.4 26.2 42.7 20.0 18.3 16.1 3.8 48.4 24.7 42.6 27.2 18.5 9.2 26.4 14.2 32.0 10.3 8.1 22.4 16.9 5.4 15.9 17.5 40.5 14.4 10.6 12.3 19.3 16.8 25.6 9.7 14.9 20.8 19.1 4.8 11.3 39.5 21.6 18.7 9.2 10.3 11.0 12.8 121.5 10.8 36.0 40.6 8.8 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213943-24216070 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm NA NA 29000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA003064: AB_10602350, HPA070338: AB_2686256" "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 14.0 18.6 6.8 3.2 6.8 3.9 14.6 7.0 7.5 14.7 6.4 12.6 3.1 11.5 7.9 7.3 12.1 4.0 18.2 7.0 6.9 16.8 10.3 9.2 5.8 6.7 6.8 12.3 15.3 5.8 20.1 4.0 6.9 13.7 3.5 4.1 10.6 4.8 15.0 12.6 9.5 4.5 7.2 11.6 11.9 7.8 6.6 5.3 13.6 4.8 4.7 12.5 11.1 7.8 4.1 9.5 7.2 4.7 6.9 6.3 0.3 4.2 8.9 8.2 8.4 5.0 10.9 15.7 10.4 4.3 2.4 3.7 3.4 8.2 5.0 5.4 3.9 6.0 3.3 12.1 6.7 7.9 4.2 4.5 7.7 4.9 9.4 8.3 5.9 11.1 1.9 11.4 7.4 21.1 11.7 12.6 2.2 7.8 16.9 8.0 5.0 12.6 8.0 5.7 8.7 8.6 6.6 14.3 9.4 3.9 8.3 4.5 3.5 8.8 8.7 3.9 4.4 18.6 8.4 11.7 8.3 3.8 6.9 5.1 13.9 16.5 7.7 15.2 7.3 13.4 9.9 9.0 16.1 12.9 11.7 9.9 4.6 12.4 13.0 29.9 16.3 10.3 6.8 6.8 7.0 7.5 7.0 6.9 6.7 6.8 6.9 7.2 6.6 7.8 6.6 6.4 12.9 0.0 11.0 4.6 3.5 5.6 16.5 3.9 8.2 11.7 0.0 4.3 2.1 5.5 0.0 3.7 7.3 5.9 13.7 13.8 5.7 4.6 5.5 8.2 11.5 7.8 0.0 19.6 5.3 8.1 9.2 4.3 5.1 4.3 8.6 5.8 7.9 3.3 0.0 10.8 12.2 3.3 8.7 3.0 6.2 10.6 17.8 0.0 21.9 5.2 4.1 0.0 0.0 11.7 6.2 7.5 25.8 2.9 23.7 21.7 13.2 2.9 13.1 7.7 8.7 4.4 3.5 11.5 4.5 2.5 9.7 3.4 8.8 2.6 MED12 "ARC240, CAGH45, FGS1, HOPA, KIAA0192, Kto, OKS, OPA1, TNRC11, TRAP230" ENSG00000184634 "Mediator complex subunit 12" Q93074 X 71118556-71142454 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003184, HPA003185" Enhanced Approved Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA003184: AB_1079349, HPA003185: AB_1079350" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (5.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.89e-3)" "unprognostic (7.14e-2)" "unprognostic (1.68e-2)" "unprognostic (1.15e-2)" "unprognostic (2.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (2.50e-1)" "unprognostic (1.22e-3)" "unprognostic (1.28e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.16e-2)" 18.9 32.3 10.1 13.4 11.6 15.1 19.3 10.8 12.2 20.3 9.3 15.2 8.1 18.1 10.7 13.4 17.8 8.5 13.4 9.7 10.5 13.1 10.3 15.2 13.6 12.3 10.9 28.9 14.9 14.1 16.3 16.8 11.3 17.4 9.2 8.2 14.3 12.6 15.4 14.7 15.9 12.6 10.2 28.4 15.5 13.4 11.2 19.1 18.1 10.6 12.2 15.2 17.1 12.0 14.2 16.4 25.5 15.3 18.3 16.1 37.1 9.9 14.0 15.2 10.8 19.8 13.1 18.5 12.7 17.2 10.5 13.8 29.7 12.3 12.1 19.6 23.0 30.7 37.9 27.5 14.3 28.8 26.2 18.9 13.2 20.0 23.3 19.6 23.8 23.1 29.0 31.6 15.2 24.3 30.5 16.3 14.7 18.2 21.3 28.0 28.5 14.0 11.8 27.5 14.0 16.9 22.7 11.8 12.2 26.2 13.9 14.2 21.1 16.5 19.7 15.4 7.0 15.4 9.5 13.7 9.8 15.8 11.2 6.9 2.1 4.3 3.0 1.9 2.5 2.0 2.1 2.8 2.1 1.9 2.3 2.0 4.1 2.7 1.3 2.8 4.4 2.4 10.1 11.6 10.8 12.2 9.7 10.5 12.3 10.9 11.3 10.2 11.2 12.0 15.4 9.6 4.2 7.2 8.4 6.0 6.3 6.5 4.6 7.2 8.6 11.0 9.3 11.5 7.6 9.2 6.2 20.7 10.9 10.8 1.9 6.9 0.4 7.9 8.9 12.8 7.8 13.7 3.8 6.3 8.0 8.2 8.6 7.1 9.5 21.1 14.6 4.4 9.1 13.5 4.2 5.8 2.0 6.5 9.8 2.3 14.0 8.9 5.4 6.5 7.4 6.3 13.4 4.0 4.2 9.4 10.0 13.5 7.3 7.5 7.5 2.7 7.5 4.9 0.0 10.0 7.6 6.6 7.3 6.1 5.7 27.2 8.8 27.9 6.8 8.6 MED22 "Med24, SRB6, SURF5" ENSG00000148297 "Mediator complex subunit 22" Q15528 9 133338312-133348131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020391, HPA063694" Uncertain Approved Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA020391: AB_1857668, HPA063694: AB_2685093" "unprognostic (2.62e-2)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "unprognostic (7.53e-2)" "unprognostic (5.56e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (5.16e-6)" "unprognostic (4.99e-3)" "unprognostic (3.23e-2)" "unprognostic (1.66e-1)" "prognostic favorable (6.46e-4)" "unprognostic (3.99e-1)" "prognostic favorable (3.76e-11)" "unprognostic (9.25e-3)" "unprognostic (2.66e-1)" "unprognostic (1.66e-2)" "unprognostic (1.62e-1)" 14.1 20.4 7.1 6.2 7.1 4.9 14.0 7.3 7.2 22.1 6.3 24.6 5.2 23.2 2.8 15.6 20.4 3.4 22.2 6.8 6.8 19.5 12.1 15.1 6.3 8.4 7.2 21.4 14.8 6.7 16.7 4.4 7.3 21.7 2.9 2.8 14.3 7.4 13.3 14.3 17.6 5.6 7.5 21.9 15.7 10.2 6.9 4.6 19.2 3.3 5.0 23.2 16.2 7.1 10.0 11.5 17.7 12.7 3.8 6.5 20.5 11.9 8.3 14.5 9.6 25.4 9.1 20.0 6.9 8.5 12.6 19.4 13.3 11.5 6.0 15.7 7.7 10.6 28.8 6.9 6.4 13.7 10.5 5.0 9.0 13.0 8.6 6.8 7.0 11.5 15.7 9.3 6.9 13.8 19.5 11.4 24.8 12.4 13.8 26.4 14.1 18.4 6.0 7.2 14.3 11.6 13.8 17.4 10.4 7.1 19.7 4.7 9.5 18.7 13.0 13.0 15.8 6.4 9.4 19.4 10.8 10.6 15.8 1.1 1.5 2.6 0.7 1.2 0.9 1.1 0.8 0.9 1.1 1.5 0.9 0.7 2.3 0.6 2.2 1.5 0.7 1.1 7.1 7.1 7.3 7.2 6.8 6.8 8.4 7.2 7.3 7.5 6.9 7.1 6.4 22.4 11.7 4.6 8.3 8.3 10.6 4.0 4.0 13.6 6.9 5.2 9.9 7.2 3.1 16.5 0.0 6.1 12.8 8.8 3.9 5.8 1.9 3.7 6.7 8.4 6.7 3.8 3.0 5.3 5.1 11.2 6.1 6.2 7.6 8.4 6.4 4.3 7.8 13.5 3.3 6.5 4.1 7.2 8.3 2.8 11.8 8.3 1.8 3.7 5.6 9.6 5.2 3.0 5.3 8.1 2.1 16.6 6.8 8.4 8.3 5.2 1.7 12.1 26.3 14.8 15.2 13.2 13.7 5.2 6.5 5.5 5.8 5.9 5.9 4.7 MICA PERB11.1 ENSG00000204520 "MHC class I polypeptide-related sequence A" 6 31399784-31415315 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 97.7;HSkMC: 65.6;hTERT-RPE1: 52.5;RPTEC TERT1: 44.6" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (1.94e-1)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.66e-2)" "unprognostic (6.10e-2)" "unprognostic (5.19e-2)" "unprognostic (4.09e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (2.18e-1)" "unprognostic (1.12e-2)" 30.8 35.3 1.5 5.2 2.4 6.1 29.3 3.6 5.6 53.4 2.7 36.8 3.7 29.1 10.9 20.3 34.0 10.6 28.9 2.1 2.3 34.5 28.6 43.1 7.2 2.6 2.4 49.9 21.6 2.9 10.7 3.4 2.3 32.1 6.6 2.3 20.0 1.2 10.5 20.5 23.0 4.3 2.0 28.5 23.1 17.3 2.3 2.2 29.5 4.2 2.5 32.4 39.1 4.2 44.5 0.3 2.4 3.5 32.3 41.3 0.7 2.0 1.4 1.4 1.3 2.0 0.1 1.8 25.8 38.3 97.7 26.0 31.1 38.4 4.4 1.7 17.1 0.0 39.4 0.7 11.9 0.0 1.4 65.6 0.1 0.3 0.5 52.5 0.9 5.4 4.5 5.5 2.7 0.4 0.7 6.0 1.4 0.2 0.0 1.3 0.0 4.6 44.6 0.6 0.8 0.1 3.3 0.3 2.2 1.0 0.7 2.2 32.9 1.8 8.7 2.5 1.2 7.0 26.4 3.5 1.3 0.4 2.6 1.0 0.4 1.7 0.6 1.0 0.8 0.5 0.7 0.8 0.8 0.8 0.9 0.7 1.4 0.2 0.3 0.3 1.0 1.0 1.5 2.4 3.6 5.6 2.1 2.3 2.6 2.4 2.3 2.0 2.3 4.2 22.9 32.1 12.2 20.5 8.3 40.0 26.9 54.4 19.4 0.8 12.4 10.7 7.2 12.8 22.3 18.4 0.0 0.2 11.6 26.0 0.0 29.6 1.8 7.1 8.2 22.7 2.4 4.2 3.8 45.4 0.5 24.1 13.3 11.6 9.5 6.7 24.7 9.4 14.6 0.0 1.2 22.0 42.7 14.5 36.8 1.5 14.9 11.6 33.8 19.7 17.7 10.0 17.5 1.5 0.1 51.2 20.1 15.8 8.6 32.7 40.1 7.0 17.1 0.8 19.7 10.7 24.1 15.3 6.6 14.8 34.4 0.8 15.2 11.3 12.2 21.1 MIER2 KIAA1193 ENSG00000105556 "MIER family member 2" Q8N344 19 301444-344815 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041439 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" "HPA041439: AB_2677481" "unprognostic (1.48e-1)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.89e-4)" "prognostic favorable (1.72e-5)" "unprognostic (6.71e-2)" "unprognostic (2.96e-1)" "unprognostic (6.95e-3)" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (4.24e-1)" "unprognostic (1.18e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (7.22e-6)" "unprognostic (8.05e-2)" "unprognostic (4.28e-2)" "unprognostic (4.94e-3)" "unprognostic (1.68e-2)" 25.0 13.1 14.0 4.5 12.7 2.1 21.2 10.9 18.8 21.6 7.9 17.3 4.5 22.9 2.9 19.7 16.6 3.2 34.3 12.1 11.6 17.7 8.4 28.1 3.8 13.7 13.0 15.3 11.5 2.3 15.7 6.3 12.6 23.1 1.2 2.0 12.9 4.6 18.1 25.5 14.2 2.8 11.1 33.4 13.4 29.4 12.6 3.4 17.1 7.8 1.8 19.7 19.8 11.6 12.8 7.9 7.0 8.1 2.5 3.7 15.1 10.3 4.8 7.6 7.9 12.3 4.0 6.6 5.4 5.4 3.0 10.7 4.5 6.0 2.3 16.0 21.8 3.9 6.9 9.5 7.5 0.0 30.1 4.8 4.6 6.2 2.2 5.1 8.6 8.8 11.3 0.1 4.3 13.5 10.5 14.3 18.1 3.8 0.0 9.1 2.3 1.8 3.7 7.2 11.2 10.1 6.0 4.5 10.7 4.2 5.1 7.1 9.3 10.3 7.2 15.8 11.6 18.5 9.9 5.5 9.7 5.7 10.4 3.7 3.6 2.5 1.1 3.1 0.9 0.5 1.4 1.6 3.9 1.0 1.8 1.2 0.2 0.9 3.5 2.1 0.7 2.3 14.0 12.7 10.9 18.8 12.1 11.6 13.7 13.0 12.6 11.1 12.6 11.6 28.7 0.0 5.4 4.2 5.0 11.2 11.2 8.8 7.4 7.6 7.7 6.9 1.3 7.2 6.0 3.7 16.7 22.3 3.7 4.4 1.9 9.2 6.4 3.4 6.3 24.1 10.7 6.1 4.9 5.4 19.2 6.9 10.2 4.8 0.0 6.9 7.9 2.3 10.2 3.3 4.4 4.6 4.1 8.5 6.3 19.0 6.2 8.7 5.4 13.1 6.7 7.4 5.2 3.0 6.7 8.5 5.9 5.7 4.5 11.9 3.8 0.9 5.7 12.8 6.6 4.1 5.7 18.4 25.1 6.3 10.7 29.4 5.5 6.5 4.9 12.7 MLLT6 "AF17, FLJ23480" ENSG00000275023 "MLLT6, PHD finger containing" P55198 17 38705273-38729795 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Bipolar cells: 291.2;Cone photoreceptor cells: 204.3;NK-cells: 218.3;Rod photoreceptor cells: 200.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 14.9;U-266/70: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004021 Approved Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "HPA004021: AB_1853995" "prognostic favorable (4.18e-4)" "unprognostic (1.50e-1)" "unprognostic (2.53e-1)" "unprognostic (1.44e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (7.12e-3)" "prognostic favorable (7.41e-4)" "unprognostic (1.78e-1)" "unprognostic (1.84e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-3)" 38.0 45.5 1.7 2.8 1.1 2.0 42.5 2.4 2.0 55.0 0.2 49.8 3.0 46.0 1.3 35.2 63.7 0.9 48.8 0.9 0.0 56.5 20.7 45.3 2.2 0.7 0.0 81.1 52.8 0.9 79.2 1.2 0.1 52.1 0.8 3.7 44.4 1.5 81.8 36.6 54.4 1.1 0.0 67.0 48.5 33.4 0.6 0.8 70.5 1.0 0.8 44.7 40.7 0.0 2.1 3.8 0.8 1.2 0.8 0.8 0.9 3.3 0.3 0.3 0.6 2.3 1.5 5.4 3.7 0.5 1.1 4.2 0.1 1.2 0.6 14.9 6.5 3.2 7.4 3.5 0.0 2.5 2.6 0.7 0.1 1.1 0.5 2.4 0.9 1.5 2.4 4.4 0.5 1.0 3.7 0.8 0.9 0.3 1.3 2.5 2.8 1.5 0.2 4.6 3.8 4.0 2.1 1.2 1.5 0.8 2.2 0.1 3.9 1.3 2.3 3.2 3.4 10.0 5.8 4.6 1.4 1.8 1.0 0.4 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 1.7 1.1 2.4 2.0 0.9 0.0 0.7 0.0 0.1 0.0 0.6 0.0 60.8 48.1 46.8 46.4 35.3 30.5 25.2 20.2 18.2 291.2 41.2 35.6 32.2 24.3 31.5 33.1 204.3 20.1 69.5 24.4 11.7 25.5 3.2 25.0 35.0 46.0 49.7 9.9 24.5 42.4 4.5 27.9 22.4 35.5 37.3 49.1 31.8 12.6 13.6 119.5 18.8 31.5 10.2 18.0 39.9 6.0 46.9 22.7 19.6 45.0 28.4 36.2 218.3 32.6 26.5 32.2 25.6 42.2 28.0 40.0 37.1 15.7 25.8 200.9 32.9 51.3 37.0 17.1 23.4 27.1 29.1 38.3 65.0 27.9 39.3 29.4 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764522-13774282 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No 880000 "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: AB_2678141" "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 15.8 19.2 7.9 9.0 8.2 9.5 18.5 9.3 8.5 24.8 7.0 17.3 9.6 21.6 4.1 20.5 21.8 5.3 12.9 7.6 7.5 22.3 23.8 15.8 10.5 8.9 7.7 24.4 19.6 7.8 18.0 11.9 8.7 19.3 6.4 5.3 20.5 8.8 11.6 26.0 21.1 5.2 7.1 23.1 18.3 3.6 8.4 7.8 23.0 4.4 8.7 17.6 22.4 10.9 14.7 9.3 5.5 13.1 6.1 9.5 13.0 17.9 9.3 13.8 12.4 9.9 11.5 7.9 6.5 6.6 7.3 25.4 24.5 15.5 10.8 12.6 39.3 6.6 18.5 12.0 4.7 20.3 14.8 9.9 9.4 7.1 6.0 14.3 13.7 7.9 11.6 0.6 7.4 18.7 21.9 14.3 9.1 6.0 27.2 20.5 7.6 17.4 8.1 11.4 10.4 9.9 6.6 13.9 14.5 7.7 11.1 8.2 8.2 8.2 7.6 29.3 8.8 11.0 11.3 2.4 6.8 22.5 9.7 3.4 1.8 0.7 1.7 1.7 1.8 1.5 1.7 2.2 1.4 1.6 1.3 1.1 1.6 1.8 1.1 2.7 1.5 1.3 7.9 8.2 9.3 8.5 7.6 7.5 8.9 7.7 8.7 7.1 8.4 10.9 9.2 9.6 19.8 15.0 10.8 11.1 8.9 10.8 6.8 4.3 9.0 8.4 0.9 8.6 13.4 16.5 8.4 13.2 17.2 8.1 5.9 9.2 0.7 11.5 14.4 13.8 9.1 13.3 22.3 12.7 8.7 12.3 14.3 14.2 13.3 9.9 12.8 10.0 7.2 1.7 19.6 9.3 6.1 7.2 8.4 1.7 17.4 7.4 1.8 9.4 10.5 5.0 17.5 18.1 15.2 6.8 11.0 15.1 13.3 4.7 16.5 10.5 19.2 9.3 26.3 10.8 13.3 0.3 4.5 13.3 11.4 5.3 16.0 22.2 9.8 6.8 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 58.5 84.9 26.4 21.0 30.2 25.4 61.6 34.0 37.7 63.3 27.6 69.2 28.6 56.3 7.4 63.7 57.7 18.9 65.2 25.0 27.9 79.4 82.8 45.0 23.6 30.1 29.0 71.4 76.3 27.5 51.7 21.7 30.4 62.5 6.9 9.2 65.7 30.8 117.9 71.8 50.7 7.5 30.5 50.7 68.1 41.1 27.7 12.5 65.3 18.2 7.4 66.5 57.5 34.3 102.5 113.6 23.3 41.5 24.0 30.6 72.4 69.7 62.2 52.9 53.4 65.1 78.0 87.1 92.8 29.3 28.9 62.8 8.5 58.1 7.0 66.4 146.1 68.9 76.6 102.6 51.1 55.1 53.2 47.8 44.6 45.1 19.8 25.2 50.0 54.7 34.9 43.3 16.3 107.7 51.4 124.5 37.9 27.7 105.8 54.7 77.8 59.4 29.4 51.9 26.1 67.6 51.0 24.5 80.7 7.5 130.9 26.1 62.4 49.4 65.9 53.4 74.4 89.9 73.5 44.5 63.1 101.5 36.4 100.4 62.2 70.8 58.0 58.8 59.4 67.1 63.5 57.7 69.7 62.8 59.9 54.9 20.9 72.3 58.7 54.3 77.0 68.0 26.4 30.2 34.0 37.7 25.0 27.9 30.1 29.0 30.4 30.5 27.7 34.3 84.3 44.8 49.6 9.8 64.5 55.7 70.6 97.2 60.3 44.0 93.6 130.8 34.3 88.6 74.7 75.4 41.7 135.3 63.7 47.2 180.0 101.1 114.1 74.3 53.2 58.8 61.1 52.6 8.9 127.2 140.6 68.9 53.5 44.5 46.9 64.8 69.3 75.7 98.4 18.5 13.4 77.7 67.1 51.5 43.6 51.5 85.4 47.6 64.0 7.5 67.6 91.5 71.1 12.1 31.0 91.0 77.4 73.7 70.8 72.0 94.3 221.0 79.7 62.4 52.6 66.1 82.2 277.1 76.6 82.6 68.5 103.7 61.6 98.1 80.6 79.2 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "MSL complex subunit 1" Q68DK7 17 40121971-40136917 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 358.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 60.2 52.0 34.3 48.0 33.6 56.7 56.7 26.1 39.6 76.6 16.1 62.7 51.7 75.1 55.9 48.1 77.5 38.6 46.8 32.1 26.5 57.1 43.9 61.5 50.8 24.1 25.7 58.3 59.3 47.8 78.8 48.5 22.2 59.8 46.8 41.1 56.5 51.9 63.6 60.8 61.6 53.7 21.8 88.2 57.1 66.2 27.9 62.3 79.8 51.6 51.6 53.3 62.0 27.7 35.9 42.2 88.3 57.9 78.5 67.6 45.0 61.6 65.3 76.1 68.4 42.4 37.8 78.8 45.6 65.0 48.4 65.2 74.7 40.5 78.2 68.0 59.6 43.6 60.5 50.6 40.9 59.7 81.6 56.9 63.6 56.1 46.5 77.4 71.0 47.2 69.3 62.8 61.4 22.8 95.0 64.8 37.6 39.4 27.2 77.1 48.7 72.1 55.4 38.9 80.9 48.0 57.5 358.8 46.5 80.1 83.5 81.0 58.7 51.0 56.4 37.8 52.3 98.5 58.5 77.7 52.0 43.7 60.7 0.0 1.0 0.8 1.7 0.6 0.8 1.1 0.9 1.3 0.7 0.9 0.9 0.8 8.7 0.7 0.8 1.4 0.6 0.5 34.3 33.6 26.1 39.6 32.1 26.5 24.1 25.7 22.2 21.8 27.9 27.7 44.1 28.9 40.7 42.7 22.7 50.0 37.8 21.7 69.4 55.2 41.6 32.3 29.5 25.8 25.8 11.0 12.5 15.4 43.8 36.4 3.9 17.2 16.1 35.8 53.9 43.3 31.2 22.3 39.8 20.7 15.4 37.4 20.4 48.1 3.8 24.8 36.4 35.9 25.2 52.2 33.4 29.1 8.2 36.4 42.8 28.5 58.4 34.2 32.0 33.7 30.6 31.3 30.9 25.1 32.4 24.7 32.1 39.9 26.8 72.7 35.4 9.0 32.7 28.4 39.5 29.2 40.7 71.8 49.2 57.5 65.8 17.0 29.9 27.5 31.4 58.7 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoli fibrillar center" Nucleoplasm "HPA059530: AB_2684052" "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 20.6 18.0 15.2 13.3 15.6 11.3 20.3 15.7 20.0 32.0 14.4 31.4 16.9 35.4 7.7 16.9 30.8 10.9 25.3 14.6 13.4 28.8 19.4 21.6 18.6 16.6 15.6 29.8 19.9 10.2 22.4 11.0 15.9 26.2 7.1 8.1 16.6 15.9 24.3 14.1 23.7 12.4 14.8 29.0 22.5 16.6 16.7 16.1 23.5 16.9 13.6 29.7 22.5 18.8 21.6 13.3 22.1 22.0 9.5 11.5 28.2 22.7 17.9 28.2 18.8 17.7 34.4 20.4 30.0 17.8 35.2 20.6 19.9 19.9 6.3 44.5 14.7 37.3 39.8 10.8 29.0 26.9 38.2 18.3 36.2 35.8 28.0 20.7 24.0 36.5 22.9 55.4 18.7 14.2 38.1 41.0 16.1 14.1 29.2 37.2 10.6 39.7 21.5 13.3 22.1 25.3 15.5 27.7 48.7 13.5 32.6 27.3 21.5 21.2 18.0 27.3 24.9 37.6 26.9 29.7 24.1 17.5 36.3 22.6 13.7 27.4 21.0 16.3 21.0 13.1 15.9 18.4 14.7 10.4 12.3 15.4 9.4 13.3 18.5 14.7 15.1 13.0 15.2 15.6 15.7 20.0 14.6 13.4 16.6 15.6 15.9 14.8 16.7 18.8 19.3 12.8 18.4 15.0 17.2 8.0 21.5 13.5 10.2 19.2 11.8 15.6 10.0 11.5 16.0 7.3 20.9 20.8 22.0 27.0 5.9 24.7 62.8 12.2 22.0 16.1 16.8 25.7 9.0 22.2 23.6 13.5 27.0 13.0 14.0 15.0 16.8 9.2 19.6 23.5 8.8 23.9 10.2 13.3 8.8 130.0 21.8 14.3 10.6 9.4 27.1 15.0 32.0 8.5 12.9 26.6 24.5 27.1 12.6 11.0 36.1 12.4 16.0 24.7 39.5 11.5 21.9 27.9 16.7 8.4 7.4 19.7 19.9 15.0 21.4 10.2 MZF1 "MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6" ENSG00000099326 "Myeloid zinc finger 1" P28698 19 58561931-58573575 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 46.0;HeLa: 41.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001757 Approved Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA001757: AB_1080718" "unprognostic (8.25e-3)" "unprognostic (2.33e-1)" "unprognostic (5.12e-2)" "unprognostic (5.16e-3)" "unprognostic (7.15e-2)" "unprognostic (4.29e-3)" "unprognostic (1.84e-2)" "unprognostic (4.62e-1)" "unprognostic (8.10e-2)" "unprognostic (7.03e-2)" "prognostic favorable (7.97e-4)" "unprognostic (2.87e-2)" "prognostic unfavorable (2.83e-8)" "unprognostic (1.47e-1)" "unprognostic (1.80e-1)" "unprognostic (4.64e-2)" "prognostic favorable (4.09e-5)" 7.5 13.5 5.4 6.5 5.5 5.8 8.5 6.5 8.5 14.7 12.7 11.3 11.6 12.0 7.0 9.6 17.5 4.4 7.5 5.5 5.1 13.5 11.4 10.0 5.9 8.1 6.6 15.8 11.4 6.7 16.9 3.6 6.3 15.4 4.0 9.2 10.1 6.0 10.8 10.3 10.4 4.3 5.4 8.2 12.8 6.6 6.2 4.5 19.0 2.4 2.9 10.7 10.6 7.2 8.0 19.9 8.1 5.0 4.5 4.0 10.1 7.2 3.5 1.2 2.4 4.3 9.4 5.7 3.5 1.9 5.9 9.0 2.0 4.7 0.6 10.3 46.0 6.0 41.5 2.6 2.7 4.5 10.0 2.7 12.3 1.8 5.3 7.7 4.1 6.4 5.0 7.0 1.8 8.8 2.7 2.6 3.1 4.6 8.1 7.4 2.0 10.5 4.1 16.9 7.9 11.0 3.7 6.7 4.6 1.6 7.1 6.1 5.1 13.0 4.1 2.3 3.7 12.6 15.3 4.9 10.5 5.0 3.4 0.0 0.9 0.4 2.1 0.6 3.2 2.1 3.6 2.6 1.6 2.7 5.9 3.8 1.7 5.3 0.7 0.4 2.4 2.4 5.4 5.5 6.5 8.5 5.5 5.1 8.1 6.6 6.3 5.4 6.2 7.2 7.9 12.8 17.0 28.4 15.0 8.0 11.4 11.9 22.2 39.4 22.0 22.4 5.9 10.0 8.0 11.0 33.3 6.0 11.1 20.3 3.9 8.3 22.1 39.1 9.8 7.2 16.8 10.7 23.4 5.4 3.6 8.8 43.3 16.7 4.5 15.8 9.7 10.7 4.9 30.3 20.1 14.5 16.2 5.3 3.3 28.7 10.5 7.6 10.6 7.5 4.2 19.4 15.5 10.6 21.3 6.5 13.4 13.2 9.0 9.6 14.7 10.6 29.8 47.8 19.7 16.6 7.7 10.2 3.8 11.2 8.2 6.4 12.5 16.3 11.9 7.8 NCAPD3 "CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056" ENSG00000151503 "Non-SMC condensin II complex subunit D3" P42695 11 134150113-134225454 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "prostate: 58.5" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 8 "prostate cancer: 50.8" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040286 Supported Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA040286: AB_2676918" "unprognostic (4.27e-2)" "unprognostic (6.05e-2)" "unprognostic (7.78e-3)" "unprognostic (8.22e-3)" "unprognostic (2.79e-1)" "unprognostic (4.29e-2)" "unprognostic (2.15e-3)" "unprognostic (2.56e-1)" "unprognostic (4.32e-2)" "unprognostic (4.75e-1)" "unprognostic (2.79e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.93e-2)" "unprognostic (3.35e-2)" "unprognostic (3.94e-1)" "unprognostic (3.48e-1)" 4.7 5.5 1.9 3.1 2.0 10.0 4.9 4.0 3.8 4.2 2.3 4.4 3.5 4.0 3.3 7.1 3.8 2.6 5.0 3.1 1.6 3.6 8.8 4.9 4.2 2.0 1.1 3.4 4.5 1.9 7.0 3.1 1.1 58.5 1.5 4.5 5.7 0.9 3.7 9.0 5.4 1.3 0.9 6.2 5.1 9.5 1.6 3.1 6.0 0.9 1.7 3.7 5.2 3.0 5.5 1.9 12.3 25.3 1.8 1.3 10.6 11.5 1.9 3.5 4.0 5.6 3.4 6.1 11.1 3.5 9.8 6.1 3.5 5.2 4.4 9.2 21.7 26.6 5.1 8.5 2.3 13.1 15.4 1.7 1.1 5.1 2.0 3.6 2.6 11.6 7.1 4.7 4.2 6.0 10.9 15.1 8.6 5.5 13.8 2.9 13.7 8.5 4.1 3.2 22.1 13.4 9.1 5.9 1.7 10.0 9.7 6.9 1.7 11.8 5.7 11.8 9.9 4.5 4.5 5.5 8.3 16.4 15.2 1.6 3.3 1.6 5.7 2.7 2.2 2.3 3.7 3.8 2.5 5.2 5.5 5.8 1.6 1.7 2.2 8.0 6.5 1.9 1.9 2.0 4.0 3.8 3.1 1.6 2.0 1.1 1.1 0.9 1.6 3.0 7.7 3.2 8.1 8.5 12.1 9.2 4.4 6.0 8.0 20.2 9.9 8.6 6.7 2.8 7.0 12.9 10.4 13.0 13.2 5.4 0.0 2.7 7.2 7.8 12.8 5.6 7.8 32.8 19.7 2.6 9.9 7.5 7.7 9.0 2.5 19.6 5.7 9.7 8.8 11.8 16.7 7.2 10.2 6.4 8.7 10.4 4.7 10.9 1.8 15.0 17.1 9.0 17.5 11.1 16.0 2.8 1.6 4.1 22.9 8.8 3.2 3.6 4.9 20.9 0.0 9.5 9.2 21.5 14.4 10.7 9.1 4.5 14.2 11.3 11.6 3.4 NCK2 NCKbeta ENSG00000071051 "NCK adaptor protein 2" O43639 2 105744912-105894274 "Plasma proteins, Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 184.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016116, HPA031004" Approved NA NA 87000 "Cluster 35: T-regs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 24: Non-specific - Transcription regulation" "CAB016116: AB_2150588, HPA031004: AB_10795571" "unprognostic (2.39e-1)" "unprognostic (3.48e-1)" "unprognostic (6.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (5.85e-3)" "unprognostic (4.04e-2)" "unprognostic (4.88e-2)" "unprognostic (1.22e-1)" "unprognostic (9.62e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.24e-2)" "unprognostic (2.14e-2)" "unprognostic (7.21e-3)" "unprognostic (4.22e-2)" 37.8 19.7 18.6 20.5 19.2 17.6 33.6 26.3 29.0 36.4 16.7 39.1 54.7 29.7 18.9 68.8 25.4 19.0 31.9 27.9 18.4 28.9 11.1 37.1 27.6 21.8 22.4 25.1 39.8 13.6 19.7 36.8 22.0 24.7 16.4 10.3 46.8 18.7 53.5 33.4 51.7 17.9 22.5 52.0 40.3 27.3 23.9 18.6 28.3 27.2 19.1 35.6 50.4 20.4 25.8 20.2 51.6 23.9 15.0 10.7 73.3 19.0 25.0 21.6 12.5 58.8 20.9 11.2 23.4 24.2 31.0 25.1 21.9 47.7 14.6 79.5 24.5 5.0 9.4 37.8 39.2 28.1 9.8 21.4 34.0 23.5 30.0 18.7 22.0 27.3 7.7 38.5 17.9 21.7 29.3 48.2 28.8 21.6 23.0 23.4 36.2 41.7 28.1 51.2 32.9 45.4 14.4 37.2 184.4 30.4 13.6 70.3 25.0 37.9 55.2 1.0 27.2 28.8 19.6 3.8 16.7 24.5 61.6 26.2 1.0 12.5 7.0 1.0 9.2 7.7 13.1 11.8 1.2 11.1 13.6 12.5 9.3 11.9 1.0 1.8 24.5 5.0 18.6 19.2 26.3 29.0 27.9 18.4 21.8 22.4 22.0 22.5 23.9 20.4 41.8 16.0 7.9 28.1 32.8 17.6 13.9 14.2 7.4 13.5 27.1 35.9 21.3 71.4 9.6 16.5 12.5 39.0 30.3 31.2 7.9 28.1 15.5 18.0 21.8 23.7 19.2 2.5 60.0 18.8 15.2 16.2 13.3 19.9 5.7 33.0 18.2 2.3 26.0 82.4 48.4 23.1 18.3 14.2 13.9 9.2 23.6 18.7 10.6 77.8 10.5 61.4 18.6 24.6 18.3 29.9 29.2 28.2 15.8 17.7 51.3 8.4 18.9 4.6 32.9 33.1 54.4 4.2 9.6 10.7 16.8 29.7 52.4 18.1 31.2 30.0 NCOR2 "CTG26, SMRT, SMRTE, TNRC14, TRAC-1" ENSG00000196498 "Nuclear receptor corepressor 2" Q9Y618 12 124324415-124567589 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.0;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 4 "granulocytes: 6.0;monocytes: 2.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001928 Approved Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA001928: AB_1079454" "unprognostic (9.51e-3)" "unprognostic (7.37e-3)" "unprognostic (4.66e-2)" "unprognostic (2.55e-3)" "unprognostic (2.14e-1)" "unprognostic (7.37e-2)" "unprognostic (3.19e-2)" "unprognostic (8.86e-2)" "unprognostic (2.21e-2)" "unprognostic (2.90e-3)" "unprognostic (6.42e-3)" "unprognostic (1.96e-1)" "unprognostic (9.86e-2)" "unprognostic (6.26e-2)" "unprognostic (1.59e-1)" "unprognostic (7.56e-2)" "unprognostic (8.90e-2)" 48.1 51.1 41.2 34.3 15.8 29.9 49.7 27.2 45.6 62.9 13.6 56.2 25.2 58.6 9.0 33.3 49.0 21.4 56.7 61.3 12.6 37.6 27.5 62.8 19.5 56.4 29.2 70.8 49.3 18.1 84.1 20.2 53.0 57.7 10.9 20.7 55.1 22.0 109.2 56.2 36.8 22.5 5.4 35.7 45.8 26.1 26.4 19.9 40.5 19.9 11.2 47.4 43.9 27.0 78.6 143.6 40.4 38.7 23.0 31.1 120.4 79.3 39.0 45.2 20.1 76.9 56.3 78.7 57.0 65.1 40.7 72.6 16.2 84.7 18.5 83.6 31.5 63.6 142.1 48.0 46.0 48.3 77.5 50.1 30.9 56.6 33.4 69.2 43.7 35.5 83.3 22.9 41.2 67.4 174.3 55.5 56.4 29.8 139.0 55.8 67.1 40.2 21.6 89.9 106.0 77.1 97.3 81.1 47.7 30.2 66.3 59.8 212.0 104.5 178.9 104.3 170.5 43.5 48.0 48.1 59.4 35.4 100.1 6.0 0.4 1.0 1.0 0.2 0.3 0.3 0.3 0.8 0.2 0.1 0.3 0.2 0.9 0.1 2.5 0.9 0.0 0.3 41.2 15.8 27.2 45.6 61.3 12.6 56.4 29.2 53.0 5.4 26.4 27.0 30.6 115.4 58.9 46.4 14.7 33.3 24.6 22.2 33.0 95.3 33.3 28.3 30.4 18.6 38.8 18.4 39.6 8.8 27.4 39.1 3.9 22.1 2.2 28.0 53.4 28.2 18.7 11.6 61.9 27.2 39.7 50.6 37.8 32.4 42.3 43.5 18.5 19.0 28.4 121.1 37.0 20.3 4.1 50.0 48.7 7.1 62.1 44.8 16.0 51.5 27.0 28.0 20.6 70.9 65.9 38.0 22.2 65.1 22.6 23.7 25.4 8.0 16.8 65.9 6.6 63.0 35.5 1.8 11.6 17.7 24.4 12.6 25.1 69.4 21.9 23.1 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357115 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Granulosa cells: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8" "Group enriched" "Detected in many" 11 "B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2" "Cell line enhanced" "Detected in many" "Daudi: 11.5;HeLa: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 8.0 14.6 2.0 3.1 3.1 4.3 11.6 6.2 5.0 14.7 2.0 9.3 5.8 10.0 1.7 7.3 12.9 3.9 5.8 2.2 1.7 8.8 12.8 8.3 6.1 1.4 0.4 13.3 10.9 3.3 11.0 2.5 0.7 12.4 1.1 2.6 16.6 4.1 9.0 8.9 8.3 1.9 0.0 8.8 10.5 3.7 1.1 2.7 10.7 0.6 3.0 8.2 10.9 2.2 2.2 3.6 2.3 1.4 0.7 0.8 4.5 1.3 0.0 0.5 0.1 0.6 4.0 11.5 2.1 0.2 1.1 6.1 1.4 0.4 0.0 5.7 9.1 2.0 11.8 1.7 0.9 2.1 2.6 0.3 1.7 0.6 0.0 5.6 1.4 1.1 1.4 3.3 0.3 2.9 0.4 6.3 2.1 0.4 0.8 2.1 1.5 0.5 2.1 2.4 1.4 2.8 2.2 1.0 3.2 1.2 4.2 3.5 6.3 1.3 2.3 1.8 1.2 5.2 5.5 9.7 1.1 9.4 1.2 0.0 0.6 0.0 5.2 0.3 1.3 4.8 0.9 1.2 0.2 6.4 1.4 1.4 0.8 15.8 0.2 0.3 0.3 1.4 2.0 3.1 6.2 5.0 2.2 1.7 1.4 0.4 0.7 0.0 1.1 2.2 15.9 22.4 19.2 19.9 33.7 6.4 15.4 10.1 23.3 20.0 22.1 15.9 2.9 10.0 21.9 14.7 10.4 10.8 19.1 13.6 1.9 9.0 20.4 31.8 7.3 16.9 21.6 8.0 33.5 8.3 3.6 7.7 22.4 15.4 11.4 105.6 24.3 11.5 3.4 10.1 29.9 20.0 10.2 5.7 7.0 2.6 19.0 3.3 8.8 8.4 1.7 14.6 55.6 5.5 4.5 7.3 16.0 13.5 9.1 9.2 21.4 8.9 41.9 6.5 6.6 6.6 6.4 1.6 1.5 11.0 5.8 4.8 10.0 2.0 14.5 8.7 NEURL4 KIAA1787 ENSG00000215041 "Neuralized E3 ubiquitin protein ligase 4" Q96JN8 17 7315628-7329393 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043678, HPA055314" Uncertain NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "HPA043678: AB_10963092, HPA055314: AB_2682782" "unprognostic (4.38e-1)" "unprognostic (1.12e-1)" "unprognostic (4.70e-2)" "unprognostic (3.25e-3)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (8.96e-3)" "prognostic favorable (2.34e-5)" "unprognostic (4.96e-2)" "unprognostic (3.72e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.47e-1)" "unprognostic (8.12e-2)" 7.3 6.7 2.6 3.3 3.1 3.0 7.9 1.2 4.2 10.7 0.6 11.9 3.9 11.4 1.7 7.0 10.3 2.4 9.0 3.1 1.2 7.9 5.7 6.9 3.9 1.8 1.6 12.8 8.7 4.6 12.3 2.3 1.5 10.0 1.8 2.5 8.4 3.3 18.8 9.4 9.8 2.4 0.3 9.3 8.6 9.8 1.6 3.8 12.4 5.2 2.3 10.0 8.6 2.4 3.3 11.5 7.3 11.7 4.4 2.8 8.7 5.0 3.2 6.0 4.9 8.0 2.7 10.2 5.1 3.0 4.9 9.4 7.8 4.7 2.6 5.5 12.3 5.1 13.2 4.7 3.0 5.0 6.9 2.7 4.8 6.2 3.5 4.7 3.8 8.5 7.3 2.1 2.6 4.2 7.5 9.3 5.1 3.9 5.6 12.9 5.8 4.1 3.7 3.4 6.8 5.7 5.2 5.2 2.0 3.7 4.4 3.5 4.8 5.5 4.2 4.6 5.6 4.3 2.9 4.3 3.5 4.6 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.1 1.2 4.2 3.1 1.2 1.8 1.6 1.5 0.3 1.6 2.4 3.4 0.0 2.2 10.4 2.4 2.5 0.8 2.3 0.6 11.4 4.9 5.3 1.6 4.3 2.3 5.5 14.6 2.3 1.9 5.4 1.9 2.5 2.0 4.3 4.1 2.9 4.2 2.1 8.4 1.4 1.8 2.1 8.2 3.8 2.5 6.4 4.6 3.4 2.6 5.0 7.0 5.0 4.1 2.5 1.8 1.6 2.8 3.5 0.0 4.7 1.9 3.1 5.2 4.5 6.4 2.4 2.1 1.9 2.0 1.6 5.1 5.8 2.5 8.7 0.0 2.7 3.7 4.2 4.5 3.4 2.8 1.9 2.5 3.2 5.7 0.6 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 58.8;Endometrial stromal cells: 28.3;Fibroblasts: 22.8;Sertoli cells: 26.3;Smooth muscle cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.8;BJ hTERT+: 49.5;hTERT-RPE1: 42.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" No No "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805" "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 48.4 54.9 9.1 6.0 9.4 0.6 47.2 8.6 10.5 126.0 9.0 71.9 4.5 82.1 13.7 22.2 82.6 17.8 30.2 9.0 9.3 35.5 5.6 30.2 4.8 10.3 9.4 142.7 13.8 9.0 37.9 18.2 8.8 51.5 5.0 2.8 20.5 16.2 9.0 25.0 29.9 18.8 8.2 17.7 35.5 42.7 9.7 1.7 50.4 2.5 3.6 66.2 65.9 8.5 0.0 0.1 17.8 0.0 25.4 36.8 0.1 17.3 49.5 23.0 20.0 0.0 14.6 14.9 0.5 25.0 1.6 0.0 7.1 0.3 13.9 0.0 0.6 11.3 20.6 0.0 12.3 0.0 0.0 26.8 0.3 13.9 0.1 42.5 18.2 4.7 3.7 0.0 4.5 0.8 0.0 1.7 2.3 1.0 0.1 1.1 1.6 2.0 0.0 0.2 2.9 11.9 0.0 3.3 5.7 8.7 10.3 4.5 10.3 21.3 4.4 20.5 0.0 10.4 1.6 11.0 4.4 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 9.4 8.6 10.5 9.0 9.3 10.3 9.4 8.8 8.2 9.7 8.5 4.1 3.2 8.1 58.8 1.1 4.5 0.9 1.9 0.6 1.3 3.3 2.8 7.8 0.0 4.8 0.0 0.0 0.6 0.0 0.8 0.0 2.8 4.4 2.5 28.3 4.6 7.7 0.0 0.1 0.2 0.6 22.8 3.6 6.4 0.0 4.1 1.4 0.2 0.6 0.0 0.2 3.4 10.2 0.0 6.8 6.5 17.4 0.4 7.2 13.1 0.0 7.6 0.0 1.0 0.2 0.6 0.3 7.5 0.2 0.8 0.4 0.2 2.1 1.5 26.3 4.3 27.1 12.5 2.9 1.0 3.4 0.5 0.9 6.0 1.6 2.3 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493068 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 169.3;Peritubular cells: 246.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 55.2 69.8 46.5 28.7 55.5 38.7 60.5 78.2 56.6 105.8 22.2 68.5 24.3 76.2 34.0 51.3 72.0 29.9 48.5 56.3 38.7 54.6 45.6 56.2 32.5 20.9 32.6 93.0 54.1 32.5 181.8 39.1 32.9 107.5 20.6 19.0 53.6 51.6 36.3 80.7 55.3 33.0 9.1 54.1 52.7 84.5 35.2 30.1 60.8 16.3 23.3 78.1 71.6 35.2 15.6 16.0 48.8 40.1 35.7 39.2 40.0 32.8 21.5 25.7 26.0 24.2 22.8 21.7 9.0 45.6 21.0 20.4 26.1 35.7 15.1 22.3 28.2 39.2 65.2 23.9 32.4 23.2 33.6 61.9 28.2 27.7 23.5 54.0 42.0 42.4 21.1 23.4 24.3 22.2 41.8 51.2 30.1 19.8 27.1 24.5 13.4 25.4 29.2 30.6 20.6 35.9 35.6 9.3 23.1 42.3 28.9 38.5 46.3 36.0 34.1 36.9 24.1 38.7 23.8 27.3 24.7 37.3 22.4 5.2 4.5 3.5 3.0 4.0 3.1 2.5 2.6 4.0 2.3 2.8 3.1 3.3 1.5 3.2 0.6 3.4 3.0 3.6 46.5 55.5 78.2 56.6 56.3 38.7 20.9 32.6 32.9 9.1 35.2 35.2 26.1 25.6 32.3 34.0 14.9 27.5 14.6 23.3 40.5 40.9 29.2 37.1 20.4 8.6 19.1 14.7 8.4 32.4 24.2 20.5 9.8 12.1 10.3 14.5 26.7 22.1 169.3 4.6 64.9 9.4 14.0 23.4 23.4 18.9 25.3 40.2 46.1 15.3 30.5 28.6 44.0 19.1 22.4 50.5 14.5 25.9 88.3 24.3 19.6 15.0 13.0 12.1 17.5 21.1 26.1 10.0 14.2 246.0 12.4 12.6 16.5 15.6 15.2 22.4 26.3 17.2 24.8 31.2 18.0 16.7 22.3 24.2 18.4 47.6 15.7 11.7 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 32.7;Horizontal cells: 57.2;Oligodendrocyte precursor cells: 45.8;Sertoli cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 42.2" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria NA NA 14000 "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Mitochondria "HPA055321: AB_2682783, HPA069278: AB_2686105" "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 25.0 18.1 25.6 4.8 26.0 0.4 21.2 13.5 25.3 61.9 0.0 36.4 1.5 57.9 7.5 10.2 46.1 7.7 18.2 23.7 18.6 16.6 9.3 16.7 2.7 18.1 15.2 66.6 9.4 7.6 23.7 3.8 13.9 29.7 2.2 15.5 13.6 9.0 11.7 14.8 16.6 12.3 12.1 16.9 16.3 6.7 20.9 0.8 14.2 2.4 1.8 31.2 32.4 19.0 7.1 9.8 42.2 24.4 12.6 18.0 1.0 11.6 18.2 19.4 17.9 2.2 2.4 0.1 5.5 16.4 11.4 3.9 7.9 4.9 10.0 10.8 7.9 3.1 9.6 1.6 6.3 3.1 10.4 14.1 3.8 15.9 2.4 29.1 6.5 3.9 2.9 5.6 7.9 6.6 1.4 3.1 7.2 0.4 4.7 12.9 5.0 1.4 5.6 1.5 0.6 17.0 5.3 2.5 3.0 8.3 6.9 0.4 9.0 16.6 20.6 10.5 5.7 6.4 2.2 1.2 17.3 2.8 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 26.0 13.5 25.3 23.7 18.6 18.1 15.2 13.9 12.1 20.9 19.0 5.4 0.0 2.6 25.8 0.5 4.7 3.1 3.3 7.4 32.7 5.6 5.2 11.0 5.7 1.0 0.0 8.4 0.4 3.4 0.1 0.0 2.7 2.0 1.5 25.3 6.8 0.0 0.0 23.5 0.4 6.3 11.5 0.5 2.3 0.0 5.8 6.1 3.2 1.0 57.2 24.8 0.3 0.0 0.8 1.8 2.9 17.1 0.7 1.8 5.6 0.6 22.3 0.0 45.8 13.6 1.6 0.0 22.2 0.3 3.0 0.1 1.3 0.8 16.8 32.9 10.8 10.7 0.5 1.1 1.2 3.8 0.8 1.7 4.3 0.3 1.2 NME3 "DR-nm23, NDPKC, NM23-H3" ENSG00000103024 "NME/NM23 nucleoside diphosphate kinase 3" Q13232 16 1770286-1771730 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 70.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041113, HPA052733" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 12000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA041113: AB_2677305, HPA052733: AB_2681930" "prognostic favorable (6.81e-5)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.22e-3)" "unprognostic (4.40e-2)" "unprognostic (4.43e-2)" "unprognostic (7.09e-3)" "unprognostic (1.79e-1)" "unprognostic (3.84e-1)" "unprognostic (3.64e-1)" "unprognostic (6.11e-3)" 34.0 84.4 21.3 8.0 22.7 3.9 34.2 21.0 36.3 41.9 16.8 47.7 15.9 36.7 3.4 27.2 44.3 2.1 36.0 20.2 23.1 44.6 36.3 29.1 5.4 23.7 22.2 43.7 37.2 4.5 71.9 5.2 19.6 59.4 3.1 1.8 35.9 13.0 17.1 31.1 33.8 3.2 22.5 39.4 38.6 16.0 22.0 1.0 40.3 3.1 1.9 38.5 33.5 24.9 1.6 26.9 0.6 21.8 6.1 3.2 2.5 15.7 4.5 2.7 2.1 0.0 31.8 0.4 42.6 2.2 2.8 23.0 1.3 8.8 0.3 32.1 70.9 0.0 12.0 13.0 11.3 5.5 9.8 14.0 7.9 2.7 1.5 5.1 5.6 0.2 11.2 4.4 2.7 40.4 0.4 10.8 28.0 5.4 21.5 15.3 0.3 43.5 4.5 1.2 30.6 23.6 47.1 35.2 4.2 1.2 33.7 13.1 19.9 5.8 21.4 18.5 10.8 11.1 3.7 2.5 8.1 0.9 13.3 10.0 50.7 34.6 33.3 49.6 32.9 36.8 46.3 31.4 45.1 31.9 39.6 31.3 10.8 44.8 55.4 70.3 45.4 41.3 21.3 22.7 21.0 36.3 20.2 23.1 23.7 22.2 19.6 22.5 22.0 24.9 128.8 35.3 62.7 69.9 64.6 72.5 141.3 97.7 179.8 116.3 147.3 165.6 28.0 90.1 76.6 126.9 60.5 86.6 77.9 76.2 60.7 62.9 22.1 66.5 102.9 84.1 135.5 25.7 34.6 37.6 46.3 100.9 76.0 77.6 50.8 71.6 99.9 63.0 74.8 65.6 30.2 109.4 50.8 60.3 91.0 20.3 149.5 71.1 81.8 29.0 136.5 126.9 77.2 40.7 63.7 37.0 104.7 127.5 93.1 98.4 157.2 150.2 70.9 126.7 118.3 75.9 100.8 2.0 40.4 100.9 65.6 46.1 87.3 183.8 107.6 100.6 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615335-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 44.3 43.9 29.5 21.7 30.8 29.5 42.0 32.2 34.0 37.5 28.2 44.8 26.8 37.7 23.4 38.2 35.5 16.6 48.2 28.7 31.1 58.5 37.9 32.2 25.8 30.9 31.4 40.7 48.9 40.2 35.9 21.1 31.0 35.1 19.8 16.6 38.0 19.2 44.5 36.9 36.4 16.0 30.8 37.8 37.9 41.7 30.7 15.2 37.1 17.1 20.3 41.4 34.9 33.8 71.7 37.2 31.7 42.7 26.9 26.1 74.4 71.8 29.3 48.4 44.4 60.0 24.9 97.8 137.4 34.4 57.7 46.5 46.9 42.4 47.8 57.5 105.0 91.2 36.3 104.0 45.4 112.0 61.4 25.5 41.5 42.5 24.2 29.8 33.6 45.5 135.7 22.2 44.7 38.1 70.6 147.6 42.1 37.0 74.1 74.4 46.8 140.5 57.9 21.7 92.5 60.3 40.9 88.0 94.9 36.2 53.6 42.8 65.7 48.0 51.9 57.8 108.3 66.2 123.2 100.2 30.7 70.7 75.6 34.5 59.6 82.1 59.2 76.4 68.2 104.0 84.7 71.4 73.2 87.8 90.7 69.0 27.4 61.9 82.9 91.4 96.0 67.9 29.5 30.8 32.2 34.0 28.7 31.1 30.9 31.4 31.0 30.8 30.7 33.8 103.1 93.0 73.5 10.4 112.5 90.8 117.3 151.0 50.1 62.1 78.9 97.0 214.9 68.6 112.0 57.0 22.9 137.4 71.5 72.7 123.3 188.7 202.3 105.8 95.0 109.2 37.1 89.4 14.0 261.2 153.8 90.9 58.1 91.6 90.6 67.0 61.1 61.8 115.1 48.8 17.1 97.8 130.2 52.6 81.8 38.9 82.6 78.5 101.4 8.4 119.7 124.2 78.2 13.6 19.0 175.0 94.3 79.4 138.8 121.7 81.2 163.6 135.6 61.7 65.7 92.5 119.4 186.3 112.9 70.8 90.5 155.3 99.5 99.2 91.0 117.2 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 4.2;Respiratory ciliated cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;hTERT-RPE1: 6.4;NB-4: 10.6;SK-MEL-30: 15.9" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 5.1 3.6 2.0 0.8 2.0 0.7 4.7 2.8 9.4 6.6 1.5 9.3 0.2 6.8 0.8 4.4 5.8 2.5 4.4 2.2 1.7 5.5 3.8 4.7 0.4 2.0 2.0 7.7 4.0 2.5 10.7 0.5 2.1 5.8 0.9 2.0 3.1 1.0 7.4 5.8 4.1 0.4 1.7 4.0 4.7 6.5 2.0 0.1 4.7 0.3 0.4 7.2 5.4 2.1 0.0 0.6 0.1 0.3 0.0 0.1 1.4 0.5 0.0 0.4 0.4 0.0 1.9 3.3 0.2 1.2 0.7 0.1 0.1 2.1 0.2 0.1 0.0 0.3 0.7 0.4 0.2 0.1 0.5 4.4 0.7 1.2 0.1 6.4 0.1 0.6 0.1 0.2 0.2 1.2 0.0 10.6 0.8 0.0 0.0 0.1 0.0 0.0 2.9 1.0 0.4 0.4 0.0 0.2 15.9 0.6 0.2 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.1 1.7 0.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.0 2.8 9.4 2.2 1.7 2.0 2.0 2.1 1.7 2.0 2.1 0.2 3.2 0.5 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.1 4.2 0.0 0.7 0.0 0.0 0.1 0.0 1.2 0.0 0.1 1.1 0.1 0.1 0.8 1.2 0.0 0.1 0.2 0.1 1.2 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.6 0.0 0.7 0.6 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.3 1.0 0.5 0.3 0.0 0.0 0.3 0.3 0.0 0.7 0.1 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.2;granulocytes: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebral cortex: 28.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 61.3;EFO-21: 58.1;HMC-1: 217.0;SCLC-21H: 53.1;THP-1: 60.6" HPA053611 Approved Approved Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 14.3 9.6 3.7 2.5 3.9 6.9 13.3 6.5 28.6 13.1 2.4 28.7 0.2 12.6 0.5 10.1 28.7 0.1 11.3 4.0 3.4 18.4 9.6 12.4 2.5 4.0 3.2 20.7 11.0 6.3 36.4 6.3 4.6 16.9 2.1 5.0 9.8 7.5 18.9 14.6 12.9 0.4 2.7 13.1 13.9 20.8 4.3 3.1 13.7 0.1 0.1 15.8 10.8 3.6 0.0 2.3 0.3 0.5 1.5 0.7 0.7 0.0 0.0 0.1 0.2 0.4 10.5 61.3 58.1 0.5 0.0 0.1 23.6 7.1 0.1 0.1 0.1 0.1 1.9 2.0 9.7 0.1 217.0 0.3 0.0 0.0 0.0 0.1 4.3 14.4 24.4 0.2 0.0 0.1 0.0 0.2 16.4 24.8 0.0 2.5 36.2 1.7 0.3 0.2 53.1 16.8 0.0 0.4 0.6 11.2 0.0 60.6 0.0 1.1 0.1 0.2 13.8 0.0 0.1 0.2 18.6 16.5 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 3.9 6.5 28.6 4.0 3.4 4.0 3.2 4.6 2.7 4.3 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 NSMCE3 "HCA4, MAGEG1, MAGEL3, NDNL2, NSE3" ENSG00000185115 "NSE3 homolog, SMC5-SMC6 complex component" Q96MG7 15 29264989-29269822 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Ubl conjugation pathway" "Tumor antigen" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 83.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "OE19: 2.6" "Low region specificity" "Detected in single" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (6.38e-2)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (1.97e-1)" "unprognostic (2.52e-2)" "unprognostic (2.47e-2)" "unprognostic (2.50e-2)" "unprognostic (4.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.56e-1)" "unprognostic (6.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.41e-2)" 3.8 5.1 0.5 0.1 0.4 0.0 3.6 0.4 0.6 3.1 0.0 4.1 0.1 5.0 0.1 2.5 4.0 0.1 4.6 0.6 0.1 3.1 4.0 3.4 0.2 0.2 0.1 4.7 2.9 0.2 5.9 0.1 0.3 2.8 0.2 0.4 3.1 0.2 4.0 2.4 4.3 0.1 0.0 5.3 3.4 6.3 0.3 0.2 4.1 0.0 0.1 3.7 2.6 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.6 0.1 0.2 0.1 0.3 0.0 0.3 0.2 29.6 16.0 9.5 0.0 68.0 0.0 28.1 0.0 29.0 39.7 15.0 21.7 0.0 10.0 0.6 9.2 10.4 22.9 80.2 2.3 15.6 22.5 23.9 15.6 26.1 19.6 13.3 9.0 0.0 16.3 14.0 20.9 11.2 14.0 5.1 22.3 21.0 15.4 20.8 43.7 0.0 4.4 0.0 17.1 0.0 72.8 23.3 34.8 0.0 0.0 20.3 41.5 39.1 0.0 0.0 12.1 4.5 31.6 77.7 19.1 4.6 26.9 2.9 41.2 26.3 30.9 28.0 83.8 31.7 12.9 0.0 11.8 80.6 36.6 4.8 18.5 NT5C "cdN, DNT-1, DNT1, PN-I, UMPH2" ENSG00000125458 "5', 3'-nucleotidase, cytosolic" Q8TCD5 17 75130225-75131757 "Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021581, HPA023632" Approved Supported Cytosol NA NA 760000 "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA021581: AB_1854663, HPA023632: AB_1854662" "unprognostic (3.83e-2)" "unprognostic (4.45e-2)" "unprognostic (2.39e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.26e-1)" "unprognostic (7.25e-2)" "unprognostic (8.26e-3)" "unprognostic (7.15e-2)" "unprognostic (2.22e-1)" "unprognostic (6.57e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "prognostic favorable (7.66e-4)" 31.6 31.4 14.5 17.9 15.9 16.3 31.8 16.5 17.4 37.0 14.8 43.0 24.5 34.7 5.2 45.9 32.1 8.4 32.6 14.1 16.7 47.8 29.1 29.2 18.3 17.1 15.5 37.5 33.7 11.7 18.9 10.2 15.6 35.7 13.1 8.7 25.8 15.3 41.1 33.8 43.7 7.6 16.6 40.7 36.8 15.2 15.5 16.0 37.7 16.1 15.2 37.9 35.9 18.4 52.5 77.7 25.3 26.5 7.5 15.4 33.7 29.5 26.2 29.7 18.8 29.5 58.3 35.5 21.5 21.0 5.2 33.7 18.1 37.7 16.5 16.1 51.3 40.5 68.7 50.0 38.0 38.8 17.2 23.1 17.4 21.3 57.0 11.9 33.0 27.6 38.4 16.8 30.2 51.2 28.0 39.0 26.5 43.6 50.6 24.9 32.9 50.9 39.3 26.7 30.0 60.1 28.3 34.8 43.9 14.0 49.8 27.2 20.4 25.0 62.1 9.8 40.3 33.3 5.6 41.1 23.8 23.3 40.4 183.7 29.7 48.9 39.2 49.6 27.7 94.9 25.5 33.6 37.9 87.4 21.6 33.5 14.4 72.6 50.7 50.4 45.2 30.2 14.5 15.9 16.5 17.4 14.1 16.7 17.1 15.5 15.6 16.6 15.5 18.4 23.0 32.1 19.5 22.2 132.9 47.4 86.1 108.8 90.5 66.0 58.8 101.9 16.4 77.2 35.2 58.8 20.9 64.9 85.8 272.8 78.2 102.2 2.1 53.2 53.5 26.6 64.1 59.5 7.7 121.4 100.4 59.8 181.5 43.2 46.3 59.0 11.7 41.9 74.5 42.1 8.0 133.4 52.9 55.7 64.4 6.8 59.4 56.2 58.7 18.7 108.4 55.9 98.9 19.6 19.2 127.5 221.6 47.4 51.2 115.8 231.6 144.2 31.1 65.5 32.9 39.0 107.6 19.0 49.6 89.4 44.3 31.2 67.4 98.4 152.8 85.9 NT5C2 "cN-II, GMP, NT5B, PNT5, SPG45, SPG65" ENSG00000076685 "5'-nucleotidase, cytosolic II" P49902 10 103087185-103277605 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Allosteric enzyme, Hydrolase" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003751 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "HPA003751: AB_1854664" "unprognostic (8.18e-2)" "unprognostic (1.98e-1)" "unprognostic (2.55e-2)" "unprognostic (2.46e-1)" "unprognostic (5.54e-2)" "unprognostic (4.87e-3)" "unprognostic (2.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.41e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-3)" "unprognostic (6.20e-2)" "unprognostic (3.26e-2)" "unprognostic (3.70e-2)" "unprognostic (6.40e-2)" "unprognostic (3.43e-1)" "unprognostic (1.50e-1)" 24.6 27.0 25.0 19.0 27.2 29.7 23.0 27.3 28.5 37.6 36.8 27.3 9.9 18.8 17.3 67.1 26.5 16.4 28.5 25.2 28.8 32.5 27.8 30.8 18.3 26.9 29.5 32.4 22.0 21.7 34.0 17.9 27.2 32.4 16.7 47.3 46.4 18.4 51.6 19.9 20.4 13.4 26.4 32.8 22.3 30.8 27.2 28.6 55.4 18.1 24.5 33.3 42.7 28.6 148.4 52.5 32.6 67.5 27.2 33.2 18.2 66.0 64.7 29.9 32.4 34.6 91.7 49.2 47.7 45.6 27.6 62.8 23.4 33.8 38.3 40.3 21.6 38.7 21.1 39.6 48.5 64.2 21.0 50.4 34.1 28.0 24.8 57.5 25.6 19.4 29.4 36.4 54.5 73.8 53.7 64.6 34.6 43.2 68.6 102.6 30.0 19.6 43.3 72.5 10.0 24.9 35.8 25.9 50.3 33.7 39.2 38.1 30.5 20.5 24.8 39.7 51.7 32.9 71.6 85.5 23.9 64.6 7.8 29.5 16.5 31.3 10.0 18.8 10.3 8.9 8.4 8.7 14.7 5.2 6.7 8.0 27.4 14.4 23.0 9.6 9.3 10.5 25.0 27.2 27.3 28.5 25.2 28.8 26.9 29.5 27.2 26.4 27.2 28.6 16.2 83.3 34.9 141.7 17.2 7.4 29.0 26.9 5.7 24.4 13.9 13.6 2.6 18.6 60.4 27.6 45.9 19.4 23.3 48.7 11.7 28.5 103.7 29.5 17.1 19.8 11.5 12.4 79.8 26.0 11.7 17.5 25.5 46.2 8.8 18.2 13.9 17.4 19.9 47.1 83.6 17.6 18.3 29.8 14.2 61.9 24.8 27.1 26.6 78.7 25.9 85.5 16.5 70.4 107.5 57.9 23.1 13.5 21.0 35.7 11.7 15.3 44.1 59.1 32.9 22.9 21.7 25.3 20.5 22.9 7.5 35.0 16.6 15.8 18.0 80.5 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037854-15056079 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 17.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 18.5;REH: 9.2;U-266/84: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavorable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 38.6 10.2 3.6 0.5 3.9 2.2 28.1 3.8 8.9 25.3 2.1 30.3 0.1 20.7 1.4 19.4 18.8 1.2 19.3 3.4 3.7 15.9 15.2 21.6 0.7 3.8 4.1 19.7 11.0 0.5 6.5 0.4 4.1 20.2 0.3 1.3 15.8 0.4 24.5 21.6 15.6 0.8 2.9 20.5 17.9 20.3 3.7 0.8 13.5 0.6 0.4 27.8 21.8 3.5 3.6 0.0 1.8 0.7 1.2 0.6 0.6 6.2 2.6 1.0 2.8 0.0 0.0 3.2 2.5 4.7 1.7 0.1 0.9 0.7 0.9 5.0 5.9 0.3 0.0 0.0 1.1 1.7 4.3 0.8 0.4 3.4 1.5 1.5 1.3 2.6 0.5 3.2 0.9 0.3 5.3 18.5 1.1 0.0 0.2 9.2 0.1 1.3 1.2 0.0 0.7 2.1 0.0 0.1 1.5 0.4 0.0 0.6 4.1 1.1 3.8 1.1 1.1 4.2 10.1 2.5 1.5 1.3 2.2 4.9 1.3 17.5 2.8 1.7 3.0 4.2 3.4 2.6 1.9 3.8 3.9 1.3 1.6 3.8 2.0 5.7 5.9 3.1 3.6 3.9 3.8 8.9 3.4 3.7 3.8 4.1 4.1 2.9 3.7 3.5 79.7 3.2 3.9 7.8 24.7 33.6 16.4 24.1 7.4 6.1 20.2 33.4 3.2 12.8 13.8 18.4 10.4 77.4 30.4 25.1 45.0 49.3 48.9 8.8 29.3 55.0 6.7 25.3 12.6 23.6 23.8 51.3 8.2 12.7 8.8 22.0 62.8 23.0 116.6 25.2 15.6 7.2 30.5 75.0 48.3 32.4 83.0 53.9 58.7 12.2 46.0 15.2 37.0 3.0 6.6 56.9 14.6 75.2 37.6 21.2 9.6 38.6 6.0 9.4 39.5 20.8 52.3 33.3 30.7 16.0 21.7 56.9 25.6 23.5 13.5 23.9 NUMBL "CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23" ENSG00000105245 "NUMB like endocytic adaptor protein" Q9Y6R0 19 40665905-40690972 "Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Leydig cells: 42.6;Peritubular cells: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058251, HPA058380" Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 50: Fibroblasts - ECM organization" "HPA058251: AB_2683653, HPA058380: AB_2683698" "unprognostic (2.78e-2)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.78e-2)" "unprognostic (1.27e-1)" "unprognostic (7.29e-2)" "unprognostic (7.14e-3)" "unprognostic (7.50e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (7.55e-15)" "unprognostic (1.91e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (1.69e-3)" 31.3 16.2 25.0 8.1 27.7 3.0 22.2 19.1 31.2 49.3 0.1 35.2 8.4 45.2 6.2 17.6 46.6 11.4 25.9 31.3 18.5 12.4 15.4 25.6 3.9 6.3 11.9 38.8 10.1 2.4 72.4 5.7 10.6 35.2 3.8 5.2 14.7 13.9 11.4 17.9 18.2 12.5 3.9 12.6 22.2 25.3 17.4 2.3 28.4 6.1 2.6 36.2 38.0 13.9 17.0 46.4 9.7 25.7 22.8 22.4 5.4 20.2 17.5 11.7 14.1 17.5 12.4 6.2 19.7 29.4 8.8 16.4 7.1 8.8 6.2 16.8 11.8 6.8 47.0 2.4 24.2 3.4 7.7 21.5 5.9 19.2 8.1 18.2 16.7 5.4 20.0 7.1 8.2 15.5 10.8 3.3 11.3 9.9 10.7 9.1 26.5 12.7 3.4 4.7 19.3 34.1 22.2 12.9 19.7 6.1 13.1 5.7 31.9 21.2 24.1 33.7 25.6 9.3 11.9 3.9 34.1 10.8 12.3 0.0 0.1 0.0 1.1 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.4 0.2 0.0 0.8 0.2 0.0 0.2 25.0 27.7 19.1 31.2 31.3 18.5 6.3 11.9 10.6 3.9 17.4 13.9 6.9 0.0 3.4 13.4 2.7 13.6 14.6 2.4 4.6 14.2 4.9 6.1 4.0 4.3 3.4 0.0 0.0 2.8 4.1 1.8 0.0 2.5 24.7 10.4 24.7 6.0 7.2 1.7 12.9 1.8 5.4 24.2 6.6 7.9 0.0 5.5 5.7 2.2 1.6 11.8 7.4 3.5 0.0 1.9 6.8 10.1 42.6 2.3 3.6 3.7 0.5 3.0 0.0 9.0 4.9 1.7 3.3 51.6 1.4 18.7 2.5 0.6 9.2 4.6 0.0 20.6 10.4 1.4 3.3 5.6 21.0 2.2 2.3 6.9 3.3 8.8 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777133-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 40.1;Endothelial cells: 21.2;Fibroblasts: 29.0;Skeletal myocytes: 63.0;Smooth muscle cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 160.0;GAMG: 34.0;HeLa: 39.8;hTERT-RPE1: 38.0;WM-115: 64.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 240000 "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 15.4 2.9 2.6 2.7 3.1 0.3 11.1 2.2 4.6 25.0 3.3 29.9 3.3 25.3 2.8 8.2 6.4 4.8 16.4 2.2 2.4 4.3 0.7 10.5 2.4 2.8 2.1 12.0 4.8 4.6 2.8 7.0 2.8 7.4 6.2 2.2 7.0 12.2 10.8 16.0 6.9 16.0 2.1 32.8 5.5 1.1 2.6 3.1 19.1 10.0 3.7 17.6 14.6 2.1 0.8 14.6 1.2 0.4 16.8 160.0 0.1 1.8 8.2 3.5 3.5 0.2 2.2 0.0 3.4 0.1 34.0 25.5 0.4 0.8 4.0 0.0 0.1 0.0 39.8 0.1 0.9 0.0 0.1 11.3 2.7 10.2 1.4 38.0 0.0 0.0 0.0 0.2 1.8 0.4 0.0 0.3 3.4 0.0 0.9 0.0 9.5 0.0 0.0 1.2 0.0 0.1 2.9 0.2 4.3 28.6 3.9 0.5 0.1 5.2 4.6 5.5 0.7 1.9 0.0 0.1 15.2 0.8 64.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 2.6 3.1 2.2 4.6 2.2 2.4 2.8 2.1 2.8 2.1 2.6 2.1 40.1 0.0 1.3 0.7 0.4 12.0 5.9 17.5 6.2 0.6 2.9 8.3 13.8 1.5 5.5 0.0 2.1 0.3 0.5 0.0 0.0 0.1 0.7 0.2 1.5 21.2 0.0 0.0 0.4 0.6 0.3 29.0 0.5 0.2 0.0 0.9 3.6 0.1 0.1 0.0 0.6 0.0 4.1 1.5 7.9 1.4 2.8 0.9 10.6 8.4 0.1 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.1 4.0 0.0 0.1 11.5 4.0 13.1 63.0 36.4 0.4 0.7 4.5 8.4 0.0 0.6 4.2 0.0 3.5 OR2A1 ENSG00000221970 "Olfactory receptor family 2 subfamily A member 1" Q8NGT9 7 144312419-144322737 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058272 Uncertain NA NA "Cluster 72: Non-specific - Transcription" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA058272: AB_2683662" "unprognostic (3.98e-1)" "unprognostic (6.53e-2)" "unprognostic (1.13e-2)" "unprognostic (9.14e-2)" "unprognostic (2.22e-1)" 0.7 0.2 0.3 0.1 0.3 0.2 0.7 0.1 0.2 0.8 0.4 0.4 0.0 0.4 0.0 0.2 0.4 0.1 0.4 0.1 0.3 0.4 0.2 0.8 0.1 0.4 0.5 1.1 0.3 0.0 0.3 0.0 0.3 0.4 0.0 0.1 0.3 0.0 0.0 0.5 0.6 0.0 0.2 0.7 0.2 0.2 0.4 0.0 2.4 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.3 0.4 0.5 0.3 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGR1 "C16orf53, GAS, MGC4606, PA1" ENSG00000280789 "PAXIP1 associated glutamate rich protein 1" Q9BTK6 16 29816152-29822489 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 166.5" "Cell type enhanced" "Detected in many" "Astrocytes: 66.6;Plasma cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041440, HPA043608" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "HPA041440: AB_10795541, HPA043608: AB_10797144" "unprognostic (2.35e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" "unprognostic (1.44e-2)" "unprognostic (4.20e-1)" "unprognostic (1.14e-3)" "unprognostic (7.09e-3)" "unprognostic (5.12e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (1.84e-3)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (8.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (5.39e-2)" 23.5 27.8 10.2 5.5 10.8 6.5 23.2 18.4 12.3 120.8 8.9 48.9 8.7 55.3 7.1 25.7 68.4 6.1 32.0 10.1 9.9 30.4 28.1 23.0 8.7 10.9 10.7 166.5 26.3 7.4 128.9 3.7 10.8 69.3 5.7 6.8 21.4 8.8 24.6 18.0 30.8 4.7 10.5 23.6 26.4 31.2 10.6 9.3 30.2 9.0 6.8 50.7 73.8 12.5 16.7 24.1 13.9 8.7 7.0 6.7 11.8 12.7 11.5 14.5 12.7 17.1 16.9 33.4 12.7 9.1 7.2 15.4 15.2 19.1 9.2 14.8 31.1 14.8 16.4 16.1 7.3 23.6 26.9 7.5 15.1 10.2 10.0 13.4 12.1 31.0 20.1 10.4 9.9 45.2 18.6 27.6 19.3 14.2 20.4 35.4 24.5 24.9 10.8 7.8 34.9 13.2 9.6 22.4 9.7 10.5 20.9 15.0 9.2 12.0 10.9 15.2 12.9 19.4 21.3 13.1 15.8 24.2 15.0 22.5 16.9 33.0 19.7 17.0 22.1 19.7 16.8 20.0 21.3 19.5 21.7 20.1 11.0 13.9 19.6 21.5 12.7 15.2 10.2 10.8 18.4 12.3 10.1 9.9 10.9 10.7 10.8 10.5 10.6 12.5 1.3 0.0 9.8 66.6 15.2 0.0 0.3 0.1 18.2 3.5 4.7 2.9 0.6 14.3 6.9 1.8 0.0 5.6 5.3 5.9 0.0 27.9 0.5 1.0 1.3 3.8 14.6 10.7 16.2 21.7 8.2 4.4 13.3 0.8 7.6 0.3 6.1 2.0 7.5 5.0 16.5 11.1 0.0 5.6 0.0 0.6 0.9 7.7 0.0 9.4 22.5 1.9 4.1 11.6 8.6 13.5 15.8 3.4 34.5 0.7 20.7 2.1 3.0 3.3 0.0 0.9 5.0 3.1 1.6 16.7 0.4 6.7 10.9 0.2 13.2 0.2 PAPOLG FLJ12972 ENSG00000115421 "Poly(A) polymerase gamma" Q9BWT3 2 60756253-60802086 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017795, HPA035349, HPA035350" Approved Enhanced Nucleoplasm No No "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (3.39e-2)" "unprognostic (5.56e-2)" "unprognostic (3.54e-1)" "unprognostic (6.72e-4)" "unprognostic (2.49e-1)" "unprognostic (6.97e-3)" "unprognostic (6.83e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.62e-2)" 3.7 3.0 2.2 2.2 2.3 1.4 3.4 3.2 3.1 4.2 1.7 3.2 1.3 4.1 1.2 3.5 3.2 1.4 3.1 2.3 2.3 2.5 2.3 3.2 3.0 2.5 2.1 4.9 3.5 1.7 3.1 2.0 2.5 2.6 1.5 4.0 3.8 1.2 4.2 3.7 3.6 1.5 1.9 4.1 3.4 3.5 2.6 3.7 6.2 1.7 2.5 3.2 4.1 3.0 1.8 1.5 3.4 2.0 3.1 3.7 2.4 1.5 1.9 1.4 1.2 2.4 1.3 2.6 1.7 1.3 1.4 2.8 3.7 1.8 2.3 4.0 2.1 4.0 1.7 1.7 1.9 4.4 2.4 2.2 2.5 1.7 3.7 2.9 2.6 2.6 3.2 1.9 1.4 1.4 5.0 3.6 5.3 2.9 1.1 3.4 4.9 2.7 1.9 1.4 1.6 2.4 2.2 2.7 1.9 3.2 1.3 2.7 2.4 1.8 1.8 1.3 1.7 2.4 1.5 5.4 2.2 4.8 1.4 3.7 0.8 1.5 1.3 1.0 1.7 1.1 1.2 1.2 0.7 1.4 1.7 1.5 2.2 1.4 1.2 0.8 2.2 0.8 2.2 2.3 3.2 3.1 2.3 2.3 2.5 2.1 2.5 1.9 2.6 3.0 11.5 12.8 12.2 13.1 13.9 12.5 13.5 4.6 12.0 6.8 8.4 8.6 7.9 7.2 8.8 9.2 25.0 6.0 21.0 6.9 3.9 4.8 4.7 6.1 13.2 10.9 2.4 13.3 29.5 4.3 4.6 11.0 6.6 6.6 13.3 14.6 11.7 5.0 7.4 5.0 24.8 5.7 10.2 10.4 22.7 4.3 7.5 17.8 12.4 25.3 12.0 5.1 8.2 19.1 22.1 4.9 6.0 8.6 12.7 15.4 4.3 3.5 7.1 10.3 26.3 9.3 11.3 30.3 17.3 13.2 15.9 8.8 20.8 10.6 4.0 16.2 PBX2 "G17, HOX12, PBX2MHC" ENSG00000204304 "PBX homeobox 2" P40425 6 32184733-32190202 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061478 Supported Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA061478: AB_2684535" "unprognostic (9.73e-3)" "unprognostic (2.16e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (4.98e-1)" "unprognostic (2.68e-2)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.81e-2)" "prognostic favorable (6.84e-4)" "unprognostic (3.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.06e-1)" "unprognostic (2.52e-2)" "unprognostic (2.27e-1)" 30.3 39.6 4.9 14.2 4.5 9.0 27.6 3.9 5.5 47.4 5.0 51.2 10.6 47.8 30.4 33.5 47.1 4.9 32.1 4.5 4.7 37.9 31.0 43.9 16.7 5.1 4.6 52.3 28.2 4.5 52.0 25.2 4.8 39.3 12.2 8.5 27.6 12.3 29.8 34.1 39.8 13.0 4.3 64.5 36.7 23.9 5.0 23.9 55.2 2.3 17.8 42.4 39.2 4.6 4.8 7.9 32.3 17.7 23.5 29.4 13.9 3.7 8.9 9.7 10.0 6.5 7.8 21.9 23.5 13.7 3.8 13.4 8.1 26.8 10.6 19.5 30.3 20.5 7.1 3.8 20.7 13.2 18.7 43.2 14.9 7.4 24.8 16.6 19.1 38.8 26.5 11.1 3.7 18.1 13.6 29.7 0.6 2.9 2.2 18.8 5.0 26.1 21.2 7.7 9.4 12.6 3.0 6.8 26.5 18.3 16.9 25.0 6.5 8.5 19.8 3.4 4.2 54.1 36.9 27.2 17.3 9.9 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 4.5 3.9 5.5 4.5 4.7 5.1 4.6 4.8 4.3 5.0 4.6 27.7 6.4 11.0 14.4 18.5 18.2 18.5 11.8 15.4 19.2 17.0 12.2 3.7 31.5 10.1 16.5 8.4 32.2 29.4 9.6 3.9 17.1 1.0 12.3 24.5 24.8 30.5 19.1 7.8 14.0 25.6 16.0 12.2 16.6 15.2 21.8 28.9 23.0 19.0 26.9 7.0 15.5 10.2 34.5 55.5 4.2 20.2 25.3 8.8 9.4 23.9 21.0 35.0 6.0 9.1 13.9 12.5 19.5 17.7 19.4 12.5 10.2 9.6 4.9 6.6 19.7 19.8 1.6 6.1 19.7 19.5 47.2 16.7 22.8 13.2 18.1 PCGF2 "MEL-18, RNF110, ZNF144" ENSG00000277258 "Polycomb group ring finger 2" P35227 17 38733898-38749817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047732, HPA063531" Uncertain Supported Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA047732: AB_2680138, HPA063531: AB_2685031" "unprognostic (1.56e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.45e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-3)" "unprognostic (2.47e-2)" "unprognostic (7.78e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (5.10e-3)" "unprognostic (8.18e-2)" "unprognostic (6.12e-2)" "unprognostic (7.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" 33.6 38.3 3.3 4.6 3.2 0.0 33.0 7.7 5.5 44.7 4.3 24.4 3.7 40.6 2.4 21.4 35.9 6.1 37.3 3.2 5.2 56.5 12.9 33.4 2.1 2.6 3.0 40.5 22.9 2.9 55.6 6.8 2.9 37.5 1.6 7.2 22.6 2.7 9.3 21.6 22.7 2.1 1.2 28.3 25.3 13.3 4.1 0.2 41.7 0.9 0.8 27.3 30.8 3.1 16.9 38.2 9.2 34.5 7.2 2.3 11.7 13.1 6.2 6.2 7.4 21.1 17.6 1.3 14.3 4.2 16.3 26.2 3.4 6.1 2.5 10.4 20.1 7.9 20.7 52.4 2.3 1.2 9.4 2.5 2.8 9.0 6.1 9.6 7.5 7.9 14.9 21.2 3.9 37.8 1.5 0.2 11.7 7.4 15.3 12.6 14.7 3.3 3.2 22.5 16.4 26.8 12.6 9.0 20.8 9.0 35.4 1.6 22.0 24.8 27.1 24.8 23.2 12.5 4.1 4.3 13.3 2.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.2 7.7 5.5 3.2 5.2 2.6 3.0 2.9 1.2 4.1 3.1 49.6 3.2 16.0 2.0 1.1 14.1 11.2 19.7 23.9 59.9 20.6 17.0 2.1 15.7 10.1 20.2 10.4 13.3 0.8 23.7 52.8 24.9 15.1 8.0 22.1 46.4 13.2 0.0 6.5 13.7 26.7 21.9 12.8 12.8 1.3 14.0 51.0 2.9 4.8 35.3 7.0 12.5 22.4 2.9 5.5 5.0 37.0 2.9 14.2 6.5 3.2 26.4 2.1 9.5 2.4 18.9 10.3 29.3 3.8 15.4 22.3 59.6 5.0 16.5 0.0 16.8 16.7 6.1 15.7 9.6 16.9 22.2 0.9 13.3 13.2 11.1 PCGF3 "DONG1, FLJ36550, MGC40413, RNF3, RNF3A" ENSG00000185619 "Polycomb group ring finger 3" Q3KNV8 4 705748-770640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061879 Approved Supported Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA061879: AB_2684631" "unprognostic (1.24e-1)" "unprognostic (2.77e-1)" "unprognostic (2.62e-1)" "unprognostic (1.06e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.73e-4)" "unprognostic (2.76e-2)" "unprognostic (4.21e-2)" "unprognostic (9.52e-2)" "unprognostic (1.47e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.36e-2)" "unprognostic (6.84e-3)" "unprognostic (2.53e-1)" "unprognostic (2.20e-1)" "unprognostic (1.96e-1)" "prognostic favorable (5.25e-4)" 32.7 45.1 17.9 15.5 18.5 30.1 34.7 30.6 19.5 41.9 16.7 31.7 22.6 35.3 8.7 35.5 33.6 14.0 27.2 18.9 17.0 31.7 29.7 34.7 18.3 18.1 17.2 50.4 27.8 7.8 31.4 19.8 17.5 38.3 10.3 13.3 37.4 9.7 18.4 53.3 36.2 10.7 16.2 51.0 32.1 23.3 17.9 18.6 34.6 11.4 11.8 27.2 39.4 24.1 22.1 19.6 35.3 40.4 15.8 16.2 43.3 29.2 15.9 23.5 23.7 21.5 23.8 15.7 19.1 28.3 23.8 14.9 16.5 23.7 17.8 20.8 17.9 22.6 24.2 38.4 19.3 15.5 28.9 20.5 31.0 20.5 9.3 15.4 30.5 28.2 31.5 12.6 23.3 24.6 41.8 54.6 23.4 14.9 35.0 41.0 22.4 10.1 14.1 35.6 50.2 37.9 15.2 16.1 16.1 22.7 31.5 21.8 36.9 22.8 18.4 19.2 38.1 30.1 27.6 24.6 18.0 24.5 43.0 3.4 7.1 3.1 3.3 5.1 2.8 4.2 2.0 2.1 3.2 5.0 2.5 1.7 4.5 4.7 2.2 4.6 3.3 2.3 17.9 18.5 30.6 19.5 18.9 17.0 18.1 17.2 17.5 16.2 17.9 24.1 29.5 12.8 28.8 19.6 12.5 25.4 17.3 17.2 25.0 12.3 28.3 21.3 21.7 17.2 21.8 9.2 12.5 13.4 13.5 21.4 3.9 20.6 52.0 17.7 28.7 27.8 19.2 9.1 18.1 19.8 30.0 17.8 35.2 21.2 16.5 22.4 25.4 15.3 12.2 6.7 18.6 21.7 20.3 15.1 21.0 54.4 16.4 20.1 23.2 23.4 14.3 9.1 16.5 27.2 22.8 32.7 19.3 15.4 22.9 24.0 19.1 9.4 14.0 8.5 6.6 18.8 18.8 19.0 25.6 22.5 28.7 23.7 13.3 20.8 20.2 38.2 PHF1 "MTF2L2, PCL1, TDRD19C" ENSG00000112511 "PHD finger protein 1" O43189 6 33410399-33416453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Early spermatids: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 25.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031038 Approved Approved Nucleoplasm NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA031038: AB_10671365" "unprognostic (1.96e-3)" "unprognostic (4.77e-2)" "prognostic unfavorable (9.64e-5)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (2.43e-3)" "unprognostic (2.31e-2)" "unprognostic (8.87e-3)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (2.42e-3)" "unprognostic (4.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "prognostic favorable (1.72e-4)" 35.0 31.9 0.3 4.6 0.2 11.2 37.6 0.2 1.1 65.8 0.4 49.6 5.9 51.8 18.1 19.4 57.8 4.2 41.6 0.3 0.2 38.2 22.8 41.1 6.3 0.6 0.2 89.6 41.5 2.1 76.6 1.8 0.3 49.9 2.3 6.1 32.8 4.2 42.2 25.5 38.6 2.6 0.3 47.3 39.7 70.2 0.3 5.5 58.4 13.1 10.3 49.1 40.6 0.6 1.4 2.0 4.5 2.8 1.9 1.1 10.3 3.1 4.8 2.5 2.6 2.8 1.3 0.5 2.0 7.4 25.9 0.4 0.9 1.6 0.6 1.8 0.9 4.3 3.6 1.2 0.3 2.5 20.0 2.2 2.0 4.6 4.0 3.3 1.5 1.4 1.7 3.6 1.9 1.1 0.8 1.5 1.9 0.4 1.4 1.8 0.6 1.5 0.3 1.9 2.9 3.3 1.6 1.6 2.6 1.0 1.2 3.0 3.0 4.5 1.2 2.7 3.4 2.9 4.5 8.3 3.3 2.6 2.7 0.2 0.2 1.0 0.7 0.2 2.1 0.6 1.6 1.9 0.3 0.9 1.6 0.9 1.5 0.7 0.2 0.1 0.6 0.7 0.3 0.2 0.2 1.1 0.3 0.2 0.6 0.2 0.3 0.3 0.3 0.6 32.9 19.2 24.8 19.2 70.5 33.9 89.0 26.8 34.1 74.4 36.0 37.1 19.6 15.7 20.5 23.9 37.5 16.9 53.3 16.7 35.2 13.1 153.8 14.9 15.3 29.9 12.0 3.8 19.1 17.9 16.3 32.6 15.3 20.3 69.2 21.4 33.2 7.6 11.8 45.4 30.3 16.0 34.6 14.1 43.1 88.6 43.2 20.9 37.4 13.1 11.4 34.7 27.8 26.2 18.0 17.9 14.5 41.0 54.8 59.0 29.6 22.9 22.1 73.6 78.9 28.9 42.3 80.9 51.2 15.9 24.0 37.5 71.4 19.1 10.1 75.1 PHRF1 "KIAA1542, PPP1R125, RNF221" ENSG00000070047 "PHD and ring finger domains 1" Q9P1Y6 11 576470-612222 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 24.2;MOLT-4: 39.0;U-138 MG: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019867, HPA062933" Uncertain NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "HPA019867: AB_1852416, HPA062933: AB_2684907" "unprognostic (5.67e-2)" "unprognostic (1.00e-2)" "unprognostic (3.94e-2)" "unprognostic (9.65e-2)" "unprognostic (1.79e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.28e-2)" "unprognostic (2.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (3.50e-2)" "unprognostic (2.33e-1)" "unprognostic (3.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" 14.3 17.5 1.2 1.0 2.6 3.1 13.9 1.4 3.6 14.4 0.9 14.2 0.0 13.2 1.3 18.7 13.5 1.1 14.0 1.1 1.1 12.5 26.5 14.5 0.0 1.5 1.1 14.6 14.4 0.0 13.9 0.0 1.5 14.5 0.0 0.2 13.8 1.2 18.7 22.2 16.3 1.0 0.5 17.6 14.3 17.9 1.7 0.1 13.5 0.0 2.1 12.6 14.4 1.7 2.6 1.6 0.4 7.9 0.0 0.4 1.5 6.2 0.5 0.6 0.0 0.0 0.2 14.8 14.7 0.3 0.3 3.1 0.2 0.0 0.0 4.6 10.5 0.9 0.0 24.2 0.0 1.7 1.6 3.6 0.0 0.0 3.9 0.0 0.3 13.1 3.5 0.0 0.0 0.8 39.0 0.5 1.9 0.2 7.2 1.4 1.5 0.0 0.0 0.3 11.4 1.8 4.3 12.9 0.1 8.9 0.4 5.1 1.2 21.2 7.4 0.5 1.5 2.7 3.7 1.5 0.5 1.2 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.1 0.4 0.5 0.3 0.4 0.4 0.2 0.5 0.3 0.1 0.4 0.3 0.2 1.2 2.6 1.4 3.6 1.1 1.1 1.5 1.1 1.5 0.5 1.7 1.7 11.5 6.4 11.1 10.1 14.9 17.6 10.1 7.4 18.2 12.2 11.6 7.9 7.8 11.5 8.2 14.7 8.4 8.0 17.1 24.1 0.0 11.6 2.1 14.0 12.9 11.9 11.4 16.0 5.9 10.6 8.0 11.3 23.4 17.7 5.1 14.7 4.6 17.5 9.5 20.2 6.6 14.2 2.0 10.6 11.7 2.8 11.8 13.1 3.6 10.3 11.3 8.2 23.7 4.5 8.4 18.0 12.2 10.5 17.5 12.4 21.8 7.0 12.5 16.0 13.1 14.1 12.2 26.4 28.0 17.4 17.8 8.9 17.2 13.0 14.9 13.6 PIEZO1 "FAM38A, KIAA0233" ENSG00000103335 "Piezo type mechanosensitive ion channel component 1" Q92508 16 88715338-88785220 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Pancreatic endocrine cells: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 270.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA047185 Uncertain NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA047185: AB_2679973" "unprognostic (1.76e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.77e-1)" "unprognostic (1.12e-2)" "unprognostic (4.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (4.39e-2)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.51e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (2.04e-1)" "unprognostic (3.59e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-1)" 79.0 26.4 15.2 20.5 16.0 29.8 65.1 16.5 19.0 30.7 10.4 86.7 7.7 40.4 0.5 48.4 38.1 9.0 29.4 12.9 13.8 57.2 48.2 67.2 14.8 25.0 17.6 15.8 21.9 5.2 6.8 18.6 22.5 49.4 4.8 1.7 33.3 11.2 6.8 48.8 41.1 14.3 17.6 55.2 38.0 5.2 17.4 7.2 32.4 4.3 5.9 65.3 40.4 21.2 42.0 42.1 6.5 31.3 27.6 30.0 155.2 99.9 43.9 36.1 14.0 61.3 68.5 34.2 68.2 48.4 18.0 88.4 13.9 36.0 7.3 33.8 56.0 58.3 77.9 49.4 41.6 26.4 9.3 24.6 19.4 28.3 23.3 21.3 43.9 56.1 80.4 42.8 21.2 270.1 32.7 91.2 14.7 19.7 25.7 77.7 9.3 86.9 16.4 61.1 12.8 3.4 130.5 68.0 17.8 6.5 93.0 76.5 120.1 86.0 49.6 58.4 51.6 8.7 21.1 21.2 67.9 46.5 52.2 1.8 5.0 3.3 8.1 9.7 7.8 2.3 6.0 5.5 9.7 3.1 1.0 2.5 0.1 1.0 13.1 1.7 5.0 3.9 15.2 16.0 16.5 19.0 12.9 13.8 25.0 17.6 22.5 17.6 17.4 21.2 69.1 73.7 19.8 27.1 14.3 19.1 12.9 27.6 5.2 2.2 23.5 16.3 5.0 10.0 17.1 58.8 16.7 6.7 16.8 19.3 0.0 37.3 1.6 6.2 15.4 45.0 21.0 12.6 0.4 21.7 30.5 13.7 25.0 9.9 8.8 0.7 55.3 22.0 23.6 3.3 0.5 29.5 10.2 16.8 19.0 1.0 5.6 21.8 16.0 21.5 15.6 1.5 3.1 16.6 5.0 85.9 18.0 2.6 30.8 48.3 8.1 5.5 9.7 4.1 0.0 30.3 9.0 0.3 2.0 18.9 15.9 5.1 21.6 5.6 12.0 21.8 PIM3 ENSG00000198355 "Pim-3 proto-oncogene, serine/threonine kinase" Q86V86 22 49960768-49964072 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 408.4;Syncytiotrophoblasts: 389.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 20.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 163.3;SK-BR-3: 144.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068758 Supported Cytosol NA Yes "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" Cytosol "HPA068758: AB_2686026" "unprognostic (3.67e-2)" "unprognostic (7.69e-3)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-2)" "unprognostic (5.83e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.09e-4)" "unprognostic (5.59e-3)" "unprognostic (1.71e-1)" "unprognostic (3.92e-3)" "unprognostic (7.27e-3)" 97.8 48.4 25.9 31.3 31.3 114.3 80.2 32.8 38.1 49.2 26.9 55.1 23.8 40.8 12.7 80.8 54.0 25.8 68.7 25.2 32.6 113.3 92.9 107.1 28.2 40.6 36.1 35.7 73.1 21.6 51.3 21.3 38.0 87.3 10.4 3.1 93.5 22.6 112.0 116.4 51.6 9.9 30.3 80.7 118.1 33.9 35.2 19.0 54.9 35.0 13.0 71.0 68.6 39.9 26.8 17.7 11.6 21.9 9.0 6.7 65.5 16.5 26.7 19.4 14.0 29.5 22.3 47.3 20.1 4.6 39.1 22.5 22.3 12.6 6.9 35.8 92.1 19.5 46.3 36.0 41.8 42.5 36.0 12.8 41.0 11.9 20.2 10.5 63.5 31.7 27.0 163.3 5.9 60.6 21.7 76.4 24.2 28.1 27.8 100.3 19.2 57.6 10.6 20.3 41.1 28.6 32.2 144.7 109.2 10.7 19.0 56.4 16.8 12.1 51.5 19.8 27.1 82.2 56.9 41.4 30.1 24.1 33.2 0.0 4.0 0.1 2.2 4.1 2.5 4.3 5.0 4.4 3.1 7.5 4.8 1.9 20.7 1.7 5.2 7.0 5.8 2.7 25.9 31.3 32.8 38.1 25.2 32.6 40.6 36.1 38.0 30.3 35.2 39.9 120.2 64.1 85.9 6.5 107.7 227.3 236.8 79.1 96.8 31.5 99.2 67.3 32.8 121.5 72.8 80.9 2.1 56.9 79.5 57.9 84.1 50.9 5.1 114.2 76.3 167.7 97.7 10.8 10.2 54.5 346.5 69.0 202.3 170.5 69.3 16.8 98.6 45.9 69.7 62.2 6.7 101.7 81.4 41.1 408.4 4.8 32.3 134.8 108.5 6.5 35.8 14.0 11.3 6.6 20.5 71.0 94.6 11.3 95.1 298.4 58.1 88.5 40.9 16.5 26.3 39.4 57.3 26.1 37.7 95.3 204.7 389.9 90.4 11.6 79.0 266.0 PLA2G4B "cPLA2-beta, HsT16992" ENSG00000243708 "Phospholipase A2 group IVB" P0C869 15 41837775-41848147 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.1;Club cells: 1.3;Rod photoreceptor cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 7.8" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (6.16e-2)" "unprognostic (6.48e-3)" "unprognostic (5.06e-3)" "unprognostic (1.27e-4)" "unprognostic (1.06e-1)" "unprognostic (2.56e-3)" "unprognostic (1.53e-1)" "unprognostic (2.27e-2)" "unprognostic (3.60e-2)" "unprognostic (1.90e-2)" "unprognostic (1.23e-2)" "unprognostic (5.14e-3)" "unprognostic (3.26e-5)" "unprognostic (4.36e-1)" "unprognostic (5.91e-2)" "unprognostic (1.22e-1)" "unprognostic (2.97e-2)" 8.8 7.6 6.9 0.5 6.9 3.7 10.7 6.9 10.1 26.0 6.9 9.1 1.6 8.3 1.9 36.6 13.9 1.7 11.4 6.9 6.9 16.9 16.7 11.4 3.4 6.9 6.9 20.0 19.3 0.3 16.3 0.5 6.9 24.8 0.8 0.4 16.7 2.4 5.3 48.8 12.5 0.6 6.9 16.9 12.5 9.6 7.0 1.3 22.9 0.1 5.7 12.3 30.2 7.0 1.1 0.8 0.0 0.0 0.2 0.1 2.9 0.3 0.8 1.0 0.2 0.4 0.5 0.2 0.1 0.6 0.1 3.6 1.0 0.9 0.2 0.1 1.7 0.9 1.3 2.5 1.5 0.2 1.4 0.6 3.6 0.3 1.0 0.2 0.4 1.6 1.2 0.1 0.2 1.6 1.1 3.1 0.8 4.0 0.9 0.0 0.9 0.5 0.8 7.8 0.4 0.7 0.0 1.4 0.8 0.6 4.2 1.4 0.0 0.0 0.8 1.0 0.1 2.5 0.1 0.7 0.2 3.8 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.1 0.2 0.1 1.5 0.2 0.2 0.0 1.1 0.0 0.1 0.4 0.0 6.9 6.9 6.9 10.1 6.9 6.9 6.9 6.9 6.9 6.9 7.0 7.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394842 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.0;Ductal cells: 5.8;Exocrine glandular cells: 3.6;monocytes: 2.0;Pancreatic endocrine cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "HPA048387: AB_2680381, HPA068609: AB_2686011" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 39.5 21.1 7.4 11.0 7.5 3.3 35.0 7.0 8.5 46.2 7.2 27.1 3.1 44.5 5.9 37.4 29.4 6.5 32.0 6.8 7.4 23.5 14.4 32.8 10.5 8.5 7.3 30.5 16.7 5.6 16.4 7.0 7.6 24.7 3.4 1.2 22.9 8.0 21.2 35.2 21.9 12.3 7.4 40.7 21.9 6.1 8.1 6.4 22.8 11.1 10.5 34.8 38.1 7.7 26.7 6.6 5.7 17.2 19.4 32.8 6.8 24.1 22.1 21.3 19.3 9.8 6.6 7.3 19.4 35.1 9.0 37.6 7.0 41.4 10.9 19.0 4.0 6.7 9.2 6.0 23.6 2.5 8.2 22.6 25.4 20.7 30.1 32.0 32.3 14.5 4.1 5.6 27.1 14.3 7.7 2.0 5.1 7.1 18.3 15.1 4.3 8.3 20.1 17.7 4.7 15.6 13.9 8.8 5.9 5.0 16.0 1.3 53.2 13.9 14.5 15.7 10.3 6.2 7.4 3.0 22.4 8.4 15.9 7.0 24.5 2.8 39.5 34.1 40.8 32.2 72.8 40.7 24.1 32.5 59.2 36.1 2.6 18.0 30.2 2.8 83.5 33.3 7.4 7.5 7.0 8.5 6.8 7.4 8.5 7.3 7.6 7.4 8.1 7.7 1.0 3.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 5.8 0.0 0.1 1.0 1.0 0.0 0.0 0.0 3.6 0.3 1.0 0.0 0.1 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 POFUT2 "C21orf80, FUT13, KIAA0958" ENSG00000186866 "Protein O-fucosyltransferase 2" Q9Y2G5 21 45263928-45287898 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 95.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044297 Uncertain "Intracellular and membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "HPA044297: AB_10965176" "unprognostic (1.32e-2)" "unprognostic (1.65e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (1.49e-2)" "unprognostic (4.09e-3)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.62e-1)" "unprognostic (2.15e-1)" "unprognostic (4.16e-2)" "unprognostic (4.20e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.66e-12)" "unprognostic (1.56e-2)" "unprognostic (2.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.25e-2)" 15.7 20.7 9.4 8.5 9.6 14.0 14.1 9.5 10.9 20.2 21.2 17.3 9.7 16.1 8.9 8.6 20.4 10.3 16.6 9.6 13.8 19.6 20.5 16.1 7.7 11.9 12.1 27.7 19.0 8.2 31.4 16.8 11.8 19.1 6.3 8.6 14.5 10.3 7.8 8.6 15.0 12.0 9.6 16.9 15.3 17.6 13.7 5.3 22.2 5.1 6.5 15.9 13.9 9.6 10.4 11.2 22.1 24.5 39.3 36.1 10.3 57.1 45.4 25.9 38.7 24.0 17.2 7.2 41.9 95.1 58.5 10.4 13.1 22.9 27.9 12.1 15.2 14.4 17.4 18.8 45.4 10.7 18.4 25.6 14.7 32.4 17.7 84.5 25.6 9.5 13.5 11.6 27.4 10.7 5.3 17.7 27.6 17.3 15.7 10.8 6.6 9.1 14.4 9.4 9.6 14.0 33.6 20.3 21.1 24.6 14.8 15.4 28.5 19.5 19.0 30.2 25.8 27.7 15.4 5.5 39.9 13.2 30.8 0.3 0.3 0.8 0.3 0.3 0.5 0.2 0.3 0.2 0.1 0.2 0.4 0.4 0.5 0.3 0.3 0.4 0.3 0.3 9.4 9.6 9.5 10.9 9.6 13.8 11.9 12.1 11.8 9.6 13.7 9.6 12.4 6.4 9.6 19.6 10.7 6.6 7.0 6.8 6.2 6.9 11.8 9.5 8.7 11.5 7.0 12.9 10.4 9.0 14.7 7.4 3.9 7.6 34.9 29.4 17.5 8.7 10.1 7.4 6.8 6.2 13.5 19.8 13.3 15.9 7.0 20.4 10.0 8.6 6.9 5.0 9.9 14.7 4.1 4.8 8.8 51.2 14.6 8.1 8.8 7.5 8.0 10.2 3.1 11.1 7.6 8.0 7.5 13.9 12.4 7.3 6.6 3.9 30.6 14.5 0.0 14.5 17.5 20.1 5.2 4.5 4.0 13.5 12.3 12.2 7.8 7.9 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Mitochondria "HPA056821: AB_2683247, HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 13.3 11.1 6.8 4.0 5.0 2.6 12.0 4.8 6.3 12.0 4.5 13.3 5.5 12.9 0.4 14.6 11.2 0.9 13.8 6.1 3.5 10.1 12.9 13.8 3.0 9.0 5.8 10.8 10.7 2.9 8.4 2.5 6.5 10.5 0.9 1.4 12.3 2.2 25.0 16.0 14.5 1.3 5.4 16.2 11.9 5.4 5.7 7.3 10.5 10.9 2.4 12.2 12.7 6.3 8.0 17.0 6.7 10.0 7.7 1.6 16.4 16.4 2.7 7.9 5.9 28.0 10.9 14.4 33.6 5.9 16.9 11.8 14.3 4.8 0.9 35.8 31.3 19.4 19.5 11.1 10.8 21.3 33.6 2.4 8.7 7.0 3.0 8.3 12.2 26.8 19.5 5.4 6.1 22.8 16.3 16.5 8.7 13.7 8.2 18.2 13.7 17.4 3.2 19.2 24.5 6.9 26.8 9.6 16.8 6.0 7.7 10.8 17.3 12.8 15.6 28.5 14.2 17.0 9.4 18.6 9.5 14.3 11.6 3.3 4.3 6.1 5.5 4.0 4.3 2.0 4.6 6.8 6.0 3.0 3.7 4.4 1.8 5.0 3.5 4.1 3.3 5.3 6.8 5.0 4.8 6.3 6.1 3.5 9.0 5.8 6.5 5.4 5.7 6.3 15.7 12.8 11.9 11.4 17.2 12.2 11.0 10.7 9.1 7.6 12.0 10.3 19.0 11.5 9.5 11.0 2.1 15.0 33.8 17.2 9.8 10.4 1.3 8.4 9.4 12.4 5.4 9.0 12.9 10.9 15.8 11.9 21.4 11.3 8.2 14.8 14.6 17.8 12.7 3.3 9.9 24.9 4.1 18.5 14.7 1.5 14.3 17.2 19.6 8.4 21.8 6.1 30.9 9.5 11.9 11.4 15.9 10.5 16.8 17.7 10.5 7.5 7.8 6.4 6.6 13.3 12.9 9.2 11.1 11.8 11.9 21.8 21.7 14.8 17.6 15.5 POLM Tdt-N ENSG00000122678 "DNA polymerase mu" Q9NP87 7 44072062-44082530 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 63.0" "Lineage enriched" "Detected in all" 6 "granulocytes: 63.0" "Cell line enhanced" "Detected in all" "HBEC3-KT: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058900, HPA066007" Approved Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA058900: AB_2683848, HPA066007: AB_2685595" "unprognostic (2.44e-2)" "unprognostic (8.18e-2)" "unprognostic (2.21e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (1.83e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (3.91e-1)" "unprognostic (9.36e-2)" "unprognostic (8.26e-2)" "unprognostic (2.46e-3)" "unprognostic (6.31e-2)" "unprognostic (1.47e-1)" "unprognostic (2.87e-1)" "unprognostic (3.87e-3)" 8.0 5.9 4.0 4.4 4.0 4.5 7.8 4.4 4.1 8.8 4.0 6.6 5.6 6.1 3.7 8.4 6.4 4.4 7.5 3.5 3.7 10.2 9.7 5.9 7.6 4.4 5.2 8.9 8.5 4.4 6.0 2.8 4.5 8.4 3.4 4.3 7.5 6.7 7.9 8.9 9.0 3.5 3.9 13.1 9.1 3.8 5.1 9.8 10.5 4.9 7.2 7.6 7.8 4.0 1.8 2.5 2.6 5.8 3.6 4.2 7.5 6.1 6.2 4.5 2.5 3.2 4.2 18.1 5.6 4.7 5.5 5.3 2.7 67.0 2.6 6.3 6.0 2.3 2.8 1.1 4.8 5.8 7.7 6.1 6.0 3.7 4.4 8.6 8.1 18.5 2.7 9.2 3.8 4.1 10.5 4.7 5.4 5.5 14.2 9.6 1.6 7.3 4.7 2.9 2.7 4.8 2.9 11.3 5.6 4.0 6.7 10.2 5.7 3.1 4.4 3.2 8.6 14.1 7.5 13.9 5.6 5.2 6.9 23.9 3.5 10.7 6.3 4.3 6.5 7.9 5.5 5.6 3.3 11.1 7.9 6.3 63.0 7.4 3.3 9.5 5.8 2.9 4.0 4.0 4.4 4.1 3.5 3.7 4.4 5.2 4.5 3.9 5.1 4.0 8.3 3.2 7.8 13.1 33.4 4.5 11.2 8.3 11.4 24.5 10.3 6.2 5.6 15.7 11.4 12.9 29.2 12.3 19.9 11.1 1.9 7.6 0.6 5.0 7.1 8.7 5.4 3.0 4.0 9.4 9.4 7.1 27.5 6.0 24.1 11.1 12.5 9.2 10.2 18.5 4.3 8.5 10.2 11.1 5.0 0.7 14.0 9.9 10.6 6.5 14.4 11.9 23.7 3.5 5.7 8.3 22.5 10.1 15.6 16.6 19.4 5.6 7.4 48.3 0.0 6.9 9.0 17.5 14.3 6.5 5.1 9.7 18.8 13.5 12.1 15.0 POLR1H "A12.2, HTEX-6, hZR14, RPA12, tctex-6, ZNRD1" ENSG00000066379 "RNA polymerase I subunit H" Q9P1U0 6 30058899-30064909 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 14.6;B-cells: 17.6;Cardiomyocytes: 15.2;Cytotrophoblasts: 28.2;dendritic cells: 20.5;Extravillous trophoblasts: 43.0;Hofbauer cells: 35.3;Syncytiotrophoblasts: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055074, HPA077979" Supported Supported "Nucleoli fibrillar center" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli fibrillar center" "HPA055074: AB_2682690, HPA077979: AB_2732366" "unprognostic (4.94e-2)" "unprognostic (2.93e-2)" "unprognostic (2.54e-1)" "unprognostic (3.81e-1)" "unprognostic (3.88e-2)" "unprognostic (8.55e-2)" "unprognostic (5.36e-2)" "unprognostic (2.82e-3)" "unprognostic (1.96e-1)" "unprognostic (9.52e-3)" "unprognostic (5.18e-1)" "unprognostic (3.28e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (2.57e-1)" "unprognostic (1.51e-1)" "unprognostic (9.97e-2)" "prognostic favorable (2.75e-5)" 26.0 26.2 5.0 4.3 5.0 2.6 22.4 4.7 9.6 24.4 5.1 22.4 16.8 22.7 4.7 29.3 21.7 1.1 23.7 5.2 6.2 32.3 24.4 19.7 2.9 5.5 5.6 25.4 30.0 2.4 18.0 5.8 5.4 21.1 14.2 4.3 16.8 2.7 25.4 23.0 24.7 4.0 5.4 33.2 26.3 30.5 5.3 13.1 17.5 7.7 3.3 23.0 22.1 5.2 17.9 5.4 20.5 40.9 5.7 5.9 6.9 7.2 19.4 19.9 18.7 23.0 9.3 16.2 7.3 8.1 10.4 10.8 37.4 27.7 25.4 2.0 43.1 24.6 13.7 31.0 36.4 33.8 8.1 22.5 13.1 20.4 49.0 6.4 32.3 25.1 60.8 8.3 15.5 29.9 22.9 67.5 0.0 29.9 28.1 18.1 26.5 30.2 11.5 23.7 12.5 20.0 10.0 19.5 10.4 9.8 19.1 30.4 7.3 19.5 8.0 0.0 23.1 9.7 10.7 20.4 3.4 33.1 25.4 22.1 5.3 4.4 6.5 3.9 6.7 4.9 6.0 6.1 6.3 4.3 6.6 5.1 4.0 5.1 3.9 4.9 7.8 4.0 5.0 5.0 4.7 9.6 5.2 6.2 5.5 5.6 5.4 5.4 5.3 5.2 14.6 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 28.2 20.5 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 43.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 17.6 4.4 0.0 0.0 0.0 POLR2J3 ENSG00000168255 "RNA polymerase II subunit J3" 7 102537918-102572653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 87.4;Extravillous trophoblasts: 65.6;Hofbauer cells: 42.5;Syncytiotrophoblasts: 110.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.5" "HPA011403, HPA046970" Uncertain Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 33: Fibroblasts - ECM organization" Nucleoplasm "HPA011403: AB_2668503, HPA046970: AB_2679882" "unprognostic (3.55e-2)" "unprognostic (2.04e-4)" "unprognostic (4.55e-3)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (9.26e-2)" "unprognostic (2.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.12e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (1.00e-1)" "unprognostic (5.90e-4)" "unprognostic (3.04e-1)" "unprognostic (7.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" 2.4 2.3 1.0 1.7 1.1 2.1 1.7 1.5 3.1 3.9 0.9 2.2 2.9 3.2 0.4 1.9 3.6 0.6 1.4 1.0 1.3 2.0 2.5 1.9 1.2 1.2 1.1 3.2 1.6 1.5 2.0 1.5 1.2 2.3 1.8 0.7 3.3 0.5 1.0 3.8 3.0 1.6 1.1 3.2 2.2 0.9 1.3 1.4 3.1 2.7 2.9 2.3 1.8 1.2 10.3 4.8 1.9 0.1 0.2 0.8 0.9 6.0 1.7 3.8 4.3 3.8 2.8 1.4 0.4 0.0 5.5 4.8 3.1 2.4 4.1 25.5 5.5 2.9 3.8 1.2 1.1 3.7 2.5 0.4 2.1 1.9 1.9 7.4 6.0 2.4 3.2 2.0 0.6 8.0 8.9 0.5 0.0 3.6 6.0 0.4 3.3 2.4 0.9 1.3 2.0 0.4 10.9 1.0 5.5 2.3 0.0 1.7 4.9 3.4 9.1 0.0 1.5 0.3 0.8 4.6 5.9 2.9 3.9 9.6 4.1 6.5 2.2 1.7 1.3 3.5 2.2 3.2 4.6 3.9 2.7 2.7 9.4 3.9 3.1 3.1 3.3 3.0 1.0 1.1 1.5 3.1 1.0 1.3 1.2 1.1 1.2 1.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 65.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.0 0.0 0.0 0.0 0.0 POU6F1 "BRN5, MPOU, TCFB1" ENSG00000184271 "POU class 6 homeobox 1" 12 51186936-51217708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Excitatory neurons: 22.2;Inhibitory neurons: 29.4;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 23.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 6.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047021, HPA050411" Enhanced Supported "Nuclear bodies,Actin filaments" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" "Actin filaments" "HPA047021: AB_2679905, HPA050411: AB_2681119" "unprognostic (4.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.48e-3)" "unprognostic (1.45e-2)" "unprognostic (2.72e-1)" "unprognostic (6.58e-2)" "unprognostic (9.70e-2)" "unprognostic (7.11e-3)" "unprognostic (4.45e-1)" "unprognostic (2.05e-1)" "prognostic favorable (6.61e-4)" "unprognostic (2.48e-2)" "unprognostic (9.36e-2)" "unprognostic (2.09e-3)" "unprognostic (1.74e-1)" "unprognostic (2.02e-1)" "unprognostic (2.33e-1)" 2.0 1.5 0.3 1.2 1.3 0.4 1.7 3.6 6.0 3.1 0.0 2.4 0.6 2.5 0.1 0.7 2.2 1.2 1.1 1.4 0.0 1.2 0.5 1.8 0.8 0.0 0.0 3.2 1.3 0.8 2.6 0.6 0.0 2.1 0.2 1.3 2.1 1.4 4.0 1.4 1.5 1.5 0.0 1.5 1.3 0.3 0.3 0.2 2.3 1.3 0.5 1.7 1.7 0.0 0.3 0.8 1.0 1.4 0.3 1.2 0.5 0.5 0.6 0.6 0.7 0.1 0.5 1.8 0.2 0.4 0.3 0.0 1.2 0.0 0.0 2.8 1.8 0.5 1.1 0.0 1.0 0.4 2.4 0.6 0.5 1.0 0.1 1.4 2.0 0.7 0.7 4.9 0.3 0.0 0.2 0.7 1.8 0.0 0.0 0.5 0.6 0.0 0.3 0.0 1.3 2.2 1.2 0.0 2.3 0.5 0.5 1.7 1.5 1.1 0.9 0.3 1.3 3.2 2.8 0.2 1.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 3.6 6.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 6.4 2.8 20.9 2.1 3.1 1.3 0.4 0.0 10.0 2.3 1.3 3.1 1.5 1.7 7.3 4.2 0.6 1.1 0.1 1.9 0.8 5.3 0.9 1.7 4.8 0.0 2.7 22.2 2.0 0.2 3.2 0.5 1.6 5.1 2.4 3.6 1.2 0.3 1.7 29.4 0.3 4.1 2.2 3.9 3.7 5.9 1.1 1.8 8.4 1.7 3.7 0.0 21.1 23.6 1.6 0.2 6.8 0.7 1.8 0.0 0.7 2.7 7.9 0.0 3.8 4.1 0.1 0.7 0.5 2.8 0.4 1.8 0.2 0.6 0.7 PPAN "BXDC3, SSF, SSF1, SSF2" ENSG00000130810 "Peter pan homolog" Q9NQ55 19 10106362-10112012 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 243.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043265 Approved NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA043265: AB_10793943" "unprognostic (1.91e-2)" "unprognostic (1.27e-1)" "unprognostic (7.97e-2)" "unprognostic (1.30e-1)" "unprognostic (4.93e-2)" "unprognostic (4.23e-2)" "unprognostic (9.47e-3)" "unprognostic (2.13e-1)" "unprognostic (3.80e-1)" "unprognostic (5.51e-2)" "unprognostic (3.10e-2)" "unprognostic (1.94e-2)" "unprognostic (2.01e-3)" "unprognostic (8.75e-3)" "unprognostic (7.52e-2)" "unprognostic (4.27e-2)" "unprognostic (2.92e-3)" 23.3 20.5 4.9 15.8 5.3 12.3 20.2 6.6 7.7 18.3 2.5 18.8 12.3 19.3 4.0 27.8 18.9 6.9 17.6 5.1 4.0 18.9 24.5 14.8 18.1 4.1 4.2 19.6 23.2 8.4 13.8 7.5 4.3 19.5 5.8 4.8 16.6 6.8 32.8 28.2 20.0 6.9 1.9 26.5 18.4 18.9 5.5 10.0 16.0 11.1 12.0 20.4 20.5 8.8 51.0 42.0 16.0 35.9 10.8 11.4 34.2 26.7 12.8 33.7 26.3 56.0 19.5 59.0 48.0 17.2 24.4 42.6 42.0 47.7 14.5 31.8 104.6 104.1 47.6 55.2 27.5 66.4 62.5 17.9 36.0 37.0 46.0 22.0 17.2 45.6 76.1 54.9 17.7 72.2 82.5 243.5 75.1 26.8 103.2 60.2 20.5 80.4 19.0 44.8 33.7 41.7 23.9 42.9 40.8 10.6 23.8 37.2 21.1 45.8 24.3 50.6 70.9 111.0 59.3 61.2 31.8 60.2 41.4 2.4 7.1 4.0 6.7 5.0 8.6 17.0 9.2 10.7 6.6 20.6 12.9 5.9 4.7 5.6 3.7 5.0 9.7 3.2 4.9 5.3 6.6 7.7 5.1 4.0 4.1 4.2 4.3 1.9 5.5 8.8 12.2 3.2 6.4 0.0 20.2 57.4 50.3 15.4 4.0 11.3 12.8 14.1 3.9 10.0 12.1 5.5 6.2 26.4 24.0 20.0 3.9 33.2 9.0 4.6 10.5 13.0 6.7 10.3 0.0 30.6 32.0 14.1 6.1 5.1 7.0 13.8 10.4 11.4 32.4 18.5 0.0 17.7 16.2 7.6 17.0 9.1 18.6 10.5 12.4 0.0 15.7 5.0 18.6 0.0 0.0 31.7 12.6 10.5 9.9 33.2 10.3 18.9 5.8 9.9 0.0 18.8 16.7 22.7 42.1 6.8 52.8 17.8 18.9 19.9 24.9 27.9 PPIE "CyP-33, MGC111222, MGC3736" ENSG00000084072 "Peptidylprolyl isomerase E" Q9UNP9 1 39692182-39763914 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, RNA-binding, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA019357, HPA020131" Approved Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear speckles" "HPA019357: AB_2670131, HPA020131: AB_1847405" "unprognostic (2.94e-1)" "unprognostic (4.32e-2)" "unprognostic (6.34e-2)" "unprognostic (6.97e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.52e-2)" "unprognostic (2.69e-1)" "unprognostic (3.88e-3)" "unprognostic (1.25e-1)" "unprognostic (9.29e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (5.86e-2)" "unprognostic (3.95e-1)" "unprognostic (9.06e-2)" "unprognostic (1.00e-1)" 26.0 27.9 22.3 16.1 22.9 18.5 26.8 22.7 26.5 31.4 20.2 41.1 18.3 33.8 24.9 31.8 35.0 18.1 33.3 22.3 22.8 33.0 33.7 23.3 27.2 22.6 22.0 36.7 40.2 23.8 27.7 20.7 22.9 32.3 22.5 20.9 26.2 23.6 43.1 29.5 29.2 25.4 23.7 32.7 31.7 41.8 22.3 20.6 29.1 30.3 28.2 36.4 29.5 24.6 24.5 34.4 37.2 25.7 40.9 36.9 14.3 40.8 42.7 58.7 56.4 32.8 64.8 68.4 52.2 47.9 34.5 32.8 57.1 52.3 68.8 41.1 38.4 75.6 37.4 9.7 50.9 68.4 36.3 32.8 47.2 53.9 21.0 42.0 54.5 52.8 74.8 39.5 46.6 24.7 34.2 42.1 39.9 49.7 31.5 41.4 28.4 38.4 37.8 37.2 47.7 42.3 43.8 31.5 28.4 49.7 40.9 155.8 35.8 36.3 35.3 48.4 57.1 55.8 66.4 52.5 27.0 86.4 52.3 38.3 62.8 32.6 83.9 64.8 82.8 107.5 89.4 83.8 74.1 109.2 103.5 82.4 6.0 123.2 70.0 63.8 101.3 122.5 22.3 22.9 22.7 26.5 22.3 22.8 22.6 22.0 22.9 23.7 22.3 24.6 28.2 32.1 36.7 10.7 37.0 24.9 43.1 69.8 23.9 25.9 30.3 47.5 31.8 21.5 62.1 33.1 14.6 62.5 39.3 22.8 66.5 57.5 29.2 34.6 27.7 28.7 28.8 38.3 7.7 48.4 59.3 34.0 16.3 23.4 55.2 44.1 37.9 31.1 56.1 23.5 8.8 32.9 40.7 33.4 26.9 76.3 29.8 30.0 39.2 8.4 46.8 34.0 58.7 8.0 13.6 40.0 24.1 45.1 31.7 32.0 39.3 69.8 63.4 29.7 59.2 23.3 40.1 76.1 51.4 24.5 26.3 34.8 36.6 36.3 35.9 32.9 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600413-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 7.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favorable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 20.9 27.5 0.2 12.0 0.1 1.0 15.8 0.2 1.3 23.3 0.1 21.8 8.9 21.2 1.1 23.1 22.0 10.7 14.6 0.5 0.4 22.8 33.6 17.4 5.0 1.2 1.3 22.8 28.0 4.8 26.3 5.0 0.6 22.8 6.4 5.2 20.1 7.9 23.0 21.1 21.0 7.0 0.3 25.1 25.2 21.7 0.3 10.1 22.9 1.2 5.6 22.5 21.8 0.2 9.1 20.0 30.9 16.8 17.0 2.2 8.9 15.9 7.0 5.6 23.3 5.0 9.7 11.5 9.6 16.0 10.5 23.6 24.3 35.7 9.7 13.1 0.0 19.8 14.1 0.2 7.6 16.3 27.3 14.2 4.0 28.0 30.9 13.2 9.7 3.9 18.4 3.7 14.4 5.4 5.5 2.4 9.1 1.9 2.3 25.4 39.3 19.8 1.4 8.0 19.3 9.1 29.5 28.3 8.8 13.0 13.8 21.8 2.6 12.7 9.0 18.5 10.7 26.9 5.1 11.3 15.8 19.9 15.8 7.9 1.2 2.0 0.9 2.1 1.6 2.9 0.4 1.7 3.3 0.7 0.5 1.1 1.0 1.0 0.8 1.2 1.9 0.4 0.2 0.1 0.2 1.3 0.5 0.4 1.2 1.3 0.6 0.3 0.3 0.2 243.9 32.1 40.3 20.5 152.7 69.8 64.9 41.1 167.9 72.7 165.1 163.8 59.1 28.6 34.2 27.6 131.3 44.0 178.9 120.5 35.2 27.2 32.0 138.2 103.8 102.6 71.3 30.5 26.1 23.0 21.8 103.2 107.0 151.4 44.9 143.0 38.2 33.6 33.1 35.3 27.0 102.2 54.9 35.5 70.6 11.3 46.3 123.4 37.4 30.0 46.4 59.0 72.1 21.1 29.7 29.8 58.3 30.1 140.1 51.9 88.1 40.3 46.9 102.2 32.9 211.5 114.9 45.9 23.4 125.7 77.9 88.5 144.1 99.9 77.0 34.5 PPP1R11 "CFAP255, HCG-V, HCGV, TCTE5, Tctex5" ENSG00000204619 "Protein phosphatase 1 regulatory inhibitor subunit 11" O60927 6 30066709-30070333 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Late spermatids: 696.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 8 "cerebral cortex: 8.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 51.5;AN3-CA: 65.6;fHDF/TERT166: 48.6;GAMG: 47.4;HBEC3-KT: 53.6;JURKAT: 76.7;RPTEC TERT1: 47.4;U-266/84: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043266, HPA060174" Approved Approved Vesicles NA NA 43000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Vesicles "HPA043266: AB_2678400, HPA060174: AB_2684216" "unprognostic (2.00e-2)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (4.24e-2)" "unprognostic (3.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.77e-2)" "unprognostic (1.18e-1)" "unprognostic (2.81e-1)" "unprognostic (1.74e-3)" "unprognostic (3.33e-2)" "unprognostic (2.68e-1)" "unprognostic (8.36e-3)" "unprognostic (1.74e-1)" "unprognostic (3.31e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-3)" 44.5 41.1 0.7 0.0 0.7 1.9 41.4 0.6 8.8 44.4 0.6 55.5 11.6 49.6 33.1 52.1 37.3 11.8 51.0 0.7 0.7 62.3 47.5 43.7 5.4 0.9 0.7 41.8 45.1 2.2 29.2 5.8 0.8 46.3 0.7 7.9 42.8 0.0 50.4 42.9 50.7 0.0 0.6 39.8 59.5 41.5 0.7 9.7 42.3 0.0 11.8 51.6 42.7 1.1 51.5 0.0 0.0 65.6 29.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 48.6 47.4 0.0 0.0 53.6 0.0 1.0 34.5 42.6 0.0 0.0 0.0 3.0 3.9 0.0 0.0 0.0 0.7 0.0 0.0 76.7 0.5 2.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 47.4 29.0 0.0 0.0 0.7 35.5 4.8 26.8 0.0 0.0 0.0 0.0 0.3 4.1 1.5 30.7 64.9 26.7 0.7 0.0 0.0 11.5 4.1 12.4 4.7 9.3 4.5 6.8 5.3 6.5 2.2 7.2 4.9 7.0 2.8 3.9 7.9 3.2 8.4 6.8 0.7 0.7 0.6 8.8 0.7 0.7 0.9 0.7 0.8 0.6 0.7 1.1 38.2 19.2 20.2 2.6 57.8 52.8 80.0 77.2 29.0 29.3 47.7 32.8 18.8 52.9 49.7 40.5 6.2 56.0 39.2 111.5 95.9 142.2 242.1 19.8 24.2 44.3 53.7 32.4 10.1 136.3 119.9 27.0 53.5 31.8 78.6 21.4 45.7 28.0 65.7 13.5 9.0 83.8 77.3 49.7 53.8 696.0 32.3 43.5 62.2 3.7 75.4 58.4 92.7 6.0 7.6 136.5 114.1 40.3 42.2 66.6 139.6 93.3 38.7 33.1 39.5 27.2 89.4 61.9 23.2 39.0 66.5 75.2 52.4 16.5 51.8 94.9 PPP1R37 LRRC68 ENSG00000104866 "Protein phosphatase 1 regulatory subunit 37" O75864 19 45091396-45148077 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "RT4: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041500 Approved Approved Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA041500: AB_10795122" "unprognostic (8.45e-2)" "unprognostic (5.23e-2)" "unprognostic (8.34e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (1.79e-1)" "unprognostic (1.04e-3)" "unprognostic (2.16e-1)" "unprognostic (1.08e-1)" "unprognostic (2.89e-3)" "unprognostic (7.72e-3)" "unprognostic (5.44e-2)" "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (4.71e-2)" "prognostic favorable (2.04e-4)" 10.4 26.9 11.3 5.8 12.8 4.8 13.0 7.9 16.7 17.9 1.2 14.3 12.1 15.7 3.2 19.8 13.1 5.3 14.8 12.3 4.7 18.2 14.0 11.7 5.2 6.6 4.9 13.5 16.4 7.2 39.3 5.3 6.6 20.0 3.6 8.0 18.4 8.8 20.9 21.3 14.6 4.1 1.8 14.0 28.3 16.5 6.7 5.7 20.4 5.4 3.1 21.7 16.9 10.8 26.2 25.4 9.2 13.4 11.6 7.8 18.4 18.8 10.6 12.8 14.6 11.5 14.2 7.1 13.4 10.0 11.8 20.1 6.3 14.4 3.6 9.3 15.7 6.1 13.6 14.3 14.4 6.4 10.1 10.0 11.1 12.1 7.7 13.7 10.4 9.6 10.8 5.5 7.1 34.2 13.5 8.9 8.7 18.7 15.1 16.3 10.9 5.3 8.4 69.5 28.2 13.0 16.0 33.2 29.3 4.7 21.3 9.4 16.4 15.2 18.2 9.1 17.0 9.3 6.3 5.3 19.7 6.4 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.8 7.9 16.7 12.3 4.7 6.6 4.9 6.6 1.8 6.7 10.8 9.4 6.4 3.4 8.5 8.1 7.6 11.1 6.8 13.1 48.6 16.9 11.7 6.2 15.7 5.6 3.7 39.6 21.1 9.7 21.9 7.9 17.9 8.8 9.8 12.1 10.3 30.6 4.8 18.9 9.8 19.0 9.8 30.5 10.9 0.0 12.1 11.0 7.4 17.9 77.4 15.2 27.7 10.2 6.4 6.3 7.0 12.2 6.2 12.4 5.6 4.4 22.7 9.2 11.6 14.3 12.0 23.4 12.4 13.1 10.6 25.6 18.2 5.9 44.1 19.7 10.3 10.1 21.6 23.9 14.3 9.5 18.3 10.4 16.0 22.3 11.4 PPT2 ENSG00000221988 "Palmitoyl-protein thioesterase 2" Q9UMR5 6 32153441-32163678 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 33.6;Smooth muscle cells: 27.8;Syncytiotrophoblasts: 23.3" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 21.3;HEK 293: 27.9;SK-MEL-30: 29.4" HPA000414 Supported Vesicles "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" Vesicles "HPA000414: " "unprognostic (1.90e-2)" "unprognostic (1.09e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.03e-5)" "unprognostic (1.62e-1)" "unprognostic (6.75e-3)" "unprognostic (2.92e-3)" "unprognostic (6.41e-3)" "unprognostic (7.12e-2)" "unprognostic (2.56e-3)" "unprognostic (5.28e-3)" "unprognostic (1.12e-2)" "unprognostic (2.75e-3)" "unprognostic (5.09e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.24e-3)" 19.0 18.0 1.1 2.1 1.1 0.1 18.7 1.1 4.8 26.5 1.0 23.7 1.6 22.0 2.6 28.2 21.7 0.0 24.5 1.1 1.1 22.1 13.9 14.3 1.7 1.1 1.2 46.2 14.3 0.0 13.7 3.9 1.1 17.2 1.5 6.2 14.9 0.0 19.0 29.4 14.9 1.3 1.1 13.3 21.0 8.3 1.1 1.9 14.6 0.2 1.0 18.1 24.2 1.3 0.0 0.0 0.0 0.4 21.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.2 1.6 0.7 5.3 2.6 5.0 0.0 0.0 27.9 4.0 0.0 0.0 0.0 3.5 1.8 4.0 1.6 0.0 7.3 3.8 0.0 14.9 0.0 1.8 1.7 13.0 4.6 0.0 0.0 0.9 0.0 6.3 5.8 0.0 14.3 0.0 1.6 5.4 8.7 5.2 29.4 15.2 0.0 3.7 0.8 0.0 11.4 0.0 0.0 0.8 12.6 3.0 5.8 2.2 3.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.1 1.1 1.1 1.1 4.8 1.1 1.1 1.1 1.2 1.1 1.1 1.1 1.3 9.4 0.0 0.5 0.0 0.7 3.3 2.9 2.6 5.7 12.4 4.2 2.9 6.8 2.8 2.8 3.7 16.7 14.5 4.4 2.4 1.9 1.8 0.3 4.5 4.3 7.6 4.9 17.4 0.0 3.0 9.2 6.3 1.5 5.0 0.0 33.6 6.4 4.4 3.0 3.3 0.0 2.6 2.0 1.3 1.3 1.1 4.1 1.1 7.2 0.0 0.2 9.5 3.1 0.0 0.0 1.8 3.8 3.0 1.7 1.4 1.4 3.1 0.6 6.1 0.0 3.6 27.8 4.0 6.7 4.4 2.3 23.3 1.4 5.0 3.0 1.5 PRICKLE4 "C6orf49, DKFZp761H221, OEBT" ENSG00000278224 "Prickle planar cell polarity protein 4" Q2TBC4 6 41780782-41787452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7" "HPA031240, HPA055593" Approved Approved "Mitotic spindle,Centriolar satellite" Yes NA "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 59: Non-specific - Transcription" "Centriolar satellite" "Mitotic spindle" "HPA031240: AB_10600929, HPA055593: " "unprognostic (1.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.56e-2)" "unprognostic (6.86e-2)" "unprognostic (1.58e-1)" "unprognostic (2.15e-2)" "unprognostic (6.41e-2)" "unprognostic (1.93e-2)" "unprognostic (3.47e-4)" "unprognostic (4.25e-2)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (1.56e-5)" "unprognostic (3.64e-3)" "unprognostic (5.74e-2)" "unprognostic (1.50e-1)" "unprognostic (2.17e-3)" 1.8 1.2 1.3 0.3 1.2 0.1 1.9 1.3 1.2 2.2 0.0 1.6 1.1 2.4 0.0 3.8 2.3 1.0 1.9 0.7 1.0 1.3 2.0 2.1 0.1 1.1 0.7 1.3 1.2 0.4 1.0 0.6 1.0 2.3 0.5 0.6 1.7 0.4 1.6 0.8 1.2 1.5 0.3 4.5 2.6 0.8 1.0 0.0 2.5 1.5 0.3 2.6 2.9 1.3 0.2 0.6 1.3 1.2 0.0 0.0 4.0 0.1 0.1 0.0 0.0 0.7 0.9 0.4 1.5 0.0 0.1 2.1 0.0 0.1 0.0 0.3 0.3 0.2 4.6 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.7 0.0 0.5 1.2 0.2 0.0 0.6 0.0 0.7 0.2 1.8 0.2 1.3 0.3 0.0 0.2 1.4 0.1 0.4 0.0 2.4 0.2 1.2 0.6 0.7 0.6 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 1.3 1.2 0.7 1.0 1.1 0.7 1.0 0.3 1.0 1.3 0.0 0.0 0.0 1.6 15.0 1.5 1.4 2.4 30.7 2.3 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.7 2.6 0.0 0.0 0.3 0.0 0.0 2.8 3.5 17.7 0.2 0.0 0.0 4.8 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 1.5 0.6 1.2 8.4 0.0 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.5 2.6 36.8 1.7 2.2 0.0 0.7 4.1 0.0 1.9 3.7 1.9 1.4 49.4 2.0 0.0 10.9 0.0 3.0 1.4 PRPF31 "hPrp31, NY-BR-99, PRP31, RP11, SNRNP61" ENSG00000105618 "Pre-mRNA processing factor 31" Q8WWY3 19 54115410-54131719 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041939, HPA061873" Supported Supported Nucleoplasm NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA041939: AB_10793938, HPA061873: AB_2684630" "unprognostic (1.32e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-2)" "unprognostic (7.98e-2)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (9.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (5.26e-3)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (2.16e-1)" "unprognostic (5.94e-2)" "unprognostic (2.53e-1)" "unprognostic (7.04e-2)" 35.1 36.0 26.1 24.3 27.5 33.2 35.1 26.6 31.3 39.6 26.9 42.3 23.1 39.7 12.5 37.8 35.3 18.9 38.8 26.7 26.1 34.2 44.5 29.7 33.2 27.0 26.3 39.0 29.3 28.6 33.7 23.1 26.7 37.6 13.9 8.1 33.9 23.6 48.2 40.2 34.6 19.0 25.5 39.7 35.7 33.0 27.2 26.3 36.5 23.7 23.4 38.3 35.6 28.5 83.7 169.4 55.0 89.8 34.6 33.0 59.4 68.3 53.1 74.6 72.5 82.4 63.8 89.1 54.2 49.9 36.0 49.8 64.6 78.6 46.4 82.4 298.4 66.6 108.3 97.0 51.7 120.9 59.7 54.2 36.0 62.3 43.1 39.4 79.4 74.4 96.8 46.2 49.9 82.8 103.3 64.1 53.4 78.5 187.1 89.2 71.7 81.5 51.8 120.8 61.6 72.8 88.0 83.2 44.7 24.5 52.3 62.5 81.2 100.4 84.7 43.6 109.0 58.6 97.7 98.5 75.7 81.9 71.0 25.0 44.3 30.1 47.9 53.1 51.8 43.5 47.2 51.4 52.9 44.5 39.7 40.5 9.1 54.4 48.6 45.6 61.0 51.1 26.1 27.5 26.6 31.3 26.7 26.1 27.0 26.3 26.7 25.5 27.2 28.5 38.7 35.3 26.7 17.0 35.0 42.7 38.9 96.1 46.7 31.4 31.3 37.6 35.9 32.9 54.2 25.8 14.6 95.0 40.2 29.3 60.7 74.6 5.9 34.9 34.9 47.3 34.8 32.4 13.4 62.9 90.8 42.0 33.6 31.0 31.7 53.5 27.8 27.3 66.4 30.3 12.4 38.9 57.0 22.2 43.2 7.4 38.2 33.7 40.9 9.4 61.2 51.1 48.4 13.6 14.9 63.2 30.1 48.9 34.0 37.6 46.9 62.0 43.6 32.2 39.5 36.1 53.4 125.2 77.9 33.9 42.1 76.2 41.5 54.3 46.3 32.8 PRPF39 "FLJ11128, FLJ20666" ENSG00000185246 "Pre-mRNA processing factor 39" Q86UA1 14 45084107-45116282 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001176, HPA078403" Approved Approved Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA001176: AB_2171026, HPA078403: " "unprognostic (1.79e-1)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (1.91e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.84e-5)" "unprognostic (9.51e-3)" "prognostic unfavorable (6.51e-4)" "prognostic favorable (8.48e-4)" "unprognostic (4.34e-3)" "prognostic unfavorable (4.04e-4)" "unprognostic (5.02e-3)" "unprognostic (1.83e-1)" "unprognostic (9.04e-2)" "unprognostic (8.93e-2)" "prognostic favorable (2.99e-4)" 4.8 4.0 1.4 0.7 1.6 2.7 4.8 1.3 2.0 5.5 0.2 5.1 1.5 5.2 1.7 3.9 6.3 1.3 3.7 1.1 1.0 5.6 3.4 3.2 1.5 1.3 0.7 5.5 4.4 1.7 4.1 1.7 1.5 3.5 1.0 2.0 4.4 1.5 7.6 4.8 4.3 1.5 0.2 3.8 5.1 3.0 1.0 1.8 3.6 1.7 1.2 5.3 4.3 2.2 7.8 8.5 7.0 3.4 2.7 2.4 7.0 6.2 3.4 4.9 4.3 5.1 5.2 4.9 6.2 4.5 3.6 5.1 9.0 4.1 7.3 8.9 6.2 6.8 11.5 4.8 3.2 6.5 1.9 1.5 2.5 2.7 3.2 2.6 3.5 6.2 9.8 5.2 5.4 7.0 7.2 3.1 6.5 5.2 8.9 9.5 6.0 6.3 2.8 10.4 6.8 1.8 2.9 3.9 4.9 3.5 3.7 5.2 7.8 4.3 4.0 3.1 8.3 5.1 12.9 11.2 1.8 6.6 2.4 5.2 2.7 4.7 4.5 4.9 6.4 5.6 4.0 4.7 4.9 5.0 5.2 6.1 2.1 4.3 5.2 2.0 5.4 3.2 1.4 1.6 1.3 2.0 1.1 1.0 1.3 0.7 1.5 0.2 1.0 2.2 14.3 25.6 22.5 21.2 18.2 27.3 15.6 6.5 18.8 19.5 10.6 7.4 14.9 7.2 13.5 7.3 14.6 12.1 21.5 7.0 9.8 8.5 1.3 9.2 19.5 12.8 9.6 15.8 36.6 9.3 10.6 15.5 12.2 11.2 16.4 16.7 10.8 7.5 7.5 16.8 37.1 9.1 6.1 5.1 14.6 4.9 14.9 9.5 14.2 25.3 8.4 10.8 5.2 31.2 55.5 8.0 6.6 14.7 19.1 14.2 14.2 5.4 6.1 24.2 6.6 13.5 16.7 11.6 11.8 18.3 25.3 12.0 19.7 13.4 9.2 10.0 PRR12 KIAA1205 ENSG00000126464 "Proline rich 12" Q9ULL5 19 49591182-49626439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011959 Approved Approved Cytosol NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Cytosol "HPA011959: AB_10610286" "unprognostic (8.30e-2)" "unprognostic (8.64e-2)" "unprognostic (5.20e-3)" "unprognostic (5.04e-2)" "unprognostic (2.59e-1)" "unprognostic (1.05e-2)" "unprognostic (4.40e-3)" "unprognostic (5.00e-2)" "unprognostic (1.59e-1)" "unprognostic (1.25e-2)" "unprognostic (3.52e-3)" "unprognostic (8.59e-2)" "unprognostic (6.18e-2)" "unprognostic (2.00e-2)" "unprognostic (2.76e-1)" "unprognostic (9.32e-2)" "unprognostic (9.65e-3)" 11.6 12.6 8.8 7.2 6.5 5.4 11.8 7.6 11.3 15.1 0.0 14.2 6.2 16.7 2.0 12.3 14.3 3.1 11.0 7.6 4.0 10.1 6.9 10.2 7.8 4.4 3.0 16.3 11.3 4.7 22.9 4.6 1.7 13.0 2.2 4.5 13.0 7.4 14.8 21.3 12.7 3.5 0.9 14.8 12.8 7.5 2.8 7.5 15.7 3.4 4.2 14.0 13.1 2.6 15.4 23.4 12.6 14.0 5.6 5.0 10.0 9.5 4.6 5.2 4.1 9.0 8.9 15.5 7.9 6.8 4.9 14.0 5.8 8.3 1.7 13.2 17.3 16.0 12.4 9.0 4.0 15.1 23.0 6.4 8.2 5.9 3.9 6.3 5.8 9.2 11.1 8.9 4.6 11.6 17.1 18.2 17.9 7.8 21.5 22.2 9.8 5.8 4.7 19.0 10.0 18.6 13.8 12.8 6.7 5.0 9.0 11.0 13.9 18.0 17.2 6.8 15.7 11.4 14.4 10.4 11.2 8.6 11.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.8 6.5 7.6 11.3 7.6 4.0 4.4 3.0 1.7 0.9 2.8 2.6 8.8 6.4 2.6 9.8 8.1 4.0 1.3 8.2 8.6 7.7 8.1 6.5 2.9 7.2 3.6 12.9 4.2 5.5 8.7 5.8 1.9 4.1 1.1 5.1 8.8 5.5 10.2 2.5 9.3 7.5 3.3 5.6 8.6 7.1 10.2 9.6 6.8 2.9 6.4 5.0 11.9 6.6 4.1 7.5 2.8 2.1 14.0 5.8 3.6 8.4 3.3 3.6 5.2 10.6 8.8 13.4 5.7 14.7 6.0 1.9 6.6 2.5 6.5 3.6 13.1 7.3 5.5 2.7 6.8 6.9 7.7 1.1 7.5 6.9 6.9 1.5 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656413 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 20.5 20.2 17.1 13.9 16.8 23.6 20.3 19.0 21.7 26.6 12.8 30.8 13.8 29.8 7.1 22.4 26.1 6.6 16.4 16.0 15.3 22.1 21.3 24.1 14.1 18.5 16.6 25.1 24.9 13.0 21.2 8.3 16.1 26.2 7.8 9.4 19.1 13.7 15.1 26.2 25.6 10.9 15.0 32.5 26.0 12.6 18.3 18.7 23.4 9.6 10.6 24.5 22.7 17.9 18.2 20.3 17.1 18.2 15.2 11.7 11.9 17.6 11.8 18.1 17.2 9.3 17.3 30.5 15.3 12.9 8.4 17.7 14.4 20.4 9.8 41.5 36.0 17.9 19.6 21.4 23.6 16.1 43.3 9.8 23.1 13.0 13.7 18.9 23.1 8.2 22.8 24.3 10.0 42.2 36.7 28.4 6.2 12.4 10.3 29.4 8.4 44.2 13.7 7.3 14.5 32.4 7.1 26.8 18.2 5.3 29.9 13.1 18.1 16.3 17.7 17.0 18.4 44.1 29.4 21.3 11.0 33.0 14.7 11.4 6.0 23.7 9.6 6.5 7.4 7.0 8.0 9.7 5.7 10.5 7.3 7.2 22.5 8.6 10.9 7.6 10.3 5.5 17.1 16.8 19.0 21.7 16.0 15.3 18.5 16.6 16.1 15.0 18.3 17.9 18.1 9.6 10.4 13.7 23.2 22.8 26.1 28.8 33.6 13.9 19.1 18.7 6.6 25.8 13.2 12.9 14.6 15.8 31.9 24.1 15.6 22.3 6.7 8.8 13.0 20.9 12.6 15.4 7.5 22.2 15.3 15.3 27.5 15.1 12.0 15.4 18.9 10.1 18.2 1.7 7.7 18.3 20.3 16.0 34.1 2.5 19.3 20.2 8.8 8.4 30.2 13.1 33.0 5.5 8.7 20.4 14.6 21.1 17.3 23.6 23.6 15.1 10.0 14.2 19.7 12.8 19.9 17.2 27.2 28.5 23.0 14.1 26.5 11.7 19.8 17.3 PRR3 "CAT56, Em:AB014077.1, Em:AB023052.2" ENSG00000204576 "Proline rich 3" P79522 6 30557280-30563723 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 16.6;HAP1: 20.1;HEL: 15.1;JURKAT: 14.7;U-266/84: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064061 Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 57: B-cells - Immune response" Nucleoplasm Cytosol "HPA064061: AB_2685185" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (8.90e-2)" "unprognostic (2.10e-3)" "unprognostic (1.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.65e-3)" "unprognostic (1.25e-2)" "unprognostic (3.73e-2)" "prognostic favorable (6.49e-6)" "prognostic favorable (5.61e-5)" "unprognostic (4.71e-2)" "prognostic unfavorable (7.84e-7)" "unprognostic (2.80e-1)" "unprognostic (2.82e-1)" "unprognostic (3.66e-1)" "unprognostic (1.21e-3)" 3.9 5.3 0.7 0.1 0.7 0.0 3.5 0.7 3.0 6.5 0.6 3.4 0.0 6.9 1.1 2.5 5.9 0.0 3.6 0.7 0.7 3.5 3.1 3.3 0.3 0.7 0.9 10.6 3.2 0.1 5.8 0.0 0.8 4.3 0.2 0.6 2.6 0.2 1.5 3.1 3.6 0.0 0.6 5.0 3.1 4.8 0.7 0.8 3.9 0.0 0.6 4.5 4.1 0.7 0.1 3.9 7.7 16.6 5.2 1.3 0.0 0.0 0.0 0.0 0.0 6.6 0.1 7.0 8.6 2.1 4.4 0.6 20.1 1.5 0.0 4.1 3.7 15.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.6 0.0 0.0 0.0 14.7 7.8 0.0 3.6 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 1.7 0.3 0.1 10.6 4.8 0.5 0.0 0.0 0.0 4.3 0.5 6.4 0.1 0.0 0.0 9.2 13.1 8.8 0.0 5.8 3.6 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.5 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.1 0.7 0.7 0.7 3.0 0.7 0.7 0.7 0.9 0.8 0.6 0.7 0.7 10.6 9.6 19.1 11.4 18.2 5.7 6.4 8.6 12.5 11.3 11.0 22.9 3.6 11.5 10.7 3.7 14.6 14.2 11.2 14.0 7.9 5.8 0.6 8.7 14.2 8.0 7.8 7.6 18.8 9.5 8.7 10.9 24.5 8.4 12.0 16.3 9.3 5.9 7.9 6.7 16.4 10.2 14.2 6.0 7.9 2.6 10.2 8.8 10.6 9.4 12.7 6.4 12.3 17.1 12.2 5.7 5.7 10.1 14.5 5.7 9.9 9.4 11.3 19.2 6.6 11.9 9.8 10.3 6.6 9.1 5.7 9.9 12.0 15.9 8.3 3.9 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase non-receptor type 23" Q9H3S7 3 47381011-47413435 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 18.5 19.1 6.2 12.6 9.2 14.7 17.4 5.8 10.5 23.3 5.1 16.3 14.3 20.9 7.5 19.0 19.2 8.4 13.2 7.1 7.2 17.5 14.0 18.7 9.1 8.8 7.2 23.5 20.2 23.5 30.9 11.6 8.5 18.7 6.5 8.5 20.0 11.4 30.0 26.4 18.4 8.8 5.5 20.0 16.1 15.6 7.7 8.0 27.1 8.9 7.3 18.5 20.4 14.4 21.5 29.9 16.4 21.4 21.0 16.0 15.8 19.2 18.9 17.5 14.8 25.0 20.7 15.1 17.2 21.9 31.2 19.0 14.3 20.8 8.5 14.3 15.1 21.0 22.2 24.0 23.0 12.3 27.5 21.4 20.9 22.9 23.2 12.4 21.7 12.5 15.9 20.3 19.0 30.2 11.5 10.4 17.5 14.9 20.1 7.2 7.9 18.5 13.2 40.9 8.6 20.6 17.1 35.6 13.6 9.8 20.3 12.0 22.4 26.7 22.2 37.7 27.5 28.8 20.4 8.7 29.0 11.6 19.5 0.8 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.3 0.3 6.2 9.2 5.8 10.5 7.1 7.2 8.8 7.2 8.5 5.5 7.7 14.4 11.1 9.6 7.0 17.0 8.2 8.0 5.2 6.9 13.6 11.7 9.5 8.0 8.7 8.6 9.5 5.5 14.6 10.6 11.0 15.7 1.9 10.5 2.1 10.3 13.7 12.4 7.3 2.5 9.8 8.9 7.9 9.1 26.5 21.1 2.5 14.9 11.4 12.7 13.9 16.8 12.0 16.3 20.3 10.4 5.5 3.1 19.3 9.5 12.4 7.5 8.7 8.8 6.2 9.5 14.3 13.5 10.4 13.5 15.4 9.3 14.6 9.4 12.6 14.2 6.6 10.2 8.8 13.6 13.3 13.2 10.9 9.3 8.9 9.4 12.8 8.2 PUF60 "FIR, RoBPI, SIAHBP1" ENSG00000179950 "Poly(U) binding splicing factor 60" Q9UHX1 8 143816344-143829352 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 332.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045733, HPA052096, HPA059714" Enhanced Enhanced Nucleoplasm NA NA 70000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110" "unprognostic (3.49e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (4.05e-2)" "unprognostic (1.81e-2)" "unprognostic (3.47e-2)" "unprognostic (1.51e-2)" "unprognostic (4.34e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-2)" "unprognostic (1.75e-1)" "unprognostic (5.45e-2)" "unprognostic (2.36e-2)" "unprognostic (2.64e-2)" "unprognostic (7.00e-2)" "unprognostic (2.28e-2)" "unprognostic (3.42e-2)" 71.6 73.5 7.9 11.0 7.6 39.6 75.5 8.1 22.9 71.4 5.3 84.8 22.3 84.9 5.9 84.9 76.3 7.3 88.5 7.8 15.4 82.8 124.3 64.0 17.7 12.2 11.6 57.2 62.9 11.7 71.0 19.2 14.1 67.2 5.8 1.3 63.3 17.8 125.5 108.7 69.5 10.5 7.3 72.3 73.2 70.8 14.5 15.9 59.8 9.0 9.7 74.5 68.6 12.4 95.7 211.5 36.7 31.3 16.6 15.6 62.7 74.4 27.4 70.3 75.1 95.4 103.9 89.4 71.2 58.9 52.8 83.0 86.5 91.4 3.6 91.4 147.7 110.2 117.0 106.3 60.4 38.5 70.0 45.4 61.8 89.8 26.9 21.1 69.0 92.1 88.7 37.4 20.5 332.5 156.1 26.4 77.8 63.3 191.6 84.2 42.9 91.8 19.5 91.8 71.5 80.3 101.6 40.4 77.7 9.1 116.7 21.4 79.0 72.9 176.2 85.7 98.6 66.7 103.9 109.7 70.7 73.3 71.9 90.8 112.6 99.8 129.0 133.7 139.3 116.8 103.1 128.6 127.1 135.9 98.6 113.1 58.8 132.6 137.6 76.8 139.0 193.9 7.9 7.6 8.1 22.9 7.8 15.4 12.2 11.6 14.1 7.3 14.5 12.4 70.2 38.5 46.4 21.5 64.7 107.7 102.1 197.4 65.4 62.8 51.3 67.9 63.7 51.5 103.0 29.5 29.2 146.6 56.4 98.0 92.0 110.7 20.5 65.6 55.3 67.3 66.9 65.0 8.2 89.8 134.3 68.4 74.9 60.3 55.8 75.0 41.7 76.8 101.1 43.7 8.3 75.9 118.0 44.0 62.3 47.8 64.0 52.3 90.7 6.5 105.2 182.6 81.4 9.5 23.7 98.2 91.4 59.0 52.7 83.0 91.9 118.1 85.4 64.8 65.7 57.1 122.9 104.2 128.5 63.1 107.1 173.3 74.2 99.3 97.7 81.2 PYURF PreY ENSG00000145337 "PIGY upstream reading frame" Q96I23 4 88520998-88523776 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036455 Uncertain Approved Nucleoplasm NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 32: Non-specific - Translation" Nucleoplasm "HPA036455: AB_10673388" "unprognostic (8.25e-2)" "unprognostic (9.14e-2)" "unprognostic (6.61e-2)" "unprognostic (2.03e-1)" "unprognostic (5.03e-2)" "unprognostic (7.23e-2)" "unprognostic (1.10e-2)" "unprognostic (8.84e-3)" "unprognostic (3.64e-1)" "unprognostic (1.48e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-2)" "unprognostic (9.04e-3)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" 71.2 72.2 35.1 23.1 37.0 44.5 70.4 38.7 43.4 69.0 33.8 72.0 30.7 74.8 45.6 64.1 65.5 22.5 58.6 34.0 37.3 84.9 81.7 56.4 27.8 36.7 35.6 65.2 59.0 41.9 66.2 28.5 36.5 61.9 31.2 22.9 55.4 33.9 66.9 67.0 53.9 36.2 39.2 54.4 56.8 42.3 36.2 27.3 54.5 42.3 29.4 61.7 62.5 39.3 60.1 19.8 39.1 46.4 76.7 78.3 26.2 43.2 60.6 53.1 44.6 15.5 46.3 0.2 47.3 61.7 36.4 25.2 35.6 54.4 66.6 73.4 61.8 66.2 24.8 59.9 58.0 110.7 40.9 54.4 80.8 34.5 69.5 50.4 88.5 20.4 75.9 64.9 77.8 45.5 68.5 67.6 32.7 70.5 37.5 68.0 36.3 69.8 44.4 33.4 46.7 45.7 54.9 49.4 119.9 38.4 23.0 54.8 60.6 56.1 51.9 55.3 40.6 45.6 40.1 7.5 49.3 55.7 63.1 82.4 92.1 79.0 90.4 94.9 102.2 98.9 103.2 98.3 111.0 80.5 105.4 101.6 18.1 108.9 95.3 68.3 116.8 186.1 35.1 37.0 38.7 43.4 34.0 37.3 36.7 35.6 36.5 39.2 36.2 39.3 136.2 51.3 71.3 0.0 92.0 230.4 176.0 167.2 158.8 28.7 207.2 205.2 5.8 84.4 98.8 86.5 10.4 232.3 106.8 65.5 287.6 118.0 44.0 69.7 103.9 127.0 114.6 98.2 0.0 129.5 120.6 119.6 53.5 51.2 105.8 97.7 114.2 147.3 139.4 26.9 0.0 99.4 101.7 115.9 124.7 98.3 125.9 100.0 348.6 0.0 129.2 113.3 176.1 0.0 0.0 103.4 102.7 120.0 84.6 208.7 128.0 236.9 79.1 33.0 59.2 107.3 109.2 108.1 62.3 189.9 289.0 163.9 119.6 136.5 132.8 142.3 RAB13 ENSG00000143545 "RAB13, member RAS oncogene family" P51153 1 153981617-153986358 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 7.0;myeloid DC: 10.5;plasmacytoid DC: 12.9" "Group enriched" "Detected in many" 11 "dendritic cells: 12.9;monocytes: 7.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 846.1" HPA003996 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane, Cytosol" "HPA003996: AB_1079728" "unprognostic (4.39e-3)" "unprognostic (1.20e-1)" "unprognostic (2.51e-2)" "unprognostic (4.11e-2)" "unprognostic (4.28e-3)" "unprognostic (3.20e-2)" "unprognostic (1.18e-3)" "unprognostic (2.80e-1)" "unprognostic (3.53e-2)" "unprognostic (2.11e-2)" "unprognostic (2.10e-1)" "unprognostic (5.93e-2)" "unprognostic (1.06e-3)" "unprognostic (2.45e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (1.28e-2)" 151.4 132.8 78.8 91.0 80.1 104.3 124.1 79.4 112.4 114.1 89.2 123.6 54.1 92.2 111.3 102.0 96.0 83.3 90.1 77.3 88.6 164.6 111.1 116.8 42.5 92.5 85.3 111.1 115.1 97.9 35.4 64.3 89.7 123.5 73.6 10.5 96.3 73.5 45.9 92.1 79.0 67.5 84.7 97.5 123.3 61.7 84.0 19.2 112.8 49.5 47.7 123.2 107.7 83.7 133.4 162.5 143.7 152.8 478.2 846.1 43.2 157.9 381.1 142.6 144.6 165.4 111.9 0.1 230.7 194.4 72.7 88.4 86.9 146.7 198.0 78.6 62.3 110.1 100.5 94.3 199.5 0.4 70.9 620.1 125.3 246.6 109.1 401.0 253.4 0.0 20.6 0.5 246.6 280.0 0.5 55.4 231.8 183.9 151.2 28.9 186.1 0.1 327.0 140.5 7.2 112.6 208.7 179.8 337.0 215.4 294.2 87.0 469.6 256.0 149.5 161.1 174.7 0.4 0.1 0.9 399.6 17.4 399.7 0.0 7.0 0.1 0.0 1.0 0.1 0.7 0.1 0.0 10.5 0.6 0.1 0.4 0.8 0.0 0.1 12.9 0.0 1.9 78.8 80.1 79.4 112.4 77.3 88.6 92.5 85.3 89.7 84.7 84.0 83.7 230.1 41.7 83.4 1.0 9.0 92.0 181.3 196.3 110.4 1.2 126.9 149.2 75.2 120.1 105.3 108.5 2.1 116.3 2.8 81.5 135.0 234.4 119.9 91.9 163.2 239.8 89.1 116.4 0.0 149.2 181.2 100.8 76.5 111.4 40.6 111.9 192.4 136.2 249.1 0.0 0.0 184.2 83.4 111.1 104.5 232.1 106.2 116.0 99.6 7.5 247.4 71.5 2.1 0.0 0.1 158.1 110.6 124.1 10.6 197.0 135.7 206.5 72.2 3.8 151.2 46.9 151.4 103.6 18.4 124.8 98.2 92.9 8.9 141.6 146.1 195.9 RAD50 "hRad50, RAD50-2" ENSG00000113522 "RAD50 double strand break repair protein" Q92878 5 132556019-132646349 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022103, CAB024979, HPA052291" Supported Supported Nucleoplasm NA NA 12000 "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "CAB022103: , CAB024979: , HPA052291: AB_2681786" "unprognostic (3.46e-3)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.50e-3)" "unprognostic (4.22e-3)" "unprognostic (6.71e-2)" "unprognostic (5.98e-2)" "unprognostic (2.76e-2)" "unprognostic (1.06e-1)" "unprognostic (6.84e-2)" "unprognostic (2.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.62e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "unprognostic (2.40e-1)" 6.3 8.0 5.8 2.8 6.9 5.9 6.6 7.6 8.6 6.9 4.0 8.7 2.5 8.1 10.3 7.6 7.3 3.5 7.1 6.8 4.9 6.1 6.2 5.0 2.5 5.0 4.4 9.2 9.2 8.8 8.1 3.6 5.7 6.2 4.6 8.5 7.1 4.2 11.3 10.4 8.0 3.8 3.4 5.4 8.6 5.5 5.4 4.0 6.0 4.7 3.5 7.9 6.9 8.6 9.1 22.8 2.1 12.1 13.3 20.0 9.8 6.3 11.2 11.0 12.8 20.4 14.8 20.6 3.7 10.3 19.7 8.8 17.6 14.2 16.5 11.7 13.4 9.5 13.3 12.5 10.8 10.2 7.6 10.8 24.1 13.4 36.7 7.2 5.4 6.5 17.9 3.2 10.1 8.6 7.7 13.9 11.7 9.0 6.8 7.2 3.7 10.1 8.8 16.9 11.5 14.9 11.7 4.7 2.8 5.6 11.5 7.0 9.5 4.7 5.5 14.5 8.3 5.7 7.7 24.2 8.4 12.5 6.7 7.0 3.3 1.1 4.1 3.8 5.6 7.0 5.4 5.4 3.6 5.8 4.9 4.5 0.3 9.3 4.8 2.5 4.0 2.7 5.8 6.9 7.6 8.6 6.8 4.9 5.0 4.4 5.7 3.4 5.4 8.6 3.5 38.5 27.1 65.6 34.6 26.0 37.3 33.7 31.9 56.8 6.6 4.8 130.0 44.3 31.6 7.3 89.6 69.6 22.9 31.0 1.9 6.3 26.4 8.2 15.8 16.6 37.1 38.5 65.9 6.0 49.2 37.6 37.2 7.6 30.4 8.5 22.1 38.5 37.4 37.0 79.7 44.1 18.3 27.2 12.2 12.6 60.6 16.5 16.0 49.6 22.4 38.0 48.4 65.9 92.4 4.8 35.6 53.4 33.0 32.1 53.7 4.4 40.8 60.8 32.9 50.9 39.9 108.4 87.2 39.2 26.7 33.1 25.2 11.5 52.3 25.1 RAI1 "DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS" ENSG00000108557 "Retinoic acid induced 1" Q7Z5J4 17 17681458-17811453 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023898, HPA054906" Approved Enhanced Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA023898: AB_10971089, HPA054906: AB_2682637" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-2)" "unprognostic (3.85e-2)" "unprognostic (3.02e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.61e-2)" "unprognostic (5.29e-2)" "unprognostic (4.20e-2)" "unprognostic (6.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-2)" "unprognostic (8.28e-2)" 6.8 10.5 5.9 7.4 5.2 4.9 9.3 5.7 13.0 17.2 1.4 13.1 6.3 16.4 3.4 11.6 15.1 7.4 12.7 3.9 2.4 9.2 5.3 10.8 5.8 4.9 0.4 15.9 10.1 10.2 18.0 4.6 1.2 16.1 2.7 8.9 15.3 9.5 5.7 12.5 8.4 6.3 0.1 11.8 10.9 6.4 0.8 7.1 14.5 1.8 4.3 15.6 14.4 4.3 29.3 39.0 24.2 20.0 3.2 6.5 4.2 9.9 10.5 8.1 7.9 20.4 12.1 9.4 13.3 12.9 6.9 33.8 8.5 19.7 3.4 9.3 19.0 17.2 24.4 10.4 10.5 6.9 10.4 7.5 9.4 7.4 11.0 9.6 10.1 11.8 7.5 7.5 4.2 25.9 14.7 6.7 1.7 15.1 11.4 34.2 18.9 13.4 6.6 34.6 16.8 30.0 15.6 13.6 32.2 27.8 18.3 8.6 19.6 12.8 16.3 20.7 14.1 6.6 1.6 5.9 12.5 8.4 35.7 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.6 0.3 0.7 0.0 0.2 5.9 5.2 5.7 13.0 3.9 2.4 4.9 0.4 1.2 0.1 0.8 4.3 6.1 12.8 20.5 24.8 4.7 12.1 10.8 11.7 12.0 28.7 14.1 10.2 4.0 11.5 14.0 14.7 22.9 0.1 10.0 4.8 0.0 18.4 2.5 9.4 9.6 11.0 11.4 4.6 37.3 9.0 0.8 8.0 12.8 10.5 14.0 7.7 15.4 6.2 2.4 23.5 35.9 7.1 4.1 3.5 8.7 4.9 6.8 4.5 8.8 14.0 5.9 6.8 7.2 26.2 17.1 13.5 2.5 6.0 1.7 11.6 2.2 1.8 7.3 13.1 6.6 5.0 7.6 1.2 11.7 10.5 8.8 0.4 6.8 12.4 8.5 12.9 RASL11A ENSG00000122035 "RAS like family 11 member A" Q6T310 13 27270830-27275192 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "ASC diff: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004859, HPA053296" Supported Approved "Nuclear bodies" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear bodies" "HPA004859: AB_2667270, HPA053296: AB_2682106" "unprognostic (1.59e-1)" "unprognostic (9.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (6.65e-2)" "prognostic favorable (5.43e-4)" "unprognostic (3.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.65e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (3.71e-2)" "unprognostic (3.34e-1)" 32.9 4.1 1.9 3.1 3.2 2.3 21.8 3.1 3.1 21.4 2.1 20.4 7.7 21.6 3.9 9.8 22.0 3.8 11.3 3.2 1.7 30.4 12.9 13.0 10.8 1.8 2.2 9.5 4.9 1.4 10.6 2.9 2.0 20.3 12.5 0.1 5.3 5.6 3.5 10.1 20.9 5.5 2.2 14.8 13.4 2.9 3.3 1.2 12.1 1.7 10.0 19.1 15.9 2.4 0.3 1.3 0.3 0.6 42.4 4.3 0.2 1.9 1.8 0.1 0.1 8.1 0.8 0.3 0.5 1.4 0.9 0.1 2.5 0.8 0.1 1.7 8.8 1.8 0.2 0.5 6.8 0.6 0.6 5.0 0.7 0.1 0.1 1.7 0.6 0.7 0.3 0.1 0.0 0.8 0.0 2.4 1.5 8.0 10.2 0.5 0.0 0.2 1.4 6.2 0.7 0.3 0.7 3.3 0.2 1.0 0.2 0.8 0.3 0.1 0.3 2.9 0.4 0.1 0.0 0.0 0.4 1.9 0.1 0.4 0.4 0.4 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.2 0.1 0.1 0.2 0.1 1.3 0.1 0.0 0.1 1.9 3.2 3.1 3.1 3.2 1.7 1.8 2.2 2.0 2.2 3.3 2.4 29.6 16.0 11.2 0.3 6.0 4.6 3.2 0.9 17.6 0.0 6.2 11.9 1.4 0.0 8.6 7.3 0.0 0.7 4.5 9.3 3.9 1.8 0.0 5.1 9.8 5.9 0.0 4.0 0.6 2.4 0.2 30.1 42.3 6.1 0.0 2.1 2.5 0.2 1.4 0.0 0.6 5.6 4.1 0.8 6.5 0.0 0.3 6.1 1.8 1.9 1.7 0.3 0.0 0.5 1.8 0.5 12.7 1.5 17.1 1.1 11.4 1.7 10.3 0.2 32.9 11.6 112.0 0.0 0.0 13.5 4.4 0.8 4.5 1.2 6.7 1.1 RAVER1 KIAA1978 ENSG00000161847 "Ribonucleoprotein, PTB binding 1" Q8IY67 19 10316212-10333638 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 255.5" "Low region specificity" "Detected in all" "HPA043575, HPA049457" Enhanced Supported Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA043575: AB_2678562, HPA049457: AB_2680774" "unprognostic (2.04e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.80e-2)" "unprognostic (1.59e-1)" "unprognostic (4.22e-2)" "unprognostic (2.01e-2)" "unprognostic (7.20e-2)" "unprognostic (2.64e-2)" "unprognostic (3.22e-2)" "unprognostic (3.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (2.97e-1)" 12.4 12.9 4.1 11.8 4.9 19.0 12.6 3.9 5.5 17.9 6.2 20.4 17.7 22.8 0.7 15.1 19.8 3.3 9.7 3.7 4.4 12.0 8.3 13.1 11.1 6.9 5.0 19.3 11.7 4.4 17.5 6.0 4.4 15.2 3.2 1.1 13.1 7.5 8.5 11.8 22.6 4.0 3.8 21.7 13.9 11.5 5.0 11.4 14.3 2.2 5.2 16.8 14.0 4.5 62.0 38.9 14.1 21.6 5.6 7.0 31.0 31.9 14.0 24.7 21.8 42.7 17.3 65.0 43.7 10.4 19.9 31.5 15.8 21.1 4.9 55.2 93.5 100.3 25.7 48.6 12.6 63.5 62.4 8.2 7.2 16.6 6.2 8.2 16.2 48.6 80.9 56.2 7.6 57.8 85.6 255.5 55.1 13.1 73.9 78.3 20.5 57.2 6.9 24.4 40.3 46.7 34.7 22.3 18.3 4.8 32.0 30.5 22.5 63.7 32.4 56.7 54.5 122.1 109.0 54.9 42.1 44.2 42.5 0.2 1.3 1.8 3.3 1.5 1.7 1.4 2.8 4.6 2.1 2.0 1.9 1.7 1.2 1.9 3.3 0.9 1.1 2.2 4.1 4.9 3.9 5.5 3.7 4.4 6.9 5.0 4.4 3.8 5.0 4.5 1.2 0.0 1.1 6.5 7.8 0.8 0.3 0.5 10.2 0.8 2.0 1.1 0.7 0.0 0.4 0.0 0.0 2.0 2.3 15.2 0.0 4.5 0.4 1.6 2.2 1.1 16.3 12.0 4.8 4.3 1.9 1.6 6.1 1.2 4.5 0.6 0.4 0.3 1.3 0.0 4.5 9.3 0.0 0.0 0.8 0.0 0.0 2.0 0.0 6.5 6.8 0.3 0.0 4.0 4.2 5.4 10.2 0.7 15.3 0.3 14.0 0.6 1.1 1.0 0.0 0.8 2.4 0.7 0.3 6.1 0.1 1.5 5.5 0.6 14.3 0.2 RBM19 "DKFZp586F1023, KIAA0682, Mrd1" ENSG00000122965 "RNA binding motif protein 19" Q9Y4C8 12 113816738-113966325 "Plasma proteins, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038860, HPA058732" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA038860: AB_10697400, HPA058732: AB_2683801" "unprognostic (2.10e-1)" "unprognostic (1.54e-1)" "unprognostic (3.61e-2)" "unprognostic (4.83e-3)" "unprognostic (1.50e-1)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.87e-7)" "unprognostic (9.32e-3)" "unprognostic (2.61e-1)" "unprognostic (5.14e-2)" "unprognostic (4.43e-2)" "unprognostic (3.53e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" 11.5 14.1 7.4 12.5 8.5 16.4 13.5 5.7 8.8 13.8 7.9 13.8 8.7 13.1 8.3 12.5 12.9 6.4 11.6 6.5 7.1 13.4 12.3 12.2 14.0 8.7 7.9 18.9 14.2 10.1 12.7 9.9 8.8 15.1 8.9 7.7 12.6 8.4 16.7 12.5 13.5 9.0 5.1 13.3 13.3 11.9 10.3 10.4 20.8 9.3 12.9 14.4 12.4 11.1 13.0 25.6 15.0 29.3 14.7 11.7 22.7 22.9 17.9 25.3 18.5 34.4 17.7 23.1 13.9 19.5 18.5 18.1 35.4 22.1 19.8 42.0 20.8 49.6 28.0 33.4 11.1 37.9 22.7 14.6 14.3 31.0 11.2 16.2 18.6 17.8 54.3 9.3 15.9 19.4 21.4 28.6 32.8 12.9 21.6 28.2 14.4 20.1 17.3 24.9 17.9 14.4 20.5 29.3 14.2 12.4 32.3 10.9 21.3 16.6 20.3 14.4 14.3 16.7 13.5 22.7 22.3 26.7 21.5 0.1 4.4 1.3 7.7 7.7 6.0 7.3 5.5 6.4 6.1 5.9 4.4 6.0 0.2 7.6 12.4 4.2 5.4 4.8 7.4 8.5 5.7 8.8 6.5 7.1 8.7 7.9 8.8 5.1 10.3 11.1 8.1 16.0 9.6 18.9 15.6 13.8 14.6 5.1 10.8 11.8 10.3 8.3 20.4 7.2 9.2 11.0 8.4 10.6 13.2 6.5 1.9 11.7 7.2 9.1 11.7 11.2 9.0 12.4 13.8 13.3 9.2 13.6 10.2 9.8 15.2 15.5 4.6 6.9 12.3 6.7 13.1 8.4 6.1 7.6 8.7 9.5 10.8 9.8 3.6 24.4 16.8 5.4 8.2 11.1 15.5 14.5 5.6 7.2 15.1 15.3 6.4 9.8 12.8 13.5 0.0 14.1 12.9 16.6 15.1 11.8 11.5 11.4 15.1 10.4 7.8 11.4 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 384.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 57.6 48.0 34.9 24.5 39.8 38.2 54.3 41.3 41.5 56.1 30.9 60.6 27.5 65.2 12.0 58.5 53.8 11.8 60.8 35.1 36.3 57.5 54.0 46.5 24.1 43.8 38.0 54.8 39.6 23.1 41.4 23.2 38.7 55.2 10.7 9.1 44.2 24.9 76.0 67.3 46.3 14.5 37.6 51.7 49.7 41.5 38.0 25.9 49.9 21.6 15.5 58.0 50.8 42.9 115.6 176.5 38.8 52.9 34.6 27.0 104.8 77.2 41.8 88.3 69.0 105.0 72.8 63.7 137.8 49.4 48.2 46.6 44.8 54.0 26.0 165.6 80.0 87.8 57.7 87.5 88.8 78.5 81.1 38.6 42.3 65.4 36.0 28.4 48.8 65.3 92.9 50.8 40.5 130.5 99.9 103.1 44.4 103.1 71.9 107.7 52.9 63.8 43.0 52.6 50.5 73.3 87.8 71.5 62.4 21.1 57.0 122.0 76.2 63.1 86.4 84.4 136.6 123.0 140.7 99.1 60.9 73.8 90.2 98.8 79.6 124.5 82.8 95.6 70.9 76.2 67.8 83.1 94.3 81.3 59.4 67.1 73.9 79.3 94.5 87.6 82.6 73.3 34.9 39.8 41.3 41.5 35.1 36.3 43.8 38.0 38.7 37.6 38.0 42.9 56.5 38.5 24.6 4.6 38.4 51.9 52.6 94.3 43.9 23.3 31.2 37.5 14.7 40.0 57.4 53.3 12.5 197.9 47.0 67.2 74.3 78.0 38.4 41.0 35.4 50.9 52.1 43.8 2.3 90.4 101.5 47.0 38.7 41.6 51.4 46.0 46.8 31.6 91.2 10.1 2.6 56.4 54.9 31.1 60.9 16.3 58.1 40.9 53.4 2.8 63.0 46.5 27.8 3.5 5.8 80.6 48.9 63.2 43.7 31.8 72.3 78.0 44.5 19.8 52.6 34.5 92.4 71.9 52.9 36.2 43.5 384.3 44.9 44.3 64.7 45.4 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.13e-5)" 65.2 75.5 51.4 43.7 50.5 45.8 58.3 56.9 96.4 108.2 53.0 81.5 43.4 70.0 34.5 51.7 81.7 27.6 74.3 51.0 54.8 74.3 78.1 64.7 59.8 53.6 51.0 96.2 89.7 36.7 72.8 30.3 50.0 98.2 39.5 64.3 50.3 36.0 44.0 54.3 78.0 42.2 48.1 103.5 69.3 66.1 53.1 48.6 74.9 25.7 50.1 67.2 68.5 51.7 28.6 18.0 73.0 48.1 70.8 38.4 25.9 47.8 41.0 40.8 42.7 31.0 31.4 147.2 27.0 47.0 41.1 23.6 61.2 40.9 51.3 57.3 23.2 68.6 46.1 41.3 40.0 71.3 69.4 36.0 50.5 45.7 50.9 76.4 52.2 37.0 57.0 36.0 39.3 26.9 66.8 106.0 57.9 34.7 32.0 26.1 31.0 38.0 40.4 57.0 28.8 51.6 43.7 31.0 30.9 62.9 25.3 55.7 48.8 41.2 48.0 33.3 48.6 49.7 123.7 84.9 23.7 58.6 40.6 16.4 8.5 5.2 13.3 4.6 11.2 12.3 9.3 8.2 8.8 11.5 9.3 10.2 5.6 7.2 8.8 9.6 7.0 6.1 51.4 50.5 56.9 96.4 51.0 54.8 53.6 51.0 50.0 48.1 53.1 51.7 76.0 57.7 75.2 172.4 87.4 54.0 43.0 34.2 67.7 120.1 43.5 33.8 35.7 40.0 45.9 62.5 102.2 38.2 91.9 46.4 11.7 33.4 31.9 51.2 69.5 57.2 47.3 51.9 195.6 28.0 33.0 53.9 64.7 46.3 43.0 93.0 45.7 36.0 27.8 92.5 216.8 44.5 36.7 56.1 82.2 25.2 65.6 50.1 60.5 161.1 66.1 43.4 62.8 154.3 177.9 34.3 32.4 60.5 106.9 51.2 60.9 17.7 49.1 145.7 46.0 55.6 63.7 135.3 56.7 46.7 45.3 36.3 66.4 66.3 39.5 35.2 REX1BD "C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391" ENSG00000006015 "Required for excision 1-B domain containing" Q96EN9 19 18588685-18592337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 154.6;Extravillous trophoblasts: 147.6;Hofbauer cells: 258.2;Proximal tubular cells: 222.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 64.5;PC-3: 98.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043414 Approved Approved Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA043414: AB_10797141" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (6.78e-3)" "unprognostic (1.22e-1)" "unprognostic (4.87e-3)" "unprognostic (2.52e-2)" "unprognostic (1.45e-1)" "unprognostic (4.60e-1)" "unprognostic (3.10e-1)" "unprognostic (5.50e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-2)" "unprognostic (4.02e-2)" "unprognostic (9.27e-2)" "unprognostic (1.48e-1)" "prognostic favorable (8.47e-4)" 42.9 40.7 25.5 5.0 23.8 8.1 41.3 21.7 45.2 40.3 11.9 39.3 6.7 39.6 0.5 31.6 34.0 1.9 76.5 24.3 25.3 48.3 63.5 33.9 2.4 25.9 22.5 38.9 52.8 4.3 32.3 3.6 24.2 40.0 1.0 0.6 33.8 6.1 106.4 42.8 33.8 2.4 22.7 47.6 39.0 10.8 26.3 3.9 27.6 9.2 2.2 39.1 38.1 24.9 18.2 20.6 2.0 3.8 2.6 3.1 64.5 19.2 3.0 4.2 4.9 3.8 21.8 18.7 58.4 3.2 1.7 12.9 0.9 4.6 1.1 19.5 47.1 12.1 7.5 9.8 3.7 11.7 28.7 5.2 5.2 2.2 1.1 1.8 5.4 8.4 16.8 6.8 2.2 26.3 19.9 18.6 29.3 9.5 98.5 21.4 5.5 47.2 7.4 15.0 9.5 34.6 9.1 10.8 25.0 0.8 5.2 7.5 18.5 2.4 18.8 25.5 10.7 52.3 17.3 12.7 18.0 18.9 9.7 100.5 150.9 152.5 148.6 140.1 153.1 126.4 151.4 134.5 146.9 91.6 135.4 128.6 89.4 101.3 132.4 125.8 134.6 143.6 25.5 23.8 21.7 45.2 24.3 25.3 25.9 22.5 24.2 22.7 26.3 24.9 126.2 28.9 41.2 0.0 38.7 0.0 0.0 0.0 0.0 0.0 100.0 136.5 0.0 0.0 21.1 77.3 0.0 127.7 84.0 0.0 154.6 72.9 0.0 52.1 67.8 39.7 0.0 0.0 0.0 116.7 147.6 53.3 0.0 63.7 41.6 122.5 0.0 0.0 258.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 58.4 0.0 0.0 0.0 0.0 74.7 0.0 0.0 25.9 0.0 0.0 222.4 19.7 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 66.5 50.9 93.6 0.0 0.0 RGL2 "HKE1.5, KE1.5, RAB2L" ENSG00000237441 "Ral guanine nucleotide dissociation stimulator like 2" O15211 6 33291654-33298942 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047039, HPA053444" Approved Approved Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA047039: AB_2732538, HPA053444: AB_2682153" "unprognostic (4.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-2)" "unprognostic (2.74e-3)" "unprognostic (2.64e-1)" "unprognostic (1.04e-2)" "unprognostic (3.30e-2)" "unprognostic (2.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.62e-2)" 10.4 8.7 2.6 0.6 2.8 2.3 9.1 2.7 1.6 13.0 8.9 10.0 2.2 11.0 0.0 5.4 12.5 2.0 8.9 2.1 3.7 8.9 2.5 11.4 0.8 6.0 3.0 12.9 6.9 2.7 20.7 5.6 2.5 9.5 0.6 0.1 7.5 3.0 18.5 5.7 8.0 4.0 2.5 24.2 9.9 5.4 4.0 1.0 16.0 8.5 0.2 9.3 7.4 2.2 15.7 2.8 0.2 1.0 2.1 7.2 0.0 1.5 6.0 2.4 1.5 0.2 2.5 2.7 14.0 2.8 5.4 0.3 0.6 5.8 1.4 0.9 0.6 6.5 0.0 2.8 12.9 1.8 5.3 5.4 6.0 5.0 3.6 2.6 19.0 0.0 4.0 0.1 2.4 0.0 1.9 7.9 1.6 1.0 9.7 4.4 0.4 4.1 4.8 3.5 2.9 11.8 0.1 0.0 20.4 0.0 0.0 4.9 22.6 5.1 5.1 3.0 14.8 2.8 1.9 1.6 3.4 4.1 10.4 4.3 4.2 8.8 2.0 3.1 1.7 1.6 1.3 1.5 3.3 2.1 0.7 1.1 9.6 2.4 1.1 0.4 1.3 2.8 2.6 2.8 2.7 1.6 2.1 3.7 6.0 3.0 2.5 2.5 4.0 2.2 75.5 16.0 41.5 52.2 20.6 28.4 36.5 30.3 37.0 30.4 58.8 40.4 28.7 20.0 38.6 22.0 22.9 30.4 18.4 8.4 13.7 21.2 5.1 19.9 13.6 60.8 28.6 7.8 13.0 14.5 39.0 20.1 16.3 21.1 11.4 21.4 75.7 10.7 32.3 32.0 18.2 10.8 22.4 27.0 23.4 17.4 16.8 23.0 17.8 30.9 13.4 22.5 19.6 17.6 11.1 22.4 25.5 14.7 7.8 30.5 5.6 11.7 39.9 30.9 26.3 20.4 26.9 26.2 18.9 20.0 24.3 102.2 16.5 28.3 10.0 39.2 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 388.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA065375: AB_2685481" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 17.4 23.8 15.7 9.6 16.4 19.6 16.8 16.8 19.4 30.6 16.4 35.0 8.5 27.3 6.5 14.6 28.2 6.3 18.9 15.9 15.5 27.5 16.8 16.4 13.9 15.3 15.7 34.0 16.9 7.5 32.3 5.5 16.1 34.4 3.9 7.7 16.5 9.6 10.1 11.9 25.0 6.1 14.5 33.1 23.1 13.3 15.8 9.8 22.1 3.6 8.0 27.9 22.2 17.6 13.5 12.9 16.6 13.1 13.3 6.3 5.4 7.4 4.6 18.6 15.4 15.8 15.4 19.9 7.7 6.8 24.1 19.5 14.0 10.3 12.2 13.5 30.2 20.2 40.9 7.4 2.3 3.5 17.7 7.3 3.6 16.7 4.7 11.0 8.0 21.4 10.9 22.7 7.8 19.9 33.9 19.0 10.3 6.4 15.6 27.1 11.3 27.4 4.9 7.8 20.6 20.4 3.5 14.5 8.1 5.1 17.6 7.1 8.2 17.9 15.7 18.3 11.7 20.6 6.3 6.7 26.6 16.8 14.8 3.3 14.6 3.7 9.2 10.7 9.9 12.7 6.2 6.8 9.2 12.8 7.6 5.7 3.0 11.2 8.0 23.3 6.9 9.8 15.7 16.4 16.8 19.4 15.9 15.5 15.3 15.7 16.1 14.5 15.8 17.6 94.0 25.6 39.9 8.5 90.6 31.6 109.5 59.8 23.9 26.7 82.2 102.7 69.8 94.4 44.5 68.0 8.4 73.5 89.5 64.6 105.7 62.6 40.0 34.1 75.5 77.7 128.4 124.2 14.3 46.6 107.8 89.5 32.6 36.7 65.4 168.7 104.6 103.6 128.0 23.5 12.5 52.7 42.7 93.6 51.4 138.2 135.8 73.1 64.0 7.5 90.7 47.5 145.2 8.5 16.9 43.4 83.1 100.1 119.0 74.5 132.5 271.4 37.5 23.5 111.7 66.1 101.7 66.5 68.5 44.1 36.9 208.0 68.6 388.0 53.9 95.9 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 64.1;Alveolar cells type 2: 59.4;Club cells: 31.1;granulocytes: 60.5;Respiratory ciliated cells: 56.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.9;THP-1: 3.7;U-87 MG: 3.7" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 1.9 4.1 0.0 0.2 0.0 0.6 1.6 0.1 0.2 2.4 0.0 1.7 0.0 1.4 0.0 2.1 1.4 0.0 2.4 0.2 0.0 5.5 2.1 2.5 0.0 0.1 0.0 1.6 1.5 0.1 3.5 0.0 0.0 1.5 0.0 0.0 1.8 0.1 2.2 1.9 1.6 0.1 0.0 2.7 1.9 1.7 0.0 0.0 1.8 0.0 0.1 1.2 1.6 0.0 0.7 2.0 0.2 0.3 0.0 0.0 0.6 1.3 1.0 1.5 1.1 1.3 0.6 1.0 0.1 0.0 0.1 0.3 0.4 2.9 0.4 0.0 2.4 0.0 1.3 0.5 1.4 0.0 0.3 0.0 0.0 0.9 0.0 0.2 0.3 0.1 0.3 0.0 0.0 0.7 1.1 1.3 1.2 0.3 0.6 0.8 0.0 0.0 0.4 0.4 0.2 1.0 0.0 0.0 0.2 0.1 0.3 3.7 0.0 0.0 0.1 1.9 0.5 0.0 0.4 0.2 3.7 0.3 0.0 2.4 2.3 1.9 0.5 1.6 0.8 1.0 0.7 0.4 2.0 0.9 0.6 0.6 3.8 0.5 1.8 2.1 0.5 1.7 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 64.1 59.4 0.0 2.6 0.4 0.0 0.3 0.6 0.0 0.9 0.3 0.0 0.0 31.1 0.0 0.0 0.3 0.7 3.2 3.9 8.3 0.0 0.3 0.2 6.5 5.4 1.3 0.0 8.2 0.2 5.3 0.0 0.3 60.5 0.0 0.7 0.1 0.6 0.0 0.0 3.2 0.0 1.2 0.8 0.0 0.3 14.8 0.0 0.0 4.8 0.0 0.0 0.0 0.0 7.7 6.1 0.4 2.8 0.1 3.9 0.5 56.2 0.0 0.0 0.1 1.3 0.2 0.1 2.0 1.0 0.8 5.9 0.1 2.6 0.1 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227502-137229640 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 3.4;pituitary gland: 5.8" "Cell type enhanced" "Detected in single" "Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA079078 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Golgi apparatus" "HPA079078: " "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.2 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.5 0.0 0.3 0.3 0.2 0.0 3.4 1.4 0.3 0.5 0.1 0.1 2.1 0.0 0.8 0.1 0.8 1.2 0.1 0.8 0.0 5.8 0.0 0.3 1.0 0.0 0.2 1.4 0.0 0.1 0.6 0.5 0.0 0.5 0.2 0.6 1.2 0.5 0.0 0.9 0.0 0.1 0.4 0.9 0.2 0.6 1.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 5.5 0.1 0.2 0.0 0.3 2.7 0.0 0.1 0.0 1.8 0.2 0.0 4.3 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.4 0.0 9.8 0.1 0.0 0.4 0.7 1.3 0.6 0.2 0.1 0.1 0.6 0.0 1.1 0.5 2.0 0.0 0.7 1.9 0.2 0.2 0.2 0.1 1.1 0.0 0.6 0.2 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.8 1.2 0.3 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.9 2.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865432-124881471 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 6.4" "Cell type enhanced" "Detected in many" "Astrocytes: 32.3;Muller glia cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 5.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "AF22: 18.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low region specificity" "Detected in many" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.8 1.8 0.5 0.0 0.3 0.2 1.9 0.0 3.2 0.7 0.0 1.3 0.3 0.8 0.0 0.7 2.0 0.0 1.8 0.7 0.2 1.6 0.4 1.1 0.1 0.9 0.9 6.4 0.7 0.0 0.8 0.2 0.2 1.4 0.0 0.2 1.2 0.0 0.5 0.7 0.9 0.8 0.2 1.6 0.6 1.2 1.7 0.0 1.4 0.0 0.0 0.7 1.2 0.9 0.0 0.0 18.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.0 0.6 0.9 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.0 3.2 0.7 0.2 0.9 0.9 0.2 0.2 1.7 0.9 13.2 0.0 7.3 32.3 0.4 2.9 14.5 16.2 4.0 1.9 5.9 10.9 2.7 1.5 5.9 12.9 0.0 0.2 8.5 2.1 0.0 9.3 0.4 0.4 0.5 11.4 3.5 2.1 6.9 0.8 0.2 19.0 0.5 0.7 8.9 19.0 7.5 0.3 1.6 0.0 2.3 2.4 10.2 1.6 20.1 0.6 13.4 8.0 3.6 11.2 1.6 45.3 8.2 4.5 9.2 1.2 2.5 8.2 0.7 8.2 1.0 0.8 0.6 2.1 0.0 14.3 4.4 10.1 10.8 2.3 1.0 0.1 3.6 3.5 2.7 6.5 RPP21 "C6orf135, Em:AB014085.3, FLJ22638" ENSG00000241370 "Ribonuclease P/MRP subunit p21" Q9H633 6 30345131-30346884 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 97.3;Squamous epithelial cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 49.2;HHSteC: 46.3;JURKAT: 59.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" "unprognostic (2.73e-1)" "unprognostic (1.09e-3)" "unprognostic (2.83e-1)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (6.46e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (2.86e-1)" "unprognostic (1.65e-2)" "unprognostic (2.65e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.54e-2)" "unprognostic (1.01e-2)" "unprognostic (4.13e-2)" "prognostic favorable (6.78e-5)" 34.8 39.6 4.9 0.7 4.4 2.7 36.4 5.0 12.9 46.8 4.1 73.1 0.8 60.2 4.1 62.7 41.6 2.6 38.9 4.6 6.2 35.5 37.7 27.0 2.3 5.4 4.1 42.0 62.1 0.1 35.3 2.5 5.2 42.1 0.0 0.4 36.2 6.8 56.5 46.6 38.8 11.8 5.2 31.8 52.1 34.5 4.6 4.2 31.3 11.0 1.4 56.7 48.2 6.0 34.0 0.0 0.0 14.8 21.8 1.6 18.7 11.7 6.8 26.3 17.6 0.9 0.0 20.4 31.0 7.1 32.1 2.1 0.0 24.4 7.9 26.0 49.2 5.7 0.0 1.0 46.3 0.0 0.0 0.7 5.3 4.1 1.5 5.8 0.1 59.8 5.4 14.4 8.1 2.4 0.0 4.7 16.9 0.0 0.0 4.9 0.0 7.3 12.2 26.9 29.1 11.0 0.0 11.6 34.3 4.6 0.1 0.6 0.8 0.0 0.0 36.0 0.0 12.7 31.1 11.7 0.0 5.3 0.0 60.4 45.4 41.8 25.9 51.8 30.4 86.6 41.2 29.6 35.3 85.2 51.9 33.1 14.4 25.4 53.8 15.9 70.1 41.9 4.9 4.4 5.0 12.9 4.6 6.2 5.4 4.1 5.2 5.2 4.6 6.0 10.6 6.4 18.4 0.0 53.3 35.7 11.4 23.5 97.3 3.2 30.3 27.6 1.2 17.2 28.9 25.8 0.0 12.9 16.7 27.1 7.9 37.0 4.5 17.1 15.1 16.2 42.6 28.8 0.0 60.1 19.3 18.5 68.8 15.8 13.3 5.8 13.6 16.5 10.4 1.7 0.0 29.9 26.4 11.0 20.0 2.1 13.7 17.0 24.9 0.0 14.4 3.0 12.3 0.0 0.0 41.8 42.6 10.5 44.1 8.7 42.7 22.2 13.0 3.3 6.6 9.2 18.5 19.1 25.4 122.9 40.5 11.4 42.3 3.3 33.7 10.2 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242249-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA058992: AB_2683873, HPA067651: AB_2685879" "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favorable (2.91e-5)" 31.1 31.2 19.6 3.5 27.1 12.8 18.6 25.7 29.4 54.5 25.8 34.0 4.7 29.6 4.4 39.3 38.9 16.3 42.9 20.7 18.1 53.5 35.1 42.4 5.8 37.3 23.6 47.8 19.6 0.9 59.9 8.8 26.0 56.3 2.0 8.5 39.1 18.2 18.8 22.4 26.0 2.1 22.9 37.6 27.2 24.4 25.0 24.4 41.3 21.2 11.4 33.4 52.7 34.8 7.7 16.8 2.2 2.4 18.3 2.7 6.6 7.1 1.3 8.2 9.2 13.7 8.5 6.1 23.0 1.0 3.0 11.4 14.7 1.3 2.8 14.4 8.9 21.0 20.5 17.9 3.9 9.7 11.3 1.8 8.9 3.8 0.0 3.2 4.8 6.3 17.7 49.9 2.3 7.6 2.2 18.5 9.1 17.1 9.7 9.2 6.9 9.1 6.1 0.3 8.9 1.9 4.7 4.7 5.1 1.4 3.9 10.6 10.7 5.7 5.6 5.0 4.1 29.1 24.0 6.3 4.3 24.1 4.5 149.6 57.0 87.4 25.5 38.0 26.7 24.8 26.8 21.6 60.4 23.5 25.3 17.3 130.4 36.6 54.5 37.9 37.6 30.9 19.6 27.1 25.7 29.4 20.7 18.1 37.3 23.6 26.0 22.9 25.0 34.8 351.6 60.9 77.0 121.1 332.7 0.0 229.7 0.0 338.6 86.9 200.1 217.0 47.7 45.8 37.8 93.8 141.8 80.3 456.5 385.9 21.5 43.0 29.8 115.2 142.0 150.0 130.6 140.9 172.6 21.1 82.8 169.0 183.0 146.4 217.1 140.1 71.4 19.6 61.9 84.1 125.4 200.1 0.0 72.2 0.0 16.5 140.1 197.5 0.0 140.5 160.6 69.3 200.8 93.0 278.8 43.6 340.3 90.3 248.4 130.3 397.9 15.2 59.0 138.8 124.9 214.1 141.8 107.6 102.8 283.0 0.0 121.2 346.7 123.8 159.6 196.8 RTL8A "CXX1b, DKFZP564B147, FAM127B, MAR8A, SIRH6" ENSG00000203950 "Retrotransposon Gag like 8A" Q9BWD3 X 135050932-135052196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 109.5;Ductal cells: 71.3;Pancreatic endocrine cells: 78.2;Proximal tubular cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 174.7" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.10e-2)" "prognostic favorable (5.35e-4)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (9.91e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (1.10e-5)" "unprognostic (2.16e-2)" "unprognostic (4.48e-1)" "prognostic favorable (2.71e-4)" "unprognostic (2.05e-2)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (3.35e-2)" "unprognostic (1.57e-2)" 38.5 30.3 22.4 6.9 25.6 4.7 36.3 25.1 38.0 46.1 12.3 44.3 10.2 45.0 4.9 57.4 41.0 9.2 43.0 21.6 27.1 37.7 19.2 32.2 6.6 25.0 24.4 47.5 20.2 10.1 51.0 10.7 23.7 41.9 5.8 7.7 31.6 17.3 19.9 39.0 28.8 10.3 21.8 26.5 30.5 12.1 24.7 6.0 38.1 8.6 4.1 44.7 43.4 27.8 47.9 57.1 28.4 62.8 29.5 25.3 40.9 18.8 17.8 45.3 49.4 59.1 20.1 0.0 50.4 29.4 50.3 29.9 14.8 32.8 14.5 16.4 52.1 9.4 59.7 0.0 71.6 3.0 13.6 48.0 55.7 46.6 20.9 17.6 33.9 9.4 15.0 0.0 21.4 174.7 3.3 30.4 14.7 12.5 57.0 10.4 29.4 0.1 9.0 26.5 52.3 67.2 21.7 15.9 50.6 10.7 17.5 8.5 35.0 34.4 29.3 66.4 46.8 7.1 12.6 0.2 20.0 13.4 27.9 31.7 19.5 21.0 6.9 27.8 6.0 4.4 7.3 8.7 14.0 5.5 8.1 9.2 4.6 4.6 34.1 10.8 5.0 8.6 22.4 25.6 25.1 38.0 21.6 27.1 25.0 24.4 23.7 21.8 24.7 27.8 43.9 60.9 19.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 52.6 63.5 0.0 0.0 26.0 62.5 0.0 60.1 7.4 0.0 109.5 71.3 0.0 39.3 49.6 21.7 0.0 0.0 0.0 63.5 60.7 22.6 0.0 38.1 11.4 34.8 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 78.2 0.0 0.0 1.8 0.0 0.0 110.5 14.6 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 28.2 5.0 54.1 0.0 0.0 RUFY1 "FLJ22251, RABIP4, ZFYVE12" ENSG00000176783 "RUN and FYVE domain containing 1" Q96T51 5 179550554-179610012 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Macrophages: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038804 Approved Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 25000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" "Vesicles, Cytosol" "Nuclear speckles" "HPA038804: AB_10673290" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.50e-1)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (9.74e-2)" "unprognostic (1.31e-1)" "unprognostic (2.73e-2)" "unprognostic (3.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" 28.2 33.1 9.6 13.4 10.5 13.3 26.1 9.8 10.2 27.2 11.3 29.1 9.4 27.5 8.1 33.9 24.5 8.8 20.4 9.5 10.1 24.1 21.3 26.6 14.2 10.2 10.0 23.9 24.4 13.5 22.7 9.0 10.1 22.4 8.2 7.4 25.8 8.6 33.8 33.1 25.9 7.8 9.9 35.2 24.2 10.9 10.0 13.6 24.7 10.1 11.5 26.3 27.2 10.6 13.9 22.5 11.8 15.7 22.3 18.2 13.4 24.2 17.2 14.1 16.3 22.0 31.6 22.4 13.4 29.6 16.2 12.6 21.9 31.6 16.4 71.2 16.6 39.2 17.1 16.0 22.8 22.0 20.7 18.5 17.1 9.5 27.0 24.6 15.5 12.5 16.2 20.8 12.7 42.0 23.5 15.2 12.6 15.0 10.5 20.9 8.4 20.9 23.5 22.4 11.7 16.7 35.4 22.5 13.2 14.8 18.0 26.6 18.8 18.3 6.2 10.0 19.3 12.8 21.2 39.8 16.9 39.0 17.2 14.9 4.8 11.9 2.2 5.1 1.3 3.8 2.7 2.3 4.2 5.7 1.9 2.4 7.9 1.8 7.1 4.8 4.5 29.8 9.6 10.5 9.8 10.2 9.5 10.1 10.2 10.0 10.1 9.9 10.0 10.6 19.8 35.3 30.8 30.0 23.6 10.3 11.5 11.7 16.5 9.3 17.8 17.5 22.8 28.6 23.1 14.7 20.9 21.7 15.7 20.0 9.8 19.7 8.0 28.2 21.9 20.9 10.8 27.7 31.8 14.4 15.8 19.7 19.9 20.0 29.8 20.4 12.5 14.1 31.1 11.8 28.4 17.5 8.2 30.7 21.0 3.4 23.0 137.2 10.6 21.5 43.7 11.9 15.5 23.1 33.9 22.1 18.5 27.1 18.3 14.2 14.1 34.0 32.8 12.0 6.6 20.8 17.8 11.1 8.4 21.9 11.4 21.2 19.5 25.0 15.3 10.2 RXRB "H-2RIIBP, NR2B2, RCoR-1" ENSG00000204231 "Retinoid X receptor beta" P28702 6 33193588-33200665 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002003, HPA063653" Supported Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB002003: , HPA063653: AB_2685076" "unprognostic (3.51e-1)" "unprognostic (8.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-2)" "unprognostic (2.00e-2)" "unprognostic (4.71e-3)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-3)" "unprognostic (8.13e-3)" "unprognostic (9.53e-3)" "unprognostic (8.30e-2)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" "unprognostic (8.53e-3)" 26.8 29.1 1.5 2.0 1.5 2.3 27.1 1.6 5.7 33.9 1.4 34.4 3.9 31.9 7.4 27.0 31.4 3.3 31.4 1.5 2.6 29.5 34.4 27.2 1.4 1.5 1.7 32.9 32.3 0.0 33.0 2.5 1.5 32.8 1.6 3.2 27.0 3.3 42.5 26.3 28.6 9.6 1.6 38.3 28.3 20.0 1.6 2.8 37.7 12.3 9.1 30.6 29.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 10.0 0.0 10.4 7.1 0.0 11.0 4.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 8.9 0.0 0.0 0.5 3.2 0.0 0.0 0.1 14.4 0.0 8.0 12.1 0.0 7.4 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 4.8 0.0 0.0 11.1 11.8 9.2 0.0 0.0 0.0 2.3 0.4 1.7 1.1 0.3 0.8 1.0 1.3 1.3 0.6 0.3 1.1 0.8 0.7 0.8 0.6 0.6 1.1 0.3 1.5 1.5 1.6 5.7 1.5 2.6 1.5 1.7 1.5 1.6 1.6 1.7 21.2 41.7 13.3 14.4 19.2 17.3 14.9 8.9 18.2 25.2 22.4 18.9 16.1 15.7 14.7 5.5 20.9 23.6 26.3 21.8 25.4 19.9 2.7 10.6 14.7 18.2 22.0 8.6 14.9 16.2 17.9 18.3 23.0 11.9 10.2 22.5 14.3 15.9 15.8 18.5 12.9 21.8 16.2 14.7 9.2 8.6 16.1 12.2 16.0 10.3 18.8 16.6 33.0 14.1 15.2 13.6 20.2 16.1 12.0 16.3 23.2 14.1 10.8 20.4 26.3 19.3 20.0 17.7 12.5 16.8 18.8 28.7 19.4 18.7 24.5 12.7 RYBP "AAP1, DEDAF, YEAF1" ENSG00000163602 "RING1 and YY1 binding protein" Q8N488 3 72371825-72446623 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 524.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053357 Approved Supported Nucleoplasm NA No "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA053357: AB_2682124" "unprognostic (6.80e-2)" "unprognostic (2.81e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-1)" "unprognostic (1.65e-1)" "unprognostic (1.14e-2)" "unprognostic (2.40e-2)" "unprognostic (3.84e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.50e-5)" "unprognostic (1.89e-1)" "unprognostic (4.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.22e-1)" 8.6 5.4 2.0 0.8 2.0 2.7 7.8 1.4 2.3 9.4 0.9 9.5 0.8 10.0 0.6 7.1 8.5 1.2 5.7 1.8 2.2 7.6 8.6 11.5 0.8 1.5 1.6 10.9 4.7 0.8 5.9 2.2 1.4 8.7 1.0 2.1 6.7 1.2 4.4 8.3 7.4 1.4 1.4 8.6 7.0 8.1 2.0 1.5 5.8 0.8 1.0 8.8 7.9 2.0 0.9 0.9 1.7 1.6 1.5 1.5 1.1 0.9 2.0 1.7 2.1 1.6 1.2 1.0 0.9 1.5 2.0 0.4 1.9 1.4 2.1 6.0 1.0 4.7 1.2 0.7 1.1 0.9 1.1 2.3 1.7 2.2 3.5 2.2 0.5 1.1 1.4 3.1 1.4 1.4 1.3 0.9 3.1 2.7 1.1 1.4 1.5 0.6 1.3 1.0 1.3 5.2 2.4 2.3 1.2 2.7 0.7 1.1 1.3 2.2 1.6 1.3 0.8 2.5 2.7 0.9 1.1 1.6 2.4 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.8 0.1 0.2 0.2 0.1 0.1 2.0 2.0 1.4 2.3 1.8 2.2 1.5 1.6 1.4 1.4 2.0 2.0 67.4 57.7 27.6 29.4 39.1 107.2 67.8 19.2 46.1 74.7 75.5 51.4 39.2 32.9 28.9 42.3 16.7 26.9 63.1 58.7 33.2 21.1 27.3 67.5 103.7 70.9 81.2 42.7 49.5 24.0 51.7 61.5 13.7 87.5 69.0 27.1 55.0 40.5 16.5 38.7 64.2 50.5 26.4 37.6 77.3 13.4 25.7 71.3 35.6 60.9 31.9 22.4 27.8 42.7 524.1 32.8 49.0 43.6 49.0 65.0 16.8 24.7 32.3 40.8 32.9 74.9 42.1 57.9 37.0 51.7 97.0 186.9 44.3 98.5 34.9 65.1 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA 48000 "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: AB_2681266" "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favorable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favorable (2.12e-4)" 26.8 35.8 23.3 22.4 23.8 35.2 25.8 28.0 30.3 48.4 21.0 35.3 22.2 38.2 21.0 23.1 44.0 15.6 30.8 21.7 29.6 40.6 30.7 27.8 24.4 24.2 23.9 56.2 30.5 18.0 48.6 14.2 23.1 43.0 16.1 34.7 27.6 18.6 41.5 25.8 34.3 19.3 17.5 39.9 27.8 32.5 23.9 22.3 38.9 20.4 21.2 31.5 35.0 27.5 44.9 54.8 38.8 30.4 36.7 23.7 47.6 40.9 21.3 24.4 23.3 69.9 31.4 84.9 36.9 19.9 19.6 39.9 47.2 24.9 39.2 59.8 53.5 64.4 59.5 54.6 21.2 53.0 58.2 23.5 25.4 35.2 26.9 23.9 24.6 29.3 63.6 40.6 28.7 48.9 65.7 53.1 69.9 33.1 59.9 82.2 34.2 47.6 27.7 70.5 37.6 35.3 54.7 25.3 35.3 24.4 36.5 33.0 40.5 30.7 32.7 39.3 57.6 55.2 52.2 58.6 31.2 47.1 52.2 42.8 12.6 22.0 14.6 10.8 16.8 13.9 13.2 11.7 11.3 14.9 14.5 11.7 23.4 9.4 12.3 12.5 13.4 7.9 23.3 23.8 28.0 30.3 21.7 29.6 24.2 23.9 23.1 17.5 23.9 27.5 40.6 41.7 45.1 79.7 69.7 46.7 58.1 41.4 47.3 70.2 39.1 30.6 28.7 20.0 39.3 33.1 75.0 46.8 63.0 46.4 23.5 49.7 7.6 44.5 92.6 49.0 43.0 45.8 36.2 44.4 44.7 47.3 44.4 58.3 42.3 45.4 26.7 23.3 30.6 43.7 42.7 46.5 57.0 27.6 49.5 13.3 72.4 46.6 26.6 32.8 52.2 77.5 52.5 29.7 34.6 42.2 48.6 65.8 70.0 50.3 54.1 61.5 55.3 78.4 46.0 75.4 47.9 68.3 78.8 37.3 41.9 32.3 79.1 59.7 44.8 54.2 SBNO2 "FLJ00173, KIAA0963, Sno, Stno" ENSG00000064932 "Strawberry notch homolog 2" Q9Y2G9 19 1107637-1174268 "Predicted intracellular proteins" "Differentiation, Osteogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 8 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "A-431: 45.3;HDLM-2: 65.2;U-266/70: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041867 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" "HPA041867: AB_2677715" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-1)" "unprognostic (6.20e-3)" "unprognostic (4.68e-2)" "unprognostic (8.48e-3)" "unprognostic (1.19e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-1)" "unprognostic (1.58e-3)" "unprognostic (3.22e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (7.98e-8)" "unprognostic (1.34e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.88e-1)" 61.3 42.8 2.8 8.5 2.9 11.4 40.2 1.8 5.0 35.7 4.6 31.8 1.9 28.0 0.2 51.8 33.8 3.0 27.1 0.9 3.2 57.8 41.5 68.4 2.7 12.0 5.4 30.9 21.4 0.2 37.8 2.4 5.4 42.7 0.3 0.1 42.9 0.7 38.6 43.0 30.8 2.1 3.5 60.0 30.0 19.3 8.6 1.5 34.2 0.5 2.5 32.1 35.7 5.5 45.3 5.7 0.8 0.5 0.1 2.8 16.1 13.0 1.4 2.9 1.6 0.3 7.3 9.0 18.2 2.2 2.3 14.6 0.0 2.0 1.0 65.2 9.8 9.9 18.3 0.1 2.4 5.8 28.7 6.8 1.8 4.3 1.7 2.2 2.8 3.9 15.3 12.4 1.1 5.5 5.7 7.4 12.3 0.9 19.1 13.1 7.9 11.0 4.0 2.1 10.3 16.1 7.9 14.2 15.8 1.1 5.0 4.6 15.0 7.9 6.2 23.6 22.1 49.0 24.8 7.8 15.7 5.3 9.0 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.5 0.1 0.1 0.1 0.0 0.1 2.8 2.9 1.8 5.0 0.9 3.2 12.0 5.4 5.4 3.5 8.6 5.5 28.8 9.6 22.8 4.6 8.8 14.9 13.2 10.7 11.4 5.7 39.7 23.9 5.4 5.7 18.8 3.7 2.1 4.7 13.2 22.3 3.9 9.4 2.8 19.3 21.9 25.3 3.0 0.4 4.4 6.8 5.7 13.1 33.6 39.1 3.8 10.4 13.9 10.8 10.3 6.7 3.4 10.2 14.2 15.9 20.7 1.6 9.3 20.2 8.8 5.6 13.0 3.3 5.2 3.5 5.8 17.9 15.1 4.1 16.2 20.8 7.9 1.8 14.5 4.9 6.6 12.0 12.9 7.7 9.0 10.6 18.8 10.9 14.4 9.5 12.3 22.1 SCAMP3 C1orf3 ENSG00000116521 "Secretory carrier membrane protein 3" O14828 1 155255979-155262430 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071167 Supported Vesicles NA NA 75000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA071167: AB_2686352" "unprognostic (4.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (2.17e-2)" "unprognostic (5.33e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (8.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.65e-1)" "unprognostic (3.74e-2)" "unprognostic (8.46e-3)" "unprognostic (1.60e-1)" "unprognostic (4.79e-1)" "unprognostic (1.07e-1)" "unprognostic (7.18e-2)" 45.1 69.6 4.6 7.1 6.8 7.9 43.5 6.3 8.2 38.1 4.5 37.4 7.7 35.2 0.2 49.9 31.9 5.0 65.0 5.0 4.5 49.0 48.4 40.9 12.1 6.3 5.2 34.9 51.9 4.7 33.8 7.3 5.6 37.0 2.4 1.1 49.3 6.1 90.9 56.4 38.4 3.5 6.4 46.5 47.0 28.3 5.4 8.3 38.6 3.2 7.2 39.5 38.6 8.2 19.7 30.2 11.2 8.8 8.3 6.8 14.5 21.6 20.7 26.3 19.4 30.0 15.7 45.1 49.3 10.9 15.7 20.5 9.0 18.7 1.8 29.8 68.3 25.7 11.7 8.5 26.1 30.5 17.4 9.7 20.9 21.2 10.3 3.3 18.9 49.3 38.2 18.3 11.6 38.3 50.5 14.6 16.5 27.9 59.4 43.1 9.1 67.5 4.8 13.1 8.3 20.0 26.2 8.0 39.1 3.4 32.1 13.7 29.0 20.9 17.5 29.3 29.6 43.3 84.8 52.9 16.7 41.1 15.2 41.0 47.5 52.8 94.4 51.7 86.8 98.8 91.3 91.1 58.1 100.3 83.3 86.6 6.7 76.0 71.4 102.4 101.0 100.9 4.6 6.8 6.3 8.2 5.0 4.5 6.3 5.2 5.6 6.4 5.4 8.2 23.0 16.0 37.1 12.4 33.8 38.2 23.8 57.3 54.1 18.5 27.3 19.3 39.1 30.0 43.7 33.1 4.2 86.4 27.2 19.0 9.8 49.0 1.7 16.3 20.8 33.1 30.1 14.5 9.9 69.4 55.1 27.1 27.0 26.3 25.3 16.6 32.9 37.9 57.3 18.5 11.9 24.3 42.7 21.3 26.7 5.3 17.1 23.0 24.9 7.5 41.3 20.2 30.9 9.5 17.4 48.5 19.9 18.8 56.1 24.7 36.8 24.4 22.6 10.9 13.1 16.7 27.3 20.0 5.5 46.7 40.1 71.3 33.4 20.5 30.1 22.5 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: AB_2797246" "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favorable (5.80e-4)" 22.0 24.0 15.2 11.3 15.9 17.8 23.2 16.5 18.1 32.0 18.6 54.6 12.7 35.4 20.5 14.0 33.1 15.8 39.3 16.1 16.9 29.8 19.7 20.6 10.4 13.6 14.7 36.3 40.1 34.7 27.6 11.0 13.1 40.4 17.0 21.0 27.5 30.7 44.9 13.3 23.4 24.6 12.2 15.5 32.5 32.8 16.7 16.6 24.1 34.2 10.5 38.9 21.3 14.1 19.5 12.8 29.9 27.5 13.4 25.4 0.1 15.4 26.7 25.2 26.0 12.3 24.6 35.4 11.4 28.1 21.1 4.8 23.3 20.6 21.6 24.7 17.8 16.6 17.7 31.2 58.2 35.7 26.2 27.7 20.5 16.7 40.2 30.5 25.7 43.3 15.7 26.8 25.0 10.6 36.0 30.8 27.7 16.4 13.5 39.3 31.3 21.0 20.4 24.1 21.0 22.5 26.7 21.1 22.1 20.2 18.8 90.7 19.0 26.3 20.4 16.4 28.5 27.1 16.2 38.6 16.5 31.5 24.4 0.6 0.6 1.2 1.6 1.1 2.0 2.4 1.9 1.5 1.9 1.1 1.3 1.1 0.0 1.6 0.2 3.9 1.4 0.9 15.2 15.9 16.5 18.1 16.1 16.9 13.6 14.7 13.1 12.2 16.7 14.1 7.1 9.6 10.8 125.4 9.4 6.6 25.8 11.5 26.7 17.0 16.4 17.0 14.9 18.6 7.4 12.9 16.7 7.3 10.8 7.2 1.9 11.4 9.4 7.2 13.8 9.6 8.4 16.0 161.3 21.3 3.3 11.4 15.3 13.1 5.1 11.9 8.9 7.3 6.2 8.4 213.0 7.4 8.2 3.3 6.5 12.4 16.4 3.2 8.8 102.1 2.7 6.9 2.1 154.3 77.9 12.4 6.2 18.0 20.2 23.3 10.4 18.1 5.8 14.2 19.7 11.9 10.3 54.3 26.1 6.1 3.7 4.8 7.4 3.5 12.4 14.5 SCUBE1 ENSG00000159307 "Signal peptide, CUB domain and EGF like domain containing 1" Q8IWY4 22 43197280-43343372 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 26.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Extravillous trophoblasts: 13.3;Granulosa cells: 37.2;Peritubular cells: 45.5;Theca cells: 14.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 10.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HMC-1: 49.8;THP-1: 20.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003190 Approved "Secreted to blood" NA NA 2170000 190000 "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA003190: AB_1079882" "unprognostic (5.29e-2)" "unprognostic (7.15e-6)" "unprognostic (6.03e-3)" "unprognostic (8.33e-2)" "unprognostic (3.65e-1)" "unprognostic (4.55e-2)" "unprognostic (1.34e-1)" "unprognostic (5.76e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-2)" "unprognostic (1.02e-2)" "unprognostic (2.70e-1)" "unprognostic (2.30e-1)" "unprognostic (6.87e-3)" 1.8 6.1 0.8 0.8 1.1 0.1 1.2 0.1 1.4 0.9 4.1 3.8 5.9 1.1 0.1 3.6 1.2 0.8 0.2 0.6 3.8 3.5 5.1 6.8 0.0 1.7 10.2 26.4 0.1 9.1 3.8 2.6 7.0 1.9 2.0 0.4 3.6 0.5 9.6 0.6 7.7 0.5 0.3 5.7 7.0 7.1 1.2 0.1 3.1 1.9 0.0 3.3 0.7 0.4 0.0 0.0 2.2 7.8 0.0 0.0 4.9 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.1 0.3 0.1 0.7 0.0 0.0 0.1 0.7 0.0 0.1 0.7 0.2 0.2 49.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.1 0.1 0.2 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.3 1.2 0.0 0.1 0.0 0.3 0.1 20.4 0.0 0.3 0.2 0.6 0.0 2.1 4.3 0.0 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.1 1.4 0.6 3.8 1.7 10.2 7.0 0.3 1.2 0.4 0.2 9.6 1.7 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.9 0.1 1.4 0.0 0.6 0.0 0.0 0.2 0.2 0.0 1.9 0.1 3.0 1.3 1.2 1.3 0.0 0.0 0.4 0.0 13.3 2.6 0.5 3.4 1.3 37.2 0.4 1.9 0.8 0.0 0.3 0.2 0.0 0.0 0.4 4.6 7.8 0.2 0.0 0.0 0.1 4.1 0.0 0.0 0.3 0.1 0.0 45.5 0.4 0.0 0.0 0.4 0.7 0.2 0.0 0.4 1.2 3.8 2.0 0.0 0.1 0.4 2.8 14.3 0.0 0.1 SCX "bHLHa41, bHLHa48, SCXA, SCXB" ENSG00000260428 "Scleraxis bHLH transcription factor" Q7RTU7 8 144266453-144268481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 14.2;Horizontal cells: 16.8" "Group enriched" "Detected in all" 6 "endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;HaCaT: 5.3" "Region enhanced" "Detected in many" "cerebellum: 10.7" "Low region specificity" "Detected in some" HPA043183 Uncertain NA NA "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "HPA043183: AB_2678357" "unprognostic (5.32e-2)" "unprognostic (1.06e-2)" "unprognostic (7.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-2)" "unprognostic (6.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (7.89e-3)" 1.4 3.4 3.0 0.9 2.3 0.6 1.4 7.8 7.0 7.8 2.9 8.3 0.9 2.9 0.5 3.4 3.8 0.1 11.0 2.7 2.9 8.4 2.1 3.5 0.4 6.2 1.9 2.5 3.8 0.8 19.6 0.2 5.4 4.5 0.2 0.1 2.7 0.1 13.8 3.2 5.0 0.2 0.9 4.6 5.9 5.2 2.3 0.7 38.1 1.2 0.1 2.6 3.2 1.8 2.0 0.4 0.1 0.5 0.0 0.0 4.8 0.1 0.0 0.1 0.0 0.1 1.4 1.3 1.4 0.2 0.2 5.3 0.0 0.0 0.0 0.9 0.8 0.3 1.9 0.2 0.2 0.1 2.2 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.2 0.6 0.1 3.0 0.5 1.1 1.1 0.4 2.3 1.6 0.2 0.8 0.1 2.0 0.2 0.9 0.5 1.8 2.2 0.1 2.3 0.9 0.3 0.4 3.5 1.6 0.3 1.8 0.6 0.3 0.8 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.3 7.8 7.0 2.7 2.9 6.2 1.9 5.4 0.9 2.3 1.8 3.4 0.0 2.7 8.5 2.5 0.0 1.2 0.0 0.6 14.2 6.7 8.3 6.2 1.5 1.3 3.7 0.0 1.5 7.5 2.2 1.9 0.6 0.2 5.7 1.4 1.2 2.4 0.0 5.9 1.4 0.6 1.2 8.2 7.1 0.0 3.2 0.4 0.4 0.4 16.8 8.5 2.3 0.0 0.6 0.0 0.9 0.3 0.9 0.0 1.0 0.0 8.2 1.0 2.5 0.3 1.5 2.1 0.7 0.7 2.7 1.5 0.2 0.0 1.5 0.0 4.2 6.4 2.5 9.0 0.6 0.0 1.1 3.1 0.3 1.8 1.0 SETD1B "KIAA1076, KMT2G, Set1B" ENSG00000139718 "SET domain containing 1B, histone lysine methyltransferase" Q9UPS6 12 121804009-121832656 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021667, HPA059412" Approved Enhanced Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA021667: AB_1856753, HPA059412: AB_2684006" "unprognostic (1.69e-1)" "unprognostic (2.38e-2)" "unprognostic (6.32e-2)" "unprognostic (3.51e-1)" "unprognostic (2.06e-1)" "unprognostic (2.75e-2)" "unprognostic (5.32e-2)" "unprognostic (1.35e-1)" "unprognostic (1.28e-2)" "unprognostic (5.65e-2)" "unprognostic (1.59e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 14.3 8.9 2.8 8.6 2.5 15.1 12.1 7.6 4.4 19.4 1.3 28.5 7.5 26.0 4.7 14.0 19.6 4.5 8.0 2.7 0.7 8.4 11.3 9.2 6.9 1.7 1.4 15.8 12.5 5.5 9.2 5.5 0.7 15.6 3.7 3.4 11.4 10.0 9.0 11.6 15.6 7.1 0.5 13.1 16.7 9.4 1.6 8.4 13.9 4.2 4.8 22.0 14.1 1.5 7.4 14.8 7.4 12.5 6.9 4.7 11.2 6.8 5.4 5.1 2.9 8.1 4.4 5.4 6.1 7.6 3.2 11.3 8.6 5.3 3.0 9.7 10.5 16.3 20.3 7.1 5.9 15.3 14.0 5.7 6.4 7.0 5.6 6.2 5.6 10.6 17.1 3.7 3.9 17.1 22.5 21.5 10.6 3.6 8.5 17.3 4.8 7.9 5.0 15.1 9.0 6.9 15.0 10.5 5.7 5.5 12.8 13.8 9.5 7.6 9.4 10.8 7.7 7.3 4.0 3.2 6.3 9.7 8.8 1.4 0.2 0.6 0.4 0.5 0.3 0.3 0.3 0.4 0.2 0.3 0.5 0.3 1.0 0.3 0.2 0.5 0.3 0.2 2.8 2.5 7.6 4.4 2.7 0.7 1.7 1.4 0.7 0.5 1.6 1.5 10.1 3.2 7.3 9.8 11.2 11.7 3.2 5.7 26.2 13.8 12.7 9.5 9.7 10.0 6.7 5.5 8.4 7.9 17.6 8.5 0.0 5.1 9.8 13.9 14.5 9.5 7.3 7.8 10.6 7.2 7.0 8.5 8.6 20.3 3.8 10.1 12.1 13.8 6.5 11.8 11.7 7.8 4.1 17.7 14.8 21.4 11.5 10.8 1.8 5.6 13.9 5.0 9.2 5.0 6.8 6.5 10.5 10.1 11.2 9.1 6.8 3.2 5.4 10.0 6.6 10.6 12.9 11.3 3.5 29.4 12.9 13.1 13.3 8.1 6.6 9.1 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 26.9 18.3 18.5 10.1 20.8 28.1 26.3 18.5 24.8 27.1 13.7 25.9 10.1 24.6 4.0 23.2 24.5 4.8 20.2 18.2 19.0 24.9 19.4 20.3 11.3 20.4 19.3 29.0 21.9 7.4 21.7 8.1 19.8 21.8 4.3 9.3 20.2 6.8 29.5 32.6 24.6 5.6 16.9 28.4 20.8 16.3 21.2 12.6 24.5 6.7 7.6 22.3 24.3 25.1 26.1 23.0 16.0 17.0 12.6 10.3 35.8 19.7 13.6 22.9 15.6 22.6 12.3 31.9 18.0 14.8 11.9 23.9 22.7 18.1 13.2 9.9 36.0 29.0 12.9 27.0 13.4 37.8 27.4 11.7 20.4 20.8 24.9 18.2 14.3 24.3 40.9 12.3 10.4 32.7 31.9 57.1 41.9 14.0 38.0 36.7 16.2 25.2 13.3 18.8 25.1 28.3 18.7 15.6 25.1 12.5 22.5 29.1 18.6 19.0 24.8 14.8 22.3 35.0 41.2 31.7 18.7 25.5 25.9 2.0 4.1 1.9 3.0 2.7 3.0 2.1 2.8 2.6 2.9 3.7 3.0 3.4 5.6 5.4 3.4 7.2 2.4 1.8 18.5 20.8 18.5 24.8 18.2 19.0 20.4 19.3 19.8 16.9 21.2 25.1 46.4 73.7 44.5 48.6 37.9 38.9 41.5 19.0 42.1 49.7 25.4 25.9 19.3 21.5 38.6 14.7 66.7 30.4 52.6 22.1 0.0 23.1 21.4 27.0 48.8 39.3 21.6 38.7 55.1 26.6 31.8 39.2 37.8 39.7 38.0 47.1 21.4 16.7 22.1 42.1 43.2 24.9 14.2 27.4 21.4 12.9 30.1 30.3 23.2 36.5 35.4 33.7 50.4 58.3 85.1 28.6 24.1 29.7 43.6 44.7 20.8 11.8 30.7 62.4 46.0 52.1 38.1 39.5 42.8 39.7 46.9 43.6 45.9 48.4 22.9 48.2 SIX5 DMAHP ENSG00000177045 "SIX homeobox 5" Q8N196 19 45764785-45769252 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042068 Approved NA NA "Cluster 72: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" "HPA042068: AB_10795390" "unprognostic (3.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (9.60e-3)" "unprognostic (2.11e-1)" "unprognostic (2.96e-3)" "unprognostic (1.00e-3)" "unprognostic (1.02e-3)" "unprognostic (3.90e-2)" "unprognostic (8.60e-2)" "unprognostic (3.82e-1)" "unprognostic (3.30e-1)" "unprognostic (1.69e-3)" "unprognostic (5.59e-2)" "unprognostic (1.95e-1)" "unprognostic (1.08e-2)" "unprognostic (8.99e-2)" 19.1 23.5 8.8 5.8 8.4 0.6 20.5 8.5 10.0 37.5 13.5 35.8 6.7 34.6 8.7 14.7 37.8 8.1 25.2 7.6 8.5 20.9 24.6 12.6 4.2 11.2 10.5 45.8 41.0 9.3 15.9 8.4 8.5 34.0 4.3 0.6 28.0 15.9 16.0 12.7 14.2 12.6 9.9 12.1 25.4 8.0 9.1 2.3 29.4 5.7 2.9 30.8 22.5 7.9 3.3 19.3 25.6 39.2 16.0 15.9 13.2 7.3 15.5 11.1 9.7 4.8 12.4 1.8 7.0 11.9 13.6 7.5 7.7 8.4 3.7 9.3 11.6 2.1 18.7 13.8 14.1 0.5 11.9 15.6 13.1 7.2 9.2 16.8 9.4 7.6 9.0 3.9 3.2 10.6 2.6 18.2 17.4 10.4 10.9 9.7 2.3 7.9 12.1 4.1 1.6 10.5 21.7 10.7 16.8 10.1 10.0 18.8 5.7 11.0 10.3 10.0 8.1 4.7 5.1 1.9 15.9 0.9 12.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 8.4 8.5 10.0 7.6 8.5 11.2 10.5 8.5 9.9 9.1 7.9 5.2 0.0 7.2 7.5 1.0 3.2 5.4 7.9 4.6 0.1 11.6 14.7 0.3 11.5 3.4 5.5 0.0 6.1 0.3 2.1 3.9 6.2 0.4 7.3 14.9 5.2 3.0 0.0 0.0 6.0 13.1 9.1 4.1 8.3 0.0 11.0 6.8 7.0 1.1 5.0 0.0 8.6 2.0 0.8 1.4 1.2 15.8 0.9 0.0 3.7 0.0 3.1 0.0 0.0 0.1 5.0 2.1 12.8 5.5 6.1 0.7 1.9 4.0 0.5 0.0 8.2 8.8 0.5 3.5 4.2 2.6 4.0 0.8 4.5 5.0 1.4 SLC39A13 FLJ25785 ENSG00000165915 "Solute carrier family 39 member 13" Q96H72 11 47407132-47416496 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 13 "Early spermatids: 298.2;Late spermatids: 905.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043971 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "HPA043971: AB_10959744" "unprognostic (7.84e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.18e-1)" "unprognostic (8.56e-3)" "unprognostic (3.81e-2)" "unprognostic (7.44e-3)" "unprognostic (1.36e-1)" "unprognostic (5.40e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (1.39e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (8.61e-2)" "unprognostic (4.12e-1)" 40.9 42.4 28.3 24.2 31.4 8.3 37.5 30.6 36.3 51.1 30.4 53.4 14.0 77.9 8.8 21.8 48.1 20.2 59.5 26.0 27.3 80.4 26.7 61.4 18.2 33.0 29.7 50.9 42.3 27.2 51.3 40.6 30.4 52.7 6.8 11.0 31.3 26.2 31.4 32.4 31.8 26.6 26.8 36.5 41.2 73.4 35.0 12.3 46.8 12.6 8.7 45.6 37.4 28.5 23.3 20.4 23.5 26.7 56.3 78.2 6.8 89.7 66.2 50.4 57.0 8.1 15.7 8.8 22.9 69.6 49.6 38.3 7.1 61.7 13.9 25.7 25.9 4.7 52.7 16.7 84.3 8.1 11.0 65.4 43.4 31.9 26.1 62.9 53.4 16.9 4.5 19.6 54.8 20.7 17.4 11.5 11.0 19.8 28.2 20.6 33.6 8.9 86.1 11.1 19.9 37.0 26.9 49.1 26.2 8.7 32.8 11.7 76.0 76.6 34.6 88.1 42.7 14.9 5.2 4.1 85.2 11.2 57.3 2.1 3.6 3.2 12.4 13.3 8.5 4.1 8.2 8.9 4.6 5.1 7.5 6.4 6.6 7.4 15.3 4.9 4.5 5.9 28.3 31.4 30.6 36.3 26.0 27.3 33.0 29.7 30.4 26.8 35.0 28.5 20.0 9.6 6.4 18.6 6.7 18.2 18.3 23.0 17.1 24.0 11.5 15.6 18.3 15.7 8.0 29.5 12.5 11.1 11.6 3.4 9.8 32.9 298.2 6.5 20.3 20.9 9.6 4.4 9.6 20.7 16.4 37.8 6.6 13.1 5.7 15.4 21.8 6.2 18.9 32.0 11.7 7.9 14.2 5.3 12.2 905.5 32.9 9.3 19.6 4.7 26.6 16.7 11.3 8.0 10.1 35.5 8.3 40.3 8.1 23.5 8.2 8.8 4.5 17.0 46.0 16.1 36.2 12.7 6.4 2.4 4.1 19.6 9.6 36.7 5.7 8.3 SLC8B1 "FLJ22233, NCKX6, NCLX, SLC24A6" ENSG00000089060 "Solute carrier family 8 member B1" Q6J4K2 12 113298759-113359493 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 75.4" "Cell type enhanced" "Detected in many" "Theca cells: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040668 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "HPA040668: AB_10793861" "prognostic favorable (9.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.27e-1)" "unprognostic (4.30e-1)" "unprognostic (1.93e-2)" "unprognostic (2.80e-3)" "unprognostic (1.90e-1)" "unprognostic (6.52e-2)" "unprognostic (1.84e-1)" "unprognostic (2.68e-2)" "unprognostic (2.60e-1)" "unprognostic (5.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.54e-3)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.02e-4)" 18.5 75.4 7.6 14.8 10.3 17.7 15.1 8.6 8.6 19.3 4.4 15.6 10.6 11.9 7.9 15.8 13.1 11.3 11.0 7.5 8.0 17.2 17.6 20.6 13.8 14.2 9.5 55.5 18.1 7.5 15.3 8.1 10.6 16.9 9.3 1.4 16.9 9.1 10.0 19.4 16.9 6.9 9.3 29.4 12.1 13.6 11.6 18.0 13.1 5.6 9.9 12.7 15.2 11.2 25.3 5.5 3.2 7.0 15.5 10.9 10.6 8.3 23.8 10.6 10.3 5.4 21.1 6.6 18.5 10.8 9.2 20.1 9.8 5.7 5.1 16.3 3.1 13.3 13.1 6.2 25.8 33.9 28.7 11.1 16.9 12.2 5.2 9.1 24.5 24.0 27.7 3.3 6.0 5.9 10.6 27.5 5.7 8.2 14.2 3.9 4.2 8.3 11.4 34.7 0.2 5.4 22.5 45.1 5.4 4.2 8.0 13.1 54.3 7.5 8.8 22.4 5.0 4.5 10.3 5.0 9.6 19.2 6.0 4.1 16.5 32.8 8.0 24.1 10.2 3.3 14.5 7.9 19.1 4.4 28.8 13.5 10.3 6.1 24.8 14.3 19.4 15.8 7.6 10.3 8.6 8.6 7.5 8.0 14.2 9.5 10.6 9.3 11.6 11.2 9.3 12.8 12.6 13.7 5.8 4.5 13.2 8.0 4.6 2.4 8.4 6.5 4.3 8.6 10.9 12.9 10.4 7.8 9.2 30.6 5.9 13.0 1.5 6.0 9.4 9.6 4.9 1.7 7.7 17.4 8.6 13.6 14.3 15.5 21.5 32.4 6.4 12.0 21.6 0.0 3.9 13.3 4.1 21.8 22.6 1.5 24.5 32.4 1.8 22.5 17.8 2.8 5.2 4.0 6.2 22.5 20.7 28.2 3.3 19.1 23.6 3.3 4.5 0.8 32.9 9.9 13.3 1.0 3.9 12.2 7.1 10.7 9.8 96.7 13.3 21.3 SMARCB1 "BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1" ENSG00000099956 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1" Q12824 22 23786931-23838009 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009196, HPA018248, HPA019127" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 57: B-cells - Immune response" Nucleoplasm "Nucleoli fibrillar center" "CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165" "unprognostic (2.15e-1)" "unprognostic (5.62e-2)" "unprognostic (6.60e-3)" "unprognostic (1.63e-2)" "unprognostic (4.01e-3)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.52e-4)" "unprognostic (4.10e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.10e-2)" "unprognostic (4.43e-3)" "prognostic favorable (1.14e-6)" "unprognostic (1.24e-1)" "unprognostic (4.58e-2)" "unprognostic (4.57e-2)" "unprognostic (7.04e-2)" 35.9 46.4 2.3 6.9 2.5 3.3 40.3 4.1 10.0 51.5 2.7 40.9 8.1 51.4 0.4 51.0 40.4 2.2 44.0 2.3 2.3 47.0 36.9 32.3 5.8 4.3 2.7 63.1 43.9 1.2 48.0 1.2 2.7 36.6 1.1 25.3 44.1 0.6 48.1 50.1 51.7 0.6 2.2 51.7 40.4 68.3 2.3 3.5 41.3 1.8 1.5 37.5 40.9 2.9 2.4 1.6 28.2 2.6 2.7 0.7 5.8 9.2 2.7 2.7 4.3 3.4 2.6 24.2 7.9 1.2 2.9 4.4 6.9 4.6 4.5 4.1 10.5 20.1 3.2 2.1 3.0 21.7 5.6 1.6 3.4 3.2 6.9 1.4 1.4 3.0 5.6 12.9 1.7 6.1 17.6 5.0 8.6 7.2 5.7 11.0 23.1 10.8 2.3 4.5 13.4 10.1 2.2 0.6 17.9 14.8 2.2 3.3 2.2 2.4 9.8 3.8 2.7 13.8 14.3 17.7 1.8 11.3 6.8 7.1 12.8 6.4 4.4 13.4 6.4 24.4 5.5 5.7 12.0 9.2 4.5 3.0 1.1 9.8 16.8 13.3 10.4 8.1 2.3 2.5 4.1 10.0 2.3 2.3 4.3 2.7 2.7 2.2 2.3 2.9 33.6 6.4 8.6 17.0 120.2 50.2 73.3 85.1 51.2 55.4 42.9 49.1 6.1 47.1 37.4 47.8 20.9 120.6 61.8 36.6 84.1 94.6 42.6 40.9 54.9 37.4 71.8 57.8 14.1 77.1 228.1 46.2 41.8 41.1 34.8 112.2 41.0 20.3 76.1 67.3 18.4 54.6 99.7 23.0 41.7 18.9 35.8 36.5 56.9 15.9 51.2 92.4 45.3 17.1 18.1 74.7 53.1 32.0 139.6 74.4 41.9 86.4 28.5 49.6 19.7 47.7 62.8 138.9 163.3 64.5 53.0 160.1 42.0 96.8 65.4 65.1 SMN1 "BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A" ENSG00000172062 "Survival of motor neuron 1, telomeric" Q16637 5 70925030-70953942 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Club cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3" "CAB016324, HPA045271, CAB069888, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" "Nuclear bodies, Cytosol" "CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: " "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.18e-1)" "unprognostic (2.09e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-3)" "unprognostic (2.10e-2)" "unprognostic (2.43e-1)" "unprognostic (9.91e-3)" "unprognostic (1.13e-2)" "unprognostic (1.01e-1)" "unprognostic (4.41e-1)" "prognostic unfavorable (6.62e-13)" "unprognostic (2.04e-1)" "unprognostic (2.17e-1)" "unprognostic (8.06e-2)" "unprognostic (4.14e-2)" 28.0 21.8 5.7 4.9 6.1 21.8 26.8 7.6 7.5 33.8 5.0 25.8 2.1 24.7 12.8 25.8 31.5 7.4 20.4 6.3 7.1 22.6 37.6 22.0 15.5 6.5 5.7 36.8 27.6 6.9 26.4 5.1 6.1 25.6 7.8 12.1 21.5 3.8 31.5 24.0 19.6 8.2 5.9 22.6 20.3 24.8 5.7 2.4 24.2 1.5 1.9 26.1 27.6 6.6 11.3 2.1 3.5 4.0 19.3 23.0 62.8 3.5 4.9 5.3 3.8 4.1 4.1 4.6 69.5 9.9 5.8 7.4 5.4 3.7 4.2 1.0 5.2 65.4 6.2 6.2 1.3 7.9 5.8 1.5 29.8 1.8 1.8 31.4 3.0 4.1 2.7 6.4 2.7 3.2 120.5 77.9 4.4 0.9 2.1 6.0 15.9 58.0 2.4 5.2 11.4 16.2 6.5 23.4 69.4 2.4 88.9 21.2 32.7 33.8 3.8 3.1 7.5 4.2 3.0 60.0 4.9 4.8 120.3 9.8 7.4 4.3 6.4 12.2 17.6 13.2 10.2 7.7 11.2 7.2 13.1 14.5 2.1 8.7 13.5 13.1 16.1 6.3 5.7 6.1 7.6 7.5 6.3 7.1 6.5 5.7 6.1 5.9 5.7 6.6 5.0 9.6 11.5 0.0 5.6 13.9 4.6 10.7 0.6 4.7 4.1 4.3 22.4 7.2 29.9 1.8 10.4 7.9 7.0 2.3 5.9 6.8 18.2 5.6 5.5 6.8 6.0 9.9 1.3 4.6 8.4 11.8 4.1 4.4 19.6 4.0 5.0 2.9 4.8 3.3 1.1 4.2 10.2 3.4 4.4 12.9 9.3 5.2 5.4 0.0 6.1 1.4 12.3 1.0 1.3 6.5 1.8 6.4 5.1 2.9 3.8 4.5 28.1 7.8 13.1 7.4 8.5 16.0 17.2 6.9 12.5 8.8 7.2 5.6 4.2 4.1 SMN2 "BCD541, GEMIN1, SMNC, TDRD16B" ENSG00000205571 "Survival of motor neuron 2, centromeric" Q16637 5 70049638-70078522 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 41.8;Club cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2" "CAB009344, HPA045271, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies, Cytosol" "CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: " "unprognostic (2.07e-2)" "unprognostic (5.70e-3)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.77e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.21e-1)" "unprognostic (5.19e-2)" "unprognostic (2.98e-5)" "unprognostic (2.36e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (1.19e-1)" 19.7 15.6 1.6 4.5 1.8 13.8 19.4 1.0 2.3 20.3 1.0 19.2 0.5 20.0 16.9 17.1 15.2 13.6 16.0 1.1 7.2 14.4 23.2 16.4 13.8 1.7 2.0 25.9 18.3 8.4 20.5 3.8 2.0 18.8 5.6 3.0 15.1 5.8 26.0 17.0 13.6 14.0 1.3 14.7 14.5 16.5 1.6 0.1 17.3 0.0 0.1 16.0 20.9 2.3 61.3 0.6 0.6 0.4 16.1 20.9 122.7 31.7 21.1 42.0 44.0 0.4 0.4 1.2 86.6 31.8 1.1 28.8 0.9 0.0 50.1 0.8 1.2 68.6 0.0 2.1 0.0 1.1 0.0 0.3 36.0 0.0 1.1 14.3 0.7 0.0 0.0 0.6 0.0 0.6 125.1 106.2 0.5 0.0 0.5 0.0 45.8 55.3 31.5 0.3 30.5 70.7 60.2 6.7 89.7 0.0 41.4 25.2 53.4 27.2 1.3 0.4 0.7 0.6 1.1 72.4 0.4 0.0 76.2 8.0 9.9 5.2 12.1 16.5 14.6 16.8 14.4 10.1 16.6 20.0 17.0 14.8 1.8 10.9 11.4 16.3 12.7 13.4 1.6 1.8 1.0 2.3 1.1 7.2 1.7 2.0 2.0 1.3 1.6 2.3 2.0 6.4 7.8 0.0 2.7 13.6 3.4 9.7 1.8 0.3 2.7 2.8 41.8 0.0 20.2 1.8 0.0 6.9 4.0 1.1 5.9 2.7 14.1 3.3 4.0 6.6 1.8 3.4 0.0 1.0 3.3 10.1 2.6 3.2 8.2 1.2 2.5 3.1 2.6 1.7 0.0 3.1 6.1 2.6 6.8 8.9 7.2 3.3 1.8 0.0 2.9 0.6 2.1 0.0 0.0 2.3 1.6 5.3 2.5 1.7 2.7 3.8 14.0 1.1 0.0 5.3 6.4 12.0 11.4 3.1 12.6 7.1 5.0 1.0 2.5 2.8 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027440-99144108 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 100.2;Microglial cells: 89.9;Oligodendrocytes: 211.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 9.2;BJ: 15.2;EFO-21: 12.8;HDLM-2: 8.1;PC-3: 18.2;U-2 OS: 8.3;U-251 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "HPA019671: , HPA055245: AB_2682757" "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 17.7 13.9 0.7 0.3 0.8 1.1 14.3 0.5 0.9 13.4 1.1 12.7 0.0 12.3 0.0 22.0 12.2 0.0 9.0 0.8 0.3 11.6 11.7 18.5 0.0 1.1 0.7 20.6 15.5 0.0 11.2 0.0 1.0 13.3 0.0 0.7 15.0 0.0 12.7 20.2 11.7 0.0 0.1 10.0 16.1 20.9 0.8 0.0 8.5 0.0 0.0 12.4 15.5 1.8 9.2 0.0 0.1 0.2 0.0 0.0 1.3 15.2 0.1 0.4 0.0 0.0 0.4 1.6 12.8 0.0 0.3 4.5 0.0 0.1 0.0 8.1 2.3 0.0 0.7 0.7 0.1 0.1 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.9 0.1 0.8 0.1 1.3 1.9 2.8 0.0 18.2 2.5 1.2 0.0 0.0 0.4 0.3 1.5 0.7 0.5 0.9 0.3 0.3 0.0 1.4 0.0 8.3 1.3 9.4 2.0 4.9 1.3 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.5 0.9 0.8 0.3 1.1 0.7 1.0 0.1 0.8 1.8 9.7 19.2 27.5 59.4 8.9 25.9 25.5 10.0 25.0 28.2 10.3 7.2 4.4 20.0 18.5 12.9 8.4 7.7 4.6 17.1 1.9 14.7 6.2 13.3 8.8 12.8 11.4 0.4 100.2 16.0 10.3 10.8 46.9 23.3 2.5 6.8 9.7 9.3 6.6 26.9 77.0 11.0 4.1 4.1 10.9 8.5 6.2 8.8 8.8 89.9 5.5 3.3 5.2 70.4 211.9 34.8 14.9 13.9 5.4 37.9 7.1 5.5 22.1 7.6 6.6 10.4 15.1 32.8 2.4 19.3 22.0 21.1 8.8 6.5 8.1 77.5 SNRNP70 "RNPU1Z, RPU1, Snp1, SNRP70, U1-70K" ENSG00000104852 "Small nuclear ribonucleoprotein U1 subunit 70" P08621 19 49085419-49108605 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001718, HPA042050, HPA043516" Supported Enhanced Nucleoplasm NA NA 74000 "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523" "unprognostic (2.22e-3)" "unprognostic (5.27e-2)" "unprognostic (9.13e-3)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (2.58e-2)" "unprognostic (4.01e-3)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.59e-5)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.12e-5)" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "prognostic favorable (5.35e-5)" 77.2 106.0 30.1 41.3 28.2 49.5 79.1 29.2 46.0 108.1 29.8 90.6 39.4 96.6 21.0 103.9 95.4 13.8 88.1 28.4 32.4 83.4 96.3 81.2 43.5 28.6 28.5 107.7 95.9 28.6 104.9 26.8 27.9 107.4 21.9 18.5 92.9 23.3 104.2 95.2 90.5 20.7 24.6 106.7 94.3 72.9 28.4 45.8 103.5 16.7 33.0 81.9 94.4 34.1 178.5 224.0 142.3 101.6 56.4 34.3 155.3 125.4 81.7 136.1 118.1 140.4 103.5 203.9 127.1 89.0 123.1 152.2 176.6 128.2 101.0 137.0 468.2 185.9 103.6 164.9 29.2 209.1 125.2 48.0 35.4 99.6 67.2 64.5 103.0 107.2 195.4 65.7 84.4 175.3 218.8 338.3 175.3 102.9 167.4 254.7 133.7 124.6 87.9 113.7 112.3 136.9 158.3 96.1 94.8 94.5 98.9 132.3 147.0 101.8 190.5 86.7 223.5 164.3 156.5 263.2 84.1 135.9 95.2 0.8 2.0 1.8 1.8 1.5 1.1 4.0 1.4 0.8 2.0 1.7 2.0 1.5 0.8 4.1 1.8 1.7 1.2 0.8 30.1 28.2 29.2 46.0 28.4 32.4 28.6 28.5 27.9 24.6 28.4 34.1 86.6 19.2 63.0 198.5 107.2 139.4 166.8 78.4 93.9 108.7 97.8 109.5 31.6 55.8 66.0 75.4 89.6 179.7 97.5 89.8 46.9 108.1 23.7 101.8 141.9 84.2 118.0 76.6 81.0 105.1 208.6 92.3 110.1 123.0 55.1 111.7 61.4 97.4 125.8 114.4 99.2 121.4 77.3 58.7 97.7 21.3 130.1 77.8 69.4 74.0 75.8 82.6 76.2 110.6 151.9 116.0 80.0 110.6 112.0 177.1 95.0 77.5 59.3 109.6 124.9 102.3 101.2 109.7 108.6 92.3 130.7 176.4 96.3 115.4 119.6 154.7 SNX17 KIAA0064 ENSG00000115234 "Sorting nexin 17" Q15036 2 27370496-27377535 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043867 Supported Enhanced Vesicles,Cytosol No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles Cytosol "HPA043867: AB_10961129" "unprognostic (2.57e-1)" "unprognostic (7.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.06e-3)" "unprognostic (1.86e-1)" "unprognostic (4.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.04e-2)" "unprognostic (9.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.20e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-1)" "unprognostic (6.32e-3)" 62.5 74.6 32.2 23.1 32.6 19.8 57.0 35.3 31.8 59.7 32.1 58.5 17.3 62.8 16.6 62.2 57.7 22.1 60.3 30.3 32.7 54.6 62.9 53.8 32.3 33.5 33.1 62.4 53.9 42.5 61.1 28.1 37.1 54.2 23.3 12.8 50.3 31.6 49.2 57.0 53.3 33.4 36.3 80.8 54.1 34.1 35.0 43.9 54.3 33.9 33.8 59.8 50.9 37.0 40.1 70.0 45.3 56.4 85.9 71.5 29.0 47.3 85.2 71.8 52.2 43.5 37.8 39.5 55.4 113.9 61.9 23.7 42.4 63.8 57.9 40.7 72.5 44.8 20.3 55.4 80.9 47.6 41.6 66.9 56.7 49.6 59.5 54.1 78.3 32.7 35.5 32.8 87.2 47.7 50.2 31.3 29.2 62.5 67.1 22.7 74.0 64.9 53.5 34.1 46.3 55.1 38.6 39.0 18.1 31.9 30.5 29.6 50.6 57.4 31.6 33.8 45.5 56.8 47.5 49.4 50.0 49.8 60.9 87.5 138.7 88.9 65.6 135.2 66.9 72.7 61.2 67.6 135.6 73.2 57.5 60.6 30.8 72.2 146.9 73.8 78.5 231.9 32.2 32.6 35.3 31.8 30.3 32.7 33.5 33.1 37.1 36.3 35.0 37.0 60.8 16.0 39.1 6.5 68.3 32.5 48.2 78.3 32.5 30.9 47.1 61.3 31.5 35.8 43.3 29.5 14.6 173.5 69.3 56.9 82.2 84.0 8.9 34.4 39.9 52.7 55.1 49.2 6.8 63.9 132.7 60.3 35.2 25.6 43.1 64.5 47.5 64.9 134.9 45.4 7.7 48.3 79.3 118.1 42.7 9.7 58.4 83.4 69.4 2.8 141.9 80.1 76.2 11.1 11.2 64.8 54.1 85.0 60.3 41.4 75.4 95.3 38.6 23.2 32.9 41.4 68.4 58.0 53.2 55.0 34.4 99.6 63.2 102.1 60.0 34.9 SNX2 ENSG00000205302 "Sorting nexin 2" O60749 5 122775079-122834543 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 349.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "memory B-cell: 290.2;naive B-cell: 289.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037400 Approved Supported Endosomes,Lysosomes NA NA 150000 "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "Endosomes, Lysosomes" "HPA037400: AB_10670381" "unprognostic (9.26e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.90e-6)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "prognostic favorable (8.76e-7)" "unprognostic (8.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.07e-1)" "unprognostic (8.59e-2)" 40.6 31.0 6.0 17.9 6.5 14.2 33.8 9.5 8.5 27.8 6.2 32.6 13.4 28.2 12.5 30.1 29.0 12.8 22.4 6.2 6.5 37.8 28.0 33.7 26.5 6.4 7.0 37.1 31.3 14.1 23.2 19.2 6.5 24.2 14.5 7.1 29.1 10.1 27.0 29.0 34.8 17.9 6.9 52.4 32.9 17.1 7.1 10.4 38.3 7.7 24.0 33.6 26.1 8.5 18.9 14.1 18.7 13.1 27.8 19.0 79.6 6.2 21.1 15.1 24.2 27.1 27.2 18.8 18.5 14.9 37.4 6.1 24.6 16.2 18.0 13.4 12.2 23.3 15.8 29.7 19.7 7.7 10.8 16.1 12.8 9.6 16.6 17.6 16.8 15.4 10.1 14.9 14.0 16.1 5.5 11.6 6.3 22.2 10.7 20.2 14.3 25.4 17.3 33.9 12.0 13.3 16.0 19.8 17.0 46.4 24.2 16.0 10.7 13.7 6.9 19.1 11.7 4.4 14.9 24.4 13.6 32.1 15.6 77.9 78.5 57.0 15.4 89.1 18.3 290.2 25.7 24.2 66.5 289.1 23.6 21.0 34.7 18.5 86.6 20.1 48.7 72.7 6.0 6.5 9.5 8.5 6.2 6.5 6.4 7.0 6.5 6.9 7.1 8.5 48.4 35.3 42.8 33.0 260.8 40.7 46.9 82.3 45.5 43.1 23.8 29.3 34.4 40.0 62.4 80.9 8.4 153.9 36.2 19.9 131.0 69.1 25.5 71.5 44.7 49.0 31.8 34.3 38.5 51.8 244.9 62.1 52.5 52.2 65.1 41.8 89.6 31.4 349.2 26.9 42.2 32.6 69.2 125.8 75.8 15.0 53.4 133.0 33.8 61.8 215.8 71.7 23.7 51.8 51.4 35.7 37.0 53.0 37.5 28.1 57.8 114.7 77.8 38.0 46.0 42.8 74.5 89.1 75.9 32.9 38.9 122.9 47.2 92.4 39.8 37.5 SPG7 "CAR, CMAR, SPG5C" ENSG00000197912 "SPG7 matrix AAA peptidase subunit, paraplegin" Q9UQ90 16 89490719-89557766 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 52: Non-specific - Transcription" "unprognostic (1.42e-1)" "unprognostic (1.72e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (2.33e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.56e-2)" "unprognostic (7.01e-2)" "unprognostic (1.44e-2)" "unprognostic (2.58e-1)" "unprognostic (1.71e-1)" "prognostic favorable (4.25e-4)" 29.8 44.8 19.3 7.0 18.8 8.2 27.9 21.3 28.6 31.5 18.5 33.3 9.9 31.8 4.0 28.2 26.4 6.8 52.3 19.4 18.3 32.4 47.0 24.9 8.9 19.7 18.6 39.0 31.9 13.8 38.7 5.9 20.3 31.2 8.1 9.9 29.0 9.7 56.7 31.3 35.5 9.0 16.9 34.1 31.1 31.9 18.7 10.5 53.1 31.0 8.0 30.1 26.9 20.0 11.5 28.3 17.3 26.6 33.2 24.2 10.9 27.3 24.6 21.0 10.4 23.0 22.3 16.5 32.5 20.1 16.2 30.5 21.5 24.4 14.7 11.7 25.3 11.4 12.0 43.4 16.2 5.5 10.3 15.2 20.1 12.8 14.1 27.9 25.6 22.0 23.1 5.5 21.7 21.0 14.4 22.5 21.9 23.8 21.4 31.8 26.2 10.8 15.9 17.3 16.4 10.5 44.9 8.3 9.5 15.2 22.6 17.0 33.7 13.9 17.2 12.0 12.2 13.7 19.8 12.8 17.7 19.8 17.7 4.5 2.5 3.9 2.7 2.4 2.6 1.6 1.7 1.3 2.8 3.4 3.1 2.0 2.9 3.7 1.7 2.3 1.8 1.0 19.3 18.8 21.3 28.6 19.4 18.3 19.7 18.6 20.3 16.9 18.7 20.0 53.9 48.1 49.4 39.2 45.6 15.9 27.9 30.1 44.9 57.8 31.2 37.2 45.8 22.8 41.5 35.0 95.9 39.9 47.6 42.3 19.6 40.0 66.0 50.5 41.7 49.9 37.2 27.3 58.5 25.8 28.8 35.9 67.2 54.1 21.5 95.3 51.0 38.1 32.2 40.4 53.1 43.8 30.5 34.8 21.8 22.1 42.9 35.2 21.4 35.6 42.6 30.5 51.5 87.0 46.2 39.5 39.5 33.4 43.5 29.5 68.2 23.8 37.7 73.7 6.6 36.9 36.2 57.5 36.5 36.7 18.0 25.9 45.5 68.3 51.0 28.7 SPNS1 "HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 26.8 30.8 17.0 19.3 17.4 37.0 24.8 17.1 26.3 27.7 18.6 32.5 22.4 30.9 6.6 25.9 23.0 18.0 27.5 16.9 15.7 32.1 33.9 31.5 20.1 19.1 16.6 22.0 24.4 20.8 21.1 19.8 17.2 26.5 10.0 6.5 24.4 14.9 25.0 35.7 27.8 15.1 15.8 33.9 28.2 20.3 19.8 20.8 27.8 14.9 10.5 30.5 25.2 18.3 25.9 59.6 22.2 51.9 41.5 22.8 62.9 28.2 28.9 46.1 40.9 55.0 60.4 16.4 67.8 25.5 38.2 53.3 36.4 31.2 16.4 19.0 61.6 23.8 57.1 69.3 70.4 26.7 49.2 38.4 40.9 49.7 21.0 26.8 42.9 30.0 54.4 28.7 23.4 68.8 29.3 75.8 52.6 20.8 39.1 36.7 26.7 73.6 24.9 24.8 39.5 51.3 20.1 59.3 44.9 18.5 59.2 31.9 36.6 37.3 28.2 52.7 22.0 43.2 36.7 15.6 47.7 40.4 30.8 13.4 32.8 13.5 9.9 42.1 8.3 5.7 9.8 13.0 27.6 4.3 10.0 6.8 5.6 7.7 28.8 11.5 12.1 18.1 17.0 17.4 17.1 26.3 16.9 15.7 19.1 16.6 17.2 15.8 19.8 18.3 24.4 6.4 7.2 8.8 14.9 21.3 21.3 29.8 14.8 31.0 17.2 15.7 0.3 20.0 20.1 20.2 29.2 63.3 26.5 10.5 13.7 58.1 2.1 15.3 19.2 24.1 12.2 21.8 10.2 45.7 72.3 24.6 16.8 18.9 22.7 40.9 19.2 14.3 98.7 26.9 10.3 13.8 46.8 45.6 28.4 3.7 22.7 61.8 33.8 15.0 32.7 28.5 24.7 7.1 8.6 37.3 16.0 16.6 18.6 14.4 41.5 18.2 26.2 38.6 6.6 17.4 23.8 24.8 33.5 16.4 22.7 87.3 20.7 37.8 20.0 19.4 SRSF4 "SFRS4, SRP75" ENSG00000116350 "Serine and arginine rich splicing factor 4" Q08170 1 29147743-29181900 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050975 Supported Supported "Nuclear speckles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 22: Epithelial cell types - Mixed function" "Nuclear speckles" "HPA050975: AB_2681296" "unprognostic (3.26e-3)" "unprognostic (8.08e-2)" "unprognostic (1.29e-2)" "unprognostic (1.57e-3)" "unprognostic (1.37e-1)" "unprognostic (5.89e-2)" "unprognostic (1.89e-3)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.36e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (4.26e-4)" "prognostic unfavorable (4.30e-4)" "unprognostic (6.25e-3)" "unprognostic (2.80e-1)" "unprognostic (7.75e-3)" "unprognostic (1.60e-2)" 84.7 61.1 43.4 46.8 45.4 77.5 78.2 47.6 46.6 82.3 44.1 86.7 49.6 79.7 38.6 73.5 71.7 36.4 61.9 43.0 46.9 62.9 95.8 83.5 57.4 44.8 43.7 88.2 61.6 38.7 56.0 57.6 45.6 72.0 35.6 51.8 62.5 39.6 94.1 76.2 73.1 40.6 43.0 81.9 66.7 44.5 45.0 63.2 73.7 51.7 43.4 77.7 76.6 46.1 108.2 63.5 117.0 42.8 83.9 63.0 72.5 87.6 65.5 103.3 88.0 58.6 64.9 122.2 79.9 74.5 66.9 99.0 99.7 81.4 104.5 148.6 118.9 185.7 95.6 92.9 87.2 127.8 114.0 51.1 101.1 87.7 111.8 83.9 86.6 70.2 154.8 95.7 71.1 54.1 162.2 110.4 125.2 64.4 60.0 150.6 126.9 83.3 71.1 110.0 71.3 81.4 107.4 61.5 105.8 103.4 41.0 76.3 84.2 82.9 66.1 91.0 146.4 88.0 70.6 134.5 79.4 161.0 91.9 72.7 45.7 102.2 64.6 55.1 63.3 49.0 59.7 70.5 55.8 53.1 51.0 55.0 89.6 48.4 62.3 43.2 78.9 51.1 43.4 45.4 47.6 46.6 43.0 46.9 44.8 43.7 45.6 43.0 45.0 46.1 142.3 80.1 129.8 23.8 94.2 99.8 179.6 65.0 91.0 70.2 50.2 42.9 51.1 45.8 92.8 51.5 85.5 132.7 100.0 68.4 54.8 64.9 8.2 85.4 98.4 131.0 39.0 114.3 20.1 47.2 124.6 87.8 76.5 99.4 91.7 76.2 101.0 75.9 68.8 57.2 21.1 72.7 59.0 69.8 79.0 11.6 85.7 83.4 55.2 14.0 88.6 74.8 92.7 19.6 19.6 56.3 78.8 89.1 121.4 172.3 83.1 58.3 91.7 108.3 72.3 99.5 97.4 64.7 51.9 95.9 103.3 142.8 105.1 75.9 78.7 210.4 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375977-70439237 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Uncertain Vesicles "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favorable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavorable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 8.6 8.3 4.7 6.4 5.8 7.4 7.2 8.4 6.5 9.3 1.6 9.2 3.5 12.5 1.1 2.6 8.2 2.5 10.5 7.1 2.9 8.2 10.3 9.0 6.3 3.1 2.6 7.2 3.6 2.6 6.4 3.2 2.6 7.1 1.6 1.7 3.2 2.8 15.8 4.2 7.1 4.1 1.9 13.2 4.7 6.7 3.3 3.6 6.0 3.1 3.4 8.4 5.6 2.9 1.7 8.6 7.7 11.2 3.9 5.4 2.3 6.1 6.0 6.2 3.0 5.5 4.0 4.6 9.8 6.3 5.8 1.9 3.2 2.5 3.3 9.9 5.0 18.0 4.5 8.7 4.7 6.7 29.4 4.1 1.5 6.7 1.3 8.2 8.6 7.6 25.1 4.2 3.7 1.5 7.5 19.8 10.1 2.9 4.5 13.9 2.9 5.9 5.1 1.5 3.7 9.4 15.8 0.6 7.1 8.1 2.4 7.3 9.9 9.0 10.0 4.0 4.7 8.6 3.9 9.7 10.0 5.9 12.5 4.2 1.9 5.2 2.0 1.8 1.7 2.0 2.3 2.0 1.0 2.9 3.8 3.0 10.1 2.8 1.3 14.3 2.6 1.1 4.7 5.8 8.4 6.5 7.1 2.9 3.1 2.6 2.6 1.9 3.3 2.9 15.4 9.6 5.2 13.4 12.6 3.3 4.2 2.1 2.2 15.7 2.8 3.0 6.8 10.0 1.9 9.2 14.6 4.7 56.1 4.5 0.0 5.7 16.9 1.7 6.5 15.0 13.2 24.8 21.3 4.4 2.5 11.0 2.6 2.2 17.7 19.7 18.2 13.1 13.7 18.5 15.2 4.5 2.0 15.4 35.1 33.2 11.8 11.9 1.8 17.8 24.9 5.6 23.7 16.6 7.4 1.8 1.5 8.2 13.5 3.0 6.8 5.7 1.3 11.1 6.6 8.5 8.8 9.3 8.9 1.1 2.4 1.8 11.5 4.7 5.6 2.3 STK19 "D6S60, G11, RP1" ENSG00000204344 "Serine/threonine kinase 19" P49842 6 31971091-31982821 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in all" 4 "Proximal tubular cells: 348.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031511, HPA068559" Uncertain Supported "Nuclear speckles" NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear speckles" "HPA031511: AB_2673915, HPA068559: AB_2686004" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.31e-1)" "unprognostic (1.86e-1)" "unprognostic (2.63e-1)" "unprognostic (1.67e-1)" "unprognostic (1.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" "unprognostic (2.25e-2)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.40e-1)" "unprognostic (4.10e-1)" 1.5 3.6 0.1 0.2 0.1 0.0 1.3 0.4 0.9 2.1 0.0 2.5 0.0 1.4 0.3 1.9 1.0 0.1 1.2 0.0 0.0 1.5 2.2 1.3 0.0 0.0 0.0 1.1 1.1 0.2 1.4 0.4 0.1 2.1 0.0 0.2 0.9 0.1 1.3 2.5 0.7 0.0 0.0 1.2 1.3 1.5 0.1 0.1 1.2 0.0 0.1 2.0 1.5 0.4 0.0 0.1 0.0 0.4 1.1 0.7 0.0 0.3 0.1 0.2 0.4 0.0 0.7 0.6 0.3 0.5 0.0 0.6 0.0 0.2 0.3 1.4 0.4 1.5 0.3 0.0 0.5 1.6 0.0 0.6 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 1.1 0.4 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.9 0.0 0.7 0.2 0.0 0.0 1.1 0.0 0.1 0.3 0.2 0.6 0.2 0.0 0.8 0.2 0.3 0.1 0.1 0.3 0.4 0.4 0.0 0.1 0.1 0.1 0.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 21.2 9.6 21.5 13.7 16.4 13.0 14.0 23.0 13.6 11.8 26.6 27.6 8.1 18.6 24.6 22.0 20.9 37.2 22.4 13.8 39.2 26.3 85.8 27.8 31.8 20.6 19.3 4.6 8.7 28.3 20.0 23.3 19.4 20.7 9.5 20.1 14.3 21.1 19.3 10.1 8.0 17.3 18.3 8.8 10.0 76.0 20.2 18.3 17.8 11.2 12.5 30.2 13.4 4.5 6.5 23.6 16.4 18.4 11.9 13.2 15.0 348.9 41.8 21.9 32.9 19.6 21.1 39.5 21.0 17.9 18.2 49.7 19.8 45.1 13.1 11.8 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328776-133336188 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA023608: AB_1857671, HPA074622: AB_2686703" "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favorable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 10.4 11.7 8.1 4.1 7.8 4.9 10.3 8.7 7.5 12.4 5.9 13.6 6.2 11.9 2.6 12.5 11.2 2.5 10.5 7.2 7.5 11.7 12.3 8.5 5.5 7.7 7.8 13.1 11.2 3.9 8.1 3.3 7.8 11.5 3.4 3.3 9.7 4.0 17.9 13.2 12.1 2.7 7.5 11.4 9.9 7.9 7.9 4.6 10.6 3.9 3.7 12.2 11.1 8.1 5.6 8.7 6.5 9.8 4.0 3.7 10.8 8.8 5.1 7.7 4.8 13.8 9.2 16.2 6.7 4.9 5.6 16.7 8.4 9.3 2.8 10.8 9.6 11.2 10.5 8.3 7.2 19.1 9.3 5.3 8.0 8.0 7.4 6.8 4.0 15.6 25.1 8.4 6.8 14.7 15.5 15.7 19.1 22.7 15.6 16.1 9.1 16.7 6.7 5.3 13.7 11.6 8.6 13.7 7.8 3.9 12.2 10.6 8.4 17.3 9.3 8.9 12.0 6.2 9.6 21.0 6.5 12.9 10.4 3.3 3.0 1.4 4.3 2.9 4.5 4.6 3.9 3.9 3.3 5.1 5.2 4.4 0.8 3.2 2.7 6.0 3.6 2.5 8.1 7.8 8.7 7.5 7.2 7.5 7.7 7.8 7.8 7.5 7.9 8.1 25.7 44.8 27.3 4.6 20.9 23.7 15.7 11.0 24.5 26.5 33.4 32.3 30.0 28.6 24.5 22.0 6.2 32.2 20.3 36.8 21.5 29.2 1.3 21.1 42.2 23.6 33.6 14.1 4.3 19.6 25.2 21.2 18.8 25.1 25.3 25.4 16.4 35.2 21.2 21.9 4.8 40.3 6.1 14.7 10.2 4.1 27.7 13.7 7.2 5.6 18.6 15.2 29.9 5.0 4.1 29.0 33.3 27.8 14.4 24.8 50.6 26.1 13.2 19.6 0.0 15.8 20.3 19.2 23.6 26.3 27.6 19.0 18.1 91.1 57.7 13.3 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33453689 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 40.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 34.5;Horizontal cells: 38.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 135 "amygdala: 11.4;basal ganglia: 11.3;cerebral cortex: 21.0;hippocampal formation: 26.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.1;HMC-1: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavorable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 9.1 8.4 11.4 6.9 11.3 3.4 7.4 0.0 21.0 18.1 6.1 12.4 3.1 18.3 2.4 7.9 19.4 3.0 7.6 26.4 0.0 7.1 3.0 11.7 5.9 0.0 0.1 21.8 5.6 4.4 40.1 3.1 0.0 9.8 2.2 5.8 5.9 3.4 2.1 7.7 11.2 5.9 0.0 11.7 7.9 10.7 0.0 7.8 10.3 2.0 3.6 11.7 12.0 0.0 2.7 1.0 26.1 10.1 5.7 6.0 3.4 7.1 4.6 3.8 3.0 11.9 1.0 8.3 1.6 3.5 3.5 4.0 3.4 3.9 2.5 4.6 2.0 20.8 3.6 0.7 4.9 3.3 22.9 4.1 1.1 7.2 3.3 14.4 2.9 6.5 6.7 3.4 2.8 6.0 5.1 4.2 14.5 1.2 3.0 19.2 0.6 3.1 2.9 2.2 6.7 5.4 2.6 5.0 2.2 6.1 11.1 3.1 0.8 7.8 7.7 3.1 1.5 4.0 1.4 5.9 4.5 3.4 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 11.3 0.0 21.0 26.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.0 0.0 2.0 28.1 7.4 3.6 2.4 3.1 17.1 23.5 4.6 5.7 1.4 4.3 4.0 3.7 10.4 0.8 7.3 1.4 1.9 2.2 6.3 18.7 21.2 7.2 9.6 4.6 34.5 1.4 1.3 8.8 2.6 3.2 5.1 6.3 10.0 0.8 1.8 38.7 21.1 1.6 6.1 2.8 7.5 1.6 11.5 2.4 3.6 7.5 2.7 4.2 6.2 12.1 6.2 1.5 0.6 13.5 3.8 1.6 1.6 8.5 21.9 7.9 19.7 3.2 9.2 9.3 8.2 9.2 4.3 0.8 12.8 11.8 2.8 1.8 TAF1C "MGC:39976, SL1, TAFI110, TAFI95" ENSG00000103168 "TATA-box binding protein associated factor, RNA polymerase I subunit C" Q15572 16 84177847-84187070 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072229 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center" "HPA072229: AB_2686499" "unprognostic (9.39e-2)" "unprognostic (1.13e-1)" "unprognostic (6.86e-3)" "unprognostic (8.20e-3)" "unprognostic (4.45e-2)" "unprognostic (3.47e-2)" "unprognostic (6.21e-2)" "unprognostic (1.26e-1)" "unprognostic (2.52e-1)" "unprognostic (3.53e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.06e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (5.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "prognostic favorable (3.22e-4)" 19.4 15.8 9.8 7.2 9.9 13.5 20.6 8.1 12.9 25.9 5.4 16.0 7.9 23.5 2.2 15.9 21.4 10.1 18.3 10.9 7.7 20.6 14.8 17.0 11.1 10.5 8.7 31.7 17.9 4.2 20.6 6.2 8.6 21.7 2.9 1.8 15.3 8.3 12.3 17.8 19.3 5.3 7.3 32.2 18.7 13.8 8.9 7.4 23.7 6.7 3.6 18.5 19.1 8.9 11.8 12.7 7.5 23.6 5.7 5.9 34.3 13.8 5.3 11.5 3.7 15.0 8.3 12.7 17.3 5.0 6.1 21.2 4.3 5.4 2.6 11.4 18.2 6.8 21.0 9.7 4.8 7.6 21.8 8.9 6.9 9.1 3.7 5.0 20.4 20.7 17.9 4.1 5.6 25.4 11.3 24.9 27.8 5.1 12.2 29.2 6.1 10.5 4.7 9.5 34.0 16.8 26.3 7.8 43.0 4.6 28.9 8.1 8.9 19.2 16.5 19.2 12.0 19.6 16.9 26.7 9.8 9.2 12.4 0.0 1.3 0.4 1.5 1.3 1.8 0.9 0.6 0.9 1.5 1.1 0.7 1.3 0.0 1.5 0.5 0.6 0.9 1.2 9.8 9.9 8.1 12.9 10.9 7.7 10.5 8.7 8.6 7.3 8.9 8.9 24.9 19.2 15.8 22.5 9.2 6.5 5.1 5.2 5.2 9.3 10.2 10.2 3.0 2.8 8.2 3.7 20.9 9.4 6.5 9.9 5.9 5.1 0.5 6.9 7.4 18.7 7.2 7.4 16.5 7.1 6.7 8.4 20.9 8.8 6.3 24.6 22.9 12.9 6.6 1.7 13.0 8.2 0.0 9.8 6.3 2.5 11.8 7.3 7.2 15.9 6.3 7.8 5.2 13.6 12.5 5.2 5.1 9.1 12.1 3.9 7.6 4.0 6.1 10.4 6.6 8.3 7.8 9.9 10.6 8.7 5.3 7.4 8.0 16.8 10.2 4.4 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973868-29992261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 31.4 36.0 23.4 14.7 21.2 12.7 30.8 18.0 26.1 24.8 11.9 21.8 17.3 25.9 11.1 20.8 22.6 12.0 32.6 23.0 18.9 22.7 17.6 34.0 14.4 21.0 20.0 24.1 19.5 17.4 29.4 19.4 18.9 22.5 8.5 14.3 20.5 13.3 23.4 22.4 24.4 13.3 15.3 33.8 21.8 34.8 20.8 13.2 25.4 12.7 10.5 22.4 21.6 19.0 22.2 41.8 22.4 35.1 25.8 17.1 34.2 40.0 21.1 26.4 24.4 33.6 28.7 23.8 32.8 28.8 18.0 33.9 20.4 20.0 14.1 37.5 43.3 25.8 46.2 34.8 18.7 25.5 47.5 20.0 17.1 28.1 11.2 18.5 44.7 22.4 23.5 23.6 25.8 41.0 29.8 36.0 21.5 16.4 27.6 54.2 32.5 22.2 16.6 20.5 26.1 20.8 22.8 30.2 12.1 14.4 37.5 28.5 62.9 45.0 20.7 32.4 23.6 34.2 23.7 22.1 27.6 28.8 33.7 0.3 0.7 0.4 0.7 0.7 0.8 0.5 0.7 0.6 0.4 0.6 0.4 0.3 1.2 0.5 0.4 0.8 0.9 0.6 23.4 21.2 18.0 26.1 23.0 18.9 21.0 20.0 18.9 15.3 20.8 19.0 52.0 9.6 11.5 21.9 6.3 10.7 4.6 7.5 7.4 14.6 10.5 5.7 9.8 7.2 9.1 9.2 39.6 7.8 7.6 27.0 1.9 8.5 3.9 8.7 9.5 35.3 13.1 3.4 7.9 12.0 6.2 9.7 14.3 8.9 3.8 16.0 47.2 11.8 9.8 10.1 10.7 16.8 12.2 11.2 11.1 4.4 12.5 8.2 7.2 7.5 9.0 8.4 11.3 9.0 12.7 16.1 14.8 12.8 5.9 7.4 27.2 8.0 10.0 21.4 6.6 8.7 8.7 19.7 21.6 9.1 9.7 12.0 9.2 16.0 14.7 7.4 TAS2R14 "T2R14, TRB1" ENSG00000212127 "Taste 2 receptor member 14" Q9NYV8 12 10937408-11171573 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 7.1;Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.2" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (4.26e-2)" "unprognostic (1.41e-1)" "unprognostic (6.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (1.93e-2)" "unprognostic (1.22e-4)" "unprognostic (2.45e-2)" "unprognostic (1.07e-1)" "unprognostic (9.29e-3)" "unprognostic (4.71e-3)" 1.2 2.1 1.0 0.4 0.5 0.7 1.3 0.5 1.4 2.4 0.6 2.1 0.5 2.1 2.4 1.1 2.1 0.3 1.3 0.9 0.5 1.4 1.7 1.5 0.4 1.1 0.8 3.3 1.7 0.4 3.0 0.4 0.7 1.9 0.5 1.8 1.7 0.4 1.0 1.0 2.0 0.5 0.5 2.0 1.5 0.9 0.6 0.1 2.5 0.2 0.5 1.7 1.8 0.5 0.3 0.2 0.6 0.1 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.6 0.4 1.0 0.1 0.2 0.3 0.4 0.0 0.3 0.2 0.5 0.5 0.2 0.6 0.3 0.0 0.3 0.1 0.4 0.2 0.8 0.1 0.5 0.4 0.3 0.5 0.0 0.4 0.1 0.2 2.2 0.6 0.1 0.3 0.3 0.3 0.3 0.5 0.6 0.1 0.6 0.5 0.0 0.0 0.5 0.1 0.3 0.5 0.4 0.3 0.2 0.5 0.1 0.1 0.4 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.5 1.4 0.9 0.5 1.1 0.8 0.7 0.5 0.6 0.5 1.4 3.2 1.5 0.0 1.7 0.6 0.7 1.0 0.6 7.1 1.3 1.8 0.5 1.5 0.5 0.0 10.4 2.1 1.3 0.3 3.9 0.6 0.1 1.7 2.6 0.9 3.5 0.8 0.0 0.4 0.6 1.5 0.0 1.0 0.0 4.8 2.2 1.4 1.3 1.7 0.0 0.9 0.0 1.0 0.3 0.0 2.1 1.6 0.0 0.0 1.3 1.4 1.0 0.0 0.0 0.7 0.2 2.6 0.8 1.0 0.4 0.7 0.8 7.7 0.0 2.2 1.8 0.9 0.5 0.4 0.1 0.5 1.2 4.4 1.0 0.4 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 52: Non-specific - Transcription" "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.3 0.1 0.0 0.2 0.0 0.3 0.2 0.3 0.7 0.1 0.4 0.0 0.6 0.0 0.2 0.4 0.0 0.4 0.2 0.3 0.3 0.2 0.4 0.0 0.3 0.2 1.4 0.4 0.0 1.0 0.0 0.2 0.4 0.0 0.2 0.2 0.0 0.5 0.2 0.3 0.0 0.1 0.3 0.3 0.6 0.2 0.1 0.4 0.0 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 TAS2R20 "T2R20, T2R56, TAS2R49" ENSG00000255837 "Taste 2 receptor member 20" P59543 12 10996495-10997875 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 52: Non-specific - Transcription" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (1.12e-3)" "unprognostic (2.16e-4)" "unprognostic (2.92e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.98e-2)" "unprognostic (5.14e-4)" "unprognostic (6.23e-3)" "unprognostic (1.27e-9)" "unprognostic (2.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-2)" "unprognostic (6.44e-3)" 1.3 1.0 0.2 0.1 0.3 0.1 1.2 0.3 0.5 2.1 0.3 1.2 0.0 1.3 0.0 0.7 1.3 0.0 1.1 0.2 0.2 0.7 1.2 1.3 0.2 0.3 0.2 2.4 1.1 0.0 1.6 0.1 0.5 1.3 0.1 0.8 1.0 0.1 1.4 1.1 1.4 0.1 0.2 1.5 0.8 0.7 0.3 0.2 1.5 0.0 0.0 1.0 1.6 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.2 0.2 0.3 0.2 0.5 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 TCF25 "KIAA1049, Nulp1" ENSG00000141002 "Transcription factor 25" Q9BQ70 16 89873570-89913627 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041699, HPA041786" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "HPA041699: AB_10960254, HPA041786: AB_10960526" "unprognostic (1.33e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "prognostic favorable (6.95e-4)" "unprognostic (6.67e-2)" "unprognostic (4.96e-2)" "unprognostic (2.72e-1)" "unprognostic (6.02e-2)" "unprognostic (2.50e-1)" "unprognostic (3.49e-1)" "unprognostic (1.05e-2)" "unprognostic (1.27e-1)" "unprognostic (7.64e-3)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (6.10e-3)" "unprognostic (1.08e-1)" 71.9 91.2 48.2 51.1 53.7 98.7 71.0 45.6 58.4 72.2 34.6 77.4 61.4 77.4 42.3 69.3 69.0 55.0 73.4 50.7 52.1 65.8 78.4 68.3 63.8 48.2 44.8 85.3 85.9 65.4 85.7 53.3 52.4 70.6 37.2 22.9 72.8 53.7 83.8 71.8 70.9 46.1 35.2 78.0 84.9 76.9 48.8 45.0 77.7 41.4 44.4 73.3 65.4 48.1 51.1 72.9 80.6 107.8 65.4 70.1 89.7 122.4 91.9 91.9 42.9 46.9 75.4 120.2 95.0 88.2 30.7 50.3 45.7 53.8 36.5 50.6 96.7 61.2 71.0 94.4 109.7 72.1 78.7 84.8 55.3 56.6 61.1 90.4 83.1 46.7 113.6 72.4 95.4 166.8 78.4 138.9 52.1 77.3 40.4 122.4 77.2 68.2 78.1 69.0 71.7 42.7 184.5 70.5 67.9 33.6 66.0 75.1 126.6 75.0 81.6 42.7 51.8 91.0 34.7 68.7 72.0 83.0 98.8 124.5 131.5 107.5 97.8 107.4 72.3 74.9 71.2 76.3 91.5 93.2 60.1 63.0 222.6 78.2 102.9 145.3 67.2 81.0 48.2 53.7 45.6 58.4 50.7 52.1 48.2 44.8 52.4 35.2 48.8 48.1 160.7 160.3 154.7 64.3 170.9 102.3 155.7 145.6 124.7 360.0 135.7 142.0 90.7 107.2 148.7 165.5 277.3 249.1 277.8 194.9 148.7 110.8 271.7 165.3 209.1 143.3 148.2 85.0 65.2 152.3 329.5 149.4 181.5 203.1 172.8 153.1 126.7 157.7 156.4 464.4 69.7 233.2 120.1 154.6 161.0 383.9 173.4 160.2 186.7 45.0 195.6 150.8 307.9 38.7 54.7 117.2 179.7 184.3 236.4 175.1 192.8 179.1 162.7 279.4 157.8 119.1 152.1 192.7 74.6 114.9 104.0 538.8 193.8 185.4 185.6 199.4 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 12.3 13.2 7.3 7.6 7.2 11.3 13.4 8.8 11.0 15.2 5.7 12.6 8.9 14.1 1.1 14.4 15.1 3.7 13.2 6.9 6.4 13.6 14.8 11.6 8.1 10.2 7.6 14.4 12.2 4.3 12.5 4.8 7.6 15.8 1.4 1.8 11.4 4.8 17.0 14.4 14.4 2.4 6.4 18.6 11.9 10.0 7.6 5.8 13.2 4.9 3.1 13.6 13.9 8.3 19.7 28.8 8.8 16.8 3.4 3.6 33.9 30.5 5.7 14.4 10.4 37.0 18.3 28.8 25.8 4.9 7.1 20.5 6.3 11.6 2.7 16.9 55.1 16.5 36.7 21.8 5.7 21.0 23.9 7.0 4.3 13.4 2.8 4.9 8.6 24.6 43.2 10.1 5.8 66.3 24.9 56.1 28.2 6.9 23.9 73.5 12.3 29.4 5.4 18.3 36.8 20.6 26.5 24.8 9.8 3.3 23.2 25.3 13.8 31.2 21.7 30.5 25.8 18.2 12.6 53.3 9.9 29.3 26.7 0.0 5.7 2.9 4.1 7.2 3.9 4.1 2.9 3.4 6.9 6.0 3.1 2.5 0.5 3.4 10.7 4.3 2.7 4.7 7.3 7.2 8.8 11.0 6.9 6.4 10.2 7.6 7.6 6.4 7.6 8.3 15.8 0.0 2.7 18.9 15.2 6.9 7.8 10.4 10.2 13.7 12.7 9.8 1.6 11.5 6.3 9.2 12.5 25.5 9.1 19.4 5.9 8.2 2.0 8.4 11.0 9.6 2.4 10.8 5.3 7.2 20.2 11.4 15.8 9.2 2.5 21.2 8.9 12.3 19.6 18.5 6.4 17.2 8.2 11.8 7.0 1.9 7.5 8.6 8.8 10.3 13.3 17.3 8.2 8.5 7.0 6.9 5.5 14.7 8.7 8.8 13.7 6.3 5.1 20.1 13.1 9.9 11.4 9.8 8.2 10.3 6.5 22.0 9.6 19.0 23.5 5.1 TENT4B "PAPD5, TRF4-2, TUT3" ENSG00000121274 "Terminal nucleotidyltransferase 4B" Q8NDF8 16 50152911-50235310 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042968, HPA048225" Uncertain Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Nucleoli, Plasma membrane" "HPA042968: AB_2678244, HPA048225: AB_2680319" "unprognostic (1.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.27e-1)" "unprognostic (2.91e-2)" "unprognostic (4.33e-2)" "unprognostic (2.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (3.30e-2)" "prognostic favorable (1.85e-4)" "unprognostic (4.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (7.00e-2)" 6.1 6.4 2.4 1.7 2.3 7.1 4.6 3.9 2.6 7.3 3.0 6.9 4.6 6.9 2.3 5.4 6.5 2.0 3.7 2.7 3.0 4.2 8.9 5.0 2.3 2.2 2.4 6.8 4.3 3.9 4.8 2.8 2.2 5.3 1.9 1.4 4.7 1.7 5.4 5.5 5.9 2.5 2.2 4.6 5.5 5.7 3.1 1.7 4.7 2.1 1.9 7.2 6.4 2.7 5.5 1.9 0.6 3.3 3.8 2.0 4.3 3.9 2.3 3.5 1.6 3.4 2.3 6.5 5.6 2.7 1.4 3.6 3.9 2.0 3.1 3.8 4.5 3.6 1.6 5.4 3.8 2.4 4.9 1.9 2.6 2.3 3.3 2.3 1.8 2.1 4.2 1.5 4.1 1.5 3.5 4.6 4.2 1.5 4.5 4.9 4.8 6.9 1.7 0.5 4.0 2.2 4.9 2.7 2.3 1.5 1.5 0.9 3.0 2.1 4.1 4.0 1.9 4.9 3.7 6.9 1.7 2.7 2.7 0.0 0.4 0.0 0.4 0.2 0.1 0.3 0.2 0.5 0.2 0.2 0.3 0.5 0.7 0.2 0.2 0.4 0.1 0.1 2.4 2.3 3.9 2.6 2.7 3.0 2.2 2.4 2.2 2.2 3.1 2.7 17.9 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 17.8 16.3 0.0 0.0 0.0 14.7 0.0 18.1 82.8 0.0 3.9 10.9 0.0 44.3 24.4 6.1 0.0 0.0 0.0 14.9 11.5 6.7 0.0 31.5 0.0 13.5 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.2 0.0 0.0 22.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 18.3 14.9 17.3 0.0 0.0 TERF1 "PIN2, TRBF1, TRF, TRF1" ENSG00000147601 "Telomeric repeat binding factor 1" P54274 8 73008856-73048123 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048379 Approved "Nucleoli fibrillar center,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoli fibrillar center" "Nuclear bodies" "HPA048379: AB_2680378" "unprognostic (1.02e-2)" "unprognostic (1.66e-1)" "unprognostic (7.24e-2)" "unprognostic (2.42e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (6.53e-2)" "unprognostic (9.55e-2)" "unprognostic (1.52e-1)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (2.34e-3)" "unprognostic (1.04e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" 13.8 15.2 6.8 4.7 7.7 8.7 13.1 10.9 8.1 13.9 7.0 13.3 8.5 13.8 6.9 9.3 14.7 7.3 11.9 7.6 7.1 14.2 11.2 9.3 7.6 6.3 6.6 17.7 10.1 12.3 11.5 6.6 6.3 12.7 7.3 9.0 10.3 9.4 11.1 10.0 9.4 8.5 7.9 8.1 14.5 10.4 6.5 7.4 11.7 4.7 4.6 18.2 12.4 8.6 17.1 15.5 14.6 12.8 11.0 7.3 14.5 18.4 7.3 10.2 10.7 10.0 13.3 9.4 27.6 9.9 22.2 13.9 19.9 11.3 10.5 14.8 31.7 13.6 3.8 6.9 9.5 7.7 15.9 11.6 7.4 11.2 18.8 14.7 11.0 23.8 14.8 12.3 9.6 10.4 31.3 8.8 60.7 37.7 14.7 21.7 7.0 9.9 17.0 8.7 11.9 15.2 13.6 49.8 14.4 42.6 19.9 5.6 7.5 7.8 13.5 17.0 15.3 15.9 16.0 18.1 10.9 12.0 16.7 11.9 6.5 10.7 11.3 6.0 10.1 12.0 10.5 11.4 7.5 10.7 12.1 12.7 3.6 9.7 7.8 11.4 11.4 6.7 6.8 7.7 10.9 8.1 7.6 7.1 6.3 6.6 6.3 7.9 6.5 8.6 41.5 28.9 29.1 39.5 47.8 27.9 39.6 45.8 35.3 77.6 22.5 32.5 23.2 21.5 27.3 31.3 85.5 53.6 109.4 27.5 25.4 35.8 16.2 24.0 41.1 38.7 92.1 31.6 52.7 37.8 62.4 52.3 24.5 27.1 36.8 44.5 41.7 31.0 34.2 70.7 58.3 26.4 36.7 25.5 26.6 8.1 74.3 27.7 30.2 22.5 32.3 85.7 72.1 48.7 55.3 25.6 21.5 85.4 34.2 30.2 17.9 65.7 24.8 55.4 59.2 63.3 49.1 117.6 131.7 23.6 24.3 31.9 52.6 62.0 28.2 27.6 TIGAR C12orf5 ENSG00000078237 "TP53 induced glycolysis regulatory phosphatase" Q9NQ88 12 4307763-4360028 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Autophagy" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hofbauer cells: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034010, HPA040354, HPA044111" Approved Supported Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Cytosol "CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814" "unprognostic (1.76e-1)" "unprognostic (6.33e-2)" "unprognostic (4.08e-1)" "unprognostic (2.60e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (5.41e-2)" "unprognostic (2.11e-1)" "unprognostic (9.37e-2)" "unprognostic (1.85e-1)" "unprognostic (5.21e-2)" "unprognostic (2.03e-2)" "unprognostic (2.02e-3)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (1.05e-1)" 3.8 5.4 1.4 1.9 1.6 1.9 2.9 1.9 3.0 1.8 1.8 3.7 0.7 2.8 1.2 3.7 2.3 1.4 5.0 2.2 1.6 4.2 3.1 3.7 2.0 1.9 2.0 1.1 2.0 0.9 5.3 1.4 2.1 2.8 1.7 2.3 3.0 1.7 5.8 2.5 3.6 2.1 2.1 5.3 3.3 3.5 1.9 1.7 2.3 2.0 1.9 3.5 2.4 2.3 4.1 9.9 4.8 7.7 10.9 6.3 47.3 9.3 8.0 5.3 7.3 5.7 3.8 4.1 0.7 5.8 5.2 5.7 5.8 7.6 7.0 3.8 2.9 0.1 4.7 7.8 14.3 2.1 0.5 8.1 12.9 5.9 6.8 3.2 14.5 3.4 0.3 2.2 9.2 7.7 2.2 0.8 8.6 5.5 1.7 3.0 6.4 1.0 6.7 5.0 0.2 2.8 7.9 3.2 10.1 22.0 0.8 1.6 10.5 8.2 5.9 5.6 3.8 1.4 2.1 6.9 5.4 0.8 5.7 0.5 1.7 0.2 0.7 3.5 0.5 0.9 0.7 0.8 1.9 1.3 0.6 0.7 1.5 0.8 3.4 1.6 1.4 0.6 1.4 1.6 1.9 3.0 2.2 1.6 1.9 2.0 2.1 2.1 1.9 2.3 10.7 0.0 1.7 0.0 14.7 0.0 13.8 0.0 5.7 4.2 6.2 7.5 10.5 1.5 0.0 5.5 18.8 27.4 16.9 5.0 15.6 15.6 28.0 4.7 5.9 9.4 7.3 1.3 0.0 13.9 28.5 6.6 11.7 4.8 0.0 4.5 5.0 5.6 59.3 1.7 0.0 1.5 0.0 20.4 0.0 27.8 3.7 30.6 0.0 0.0 34.9 11.5 7.2 0.0 0.0 17.5 2.6 4.5 16.3 9.5 2.9 11.7 0.0 3.3 6.6 5.7 8.3 19.9 22.3 8.1 0.0 34.3 11.8 10.8 2.3 15.6 TLE2 "ESG, ESG2, FLJ41188, GRG2" ENSG00000065717 "TLE family member 2, transcriptional corepressor" Q04725 19 2997639-3047635 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.7" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 44.4;RT4: 35.2;T-47d: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049103 Enhanced Supported "Nuclear bodies,Focal adhesion sites" NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Focal adhesion sites" "HPA049103: AB_2680631" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (2.89e-1)" "prognostic favorable (2.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.87e-3)" "unprognostic (6.40e-3)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "prognostic favorable (2.39e-6)" "unprognostic (2.12e-1)" "prognostic favorable (9.49e-6)" "unprognostic (2.66e-1)" "unprognostic (5.99e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.88e-4)" 35.6 31.5 19.4 5.2 20.6 1.6 34.2 67.6 21.2 45.0 10.5 52.4 12.5 62.6 5.2 13.5 62.2 9.0 75.6 13.4 18.9 52.0 17.1 42.5 5.5 22.0 21.5 29.3 36.7 20.4 25.9 9.3 27.2 55.5 6.6 8.7 85.5 28.0 66.4 21.9 18.4 11.1 18.5 46.9 30.2 23.0 27.9 4.9 72.5 30.9 2.1 67.4 25.7 22.2 0.5 2.8 0.2 44.4 6.7 1.1 9.5 0.4 0.0 2.1 1.1 14.0 5.1 0.2 5.9 3.2 1.3 7.6 7.7 2.7 0.5 1.2 2.1 0.0 3.4 0.6 8.6 0.0 0.4 9.6 1.2 4.9 0.1 2.6 18.0 12.6 16.2 0.2 0.3 15.0 0.4 0.2 0.1 1.3 2.9 3.9 2.2 4.4 5.5 35.2 2.3 11.1 3.0 22.0 1.1 0.9 25.1 0.1 11.7 14.0 14.4 0.8 0.5 0.5 0.5 3.0 0.3 3.3 2.8 0.0 0.0 0.1 1.1 0.0 0.9 1.7 0.7 0.4 0.0 0.1 1.2 0.7 0.0 0.0 0.0 0.0 0.2 0.3 19.4 20.6 67.6 21.2 13.4 18.9 22.0 21.5 27.2 18.5 27.9 22.2 27.1 19.2 17.6 1.6 0.7 3.6 34.2 8.3 11.4 36.9 27.0 16.5 24.9 12.8 7.0 36.8 2.1 1.8 2.8 21.7 1.9 11.3 6.5 1.8 9.6 10.3 13.8 0.4 10.3 2.7 4.4 14.8 8.2 6.0 0.0 7.2 16.1 4.0 0.7 1.7 29.3 14.9 8.2 0.3 3.1 18.8 11.8 1.1 5.4 3.7 0.1 19.2 2.1 10.6 14.6 2.7 9.8 15.1 0.3 28.2 1.3 1.1 10.0 4.4 0.0 1.5 11.2 1.2 5.8 4.6 2.3 6.7 2.3 0.7 26.5 32.5 TMEM14C "bA421M1.6, C6orf53, HSPC194, NET26" ENSG00000111843 "Transmembrane protein 14C" Q9P0S9 6 10722915-10731129 "Predicted membrane proteins" "Heme biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" "unprognostic (4.08e-3)" "unprognostic (1.10e-1)" "unprognostic (2.82e-2)" "unprognostic (3.53e-2)" "unprognostic (3.77e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.66e-4)" "unprognostic (2.83e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (5.93e-2)" "unprognostic (3.39e-3)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (2.34e-1)" 95.8 124.6 30.4 22.6 31.5 59.8 87.2 33.8 37.5 90.5 41.6 91.1 42.5 94.0 42.7 64.0 84.7 40.3 104.8 28.1 33.8 93.5 70.3 67.0 29.7 32.0 31.4 88.0 66.7 60.3 52.5 37.3 32.7 86.8 37.6 25.8 80.4 41.8 123.8 60.3 63.3 34.2 33.3 51.3 81.3 32.6 33.1 33.7 79.2 70.6 26.5 80.2 73.4 35.0 123.7 70.1 53.7 80.4 103.4 115.5 52.4 70.8 114.5 80.5 89.5 71.6 88.2 81.8 151.8 81.6 159.5 57.3 30.1 85.1 62.4 53.7 51.0 52.4 67.8 109.4 127.3 41.0 36.6 103.5 91.1 60.6 98.7 88.6 42.8 21.4 130.4 29.8 110.3 67.2 27.8 114.4 64.4 59.0 73.6 51.4 71.5 132.7 113.0 51.3 44.8 58.5 70.3 109.8 134.4 105.7 68.3 49.0 102.3 106.6 64.7 44.4 109.5 69.3 132.7 38.6 61.4 52.8 114.2 48.2 39.2 68.2 10.9 39.4 32.1 31.2 27.0 16.3 70.5 23.7 26.2 22.2 4.0 32.0 35.6 66.1 32.2 31.6 30.4 31.5 33.8 37.5 28.1 33.8 32.0 31.4 32.7 33.3 33.1 35.0 163.2 115.4 77.3 15.7 59.1 99.4 135.2 318.8 99.6 41.0 167.4 219.2 129.3 151.5 171.0 156.3 8.4 239.7 60.3 148.4 270.1 200.0 4.8 132.3 159.6 122.7 122.4 472.5 10.0 138.6 275.2 158.9 66.3 128.2 137.1 104.4 124.2 142.5 390.8 16.8 14.6 177.6 189.2 151.5 228.0 15.0 179.3 146.3 193.9 9.4 288.6 199.5 8.2 7.1 18.0 206.3 192.6 190.7 90.8 163.9 274.4 310.4 128.3 51.5 177.5 114.3 160.3 41.5 99.0 134.2 115.5 195.2 56.7 176.2 204.5 141.8 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 17.7 18.1 4.8 9.5 5.5 5.3 14.0 5.3 6.5 15.5 5.3 13.5 8.4 16.6 6.9 11.6 14.8 7.4 10.2 4.6 5.4 12.7 12.9 12.0 10.5 6.0 5.5 15.0 14.5 10.3 15.2 5.9 5.8 13.0 6.0 6.5 10.9 6.8 9.2 8.9 11.8 8.3 5.7 16.6 13.2 5.6 5.1 8.4 10.9 5.7 7.0 13.8 13.2 6.3 12.5 24.0 14.9 18.2 13.5 18.6 9.0 12.2 9.2 9.3 12.0 2.5 35.9 15.6 29.9 7.5 14.2 14.2 9.4 11.6 12.2 22.0 13.5 35.1 6.1 10.0 13.3 11.1 12.6 14.7 15.2 16.5 19.6 14.9 13.7 19.1 14.4 19.4 16.2 6.4 2.9 23.3 12.2 34.0 22.6 16.3 18.0 12.0 8.3 12.3 12.9 19.4 16.6 6.6 9.1 8.7 31.3 15.7 17.6 11.4 10.3 13.4 13.5 11.1 10.1 12.9 9.1 22.9 20.3 43.7 40.1 17.4 21.6 31.6 18.7 29.6 20.5 20.5 47.4 23.9 17.2 20.4 15.7 32.5 30.9 41.1 20.5 27.0 4.8 5.5 5.3 6.5 4.6 5.4 6.0 5.5 5.8 5.7 5.1 6.3 21.0 19.2 13.4 7.8 17.8 12.1 19.6 34.6 19.4 7.0 22.1 24.6 8.1 15.7 16.6 14.7 0.0 28.0 18.1 5.7 27.4 20.5 3.4 23.1 22.4 15.8 10.8 14.5 4.4 16.2 18.4 21.1 8.6 10.6 3.8 22.2 18.5 15.1 42.2 23.5 7.4 11.7 20.3 21.0 17.5 1.9 10.2 21.9 17.8 14.0 26.0 26.0 18.6 9.5 11.2 13.1 3.9 16.6 15.8 9.4 8.5 19.7 29.4 12.4 26.3 16.7 18.3 16.6 13.8 18.0 14.2 9.7 14.5 27.0 13.7 16.6 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93188463 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 113.5;Hofbauer cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 16.6 22.9 7.3 6.4 7.8 2.7 16.9 7.9 10.0 15.5 8.2 22.9 10.3 14.2 16.5 13.1 14.7 6.7 25.6 7.6 7.6 33.2 17.2 17.1 8.0 7.7 7.8 14.2 21.2 10.3 19.8 6.9 7.8 25.7 12.5 20.7 19.6 9.2 30.6 13.7 18.1 6.8 7.4 15.9 21.8 8.4 8.1 8.6 17.6 12.4 6.9 17.2 12.8 9.0 11.0 12.1 15.3 16.1 17.2 7.3 9.4 7.9 8.2 12.7 16.2 7.8 11.1 12.1 12.9 7.9 15.9 15.9 17.8 12.6 17.7 9.3 13.4 10.9 8.8 18.3 15.2 16.0 14.7 9.3 14.6 10.0 16.2 6.8 12.2 13.5 9.3 12.0 11.6 52.5 10.2 12.8 8.3 28.0 11.6 4.7 16.0 11.3 16.6 23.6 12.9 13.4 11.7 6.0 36.9 12.4 17.7 11.4 5.0 6.1 10.8 14.6 9.4 9.3 16.0 11.8 11.4 6.1 9.1 6.8 9.7 13.6 3.9 9.4 2.9 4.7 4.6 4.4 8.0 5.5 5.2 5.9 10.5 5.3 13.0 7.3 4.1 4.2 7.3 7.8 7.9 10.0 7.6 7.6 7.7 7.8 7.8 7.4 8.1 9.0 13.4 3.2 14.4 5.2 22.4 23.2 37.9 33.6 13.1 14.8 41.1 39.1 22.5 32.9 22.0 31.3 27.1 36.6 16.5 44.8 113.5 30.3 1.8 33.1 16.3 11.9 15.0 11.3 5.9 26.6 21.1 16.6 20.9 35.7 17.2 15.2 8.9 19.2 110.1 13.5 7.8 36.1 26.4 28.4 20.0 2.3 11.8 39.6 32.0 2.8 16.2 34.8 12.3 5.0 13.8 17.7 23.8 10.9 13.1 43.3 31.7 69.6 17.2 30.6 39.5 13.9 23.2 4.5 17.8 18.1 31.1 27.4 16.1 17.6 30.9 36.4 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759226-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "basophil: 31.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 14.2 6.1 1.3 3.7 1.3 0.7 10.6 1.1 2.2 10.1 2.1 4.0 1.6 8.4 0.3 3.9 8.1 3.6 6.6 1.6 3.7 10.1 3.4 13.2 2.4 2.1 1.3 4.3 3.1 1.6 3.5 1.0 1.7 7.0 1.4 0.4 4.2 2.2 2.9 4.2 4.8 5.0 1.4 8.2 4.3 3.3 1.9 0.8 11.2 3.9 1.8 7.5 7.1 1.5 10.3 0.0 0.6 0.0 2.8 0.0 0.1 4.8 10.7 5.5 3.5 0.4 0.2 0.2 0.1 7.7 12.5 1.5 1.1 0.7 2.3 0.1 0.9 0.3 0.4 0.0 1.4 2.9 28.6 1.8 2.3 11.7 4.6 15.7 38.8 0.6 0.1 0.2 12.0 0.2 1.5 0.9 1.0 1.6 39.3 1.8 0.8 25.1 5.4 0.5 2.2 5.1 0.2 1.5 0.1 1.0 0.6 8.2 35.9 1.6 10.3 0.6 1.7 0.0 0.0 1.9 40.6 2.7 0.3 31.2 5.4 0.7 0.0 5.5 0.0 0.9 0.0 0.0 1.5 2.8 0.0 0.0 2.7 0.0 4.0 0.0 0.0 1.4 1.3 1.3 1.1 2.2 1.6 3.7 2.1 1.3 1.7 1.4 1.9 1.5 65.0 6.4 4.8 2.3 1.9 5.9 1.2 0.9 1.2 0.9 1.1 1.7 9.1 0.0 0.2 1.8 0.0 0.1 0.3 0.0 1.9 8.2 0.8 0.3 0.8 81.5 1.2 3.2 2.7 1.7 0.1 4.7 0.0 0.2 39.3 2.3 105.0 0.7 12.9 0.0 0.1 0.2 0.0 17.4 14.6 1.1 7.8 16.3 8.8 7.5 3.4 0.5 0.0 0.0 0.6 1.3 0.1 3.0 1.4 1.7 0.0 0.1 0.5 0.8 6.6 0.9 3.6 5.1 19.1 0.2 4.7 0.0 1.8 2.1 0.3 1.0 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.2;Spermatogonia: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 21.0 23.0 18.4 14.7 18.2 6.5 23.8 19.5 22.0 30.5 17.3 30.2 23.7 27.8 24.8 42.5 30.1 8.4 15.3 19.3 16.5 36.0 20.2 17.5 21.2 21.2 18.1 29.7 29.7 17.8 34.3 8.7 19.0 29.9 17.5 9.1 31.5 19.4 19.7 31.0 31.1 12.7 18.9 34.3 30.8 24.8 19.0 19.7 47.6 11.8 21.3 27.8 30.6 19.9 37.8 17.5 11.0 14.3 23.6 11.1 19.0 8.5 4.7 8.9 9.6 23.9 42.0 16.0 7.3 13.2 15.8 26.8 16.2 9.7 6.3 11.0 41.7 9.7 19.0 14.5 13.9 12.8 16.8 25.7 19.9 4.0 6.2 17.5 10.5 18.9 12.1 17.7 11.4 12.2 16.8 8.7 10.4 29.9 8.4 12.2 7.6 31.5 12.7 5.7 31.1 9.8 12.8 23.5 12.3 7.3 18.2 11.9 15.0 14.9 7.8 3.4 6.4 8.4 3.2 14.8 15.6 15.9 6.5 8.3 26.5 35.4 21.0 25.9 18.4 26.7 15.7 16.0 21.8 30.1 22.3 20.0 12.8 21.4 32.0 22.0 21.4 20.7 18.4 18.2 19.5 22.0 19.3 16.5 21.2 18.1 19.0 18.9 19.0 19.9 15.1 6.4 20.7 13.7 24.0 15.3 15.9 25.6 17.6 22.7 31.7 36.8 19.3 15.7 20.2 20.2 8.4 33.9 19.4 15.4 11.7 13.0 9.2 17.1 15.8 14.4 12.1 8.6 13.9 17.1 9.8 20.8 9.7 19.9 7.0 15.9 12.8 6.2 17.6 55.5 13.1 22.7 28.5 13.2 13.6 9.5 42.6 12.7 12.4 11.2 19.7 23.2 26.8 16.6 16.7 10.6 10.3 28.6 11.5 12.3 22.1 8.1 19.4 9.1 32.9 23.4 21.2 82.2 87.2 13.7 17.2 15.2 16.7 21.6 19.5 12.3 TNIP2 "ABIN-2, FLIP1, KLIP, MGC4289" ENSG00000168884 "TNFAIP3 interacting protein 2" Q8NFZ5 4 2741648-2756342 "Predicted intracellular proteins" "Apoptosis, Inflammatory response, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020818, HPA049886, HPA063197" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Cytosol "CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960" "unprognostic (1.22e-1)" "unprognostic (2.09e-1)" "unprognostic (2.44e-1)" "prognostic favorable (1.13e-4)" "unprognostic (3.64e-1)" "unprognostic (9.87e-2)" "unprognostic (4.36e-2)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.77e-1)" "unprognostic (2.47e-2)" "unprognostic (8.34e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.94e-5)" "unprognostic (3.00e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-3)" "unprognostic (4.02e-3)" 30.0 19.9 15.8 16.5 16.6 23.9 26.3 16.3 18.5 20.9 15.7 32.1 17.7 20.2 6.4 27.2 18.1 10.6 31.4 14.8 15.9 37.1 30.1 29.9 17.6 18.0 16.9 18.8 22.8 5.5 19.7 15.7 17.0 24.5 10.5 2.6 19.2 9.2 41.5 19.6 39.4 9.9 16.9 31.2 27.8 22.9 17.3 10.8 22.3 13.6 15.9 30.2 20.8 16.3 24.4 32.6 10.1 15.4 31.5 21.6 43.7 25.8 22.9 23.6 22.9 37.2 38.5 22.1 28.7 28.3 52.9 15.8 18.3 29.8 13.8 17.2 23.0 26.4 19.9 41.9 39.0 21.9 32.2 27.9 26.5 26.1 23.5 18.1 33.9 19.8 27.4 30.4 16.5 50.6 29.0 53.6 26.6 35.9 55.0 18.9 15.3 11.6 25.5 26.9 15.1 17.0 20.2 21.0 29.6 17.2 23.0 32.0 40.0 18.2 20.1 29.0 40.4 31.3 22.8 16.0 33.3 39.1 20.2 7.6 8.9 27.1 7.4 13.9 8.1 9.6 11.3 12.5 8.7 14.4 9.2 7.6 8.4 5.7 14.8 4.0 13.3 6.3 15.8 16.6 16.3 18.5 14.8 15.9 18.0 16.9 17.0 16.9 17.3 16.3 48.2 6.4 9.8 3.6 40.7 61.3 49.3 42.5 19.4 2.0 25.3 17.8 13.2 7.2 19.0 14.7 2.1 52.4 44.6 56.0 13.7 58.2 2.3 26.0 26.4 46.7 19.2 8.2 1.1 59.6 106.1 28.4 28.5 33.3 13.3 21.4 41.0 16.7 34.5 0.0 0.7 38.0 24.4 21.2 112.7 7.5 21.5 34.6 26.6 3.7 71.8 12.4 48.4 0.5 3.4 71.8 63.0 17.7 21.2 86.6 174.3 46.8 13.0 6.8 19.7 18.7 38.0 23.6 62.4 28.1 79.0 95.6 44.9 17.1 38.0 84.7 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing adaptor 6A" Q8NDV7 16 24610209-24827632 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 289.3;Excitatory neurons: 283.8;Inhibitory neurons: 414.6;Oligodendrocyte precursor cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.2 21.0 5.0 6.4 3.6 6.0 14.9 10.8 7.1 17.8 6.1 17.8 5.5 23.5 11.5 11.3 17.7 6.4 11.1 3.4 6.6 10.3 13.0 12.8 7.1 6.1 4.8 20.6 19.2 13.2 22.8 6.6 6.1 14.6 6.4 7.0 14.9 8.0 14.0 13.1 15.3 8.1 2.2 9.9 15.2 6.6 7.0 8.6 17.8 6.9 7.4 13.0 13.4 7.4 10.1 13.8 16.0 8.7 13.6 17.7 9.1 16.9 13.6 12.0 13.1 10.2 8.2 10.2 7.1 17.0 12.4 11.2 20.1 14.2 18.0 10.4 10.4 10.2 16.7 14.1 11.7 10.5 6.9 18.0 7.3 15.8 10.2 14.8 16.7 6.6 15.7 6.2 15.8 11.9 8.8 6.9 23.1 4.9 6.8 17.1 12.4 9.1 9.1 9.3 7.7 10.8 11.8 7.2 6.6 12.1 8.4 6.8 15.5 15.3 10.5 7.6 12.0 13.7 11.6 16.5 14.3 6.4 11.3 0.5 0.5 0.4 0.5 0.3 0.4 1.1 0.5 0.5 0.2 1.0 0.7 0.5 0.3 0.6 0.3 1.0 0.5 0.3 5.0 3.6 10.8 7.1 3.4 6.6 6.1 4.8 6.1 2.2 7.0 7.4 51.2 38.5 60.0 289.3 45.5 34.9 17.8 21.9 39.9 97.1 42.8 41.0 75.3 51.5 32.3 46.0 118.9 22.4 49.9 38.3 17.6 23.6 17.2 38.7 65.5 45.5 55.9 34.9 283.8 24.5 15.1 50.5 33.6 42.8 39.3 76.5 60.3 115.3 21.2 176.7 414.6 36.3 22.4 56.2 26.5 11.3 69.0 28.7 30.2 138.7 36.1 42.0 50.4 265.4 234.2 28.5 36.1 81.3 44.7 26.0 42.8 19.2 29.8 81.7 19.7 52.8 60.9 41.2 30.6 38.1 28.7 8.2 39.0 36.5 35.8 17.4 TNXB "TNXB1, TNXB2, TNXBS, XB, XBS" ENSG00000168477 "Tenascin XB" P22105 6 32041153-32115334 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 274.8" "Cell type enhanced" "Detected in many" "Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 1500000000 "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-3)" "unprognostic (9.57e-2)" "unprognostic (1.16e-1)" "unprognostic (9.51e-4)" "unprognostic (5.71e-2)" "unprognostic (2.30e-1)" "unprognostic (6.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.61e-2)" "unprognostic (2.17e-1)" "unprognostic (9.70e-2)" "unprognostic (3.13e-2)" "unprognostic (2.02e-1)" "unprognostic (1.90e-2)" "unprognostic (1.01e-1)" 68.0 274.8 2.0 0.9 3.1 3.4 40.0 4.4 1.8 45.1 3.5 35.9 3.0 66.7 3.2 18.1 37.4 4.7 73.8 0.7 0.8 13.0 17.6 51.1 0.8 1.5 1.1 67.0 3.7 0.4 6.8 3.8 1.5 15.6 1.7 0.3 19.5 1.0 14.2 27.4 29.0 3.1 2.2 30.7 18.8 11.4 3.0 0.7 27.7 7.2 0.4 34.5 35.2 0.4 0.1 0.3 0.3 0.2 12.4 20.1 0.2 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.4 1.2 0.0 0.1 0.0 0.0 0.1 1.3 1.1 0.2 0.6 0.0 2.8 0.0 0.3 0.2 0.2 0.5 0.0 0.5 0.0 0.5 0.7 0.4 0.0 0.2 0.0 0.1 0.3 0.0 3.5 0.3 0.1 0.2 0.0 0.1 0.1 0.2 1.3 0.0 0.1 0.1 0.0 0.3 0.2 0.1 0.4 15.8 0.0 0.4 0.4 0.2 8.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 3.1 4.4 1.8 0.7 0.8 1.5 1.1 1.5 2.2 3.0 0.4 54.7 3.2 2.4 2.6 0.5 32.9 0.2 0.3 0.6 1.3 1.3 1.8 2.5 4.3 0.2 0.0 0.0 0.5 1.0 0.0 0.0 0.2 3.0 1.3 39.7 38.8 0.0 25.0 7.1 0.0 2.6 318.4 6.1 1.1 0.0 94.8 12.8 0.9 0.7 0.0 4.2 0.1 0.0 0.6 39.1 2.8 27.1 4.7 32.0 17.8 0.0 1.2 0.0 1.0 1.2 0.0 0.1 4.5 2.5 0.5 0.0 0.3 0.9 0.6 0.0 21.7 20.8 4.1 2.1 1.6 26.6 1.0 4.8 5.6 0.2 0.4 TOP3A "TOP3, ZGRF7" ENSG00000177302 "DNA topoisomerase III alpha" Q13472 17 18271428-18315007 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, Disease variant, Dwarfism, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002449 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "CAB002449: AB_564037" "unprognostic (5.49e-2)" "unprognostic (9.04e-2)" "unprognostic (8.99e-2)" "unprognostic (7.24e-3)" "unprognostic (4.01e-2)" "unprognostic (1.95e-2)" "unprognostic (2.33e-3)" "unprognostic (6.54e-2)" "unprognostic (2.34e-1)" "unprognostic (2.74e-1)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (4.59e-4)" "unprognostic (5.58e-2)" "unprognostic (8.80e-2)" "unprognostic (3.53e-2)" "unprognostic (5.05e-2)" "unprognostic (6.05e-2)" 9.4 8.0 1.9 3.3 1.8 5.7 8.6 3.1 2.6 8.6 2.1 7.8 2.3 8.4 1.6 8.6 8.5 2.1 6.0 1.8 1.8 7.0 11.2 7.7 3.6 1.7 1.6 7.5 7.7 2.6 8.9 2.5 1.7 7.7 2.4 2.1 8.1 1.7 10.0 11.3 8.2 2.6 1.4 11.4 7.6 11.7 2.0 4.2 6.7 2.5 3.3 8.5 7.8 2.0 9.3 14.2 9.4 11.1 3.8 4.6 10.9 9.4 4.9 14.2 12.8 22.4 3.4 13.7 6.0 6.5 6.6 11.7 12.6 6.7 11.5 11.6 11.4 13.1 15.2 7.9 4.3 5.8 11.9 2.9 4.6 15.0 8.7 2.9 7.3 11.5 11.3 5.7 6.1 6.4 15.2 5.9 8.7 13.8 6.8 17.4 22.6 14.8 3.2 8.1 7.7 13.6 12.6 8.3 8.4 24.5 16.1 6.5 6.5 10.6 8.1 18.2 15.4 5.8 13.7 10.4 6.6 8.0 10.5 1.1 3.1 3.4 1.8 2.7 1.3 0.7 1.3 1.6 1.3 0.8 1.1 1.2 4.2 2.2 1.5 1.2 1.2 2.0 1.9 1.8 3.1 2.6 1.8 1.8 1.7 1.6 1.7 1.4 2.0 2.0 5.3 6.4 4.8 6.5 9.7 2.0 4.5 4.5 6.8 20.8 6.2 3.9 3.1 5.7 7.4 11.0 39.6 7.4 11.8 4.6 3.9 4.2 7.2 5.0 8.7 6.2 0.0 9.9 16.4 3.7 6.9 6.3 6.6 6.3 5.1 12.1 6.4 7.0 5.4 21.9 17.2 4.2 4.1 12.4 6.3 7.9 8.1 11.6 1.8 12.2 13.9 6.4 15.5 11.6 11.2 3.6 2.8 6.4 12.0 5.8 3.8 2.1 6.5 22.2 13.1 9.3 6.6 26.7 25.5 5.2 3.4 4.4 9.0 13.1 5.9 5.0 TPGS1 "C19orf20, GTRGEO22, PGs1" ENSG00000141933 "Tubulin polyglutamylase complex subunit 1" Q6ZTW0 19 507497-519654 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 5.3;granulocytes: 3.9;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HEK 293: 35.8;SH-SY5Y: 35.9;U-266/70: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.42e-1)" "unprognostic (2.51e-3)" "unprognostic (7.05e-2)" "prognostic favorable (2.24e-4)" "unprognostic (5.85e-2)" "unprognostic (1.37e-2)" "unprognostic (2.52e-1)" "unprognostic (1.63e-2)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "prognostic favorable (8.82e-4)" "unprognostic (8.71e-3)" "unprognostic (5.03e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (4.18e-1)" "unprognostic (3.84e-3)" 15.6 15.8 4.9 1.2 4.0 2.0 13.9 5.4 6.9 14.6 2.3 11.9 3.9 17.0 0.0 11.4 12.4 0.2 10.7 5.2 3.9 18.2 16.9 10.8 0.6 6.7 5.3 12.8 17.0 0.4 14.1 0.9 5.2 11.5 0.1 0.0 10.7 0.8 10.5 13.1 10.6 0.3 4.5 11.7 13.8 9.0 5.5 0.2 13.9 0.1 0.2 12.8 12.2 6.1 13.9 1.7 0.5 2.7 0.1 0.6 7.8 8.8 1.5 1.3 1.0 0.7 2.9 11.9 7.2 0.8 0.2 8.7 0.0 0.2 0.0 16.6 35.8 3.4 2.4 1.1 1.0 5.8 11.7 1.4 1.0 0.1 0.1 0.5 0.9 2.0 13.6 3.3 0.6 2.8 10.1 16.1 6.8 0.2 14.8 9.5 4.2 12.7 0.4 0.6 11.2 35.9 3.9 1.1 18.6 0.0 2.3 3.4 8.4 4.8 8.5 11.7 7.0 34.9 10.9 5.4 6.8 5.4 4.5 0.1 0.8 3.9 0.7 0.4 0.4 2.7 0.9 1.7 0.7 5.3 1.0 0.4 0.8 0.9 0.8 0.6 3.7 0.5 4.9 4.0 5.4 6.9 5.2 3.9 6.7 5.3 5.2 4.5 5.5 6.1 37.0 35.3 36.2 5.5 23.9 27.0 30.0 1.4 29.0 30.9 43.0 43.6 4.4 48.6 16.1 40.5 25.0 38.7 36.5 70.9 76.3 8.3 7.6 32.5 29.1 34.6 55.6 42.9 3.0 8.9 13.3 38.8 40.8 24.6 32.4 32.0 38.9 35.0 51.5 28.6 4.0 62.5 0.0 59.6 41.8 4.6 28.9 42.2 32.0 3.7 34.2 51.9 59.8 2.5 9.8 4.2 55.5 31.2 32.1 27.9 71.7 147.8 12.3 33.9 32.9 35.9 39.6 7.5 4.5 31.5 35.5 48.3 42.7 48.7 40.4 34.2 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavorable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 22.0 19.8 16.5 16.2 15.3 21.1 21.0 14.7 22.1 24.3 14.8 20.0 11.8 22.9 6.3 22.3 23.6 8.9 17.3 15.5 14.7 18.0 22.1 17.3 23.2 16.0 14.8 28.7 25.4 10.0 17.2 11.3 16.8 23.0 10.9 6.5 17.0 11.4 28.8 23.4 21.7 12.5 14.2 30.6 18.9 16.8 16.2 11.6 19.2 10.5 15.9 22.3 22.2 17.6 38.6 25.3 26.9 46.0 26.7 34.1 38.7 42.1 20.9 45.3 39.1 27.4 30.8 47.7 53.6 22.9 23.7 34.8 45.2 37.3 20.9 31.3 62.8 38.0 68.7 46.5 48.7 77.2 43.1 48.4 48.4 47.3 44.1 28.9 33.8 35.2 83.7 14.9 28.6 42.6 31.7 83.3 64.0 24.2 57.5 52.5 34.6 65.8 28.3 38.2 63.5 28.9 26.2 53.7 44.8 19.4 21.0 42.8 38.2 65.1 25.5 39.8 75.1 25.6 53.4 44.1 30.3 80.7 34.7 1.8 18.9 0.6 8.9 15.0 8.6 12.4 9.6 8.6 18.2 12.9 11.1 8.5 3.7 5.6 9.9 10.6 6.9 10.7 16.5 15.3 14.7 22.1 15.5 14.7 16.0 14.8 16.8 14.2 16.2 17.6 15.5 12.8 13.1 8.5 47.5 24.0 27.0 16.8 22.8 8.9 16.6 20.2 8.3 11.5 9.6 12.9 2.1 21.7 19.6 16.6 5.9 17.3 22.4 7.9 11.7 17.6 7.2 13.0 12.0 14.9 22.6 14.3 17.9 9.8 29.8 19.7 6.1 10.8 47.7 8.4 9.1 14.1 4.1 80.0 51.0 47.9 14.0 57.4 17.8 10.3 64.8 6.1 12.3 2.5 7.5 12.8 6.8 12.8 24.2 29.0 7.8 14.2 9.2 12.6 13.1 17.5 16.1 21.1 20.0 20.7 20.6 15.5 24.4 14.6 22.5 20.3 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484421-12541549 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.9 9.4 3.4 1.1 3.9 0.3 8.9 4.4 4.8 11.5 3.7 11.5 1.4 10.9 2.6 8.6 12.0 1.8 15.5 3.5 3.7 10.2 8.5 6.0 2.2 3.6 3.5 14.2 12.1 3.2 10.9 0.9 3.6 10.0 2.3 3.4 6.7 3.2 15.9 8.3 6.9 3.2 3.3 6.6 9.7 6.7 3.9 2.6 9.0 3.8 2.2 11.5 9.7 3.8 6.2 11.8 5.5 7.4 6.3 7.7 7.6 5.8 4.3 6.6 5.1 4.2 5.2 5.5 3.3 4.0 5.8 5.8 7.8 9.4 5.4 5.5 9.8 5.1 9.1 5.7 5.4 9.3 2.1 4.9 11.2 10.1 9.7 3.3 4.7 8.8 10.7 3.4 6.5 11.9 9.6 6.1 6.5 10.5 13.5 4.6 2.3 13.5 9.9 4.8 1.5 4.5 6.7 5.0 4.8 3.1 10.1 5.1 4.5 4.2 3.9 4.7 9.7 3.1 8.6 6.2 5.6 11.8 5.4 0.6 1.9 0.0 2.7 1.6 4.4 3.7 4.6 3.8 2.3 3.2 6.2 5.1 0.4 2.5 1.7 3.4 1.6 2.6 3.4 3.9 4.4 4.8 3.5 3.7 3.6 3.5 3.6 3.3 3.9 3.8 5.5 3.2 3.3 26.1 8.9 2.9 11.2 5.6 13.1 28.1 3.7 4.3 7.0 10.0 3.8 11.0 43.8 8.8 2.6 9.2 1.9 6.2 1.6 7.1 7.4 6.2 4.2 8.4 42.8 4.2 4.3 5.7 13.7 3.7 5.1 17.7 3.6 5.0 4.6 10.1 46.4 5.2 4.1 3.5 1.7 2.8 9.0 3.6 3.6 16.9 2.4 8.0 6.2 19.1 31.8 4.5 5.0 10.1 3.8 6.2 2.3 6.9 11.1 34.1 6.6 7.9 6.3 14.0 23.0 7.1 4.8 1.9 4.6 15.3 8.4 8.0 TSEN34 "LENG5, SEN34, SEN34L" ENSG00000170892 "TRNA splicing endonuclease subunit 34" Q9BSV6 19 54189938-54194536 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Disease variant, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 5.0;eosinophil: 1.9;neutrophil: 4.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 5.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041111, HPA048208" Approved Supported Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA041111: AB_10794263, HPA048208: AB_2680313" "unprognostic (3.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (3.48e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.44e-7)" "unprognostic (2.38e-1)" "unprognostic (7.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.04e-3)" "unprognostic (8.98e-2)" "unprognostic (4.55e-3)" "unprognostic (2.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.81e-1)" "unprognostic (1.12e-1)" 28.5 68.2 2.2 1.3 1.8 1.3 29.5 2.4 2.4 38.8 1.8 34.7 1.1 37.1 1.9 41.0 37.8 1.5 26.3 2.1 1.7 39.1 41.3 31.5 1.3 2.2 1.7 47.9 43.0 1.8 36.0 1.3 2.0 36.2 1.3 2.0 34.0 1.9 26.7 40.5 27.7 1.2 1.3 44.1 34.3 45.0 1.7 0.5 30.9 1.8 0.7 38.9 34.2 2.2 3.3 1.7 2.5 3.1 1.3 2.0 3.9 0.6 1.0 0.9 1.7 2.1 1.1 1.1 0.0 0.9 2.5 2.5 2.6 2.3 1.4 1.1 6.2 1.0 1.1 2.0 0.5 1.1 1.1 1.9 1.1 2.0 1.3 0.9 1.3 0.0 1.7 0.9 2.4 1.4 0.4 0.2 1.5 2.9 1.1 1.4 2.6 0.7 3.4 2.4 0.1 1.7 0.0 3.5 3.0 2.5 2.6 3.1 1.1 0.2 2.8 2.7 3.4 1.4 1.9 0.9 2.6 1.3 1.2 5.0 0.6 1.9 0.2 0.5 0.4 0.1 0.3 0.1 0.3 0.4 0.4 0.2 4.8 0.0 0.3 0.4 0.0 0.2 2.2 1.8 2.4 2.4 2.1 1.7 2.2 1.7 2.0 1.3 1.7 2.2 33.1 12.8 27.7 6.8 28.2 73.5 92.0 137.7 67.2 35.4 62.9 60.8 11.8 52.9 60.9 44.1 29.2 102.5 45.4 58.8 95.9 68.7 24.0 39.4 37.0 32.5 76.8 13.7 3.8 59.7 98.2 47.5 19.9 35.3 26.6 47.7 35.7 40.6 57.8 16.8 4.9 103.7 122.1 37.0 53.6 17.2 67.7 45.0 46.2 1.0 51.8 81.9 18.6 6.0 5.9 50.4 55.9 66.5 27.6 79.8 57.8 110.5 70.0 48.9 59.2 38.7 60.8 40.1 77.2 56.7 70.2 111.0 32.8 100.3 66.5 62.3 TSEN54 "SEN54, SEN54L" ENSG00000182173 "TRNA splicing endonuclease subunit 54" Q7Z6J9 17 75515944-75524735 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease variant, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 78.4;granulocytes: 81.7;NK-cells: 87.6;T-cells: 70.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024543, HPA053097" Uncertain Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA024543: , HPA053097: AB_2682043" "unprognostic (3.52e-2)" "unprognostic (2.52e-3)" "unprognostic (9.60e-3)" "unprognostic (2.55e-3)" "unprognostic (1.81e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (2.33e-2)" "unprognostic (8.37e-2)" "unprognostic (9.04e-2)" "prognostic favorable (2.62e-5)" "unprognostic (7.26e-3)" "unprognostic (5.01e-2)" "prognostic favorable (7.78e-5)" "unprognostic (8.69e-2)" "unprognostic (2.03e-2)" "prognostic favorable (8.54e-4)" 11.1 14.9 2.8 1.3 4.2 2.1 12.7 5.2 3.2 14.1 2.3 19.2 2.9 11.8 0.2 23.2 15.5 3.1 8.3 2.6 3.2 27.2 18.2 17.8 2.9 5.0 4.1 12.4 29.9 4.1 18.3 1.7 3.5 20.0 2.1 0.4 17.4 3.4 9.5 24.3 22.5 2.3 4.1 25.4 20.4 14.2 3.5 5.1 18.1 1.8 2.5 15.1 17.0 4.6 21.8 25.3 2.6 7.2 2.7 2.7 14.7 6.1 6.6 14.4 13.0 35.4 3.9 32.5 9.1 3.6 12.3 11.9 14.3 11.1 7.5 7.7 33.9 26.2 4.7 23.9 11.8 7.5 36.0 2.7 13.7 6.2 5.8 2.0 14.0 20.7 31.5 6.0 2.8 36.6 46.7 19.1 9.0 31.7 30.5 26.4 23.6 25.1 8.4 9.5 19.0 17.0 13.2 30.8 14.3 8.5 11.9 17.3 3.0 6.2 20.7 13.7 12.5 22.6 14.1 19.0 6.1 32.7 6.4 20.0 4.1 14.4 82.1 9.7 56.1 11.5 34.1 62.4 10.8 7.2 26.5 50.0 0.2 47.7 9.8 26.2 21.2 27.1 2.8 4.2 5.2 3.2 2.6 3.2 5.0 4.1 3.5 4.1 3.5 4.6 9.8 9.6 9.6 15.7 13.3 26.4 10.7 19.0 17.6 15.4 11.3 11.9 2.6 20.0 11.6 9.2 4.2 13.6 78.4 25.4 11.7 17.8 6.1 7.7 6.9 10.8 18.7 14.9 14.7 17.2 18.2 8.1 29.0 7.0 81.7 10.2 8.6 8.6 13.2 32.0 15.0 16.9 24.4 4.7 11.1 4.6 4.7 9.2 16.0 5.6 12.5 15.4 87.6 14.1 23.9 14.5 13.8 7.5 29.2 22.3 23.1 13.1 5.0 7.7 13.1 5.9 7.4 15.0 33.8 21.3 24.3 7.5 70.4 14.6 22.6 8.7 UBXN6 "UBXD1, UBXDC2" ENSG00000167671 "UBX domain protein 6" Q9BZV1 19 4444999-4457794 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1342.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040906, HPA041313, HPA061872" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.50e-2)" "prognostic favorable (5.68e-5)" "unprognostic (1.67e-1)" "unprognostic (2.65e-3)" "unprognostic (1.83e-2)" "unprognostic (1.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.48e-1)" "prognostic favorable (6.95e-4)" "unprognostic (3.93e-2)" "prognostic favorable (2.78e-5)" "unprognostic (4.61e-2)" "unprognostic (2.67e-1)" "unprognostic (1.43e-1)" "unprognostic (1.79e-1)" 99.7 188.7 60.5 35.0 60.9 85.8 89.4 53.3 91.6 94.9 64.0 93.6 49.2 94.5 21.1 89.7 89.1 33.7 116.1 72.3 53.1 118.4 122.2 72.0 35.2 64.0 64.8 115.2 100.3 64.7 146.1 34.8 64.1 93.8 14.1 23.8 86.1 50.7 216.6 113.8 67.7 23.2 52.9 77.8 88.5 174.8 55.1 26.9 111.8 84.3 18.1 91.8 85.3 57.5 71.7 49.4 23.3 50.6 57.7 70.6 35.1 71.3 84.3 50.9 54.1 30.8 58.8 31.8 63.5 70.8 26.3 40.8 18.2 54.8 18.6 56.3 39.4 26.4 53.5 41.4 94.5 33.6 51.1 65.2 70.4 40.1 38.7 62.3 62.9 42.7 55.6 83.6 38.3 45.4 67.2 56.8 37.6 27.4 42.9 30.4 33.3 76.0 48.3 43.9 67.1 97.3 40.1 40.9 116.7 10.8 48.5 54.4 76.8 67.4 51.4 145.0 47.7 186.6 80.7 33.2 128.7 62.5 61.4 6.4 6.6 10.4 3.8 8.0 6.2 5.3 4.5 5.2 6.7 6.0 5.3 4.2 6.7 2.7 4.9 10.2 5.5 4.9 60.5 60.9 53.3 91.6 72.3 53.1 64.0 64.8 64.1 52.9 55.1 57.5 26.7 41.7 30.1 13.7 25.1 37.2 44.9 26.7 15.9 37.2 36.3 25.1 47.2 64.3 21.2 44.1 27.1 54.5 31.9 105.0 80.3 58.1 297.0 29.1 35.6 30.5 46.8 172.0 14.4 65.0 43.1 39.0 28.5 32.2 34.3 50.0 47.5 61.6 54.8 13.5 11.9 66.2 20.3 52.8 35.9 1342.0 100.0 37.5 53.4 1.9 49.0 60.1 25.7 5.5 10.3 65.6 90.1 73.0 16.4 50.9 136.9 112.2 21.4 35.2 72.3 38.8 29.5 139.9 68.9 20.4 41.1 79.6 18.5 41.4 58.4 48.5 UCKL1 "FLJ20517, URKL1" ENSG00000198276 "Uridine-cytidine kinase 1 like 1" Q9NWZ5 20 63939829-63956416 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 148.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004722, HPA004769" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 72: Non-specific - Transcription" "Cluster 39: CACO-2 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" "HPA004722: AB_1080455, HPA004769: AB_1080453" "unprognostic (1.03e-1)" "unprognostic (2.77e-2)" "unprognostic (2.64e-1)" "unprognostic (8.34e-2)" "unprognostic (7.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.45e-1)" "unprognostic (1.29e-1)" "prognostic favorable (4.42e-4)" "unprognostic (5.87e-2)" "unprognostic (3.18e-2)" "unprognostic (9.11e-2)" "unprognostic (2.81e-1)" "unprognostic (3.01e-1)" "unprognostic (5.26e-3)" 41.9 47.3 21.2 17.4 23.2 24.7 44.0 32.0 33.2 53.7 24.4 46.9 33.5 41.9 7.2 50.4 49.8 11.9 57.1 20.4 21.2 55.1 55.6 40.6 21.2 23.9 21.5 74.9 46.3 17.2 52.3 17.9 23.7 49.4 8.7 55.9 43.4 17.6 61.1 43.0 51.8 9.6 19.4 64.7 37.2 25.7 22.7 15.9 59.0 36.6 11.0 40.1 54.0 31.4 29.2 30.3 25.5 34.2 18.4 15.6 40.9 22.8 15.4 46.2 23.0 72.8 22.0 29.3 37.5 14.9 31.6 46.7 20.0 31.4 9.2 12.3 33.6 22.2 67.8 108.1 20.3 38.2 40.8 21.9 27.6 18.5 15.1 18.3 21.5 28.4 32.1 30.3 14.6 37.4 45.1 66.3 18.9 23.0 70.0 45.4 19.2 51.0 19.1 41.4 60.3 35.3 32.9 31.8 36.2 12.7 33.4 34.1 24.2 48.7 18.2 32.1 30.1 31.5 18.1 13.6 25.0 27.1 18.8 8.0 11.4 9.9 18.3 19.7 21.0 31.0 17.8 15.8 13.3 17.1 10.1 12.4 1.8 8.5 22.2 7.6 20.8 12.1 21.2 23.2 32.0 33.2 20.4 21.2 23.9 21.5 23.7 19.4 22.7 31.4 31.7 25.6 8.3 17.0 24.1 18.9 21.4 29.9 14.8 30.7 13.5 17.3 20.3 18.6 17.7 9.2 83.4 31.2 16.8 24.7 23.5 19.4 2.4 18.2 17.0 19.4 21.5 5.5 7.8 11.1 23.6 17.5 25.0 22.7 13.3 21.1 13.6 12.4 17.6 20.2 9.7 21.2 32.6 11.4 16.4 3.7 17.7 14.5 10.6 4.7 17.0 18.5 12.3 10.1 12.2 17.5 27.4 20.7 21.4 17.8 38.7 16.1 11.3 148.0 26.3 16.2 30.1 12.7 12.4 22.5 19.0 33.4 22.0 28.4 24.3 19.2 UNK "KIAA1753, ZC3H5, ZC3HDC5" ENSG00000132478 "Unk zinc finger" Q9C0B0 17 75784806-75825799 "Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 130.3;Spermatocytes: 120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023636, HPA027962" Uncertain Supported "Cytosol,Cytoplasmic bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Cytosol, Cytoplasmic bodies" "HPA023636: AB_10601774, HPA027962: AB_10611522" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (3.37e-1)" "unprognostic (1.04e-3)" "unprognostic (9.51e-2)" "prognostic favorable (2.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.11e-1)" "unprognostic (6.73e-2)" "unprognostic (9.78e-2)" "prognostic favorable (6.58e-5)" "unprognostic (5.31e-2)" "unprognostic (1.41e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.01e-2)" 12.0 11.7 8.5 8.6 9.1 8.4 13.6 9.5 9.6 20.9 9.6 12.7 6.8 18.2 4.0 13.7 17.5 5.3 10.5 7.4 7.8 15.1 12.8 10.1 10.6 9.4 8.8 22.1 14.8 9.8 20.1 5.8 8.1 16.0 3.4 5.6 14.2 6.4 9.1 18.4 14.1 4.7 7.4 21.2 11.4 9.3 10.0 10.1 16.9 4.2 5.2 14.0 15.3 13.0 9.3 14.7 16.0 13.6 5.0 4.6 13.0 6.1 6.6 6.7 8.2 5.4 10.5 19.8 5.2 6.6 11.1 8.4 8.1 7.3 3.1 10.3 26.6 12.4 12.8 11.6 6.7 9.6 15.2 9.1 4.4 5.8 6.2 7.6 8.9 14.0 6.5 9.6 5.4 18.6 21.4 13.2 6.9 6.5 9.6 22.4 16.0 10.1 6.3 9.8 14.7 28.8 7.9 11.0 22.0 8.0 13.4 14.7 6.5 15.9 8.6 7.1 7.9 16.4 5.1 11.0 11.5 6.1 10.0 0.0 0.2 0.1 0.5 0.1 0.4 0.2 0.2 0.3 0.1 0.7 0.4 0.4 0.0 0.2 0.2 0.4 0.3 0.4 8.5 9.1 9.5 9.6 7.4 7.8 9.4 8.8 8.1 7.4 10.0 13.0 12.7 16.0 17.0 33.6 25.4 15.2 17.3 19.3 10.2 26.4 16.5 14.7 11.2 11.5 21.3 3.7 14.6 9.1 18.9 11.4 3.9 15.3 130.3 14.7 11.8 13.3 16.8 10.9 15.4 22.9 15.8 14.1 15.8 9.1 19.0 15.6 7.9 6.0 14.3 21.9 21.1 13.3 38.7 10.8 14.3 22.6 19.0 10.1 26.6 28.1 10.8 22.5 18.6 27.2 26.0 21.3 12.7 10.5 24.4 12.9 7.0 6.1 24.0 24.4 19.7 15.1 15.5 120.5 73.5 13.0 21.9 17.2 19.1 10.5 14.0 13.9 UQCRHL ENSG00000233954 "Ubiquinol-cytochrome c reductase hinge protein like" A0A096LP55 1 15807169-15809348 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 16.6" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 444.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA042574 Approved NA NA "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA042574: AB_10960998" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (3.70e-2)" "unprognostic (3.19e-2)" "unprognostic (7.10e-2)" "unprognostic (4.01e-3)" "unprognostic (4.83e-1)" "unprognostic (6.76e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-1)" "unprognostic (9.67e-3)" "unprognostic (9.76e-3)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (9.70e-3)" "unprognostic (1.02e-1)" 3.6 2.2 1.3 0.3 1.3 1.1 2.8 3.0 1.6 3.2 0.8 4.4 0.3 2.3 0.7 4.6 2.7 0.3 16.6 1.3 1.1 5.8 3.4 2.4 0.3 1.6 1.3 3.8 3.0 0.1 2.7 0.1 1.6 2.6 0.2 2.9 3.3 0.1 10.4 3.1 3.3 0.2 0.7 2.8 3.5 1.7 1.5 0.3 2.4 0.1 0.2 3.0 3.2 2.3 0.2 0.1 0.8 0.8 0.2 0.2 0.3 0.1 0.1 0.0 0.1 0.2 0.6 0.3 0.2 0.1 0.2 0.3 0.1 0.1 0.1 0.6 0.1 0.3 0.6 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.3 0.0 0.4 0.2 0.5 0.0 0.5 0.1 0.4 0.4 0.1 0.3 0.3 0.2 0.2 0.0 0.4 0.5 0.4 0.2 0.5 0.2 0.2 0.2 0.7 0.1 0.5 0.3 0.3 0.2 0.5 0.2 0.3 0.2 0.5 0.2 1.8 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.4 0.3 0.3 1.6 0.4 0.2 0.4 0.2 0.2 1.3 1.3 3.0 1.6 1.3 1.1 1.6 1.3 1.6 0.7 1.5 2.3 1.4 0.0 1.1 6.2 12.3 0.0 39.0 0.0 1.8 3.8 3.1 6.2 444.8 24.3 0.6 9.2 6.2 21.4 4.1 6.1 23.5 1.1 3.0 4.0 6.7 10.7 7.3 6.6 5.3 0.7 21.5 13.9 1.5 4.6 2.5 9.7 17.9 23.1 20.6 1.7 5.4 12.6 0.0 48.3 0.0 3.6 11.1 11.9 0.0 0.0 12.9 3.0 16.5 1.0 2.9 0.6 6.1 12.4 7.8 31.9 11.5 10.3 0.0 6.9 6.6 33.2 12.7 6.2 12.5 5.5 0.0 23.5 5.4 3.9 15.4 31.1 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;JURKAT: 2.2;MOLT-4: 1.3;NB-4: 5.7;RPTEC TERT1: 2.1;THP-1: 2.9" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 5.7 5.2 3.8 0.0 3.5 0.0 5.2 3.6 4.4 5.9 4.0 6.1 0.3 7.1 0.0 4.4 5.9 0.0 6.2 3.4 3.5 5.9 7.7 4.7 0.6 3.3 3.9 5.5 6.8 1.2 5.5 0.0 3.3 5.3 0.0 2.2 6.6 0.0 6.7 3.7 5.6 0.2 3.3 5.1 5.9 3.2 3.7 1.8 6.1 2.4 0.0 5.5 5.1 3.8 0.0 0.0 1.2 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 1.3 5.7 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 4.4 3.4 3.5 3.3 3.9 3.3 3.3 3.7 3.8 9.9 6.4 17.5 8.5 8.2 5.9 5.6 10.8 9.6 13.9 13.7 7.9 23.8 12.8 15.8 16.5 4.2 10.1 5.1 21.2 0.0 7.3 0.4 9.1 13.9 13.9 18.6 19.9 8.9 7.6 9.6 13.9 5.1 12.4 11.4 14.4 14.6 33.6 9.3 25.2 9.0 14.7 8.2 13.5 3.9 0.8 10.5 8.1 8.8 5.6 8.2 14.1 10.3 6.6 10.7 7.7 11.3 14.3 8.4 12.7 9.9 6.4 14.8 11.6 6.6 20.2 12.6 7.2 13.3 14.0 8.4 7.0 7.2 9.4 14.1 6.7 VARS2 "DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL" ENSG00000137411 "Valyl-tRNA synthetase 2, mitochondrial" Q5ST30 6 30914205-30926459 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062449, HPA070267" Approved Approved Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA062449: AB_2684766, HPA070267: AB_2686245" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "unprognostic (1.96e-3)" "unprognostic (2.50e-1)" "unprognostic (5.80e-2)" "unprognostic (3.05e-2)" "unprognostic (2.43e-2)" "unprognostic (1.66e-2)" "unprognostic (3.14e-1)" "unprognostic (8.98e-2)" "unprognostic (4.23e-2)" "unprognostic (2.60e-2)" "unprognostic (2.15e-3)" "unprognostic (1.04e-2)" "unprognostic (7.23e-2)" "unprognostic (1.19e-2)" "unprognostic (2.43e-2)" 10.2 14.4 1.3 2.1 1.5 1.9 9.7 1.5 1.6 12.5 0.4 10.5 1.2 10.4 1.5 22.5 10.1 0.2 11.1 1.4 1.3 12.5 18.9 10.5 3.1 1.3 1.6 15.3 14.0 2.3 17.1 0.9 1.4 10.2 2.2 1.4 10.9 1.1 20.9 10.1 12.8 0.7 1.2 13.4 11.7 11.8 1.3 4.1 15.0 0.2 2.3 10.5 13.2 1.3 13.8 9.6 5.5 23.1 4.9 4.4 0.7 2.2 1.9 2.5 1.6 12.6 8.9 11.9 7.5 3.0 9.4 0.0 21.3 0.0 2.4 4.6 15.7 13.2 10.2 0.9 6.7 2.3 0.3 6.2 8.1 5.9 1.3 0.9 1.3 19.5 0.1 10.5 5.4 0.0 4.6 0.0 1.7 0.0 1.2 9.1 0.0 10.3 18.3 0.0 8.5 0.2 0.2 6.6 5.4 5.0 16.3 7.4 2.2 14.2 1.4 1.0 0.1 10.0 17.1 18.8 0.0 0.6 8.7 0.0 0.0 0.0 0.3 0.1 0.4 0.3 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.2 0.1 1.3 1.5 1.5 1.6 1.4 1.3 1.3 1.6 1.4 1.2 1.3 1.3 3.0 6.4 12.5 14.7 8.0 4.0 4.9 4.7 4.0 6.6 6.4 3.7 11.6 8.6 5.5 9.2 0.0 8.7 4.1 10.1 1.9 6.7 1.5 7.7 5.2 3.9 13.1 3.4 8.3 7.1 9.6 4.8 11.7 8.6 12.7 12.9 7.5 22.5 9.2 8.4 9.1 8.4 2.0 6.9 3.5 1.6 4.1 5.1 1.8 3.7 7.9 2.8 4.1 8.0 7.2 8.9 4.7 4.1 12.3 2.3 12.4 12.5 8.9 6.0 0.0 2.9 3.7 10.4 8.0 9.0 4.1 3.4 4.8 6.9 10.9 3.8 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383538 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 58.7;Fibroblasts: 104.2;Leydig cells: 50.1;Peritubular cells: 60.9;Sertoli cells: 98.6;Smooth muscle cells: 80.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 21.8;MCF7: 18.4;U-2197: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2000000000 "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 55.7 15.5 1.5 5.8 2.3 2.7 31.5 0.8 2.3 48.1 3.0 12.1 3.4 30.3 0.0 34.1 24.6 7.3 30.5 1.1 0.5 56.1 31.8 44.9 2.8 6.3 5.5 40.0 10.3 0.0 12.8 10.4 1.7 17.9 0.0 0.3 15.9 0.0 6.9 38.8 11.2 0.0 1.6 13.0 13.4 16.8 4.6 0.0 26.8 0.0 0.0 26.5 38.9 2.7 4.2 0.0 0.6 0.5 0.2 0.2 12.6 21.8 0.1 0.0 0.0 1.9 5.5 0.0 4.5 0.3 2.6 0.3 0.0 0.0 0.0 13.7 2.2 0.9 15.9 14.9 0.6 0.0 0.4 7.9 0.0 0.3 0.0 3.1 0.0 0.1 3.1 0.8 0.0 18.4 1.0 5.3 2.2 0.4 2.4 1.0 0.0 0.0 0.0 0.1 1.4 9.3 6.5 13.5 0.6 2.2 6.8 2.5 0.0 17.5 12.5 78.4 4.6 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.3 0.8 2.3 1.1 0.5 6.3 5.5 1.7 1.6 4.6 2.7 10.0 6.4 13.1 5.5 1.4 9.6 7.8 4.2 9.1 0.5 21.9 10.9 16.2 32.9 6.4 23.9 0.0 5.4 2.8 1.5 7.9 13.1 1.1 12.1 58.7 4.6 0.0 0.0 1.1 2.9 7.2 104.2 16.8 20.5 3.8 4.6 2.9 15.3 3.4 0.0 0.9 2.0 2.0 0.6 21.7 2.8 50.1 2.0 14.2 2.8 0.0 18.3 0.0 0.5 0.3 28.3 1.2 60.9 0.8 6.4 0.2 12.3 2.7 0.7 98.6 12.6 80.9 0.8 4.1 3.7 7.5 10.0 3.5 2.3 0.8 4.9 VEGFB "VEGFL, VRF" ENSG00000173511 "Vascular endothelial growth factor B" P49765 11 64234584-64239264 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 204.9;Muller glia cells: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 30.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 30.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 186000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (4.88e-2)" "unprognostic (6.04e-2)" "unprognostic (1.33e-2)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.38e-2)" "unprognostic (2.45e-1)" "unprognostic (4.68e-1)" "unprognostic (5.01e-3)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (1.67e-2)" "unprognostic (8.08e-3)" "unprognostic (2.00e-1)" "unprognostic (4.15e-2)" "unprognostic (4.31e-3)" 209.8 82.0 45.7 12.0 51.3 3.9 151.3 41.8 53.1 103.6 48.2 151.5 12.1 99.9 7.2 50.8 72.5 19.2 253.3 38.7 45.1 84.6 44.0 82.5 14.4 54.8 47.4 82.6 84.9 18.3 104.2 9.8 45.0 92.7 4.7 12.7 57.7 28.5 143.8 77.3 59.5 10.2 44.2 55.9 89.2 17.5 50.6 6.6 83.7 51.5 9.1 118.0 77.5 37.3 15.4 25.9 9.9 28.1 49.7 36.8 12.7 14.7 27.8 13.1 16.0 13.8 31.7 19.8 28.6 14.0 28.8 20.8 15.8 11.5 2.3 20.6 15.1 16.7 33.9 13.3 45.4 4.8 20.1 39.6 12.0 19.6 12.2 33.9 18.4 20.6 20.2 32.5 22.2 31.8 27.4 12.6 7.0 10.9 22.3 32.1 20.5 46.5 11.0 19.5 14.0 46.4 12.4 38.1 57.4 7.6 25.1 5.6 13.0 50.8 30.2 23.1 8.7 90.5 45.5 15.4 41.6 5.3 25.1 0.3 0.2 0.6 0.9 0.0 0.8 3.0 0.8 0.9 0.4 2.4 0.9 1.6 0.0 0.4 0.0 30.5 0.5 0.4 45.7 51.3 41.8 53.1 38.7 45.1 54.8 47.4 45.0 44.2 50.6 37.3 54.1 19.2 32.6 43.8 27.6 12.7 6.7 10.1 2.2 47.9 32.8 65.7 204.9 10.0 7.6 14.7 33.3 9.6 68.3 11.9 39.2 14.8 1.1 24.2 47.7 21.9 53.3 4.4 7.3 12.9 16.8 68.6 5.1 31.6 18.4 62.7 19.6 9.8 51.4 65.6 26.6 12.2 20.3 31.5 21.5 3.5 60.9 50.0 35.6 19.7 17.7 130.6 12.3 29.1 11.8 14.5 7.3 109.1 12.3 11.5 20.3 31.6 8.9 39.6 6.6 47.4 53.7 0.5 1.2 6.4 13.9 8.9 19.0 34.3 12.8 7.5 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621182-2660056 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 77.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 78.1;Cone photoreceptor cells: 104.3;Oligodendrocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "eosinophil: 6.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 22.3;JURKAT: 20.5;THP-1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Uncertain "Vesicles,Cytokinetic bridge,Centriolar satellite" Yes NA 330000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 15.7 16.3 2.7 2.2 6.4 0.8 8.5 5.3 4.2 10.3 6.4 6.6 0.5 9.6 3.2 19.2 13.8 2.9 43.7 3.2 5.3 10.6 3.1 10.7 0.7 7.7 5.6 77.5 27.4 19.5 6.5 5.9 5.9 6.6 2.0 12.3 11.6 2.0 26.2 5.3 1.9 6.8 4.0 5.5 9.0 6.0 4.9 0.8 11.6 11.7 1.7 12.5 10.4 9.8 0.1 0.8 14.3 0.4 1.5 0.5 22.3 7.0 2.2 1.7 4.3 3.6 0.3 0.0 6.4 2.8 0.6 0.3 3.4 5.6 4.5 9.7 2.4 0.1 1.6 1.8 1.9 9.2 1.7 1.5 3.3 0.7 0.1 7.6 0.7 20.5 0.0 17.4 1.1 0.9 1.1 1.1 9.9 1.5 0.9 0.1 0.4 0.0 6.4 0.4 2.5 2.4 0.6 0.6 10.4 7.5 0.3 33.3 0.3 2.8 4.5 0.1 3.3 14.1 6.1 2.6 14.7 8.2 0.6 0.0 0.0 6.3 0.2 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 2.7 6.4 5.3 4.2 3.2 5.3 7.7 5.6 5.9 4.0 4.9 9.8 4.2 16.0 8.8 1.0 0.1 2.7 1.2 18.7 4.6 23.8 4.3 3.9 78.1 1.5 9.7 5.5 104.3 13.2 1.6 9.8 1.9 11.3 5.7 8.6 6.1 3.6 10.9 0.0 8.3 10.3 29.0 17.2 3.1 19.3 0.0 5.7 2.2 2.8 2.3 11.8 10.9 1.4 24.4 1.0 1.1 2.8 7.8 0.6 10.6 2.8 1.0 3.9 0.0 8.0 39.1 8.6 4.3 10.9 0.5 5.1 0.0 8.0 11.9 32.5 0.0 2.7 9.4 8.2 6.4 5.0 2.0 3.4 1.7 15.9 1.3 6.0 VPS28 ENSG00000160948 "VPS28 subunit of ESCRT-I" Q9UK41 8 144423601-144428563 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;SH-SY5Y: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024688, HPA024745" Supported NA NA 63000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA024688: AB_1858766, HPA024745: AB_1858765" "unprognostic (2.87e-2)" "unprognostic (1.87e-1)" "unprognostic (1.27e-1)" "prognostic favorable (9.93e-4)" "unprognostic (3.18e-1)" "unprognostic (2.03e-1)" "unprognostic (9.29e-2)" "unprognostic (7.94e-3)" "unprognostic (1.54e-2)" "unprognostic (2.00e-2)" "unprognostic (7.92e-2)" "unprognostic (6.85e-2)" "unprognostic (3.15e-1)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.27e-1)" "unprognostic (2.37e-2)" 132.8 137.6 0.1 0.0 0.1 0.0 132.9 0.0 0.3 147.7 0.0 150.5 0.0 133.7 0.0 138.0 127.3 0.1 177.5 0.1 0.2 173.8 162.7 123.1 0.1 0.1 0.2 159.6 146.5 0.0 129.3 0.1 0.5 136.3 0.0 0.7 119.7 0.2 197.7 150.4 140.0 0.0 0.0 144.9 154.1 151.8 0.1 0.0 144.5 1.1 0.0 128.7 135.4 0.2 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.5 0.0 0.1 0.2 189.6 112.2 128.6 32.3 126.9 103.2 138.6 180.0 105.9 91.9 139.0 171.2 70.1 131.5 133.9 169.2 60.5 166.4 126.6 387.2 273.9 264.5 208.6 130.4 131.5 149.7 172.7 139.3 20.1 251.1 160.9 142.9 154.9 164.9 185.5 191.5 142.1 141.4 250.7 57.2 25.9 256.8 128.1 178.9 155.9 183.1 198.8 172.1 188.5 22.5 285.8 168.6 144.1 20.1 32.3 287.3 462.2 156.1 112.8 128.9 561.9 526.5 134.6 121.8 157.8 140.0 206.5 232.1 127.2 142.7 133.5 112.7 160.9 275.7 206.0 168.8 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50 subunit of EARP/GARPII complex" Q96JG6 7 93232340-93361123 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 7.4 9.0 4.2 3.4 4.6 2.6 8.2 5.7 5.3 7.3 4.6 8.9 1.9 8.2 4.2 9.2 6.8 2.7 7.7 4.4 4.0 7.1 6.1 6.1 4.9 4.1 4.0 7.6 7.8 6.0 7.7 4.8 4.2 6.4 5.2 5.1 8.8 3.2 12.0 8.8 8.2 3.5 4.2 9.5 7.8 6.5 3.8 4.3 7.3 4.9 4.8 7.9 7.8 5.0 6.5 2.2 2.6 5.0 8.2 7.9 6.3 5.5 5.0 9.1 6.1 5.5 9.0 5.5 5.1 4.2 13.6 3.6 10.4 7.0 11.3 5.8 4.6 14.6 3.1 2.4 4.9 3.4 4.5 3.8 8.7 9.9 9.5 5.9 11.5 3.9 10.2 8.2 11.3 4.7 5.3 4.6 6.2 8.7 5.9 3.5 6.3 8.1 5.1 2.9 3.7 7.8 4.8 13.5 4.4 7.5 6.3 2.8 5.8 12.4 4.4 16.3 4.5 3.3 8.0 9.1 6.9 6.1 6.8 3.1 3.2 2.1 2.6 3.5 4.6 2.4 2.7 2.7 4.5 2.4 2.0 2.5 1.1 1.4 2.5 2.8 2.9 2.0 4.2 4.6 5.7 5.3 4.4 4.0 4.1 4.0 4.2 4.2 3.8 5.0 10.9 12.8 11.3 0.0 13.5 0.0 3.4 0.0 6.8 14.1 11.7 6.3 0.0 2.8 5.0 5.5 16.7 7.5 11.0 5.5 3.9 6.2 27.9 7.6 10.8 7.9 2.4 10.8 0.0 5.5 11.7 6.4 11.2 8.2 7.6 12.6 9.7 6.1 10.7 10.1 0.0 7.1 0.0 13.7 0.0 14.2 9.0 10.0 0.0 0.0 9.4 10.3 6.2 0.0 0.0 6.9 9.4 7.2 10.2 2.7 6.1 8.3 5.8 14.3 6.6 11.2 6.3 18.1 12.8 7.9 0.0 9.4 8.5 13.9 5.1 2.8 VPS52 "ARE1, SACM2L" ENSG00000223501 "VPS52 subunit of GARP complex" Q8N1B4 6 33250272-33272047 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 45.3;THP-1: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042667, HPA048128" Approved NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "HPA042667: AB_2678105, HPA048128: AB_2680278" "unprognostic (2.65e-2)" "unprognostic (2.13e-1)" "unprognostic (9.44e-2)" "unprognostic (1.03e-3)" "unprognostic (6.07e-3)" "unprognostic (3.13e-1)" "unprognostic (2.28e-2)" "unprognostic (4.38e-2)" "unprognostic (1.49e-3)" "unprognostic (2.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.17e-1)" "unprognostic (3.33e-2)" "unprognostic (7.63e-2)" 20.1 28.1 2.4 8.2 3.6 3.8 21.6 2.2 4.8 24.6 5.6 23.6 9.9 23.2 8.3 29.9 20.7 7.3 20.0 2.4 4.0 21.6 24.3 18.2 12.4 4.6 3.0 24.9 25.3 0.0 26.2 3.2 3.9 22.7 6.2 2.9 24.0 2.7 37.8 27.6 25.1 7.0 2.3 27.6 23.7 17.9 3.4 10.4 27.9 23.3 10.0 22.4 24.0 4.0 0.1 6.6 0.4 26.4 9.3 9.2 24.7 0.0 0.0 0.0 0.0 11.1 0.0 0.0 18.1 0.0 10.9 20.2 25.3 0.0 0.0 0.0 2.9 0.0 6.6 13.4 11.2 0.0 24.2 0.0 0.0 0.0 17.8 16.4 11.8 10.5 27.1 2.0 0.0 0.1 0.4 0.0 20.8 11.0 16.7 9.9 4.0 27.5 15.0 17.4 0.0 16.3 13.1 45.3 14.4 0.0 0.8 39.1 0.0 13.7 7.0 16.0 22.2 0.0 0.0 18.7 0.0 11.5 0.0 5.7 4.5 4.1 2.8 3.6 2.1 2.4 3.0 4.1 3.7 2.2 3.3 4.0 2.0 4.9 2.9 1.7 4.5 4.2 2.4 3.6 2.2 4.8 2.4 4.0 4.6 3.0 3.9 2.3 3.4 4.0 8.4 12.8 13.0 18.9 8.8 6.6 6.3 9.0 10.8 13.0 12.2 10.4 1.3 10.0 9.3 3.7 2.1 16.7 6.9 17.7 7.9 11.0 7.8 10.0 8.8 8.7 7.2 7.8 10.7 11.8 16.0 7.3 18.3 14.2 1.3 10.7 11.4 19.1 11.4 6.7 11.1 14.5 12.2 14.1 4.6 7.2 6.8 8.5 7.2 15.9 11.4 13.3 2.1 7.5 16.4 9.7 7.7 9.1 14.2 4.3 13.7 8.9 10.6 12.6 13.1 7.0 6.9 25.7 14.2 15.4 8.7 17.6 6.6 8.4 12.5 6.4 WAC "BM-016, FLJ31290, MGC10753, PRO1741, Wwp4" ENSG00000095787 "WW domain containing adaptor with coiled-coil" Q9BTA9 10 28532493-28623112 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036528, HPA042609, HPA074604" Approved Enhanced Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: " "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.80e-1)" "unprognostic (4.53e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.27e-6)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.07e-1)" "unprognostic (2.90e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (3.13e-2)" "unprognostic (6.63e-2)" "unprognostic (1.36e-1)" 53.2 39.9 18.4 30.8 24.3 51.6 48.9 45.2 22.0 49.4 17.9 66.3 27.3 50.3 16.7 45.9 47.1 23.7 44.8 19.6 20.5 38.1 35.9 50.4 31.6 19.2 21.9 53.1 39.5 34.0 36.9 31.6 19.6 40.6 23.2 34.5 44.2 25.6 55.1 50.2 47.4 25.0 19.1 45.6 45.8 37.3 21.8 45.8 43.7 34.0 28.4 54.9 46.7 26.3 72.4 45.2 65.5 51.1 40.7 31.4 59.9 58.2 33.1 60.9 50.5 68.7 73.2 71.8 42.8 46.6 44.6 63.1 51.5 46.8 55.1 92.1 54.0 89.0 40.6 41.2 51.2 39.9 66.7 33.0 57.7 65.6 46.7 38.4 44.4 65.8 76.8 69.9 38.4 60.0 87.8 24.6 41.9 48.1 21.4 71.8 109.3 56.2 29.3 36.1 60.1 56.8 50.7 57.4 78.2 40.6 45.8 56.1 47.9 38.5 64.3 40.1 52.8 40.8 44.4 82.6 47.8 70.5 38.8 13.7 10.7 9.2 10.5 15.0 10.5 12.7 8.7 12.7 11.2 12.3 10.3 9.2 13.0 13.4 14.3 7.3 9.2 8.5 18.4 24.3 45.2 22.0 19.6 20.5 19.2 21.9 19.6 19.1 21.8 26.3 110.8 93.0 75.1 114.6 94.1 176.0 94.6 44.2 105.9 114.5 95.8 78.9 109.6 81.5 52.9 40.5 95.9 59.2 115.7 77.1 31.3 47.0 99.8 92.9 107.4 92.8 69.5 97.8 117.8 47.6 61.5 86.4 58.6 142.4 55.8 94.1 75.3 61.4 53.6 107.7 107.1 86.2 44.7 111.5 154.8 123.6 83.0 107.2 76.5 138.7 92.1 68.4 87.6 142.7 180.9 55.0 68.5 82.8 86.0 128.5 73.2 59.4 45.5 92.4 59.2 113.5 85.1 85.9 59.2 80.5 184.1 99.1 100.4 83.4 71.6 134.5 WASHC1 "FAM39E, FLJ00038, WASH1" ENSG00000181404 "WASH complex subunit 1" A8K0Z3 9 14475-73865 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 50.9;Proximal tubular cells: 47.5;Syncytiotrophoblasts: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002689 Uncertain Supported Vesicles NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA002689: AB_1078803" "unprognostic (9.43e-2)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (5.00e-1)" "unprognostic (5.40e-3)" "unprognostic (3.37e-3)" "unprognostic (6.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-1)" "unprognostic (3.38e-1)" "unprognostic (2.31e-2)" "unprognostic (1.02e-1)" 15.7 18.1 13.2 7.1 14.2 16.3 17.6 13.2 15.1 24.5 16.5 19.6 10.2 20.3 21.9 19.2 24.1 9.0 17.9 13.3 13.5 25.9 20.9 17.1 13.4 14.4 13.8 23.0 21.9 5.2 21.2 6.6 14.3 27.0 4.7 15.9 17.6 13.5 22.8 26.1 21.9 15.3 13.4 29.0 18.3 24.1 14.5 8.6 22.1 6.8 6.0 19.7 20.5 14.9 13.5 8.5 5.0 10.3 8.5 5.7 12.4 11.7 11.4 6.9 5.5 8.4 8.3 5.7 6.6 4.8 6.2 16.7 7.4 5.7 2.5 5.9 14.4 5.5 7.0 8.6 4.7 11.3 10.0 4.3 4.2 3.5 4.7 17.3 2.1 5.0 12.6 21.0 2.2 4.0 11.6 9.4 9.2 9.1 10.5 7.9 4.3 7.2 5.1 9.8 5.6 14.9 6.8 14.3 8.6 6.2 8.6 10.5 8.0 9.2 6.7 4.0 10.3 9.4 7.9 4.5 8.6 12.0 8.6 1.2 2.5 2.2 1.9 2.7 1.5 1.3 1.5 1.6 2.3 1.2 1.6 1.3 1.4 2.1 4.0 2.1 1.8 1.5 13.2 14.2 13.2 15.1 13.3 13.5 14.4 13.8 14.3 13.4 14.5 14.9 34.5 22.4 22.5 0.0 10.5 0.0 0.0 0.0 0.0 0.0 29.0 28.3 0.0 0.0 7.4 60.7 0.0 37.4 21.5 0.0 50.9 13.7 0.0 24.7 28.6 7.5 0.0 0.0 0.0 15.8 26.1 10.8 0.0 22.9 16.4 27.3 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 13.1 0.0 0.0 6.7 0.0 0.0 47.5 8.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 42.8 11.4 14.3 0.0 0.0 WDR46 "BING4, C6orf11, UTP7" ENSG00000227057 "WD repeat domain 46" O15213 6 33279108-33289247 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043004, HPA055425" Uncertain Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA043004: AB_10967417, HPA055425: " "unprognostic (1.84e-1)" "unprognostic (7.54e-2)" "unprognostic (2.82e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.51e-3)" "unprognostic (2.63e-3)" "unprognostic (2.62e-1)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (9.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.97e-1)" "unprognostic (2.32e-1)" 19.4 19.0 2.2 14.1 2.4 12.6 18.9 1.8 3.8 21.2 2.5 16.4 13.5 23.6 13.6 19.1 17.4 3.2 12.8 2.7 2.7 15.6 17.1 14.7 10.6 2.2 2.4 17.3 19.2 3.0 19.7 5.5 2.6 16.8 11.2 3.0 18.7 2.7 26.1 23.9 15.6 9.6 2.2 20.4 16.7 14.8 2.5 6.3 16.4 12.6 18.8 19.6 17.8 3.5 0.9 21.1 15.3 61.2 11.4 1.6 56.2 42.3 4.9 0.2 7.0 27.8 15.5 49.4 35.5 22.5 60.2 23.4 3.9 31.0 19.3 31.6 32.2 65.6 20.3 54.0 10.4 56.6 74.2 12.5 5.2 18.4 9.5 15.6 0.0 26.6 37.5 13.8 6.8 23.3 32.1 46.8 45.1 8.5 18.3 47.1 28.1 40.3 9.3 20.7 30.9 40.3 20.4 44.4 46.9 18.3 17.2 37.8 30.9 37.9 42.8 31.6 64.3 56.5 104.3 83.5 16.4 55.9 35.3 12.1 17.3 6.2 24.9 28.7 21.4 16.1 18.2 22.4 27.9 18.9 17.0 21.7 1.2 28.1 33.9 13.7 18.6 20.1 2.2 2.4 1.8 3.8 2.7 2.7 2.2 2.4 2.6 2.2 2.5 3.5 21.0 0.0 11.7 2.9 30.4 43.7 30.8 40.7 28.5 14.4 23.8 20.2 7.2 17.2 25.7 23.9 6.2 44.0 33.9 20.4 11.7 43.5 65.0 19.0 30.9 22.9 13.8 13.7 11.1 43.0 48.7 27.7 20.4 24.3 21.6 35.1 14.6 26.4 28.9 13.5 6.5 21.5 22.4 19.0 24.1 23.3 25.7 22.0 17.8 5.6 29.0 17.9 36.0 2.5 2.8 33.1 15.6 23.0 25.0 38.0 18.2 37.8 14.7 10.1 13.1 35.7 28.3 42.3 37.2 23.6 42.6 38.2 26.1 46.8 31.9 30.0 WDR86 ENSG00000187260 "WD repeat domain 86" Q86TI4 7 151375909-151410727 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix: 23.6;thyroid gland: 29.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 17.9;Endometrial ciliated cells: 13.9;Endometrial stromal cells: 22.5;Fibroblasts: 10.0;Microglial cells: 7.5;Muller glia cells: 11.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 14.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 13.7;NTERA-2: 2.6;SCLC-21H: 5.8;SH-SY5Y: 4.1;SuSa: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "unprognostic (8.93e-3)" "unprognostic (1.83e-2)" "unprognostic (3.13e-4)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.34e-2)" "unprognostic (6.02e-2)" "unprognostic (1.14e-2)" "unprognostic (6.32e-3)" "unprognostic (2.20e-1)" "unprognostic (1.84e-6)" "unprognostic (7.22e-2)" "unprognostic (1.96e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-1)" 10.9 1.3 7.0 0.3 4.9 0.1 8.1 0.2 5.4 23.6 6.6 10.5 0.8 9.1 0.2 1.4 19.2 0.9 0.6 5.1 0.4 3.0 0.8 1.3 1.1 2.5 3.3 6.2 0.9 7.6 8.0 2.9 0.9 4.1 0.1 0.4 1.3 4.7 0.5 0.7 3.1 0.4 1.4 18.5 5.8 0.8 0.5 0.2 29.1 0.0 0.1 2.2 6.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 4.1 0.0 0.0 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.0 4.9 0.2 5.4 5.1 0.4 2.5 3.3 0.9 1.4 0.5 0.4 3.4 0.0 0.5 2.6 1.3 0.0 0.2 1.9 1.2 0.3 3.4 17.9 1.4 0.0 1.5 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 13.9 22.5 1.5 0.0 0.0 1.8 0.0 1.4 10.0 0.5 3.1 0.0 0.7 0.4 0.2 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 7.5 1.2 11.5 1.0 1.5 0.2 0.0 0.0 3.0 0.4 0.0 0.0 0.0 5.4 0.8 0.0 0.2 4.6 0.1 0.5 0.0 0.3 0.8 3.1 0.1 0.0 0.3 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178621 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 22.9 17.2 14.3 16.4 17.3 10.2 22.9 15.6 14.6 27.2 15.2 20.1 19.0 24.9 17.6 16.1 25.3 16.6 13.1 12.9 17.3 24.8 24.2 20.7 24.5 16.8 17.4 34.6 21.6 24.0 25.8 15.6 17.4 22.9 15.6 15.2 18.5 23.6 21.3 31.9 24.0 17.5 15.2 24.2 17.4 12.4 16.0 21.2 26.7 9.8 21.7 22.9 20.3 18.3 14.3 33.8 36.7 22.6 51.0 35.8 124.8 33.6 88.7 29.9 22.3 11.8 14.7 46.6 14.5 37.5 14.7 15.6 23.6 49.3 23.6 21.5 24.7 24.9 35.7 21.7 45.0 16.8 42.2 50.1 56.4 39.7 77.4 34.2 34.5 19.0 31.2 22.5 32.5 27.2 17.9 16.3 23.5 20.4 21.2 19.3 17.9 33.7 36.2 36.9 8.8 29.9 36.1 27.2 23.5 54.6 29.9 13.8 57.1 11.2 32.1 18.4 15.4 54.5 46.4 25.4 26.5 19.4 41.6 41.4 20.2 26.8 23.2 16.6 22.7 27.1 26.7 23.5 17.9 25.0 28.3 20.8 73.1 24.3 23.3 17.4 24.7 16.9 14.3 17.3 15.6 14.6 12.9 17.3 16.8 17.4 17.4 15.2 16.0 18.3 26.0 60.9 63.2 16.6 39.9 13.8 20.4 25.5 59.2 35.6 19.0 25.9 11.8 31.5 47.7 16.5 39.6 42.5 38.9 13.4 35.2 19.3 2.3 32.2 44.8 29.9 16.3 20.8 18.0 19.2 20.3 29.2 15.3 25.5 47.4 25.0 22.9 40.5 18.2 26.9 22.0 13.9 20.3 23.9 14.9 2.7 30.7 19.6 8.8 15.0 40.1 24.9 54.6 17.1 27.5 19.5 15.0 28.2 29.1 18.9 32.7 66.1 55.0 51.0 26.3 43.3 27.7 28.7 54.9 21.4 11.1 32.0 42.3 26.3 18.1 10.5 ZBTB12 "C6orf46, D6S59E, G10, NG35" ENSG00000204366 "Zinc finger and BTB domain containing 12" Q9Y330 6 31899613-31902086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.6;Erythroid cells: 2.5;Horizontal cells: 3.3;Oligodendrocytes: 2.2;Rod photoreceptor cells: 1.7;Squamous epithelial cells: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.5;HEK 293: 3.1;NTERA-2: 2.5;REH: 4.6;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047161, HPA070639" Approved Enhanced Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA047161: AB_2679962, HPA070639: " "unprognostic (2.05e-1)" "unprognostic (3.15e-2)" "unprognostic (3.77e-1)" "unprognostic (2.93e-1)" "unprognostic (1.24e-1)" "unprognostic (8.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.55e-1)" "unprognostic (5.22e-2)" "unprognostic (8.16e-2)" "unprognostic (2.58e-1)" "unprognostic (5.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.87e-1)" "unprognostic (2.11e-1)" "unprognostic (6.39e-2)" "unprognostic (8.98e-3)" 1.8 2.8 0.6 0.0 0.6 0.0 1.9 0.5 0.7 5.7 0.0 2.7 0.0 5.0 0.0 2.7 4.1 0.1 1.7 0.5 0.3 1.9 1.3 1.5 0.0 0.7 0.7 6.4 2.1 0.0 2.2 0.0 0.6 3.2 0.0 0.0 2.4 0.0 2.0 1.5 2.4 0.0 0.6 2.4 2.1 2.3 0.7 0.0 2.5 0.0 0.0 4.2 3.1 1.1 1.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.1 1.1 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.5 0.2 2.5 0.0 1.2 4.6 0.3 0.2 0.0 0.0 1.1 1.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.1 1.4 3.1 0.6 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.5 0.7 0.5 0.3 0.7 0.7 0.6 0.6 0.7 1.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.8 0.3 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.6 0.4 0.0 2.5 0.4 0.0 0.0 0.2 0.5 0.2 0.0 1.0 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 1.7 0.0 0.3 1.1 0.0 0.0 1.5 0.0 0.0 0.2 0.5 0.1 0.1 ZBTB22 "BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A" ENSG00000236104 "Zinc finger and BTB domain containing 22" O15209 6 33314406-33317942 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043848 Approved Nucleoplasm No No "Cluster 2: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA043848: AB_10961146" "unprognostic (1.32e-1)" "unprognostic (2.87e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.82e-1)" "unprognostic (1.31e-1)" "unprognostic (1.55e-2)" "unprognostic (2.06e-1)" "unprognostic (6.88e-2)" "unprognostic (4.98e-2)" "unprognostic (1.81e-1)" "unprognostic (6.54e-3)" "unprognostic (1.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.66e-2)" "unprognostic (9.32e-3)" 10.2 15.1 1.2 2.6 1.2 2.1 11.3 1.1 3.5 15.6 0.7 10.4 4.7 15.6 8.5 13.3 12.6 1.7 10.6 1.2 0.9 11.9 10.1 12.0 1.1 2.1 1.3 14.9 12.2 11.6 10.5 2.3 1.4 12.1 4.2 5.7 12.0 3.8 8.6 19.2 11.6 3.0 1.5 13.7 11.8 6.1 1.0 5.3 15.1 3.9 3.9 12.0 13.2 1.4 0.3 0.3 8.5 4.4 8.3 3.3 3.5 7.5 7.3 7.1 4.6 0.1 1.9 1.9 5.6 12.5 9.1 0.6 0.3 4.6 5.2 11.7 2.8 7.5 4.4 4.1 0.0 0.0 2.8 10.8 10.0 0.3 2.6 9.8 0.7 6.3 2.9 7.8 2.6 4.7 4.6 6.7 0.0 0.4 2.2 0.5 0.1 4.2 6.3 0.4 9.7 0.6 0.7 0.4 4.3 5.0 0.7 0.4 10.7 3.9 4.5 0.2 0.2 4.3 4.5 1.9 5.6 1.1 4.3 0.8 0.2 0.8 0.3 0.3 0.1 0.5 0.4 0.2 0.2 0.3 0.7 0.1 0.3 0.1 0.2 0.4 0.1 0.2 1.2 1.2 1.1 3.5 1.2 0.9 2.1 1.3 1.4 1.5 1.0 1.4 9.4 0.0 5.0 2.6 7.3 6.4 16.3 6.0 8.6 20.1 9.9 7.6 4.3 4.3 4.9 7.3 8.4 6.3 3.3 9.8 23.5 11.0 1.6 8.3 5.2 7.7 7.7 4.0 2.8 7.1 4.6 6.7 5.6 6.9 3.8 6.5 7.9 2.0 5.3 20.2 2.8 8.7 12.2 4.4 4.0 1.8 9.3 5.3 1.8 3.7 12.1 18.2 8.2 3.5 2.6 6.5 8.6 6.4 4.0 10.9 7.6 8.3 6.0 21.2 13.1 10.0 7.6 2.2 2.0 8.1 7.4 10.1 4.9 8.0 5.8 11.8 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 34.8 36.1 22.1 7.4 20.6 3.0 31.4 19.9 23.1 41.9 11.7 47.2 6.3 40.3 16.2 26.4 40.5 9.6 38.8 21.2 21.0 24.1 7.8 30.0 8.3 27.1 21.7 48.4 23.1 36.1 28.6 10.8 27.0 33.1 6.6 23.1 28.0 21.4 32.4 27.2 23.0 16.4 19.7 22.1 27.3 15.9 23.3 9.5 43.9 14.8 9.0 42.3 33.9 21.5 10.7 14.4 3.6 6.9 37.1 19.1 6.5 14.7 21.0 13.0 12.9 4.8 5.1 1.1 11.4 28.0 9.5 16.7 3.6 20.6 9.5 17.0 6.2 5.3 12.3 3.4 10.4 1.0 12.2 13.4 21.1 12.5 15.9 30.6 11.5 4.0 1.8 3.4 14.5 7.1 3.7 2.2 1.5 4.3 6.8 6.8 6.2 1.6 15.9 8.9 2.1 5.3 6.5 4.6 6.9 6.3 8.6 2.4 16.1 14.6 5.7 13.9 12.3 6.1 4.5 0.7 15.7 3.3 7.7 0.4 0.3 0.5 1.0 0.5 1.0 0.5 0.8 0.8 0.2 0.5 1.0 1.0 0.2 0.6 1.7 0.4 0.4 0.6 22.1 20.6 19.9 23.1 21.2 21.0 27.1 21.7 27.0 19.7 23.3 21.5 27.4 51.3 53.1 33.6 14.6 30.7 16.3 18.4 18.8 86.6 23.6 20.6 92.6 20.0 24.8 20.2 68.8 10.3 24.5 4.6 3.9 14.4 40.8 21.1 25.2 26.1 17.4 9.5 36.9 14.4 2.2 24.8 7.1 26.0 13.9 25.7 23.9 8.1 13.5 74.0 37.3 10.1 14.2 30.0 34.6 57.0 51.9 18.6 17.8 15.9 12.0 27.0 24.7 21.6 26.7 19.0 5.3 70.0 9.5 16.2 8.2 11.2 32.2 39.9 32.9 37.8 27.4 7.3 4.3 17.3 23.4 5.2 21.1 16.3 9.0 14.7 ZBTB45 "FLJ14486, ZNF499" ENSG00000119574 "Zinc finger and BTB domain containing 45" Q96K62 19 58513530-58538911 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035754, HPA075485" Uncertain Approved "Nuclear bodies,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "Nuclear bodies" "HPA035754: AB_10603461, HPA075485: " "unprognostic (1.38e-1)" "unprognostic (7.12e-2)" "unprognostic (2.31e-1)" "unprognostic (7.34e-2)" "unprognostic (2.60e-1)" "unprognostic (4.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.19e-2)" "unprognostic (2.63e-2)" "unprognostic (3.02e-1)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.38e-4)" "unprognostic (2.08e-1)" "unprognostic (1.06e-1)" "unprognostic (5.47e-2)" "unprognostic (1.40e-1)" 7.9 8.5 6.5 5.1 6.7 4.9 8.6 5.2 11.4 9.9 1.9 10.3 6.1 12.0 1.1 10.1 9.5 3.1 9.1 7.1 4.9 7.7 6.9 6.1 4.2 8.9 6.4 9.3 8.2 4.2 7.1 3.1 8.3 9.5 1.6 2.1 9.0 4.1 10.3 12.7 7.6 2.4 4.5 8.0 8.3 4.9 6.7 3.3 8.3 3.0 2.3 10.5 9.0 7.4 21.3 29.7 7.6 11.7 7.7 6.6 9.6 11.8 4.8 3.0 2.9 5.8 13.4 31.9 15.6 6.6 8.4 13.2 4.2 10.7 1.1 21.4 55.3 17.3 15.1 7.1 4.9 11.1 11.1 6.3 7.4 4.7 3.9 5.6 6.2 32.1 16.0 1.8 4.6 14.2 17.4 11.6 10.6 12.5 26.1 13.8 4.7 19.4 6.2 19.4 23.4 16.7 8.7 22.5 6.1 4.6 33.4 7.6 13.1 12.9 5.6 4.3 11.7 34.8 27.2 15.9 14.7 4.6 8.4 5.8 5.0 10.2 5.7 7.6 6.8 4.4 3.9 5.3 5.3 5.0 4.6 3.4 4.4 5.5 9.1 6.4 3.7 4.7 6.5 6.7 5.2 11.4 7.1 4.9 8.9 6.4 8.3 4.5 6.7 7.4 3.3 9.6 0.5 2.9 5.6 1.7 3.7 5.5 2.2 4.2 4.5 4.6 3.3 1.5 4.0 12.9 0.0 8.9 5.1 6.3 5.9 10.6 0.6 3.4 4.6 5.0 10.3 7.4 1.9 8.9 8.0 3.9 8.6 3.8 0.0 5.6 8.6 4.5 6.6 6.7 2.0 4.6 8.2 6.8 2.4 1.3 5.9 3.7 7.2 0.0 12.3 3.7 7.2 1.5 1.6 8.8 2.6 9.8 3.6 3.8 5.9 5.6 3.8 3.0 13.1 2.5 5.1 5.2 5.9 3.5 2.7 5.6 3.1 4.8 6.0 2.6 ZBTB46 "BTBD4, BZEL, FLJ13502, RINZF, ZNF340" ENSG00000130584 "Zinc finger and BTB domain containing 46" Q86UZ6 20 63743668-63832038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 28.6;Excitatory neurons: 26.0;Hepatic stellate cells: 28.9;Microglial cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013997, HPA048051" Uncertain Approved Nucleoplasm NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA013997: AB_1858961, HPA048051: " "unprognostic (1.11e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.13e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (9.33e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.17e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (3.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.70e-2)" "unprognostic (2.12e-1)" 8.4 5.0 5.1 2.2 4.7 1.2 7.5 13.9 5.5 8.0 4.3 2.5 1.2 7.2 4.5 2.1 7.7 2.5 10.7 4.3 5.5 9.1 4.7 5.8 3.5 4.3 3.5 12.2 3.2 2.2 10.0 4.1 3.9 4.5 0.7 4.1 2.9 2.6 3.7 2.4 3.4 1.8 3.4 16.6 2.7 3.9 5.1 1.3 9.8 3.7 1.2 3.5 3.4 3.0 1.6 0.6 6.9 1.9 0.4 0.8 3.6 0.4 2.7 0.4 0.2 1.8 4.7 0.2 7.2 0.1 1.5 1.2 0.4 0.1 0.4 0.5 1.7 0.3 1.0 3.3 1.8 0.5 1.0 0.4 0.1 0.1 0.0 0.8 0.8 0.2 2.4 0.5 1.5 4.1 0.1 9.7 1.0 1.9 2.4 1.8 2.4 2.9 0.5 1.1 7.2 1.7 0.7 3.9 0.5 3.8 4.0 5.7 0.1 4.1 2.4 1.7 0.6 1.2 3.3 0.4 0.2 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 4.7 13.9 5.5 4.3 5.5 4.3 3.5 3.9 3.4 5.1 3.0 28.6 0.0 1.1 14.4 0.8 0.4 1.3 2.0 1.2 4.7 2.6 2.0 10.8 1.5 2.8 1.8 18.8 4.3 0.6 1.0 0.0 1.6 0.6 1.5 11.2 14.5 1.2 4.0 26.0 0.6 0.9 5.1 0.0 1.6 2.5 0.1 28.9 0.3 3.0 1.7 6.9 0.0 4.1 3.8 14.6 2.3 8.1 4.2 1.8 45.0 1.7 3.9 0.0 12.1 2.0 2.3 0.1 8.6 0.5 2.6 0.2 1.3 1.7 10.1 0.0 2.2 8.0 0.7 1.9 0.3 0.4 3.7 0.5 13.4 0.2 2.0 ZDHHC1 "C16orf1, HSU90653, ZNF377" ENSG00000159714 "Zinc finger DHHC-type containing 1" Q8WTX9 16 67394152-67416833 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 84.6;Late spermatids: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 11.4;ASC TERT1: 11.3;U-138 MG: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042531, HPA048659" Uncertain Approved Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA042531: AB_2678041, HPA048659: AB_2680483" "unprognostic (8.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.05e-3)" "prognostic favorable (1.25e-6)" "unprognostic (1.68e-2)" "unprognostic (9.33e-2)" "unprognostic (6.03e-2)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" "prognostic favorable (5.99e-4)" "unprognostic (2.17e-1)" "prognostic favorable (1.55e-6)" "unprognostic (2.10e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (5.63e-3)" 17.7 10.9 3.7 1.8 3.5 0.2 17.9 3.2 5.6 27.1 7.4 14.5 2.3 21.7 3.9 6.8 22.4 6.3 10.8 3.4 4.2 19.3 4.4 12.4 1.4 4.9 6.7 23.6 17.7 7.8 20.4 3.1 4.1 19.5 1.7 0.8 17.0 6.7 10.7 19.1 7.4 3.9 4.7 14.9 10.6 20.3 4.4 0.6 29.4 3.0 0.8 12.8 16.3 2.8 5.2 6.0 1.4 7.3 11.4 11.3 0.0 3.2 9.0 2.6 2.8 0.0 2.6 0.0 1.3 4.2 2.5 3.3 0.4 0.6 0.5 1.6 4.6 0.5 0.1 0.4 5.2 0.2 4.0 6.0 5.3 2.7 0.6 6.0 3.3 0.0 0.0 0.0 1.8 0.3 0.0 0.0 2.9 1.8 0.1 0.0 0.0 0.0 3.5 2.9 2.1 7.4 0.5 0.1 6.5 0.4 1.9 1.1 5.8 11.7 2.0 5.6 3.3 1.4 0.3 0.0 7.2 0.1 4.7 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 3.7 3.5 3.2 5.6 3.4 4.2 4.9 6.7 4.1 4.7 4.4 2.8 7.0 0.0 0.0 10.4 0.9 7.1 6.7 1.3 10.8 2.2 7.5 7.0 1.1 10.0 1.4 7.3 4.2 2.0 0.3 5.2 9.8 3.4 29.3 84.6 10.9 5.2 9.0 0.4 5.7 4.0 0.2 13.6 8.6 7.3 0.0 8.5 6.1 2.0 2.0 3.3 5.0 12.9 2.0 16.4 6.8 53.0 14.6 9.3 5.4 2.8 8.2 7.9 1.0 4.0 2.5 2.2 4.9 10.9 0.7 7.2 2.0 6.6 5.5 0.5 0.0 5.1 9.4 12.4 8.6 6.2 7.1 5.7 0.7 10.4 6.8 4.8 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type palmitoyltransferase 8" Q9ULC8 22 20129456-20148007 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 31.6 31.2 13.8 18.6 15.1 10.7 30.4 11.3 26.4 32.6 0.0 22.8 12.1 31.2 7.5 29.3 27.7 13.0 31.6 13.9 7.0 30.4 36.1 31.0 17.1 12.2 10.0 34.6 35.6 14.4 41.3 16.9 9.9 28.1 7.0 7.4 27.6 15.4 23.6 32.2 24.7 13.1 6.6 35.7 26.4 14.9 12.3 13.7 37.3 10.3 11.7 25.3 30.9 12.8 30.0 18.7 29.3 38.7 42.0 25.0 26.3 55.1 37.3 36.6 32.6 9.8 15.2 0.1 22.3 46.0 19.8 40.2 15.5 42.2 18.0 43.2 59.4 14.5 57.2 23.0 34.5 0.0 19.5 43.7 27.9 28.2 23.6 22.5 41.4 21.0 101.4 22.8 33.0 14.7 17.8 39.1 14.9 13.2 29.4 37.8 25.6 10.9 15.6 35.9 46.9 23.7 22.4 10.7 26.6 13.1 0.7 20.4 48.0 82.5 59.8 46.8 25.0 32.6 11.5 11.7 24.2 18.7 24.8 1.3 0.4 0.1 0.8 0.5 0.4 0.2 0.2 0.4 0.1 0.5 0.4 0.5 0.0 0.4 0.2 1.3 0.7 0.2 13.8 15.1 11.3 26.4 13.9 7.0 12.2 10.0 9.9 6.6 12.3 12.8 17.4 3.2 3.1 17.6 3.7 9.1 3.8 3.6 5.7 11.9 8.2 8.1 7.1 4.3 3.5 11.0 14.6 3.6 9.2 4.3 1.9 5.2 0.5 4.3 15.7 11.5 4.2 0.8 16.6 4.5 8.5 9.3 10.2 8.7 5.7 8.7 10.4 9.8 4.9 13.5 9.9 5.9 10.2 5.0 5.0 2.1 10.8 5.7 5.4 9.4 3.7 7.4 1.0 13.0 13.3 7.7 5.4 14.7 2.7 7.6 2.7 2.1 1.5 10.8 6.6 10.5 6.8 1.4 3.8 5.5 9.8 3.4 4.2 8.0 5.0 3.4 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 6.2 5.8 2.8 1.9 3.0 1.1 5.7 4.6 3.0 6.3 2.1 7.2 2.1 6.3 2.7 4.5 6.1 2.2 5.4 2.8 3.3 5.6 6.3 4.6 2.4 3.1 3.0 7.4 5.9 3.3 7.4 2.7 2.9 6.0 2.4 5.7 5.2 2.9 11.6 4.8 5.0 2.7 2.7 4.8 5.2 5.7 3.1 3.2 7.6 4.2 2.3 6.9 5.6 3.5 2.6 1.2 10.4 3.4 5.5 6.4 0.4 5.0 6.5 4.3 4.6 2.1 2.3 2.1 3.1 4.0 2.6 1.7 4.8 4.0 4.4 0.4 1.2 9.0 4.0 1.7 5.7 6.8 2.4 6.7 5.2 4.9 7.3 5.6 3.2 2.8 6.1 3.7 6.3 0.6 3.9 4.9 7.2 2.8 3.4 1.5 7.3 2.9 3.9 2.6 4.2 7.3 4.5 2.3 6.0 5.5 6.2 6.8 3.1 4.5 3.6 7.0 4.2 4.9 5.6 1.4 3.5 2.3 4.5 0.4 0.7 0.5 0.7 0.3 0.6 0.5 0.6 0.6 1.0 1.7 0.7 0.4 0.3 1.3 4.7 1.7 0.8 0.3 2.8 3.0 4.6 3.0 2.8 3.3 3.1 3.0 2.9 2.7 3.1 3.5 7.3 16.0 8.7 13.1 3.8 2.5 4.6 4.1 5.7 12.4 4.5 3.9 12.3 1.5 9.7 0.0 8.4 1.1 5.7 7.2 1.9 7.4 16.7 4.6 8.0 5.4 6.1 3.0 13.5 8.9 0.7 6.2 3.6 4.5 3.8 10.9 6.8 7.6 4.6 16.8 17.1 6.5 2.0 5.1 3.4 4.5 5.6 5.1 5.4 12.2 8.5 13.2 7.2 14.6 20.1 6.8 5.2 5.3 5.4 5.0 6.4 4.5 4.6 8.5 6.6 6.6 6.4 11.2 5.7 3.3 3.4 0.4 4.6 13.5 5.1 3.6 ZNF219 ENSG00000165804 "Zinc finger protein 219" Q9P2Y4 14 21090077-21104722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030761, HPA056168" Approved Supported Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA030761: AB_2673598, HPA056168: AB_2683052" "unprognostic (9.82e-3)" "unprognostic (4.50e-3)" "unprognostic (3.35e-1)" "unprognostic (1.11e-3)" "unprognostic (4.49e-2)" "unprognostic (1.96e-1)" "unprognostic (2.54e-1)" "unprognostic (6.79e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.80e-3)" "unprognostic (6.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.56e-2)" "unprognostic (2.35e-2)" 44.2 77.1 15.2 7.4 10.7 4.5 35.5 32.0 17.9 33.9 14.3 83.3 22.4 41.6 9.4 49.2 29.6 5.4 42.0 22.0 14.8 20.6 17.1 32.8 2.5 20.7 25.7 30.7 24.7 12.4 23.5 6.5 20.3 38.3 10.3 11.0 28.2 21.7 34.0 45.6 33.1 9.3 13.6 13.1 33.3 11.9 17.8 10.9 32.3 5.9 3.6 44.7 36.1 9.1 8.1 26.6 33.6 49.5 4.5 4.3 48.1 9.8 15.0 4.9 7.7 15.5 17.7 12.0 7.2 3.7 5.4 59.1 10.8 31.4 3.4 24.6 11.5 7.1 42.2 32.7 2.8 1.5 10.9 6.6 25.9 8.0 14.7 6.5 6.0 11.0 6.9 3.5 2.7 22.4 16.2 11.3 47.5 15.3 5.7 33.7 5.6 3.1 3.8 44.0 38.2 34.4 13.5 7.9 7.8 6.7 9.5 4.2 1.2 6.0 26.4 14.7 4.0 6.1 4.2 2.7 3.8 6.0 11.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.4 0.0 0.0 15.2 10.7 32.0 17.9 22.0 14.8 20.7 25.7 20.3 13.6 17.8 9.1 5.6 3.2 10.7 12.7 1.8 14.8 13.3 13.5 11.4 36.6 14.4 19.6 7.6 10.0 4.3 3.7 27.1 9.6 3.4 33.0 1.9 10.3 9.2 2.5 1.9 6.3 7.8 8.2 3.5 11.3 1.0 6.0 5.1 4.6 14.7 35.1 9.3 8.0 7.4 11.8 4.9 17.4 10.2 7.5 11.8 5.6 9.9 5.9 8.8 7.5 0.8 33.0 1.0 13.6 2.5 7.8 10.0 12.4 3.9 12.0 23.6 6.8 4.3 27.4 13.1 9.3 14.7 8.9 8.7 13.5 15.6 12.4 5.2 6.3 26.6 12.7 ZNF414 "MGC15716, Zfp414" ENSG00000133250 "Zinc finger protein 414" Q96IQ9 19 8509678-8514167 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 93.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 40.5" "Low region specificity" "Detected in all" HPA053769 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA053769: AB_2682255" "unprognostic (7.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.26e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.45e-1)" "prognostic favorable (1.67e-6)" "unprognostic (1.21e-1)" "unprognostic (2.32e-1)" "unprognostic (6.42e-2)" "unprognostic (7.29e-2)" "prognostic favorable (4.59e-4)" "unprognostic (1.08e-1)" "unprognostic (2.07e-2)" "unprognostic (3.84e-1)" "unprognostic (1.94e-1)" "unprognostic (1.91e-1)" "prognostic favorable (8.71e-4)" 14.3 19.6 5.6 5.2 6.3 9.1 15.9 5.0 12.3 22.3 0.5 16.8 7.9 23.2 1.3 18.3 17.2 1.8 16.7 5.7 4.8 17.2 20.9 11.4 6.3 7.1 5.6 22.4 14.9 3.4 21.3 3.7 6.3 23.9 1.1 2.1 15.0 4.4 18.1 21.9 15.6 1.8 3.5 19.3 14.5 20.6 6.6 4.3 22.5 2.7 1.9 17.2 18.0 11.1 9.2 7.8 4.2 6.8 1.1 2.6 9.2 6.9 2.6 4.4 3.9 6.9 4.4 12.5 19.3 2.1 3.2 12.5 1.4 5.6 0.6 11.4 31.0 7.9 7.2 8.3 5.9 7.0 10.3 4.8 4.0 3.6 1.3 2.4 1.9 7.8 10.7 18.0 2.7 11.3 15.7 40.5 12.5 2.4 22.0 18.1 2.2 12.8 3.1 7.5 14.4 22.3 7.5 5.7 6.6 0.8 10.8 8.1 7.1 12.8 6.5 18.7 8.9 26.0 11.8 10.0 10.2 5.8 7.1 1.4 0.5 0.3 0.6 0.4 0.3 0.8 0.9 0.9 0.5 0.8 0.8 0.8 1.6 0.8 0.7 1.2 0.4 0.4 5.6 6.3 5.0 12.3 5.7 4.8 7.1 5.6 6.3 3.5 6.6 11.1 9.7 0.0 1.1 4.2 11.8 11.9 13.5 6.9 26.2 18.3 12.1 14.7 2.1 11.5 2.5 3.7 10.4 28.8 15.8 14.3 15.6 3.9 27.1 5.7 9.2 8.2 22.2 9.2 3.6 5.3 22.8 11.8 17.3 8.0 4.5 15.0 13.2 10.9 13.1 11.8 3.6 14.6 2.0 12.7 7.6 93.4 20.5 11.6 8.8 3.7 8.8 20.4 11.3 4.0 6.5 4.6 16.0 16.1 9.3 9.1 16.2 17.6 1.4 21.9 13.1 11.5 10.0 21.3 38.3 18.0 12.1 31.5 12.8 19.0 13.2 9.8 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431705-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 4.2 3.0 2.3 1.8 2.5 1.3 3.9 4.3 2.4 6.0 1.1 4.7 1.4 5.1 2.0 2.7 5.0 1.6 3.6 2.4 2.4 3.3 4.9 4.1 1.9 2.1 2.1 7.0 4.4 2.8 5.0 2.0 2.2 4.4 1.7 4.2 3.6 2.1 4.4 3.7 3.5 2.2 1.7 3.9 3.9 3.1 2.2 3.3 3.8 2.7 2.1 4.1 4.4 2.9 1.9 2.1 6.4 5.1 3.5 3.6 2.9 2.5 2.1 3.7 3.7 3.2 1.6 3.3 1.5 2.6 2.3 1.5 4.4 1.7 4.5 3.6 1.6 6.1 4.7 3.2 2.2 7.8 4.9 2.5 2.1 4.2 2.6 3.1 2.6 4.6 4.8 2.4 3.0 1.2 7.5 5.2 4.4 1.2 1.9 3.3 4.0 1.6 2.0 3.8 3.2 3.9 3.9 2.0 1.0 4.7 3.7 3.4 3.2 5.2 4.6 3.2 3.2 1.9 1.5 2.7 1.9 3.8 3.2 1.0 0.3 0.6 0.3 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.3 0.2 1.0 0.5 0.8 0.3 0.1 0.1 2.3 2.5 4.3 2.4 2.4 2.4 2.1 2.1 2.2 1.7 2.2 2.9 11.7 12.8 17.4 19.2 8.4 4.1 4.4 2.9 9.6 36.0 4.8 4.4 11.1 5.7 7.6 11.0 37.5 4.1 15.7 3.8 1.9 5.8 2.5 6.3 14.1 9.7 7.2 10.3 21.7 8.4 1.7 9.0 7.1 6.8 11.4 26.6 13.2 10.1 5.7 28.6 24.3 6.3 2.0 16.4 4.7 2.2 9.3 10.5 0.0 9.4 11.6 10.1 22.6 11.6 19.5 4.9 6.0 9.8 9.5 5.6 4.3 2.8 9.6 28.4 13.1 14.5 10.6 6.7 6.9 5.6 2.6 1.4 9.8 9.3 7.2 3.8 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: AB_2683565" "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 4.1 3.2 1.7 2.5 1.9 2.2 4.1 4.4 3.1 5.4 1.8 4.7 2.8 6.0 1.6 3.2 4.9 1.9 3.0 2.4 1.1 3.0 2.7 3.1 3.1 2.3 1.7 6.6 3.6 2.6 4.0 2.2 1.1 4.8 1.7 1.7 4.2 2.6 3.3 4.5 3.5 1.5 0.5 4.7 3.6 3.8 1.4 2.4 4.6 1.4 2.2 4.8 4.4 3.0 1.8 7.2 2.3 6.2 2.7 2.4 10.7 5.2 5.7 6.4 4.3 3.2 3.4 3.8 4.4 2.8 2.3 4.0 4.5 2.7 4.6 2.8 7.4 3.1 10.8 4.4 3.8 2.3 3.3 2.9 6.5 2.9 5.3 6.2 3.6 4.8 4.7 5.9 2.5 4.0 4.7 4.0 3.0 1.4 2.6 8.1 5.6 7.6 2.1 2.0 8.7 5.7 4.5 6.6 2.0 1.6 4.3 3.6 4.1 6.0 4.4 6.7 2.5 5.6 4.1 3.4 1.8 1.9 3.8 1.3 1.0 1.5 1.5 1.0 1.2 2.1 0.9 1.1 0.5 1.9 1.5 1.9 1.1 1.2 0.7 2.6 1.7 1.0 1.7 1.9 4.4 3.1 2.4 1.1 2.3 1.7 1.1 0.5 1.4 3.0 4.8 12.8 2.7 5.5 5.8 2.4 3.2 3.6 1.8 19.1 3.7 3.0 5.3 5.7 3.0 7.3 25.0 6.8 10.1 4.6 1.9 4.6 8.9 5.1 6.4 5.5 8.4 5.7 8.8 3.1 4.4 5.9 4.6 2.9 7.0 12.0 12.1 4.1 3.3 18.5 6.3 6.8 4.1 4.8 3.8 1.8 11.5 3.4 1.8 3.7 8.4 11.1 6.2 6.0 5.9 3.5 2.3 11.3 4.3 5.2 7.3 3.3 6.6 20.8 0.0 8.0 4.8 13.2 8.8 1.7 2.3 4.5 5.0 9.8 5.5 1.8 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401764 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 255.0;Squamous epithelial cells: 189.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 115.1;PC-3: 149.2;U-87 MG: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (3.50e-4)" "prognostic favorable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 14.5 39.9 6.1 3.1 10.1 2.0 9.2 3.8 5.2 34.5 1.0 17.7 8.1 44.1 10.3 20.1 23.8 2.4 9.0 7.4 5.5 25.6 7.1 14.2 1.5 12.0 9.2 46.3 25.4 4.6 4.8 3.3 7.6 17.5 1.8 1.4 9.5 17.6 3.6 5.3 8.5 7.7 10.0 8.0 16.3 2.4 8.1 1.1 7.8 2.1 1.0 13.8 18.2 6.5 5.2 4.9 1.1 6.3 10.6 7.1 1.6 4.6 2.8 1.9 1.7 7.5 20.4 0.0 13.4 4.6 1.1 9.4 0.7 4.9 1.4 0.0 115.1 0.0 12.4 24.8 8.5 6.1 12.9 19.1 4.8 3.5 2.0 16.6 0.5 0.5 0.1 0.2 2.6 2.7 0.2 18.8 0.1 3.8 149.2 0.0 5.6 0.1 2.8 4.1 4.1 5.2 8.5 0.6 27.1 1.0 1.0 4.2 3.9 14.6 16.3 30.7 13.0 0.0 0.0 0.0 44.9 27.2 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 10.1 3.8 5.2 7.4 5.5 12.0 9.2 7.6 10.0 8.1 6.5 27.2 38.5 11.6 2.3 1.7 27.1 35.6 15.0 255.0 23.7 7.7 42.3 20.4 10.0 10.1 40.5 20.9 0.5 2.1 0.8 58.7 45.9 0.1 53.2 72.2 41.0 3.6 5.3 12.6 34.7 0.3 60.1 18.3 48.1 6.3 2.7 44.6 10.3 13.5 6.7 3.2 6.7 10.2 27.4 30.5 2.0 59.7 30.7 24.9 13.1 8.2 7.7 0.0 4.0 0.7 33.2 1.5 49.2 3.9 19.7 13.4 32.5 1.7 26.3 39.5 10.2 78.1 0.2 6.0 189.3 13.9 0.3 4.0 24.5 9.7 14.3 ZNF517 ENSG00000197363 "Zinc finger protein 517" Q6ZMY9 8 144798876-144811169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055337 Approved Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA055337: AB_2682788" "unprognostic (9.54e-3)" "unprognostic (4.72e-2)" "unprognostic (3.20e-2)" "unprognostic (3.06e-2)" "unprognostic (1.81e-1)" "unprognostic (1.55e-2)" "unprognostic (2.22e-2)" "unprognostic (3.13e-1)" "unprognostic (4.83e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.66e-4)" "unprognostic (1.83e-1)" "unprognostic (4.23e-2)" "unprognostic (2.75e-1)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "unprognostic (9.57e-2)" 2.9 5.9 2.4 2.1 2.0 1.0 3.2 1.9 3.2 5.5 0.4 4.8 2.2 6.8 0.4 3.3 5.5 2.0 3.2 3.2 0.7 4.2 3.6 2.6 2.3 1.8 1.6 7.2 3.5 1.8 5.0 1.4 2.2 5.0 0.3 2.2 4.2 1.0 6.3 6.3 3.4 0.6 0.9 3.4 3.7 4.0 2.0 1.1 4.8 0.8 0.9 4.9 4.0 2.3 1.7 3.2 5.2 5.1 0.8 1.5 2.7 1.4 0.4 0.3 0.2 1.0 1.9 0.9 3.6 0.5 2.2 1.7 0.2 0.6 0.7 3.8 1.4 2.2 2.0 11.7 1.9 0.5 2.2 1.1 1.3 0.2 1.0 2.9 1.2 2.7 2.6 1.4 0.9 2.8 2.3 1.3 3.6 3.5 3.5 3.2 1.6 0.8 0.5 2.1 2.3 6.6 4.3 1.7 1.7 2.5 4.2 2.0 1.5 3.5 5.3 1.8 1.6 2.2 0.4 0.7 3.7 0.9 2.9 0.1 0.3 0.0 0.5 0.7 0.3 1.4 0.4 0.3 0.3 0.1 0.3 0.3 0.1 0.3 0.4 0.1 0.6 0.4 2.4 2.0 1.9 3.2 3.2 0.7 1.8 1.6 2.2 0.9 2.0 2.3 1.8 0.0 0.5 1.3 1.2 0.5 5.8 0.9 0.6 3.9 1.6 1.3 3.3 2.8 1.1 0.0 8.4 0.8 1.2 0.8 1.9 0.8 1.3 1.8 1.5 1.5 1.2 0.8 0.9 0.5 0.7 1.7 1.1 1.3 0.0 2.2 2.2 2.3 1.5 3.3 1.3 1.5 2.0 2.2 0.5 0.0 0.9 1.4 0.0 1.0 0.5 2.5 4.1 1.5 0.6 0.9 0.3 1.2 0.9 1.6 1.3 3.3 0.8 3.6 0.0 1.8 1.5 4.3 3.0 0.9 1.1 0.4 1.5 2.2 0.9 4.1 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.3;Inhibitory neurons: 64.3;Oligodendrocyte precursor cells: 30.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 5.5;SCLC-21H: 6.6" HPA028982 Uncertain Approved Nucleoli NA NA "Cluster 72: Non-specific - Transcription" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 0.9 0.5 0.3 0.3 0.3 0.3 0.9 1.3 1.0 2.4 0.0 2.4 0.1 1.9 0.3 1.7 1.5 0.4 0.8 0.3 0.2 0.3 0.4 0.5 0.6 0.2 0.2 2.0 0.6 0.2 0.8 0.2 0.3 1.2 0.5 0.4 0.8 0.4 0.4 0.9 1.0 0.7 0.2 0.9 0.7 0.8 0.2 0.6 0.9 0.3 0.4 1.6 1.7 0.4 0.6 0.0 2.3 2.2 0.0 0.5 0.9 0.4 0.3 1.7 1.6 0.7 0.6 1.2 0.8 0.2 0.5 0.6 2.3 0.3 2.5 1.0 1.4 2.7 1.3 0.4 0.0 5.5 0.8 0.1 0.6 1.2 0.3 0.3 0.2 1.9 0.9 1.8 0.7 0.3 3.7 0.8 0.9 1.2 0.7 3.3 2.9 1.6 0.3 0.4 6.6 1.2 1.2 0.1 0.8 1.8 0.4 0.8 0.2 2.7 2.5 1.1 0.9 0.3 0.6 1.3 0.7 1.8 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 1.3 1.0 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.4 4.6 6.4 9.5 17.6 7.6 2.0 2.4 2.5 11.4 15.0 2.8 3.8 4.9 1.5 1.3 0.0 2.1 3.2 3.3 0.6 1.9 2.5 1.1 0.6 11.2 3.2 1.2 8.0 83.3 2.0 4.2 7.6 3.1 1.1 3.8 18.2 2.9 0.7 1.7 3.3 64.3 1.9 4.1 3.1 1.9 1.8 6.5 2.3 1.8 23.4 1.6 5.9 6.2 30.2 15.9 1.0 0.4 9.1 6.0 1.2 0.3 0.7 2.0 7.4 0.0 8.4 4.2 10.7 12.2 18.3 1.3 0.8 6.4 3.6 2.4 1.4 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 18.9;Paneth cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: AB_2681643" "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 2.8 1.6 1.5 1.1 2.2 0.6 2.1 2.5 4.4 3.0 0.0 4.5 1.6 2.9 1.0 1.6 2.3 0.7 2.3 2.1 0.0 2.1 2.1 1.6 1.1 0.9 0.2 3.1 1.5 0.5 3.2 0.4 0.9 2.1 2.0 0.6 1.7 1.0 4.6 2.0 2.2 0.8 0.0 2.1 1.5 0.8 1.1 1.1 2.1 0.5 0.6 2.2 2.3 1.5 1.9 1.7 0.4 0.5 2.4 2.0 0.1 1.2 0.8 0.4 0.6 0.4 0.7 0.4 0.8 0.9 0.2 1.0 0.0 0.2 0.2 2.7 0.3 1.4 0.7 0.3 0.5 0.6 1.7 1.2 0.7 0.6 0.1 1.3 0.3 2.6 0.5 2.6 0.7 1.3 7.7 0.2 0.1 1.3 0.8 4.1 0.0 1.0 0.4 1.1 0.3 0.6 0.9 1.2 1.3 0.3 0.3 0.7 1.3 2.3 1.5 0.5 0.9 1.3 2.2 1.2 1.4 1.7 2.4 0.0 0.4 0.3 1.4 0.2 0.5 0.7 1.3 1.4 0.6 1.8 2.1 1.5 0.4 3.3 0.2 0.9 1.4 0.7 1.5 2.2 2.5 4.4 2.1 0.0 0.9 0.2 0.9 0.0 1.1 1.5 1.5 6.4 1.1 1.6 1.3 0.1 0.6 1.2 1.8 1.2 1.1 1.9 2.0 0.0 0.9 0.0 4.2 1.3 1.9 18.9 3.9 0.4 0.1 0.5 1.6 1.8 1.2 1.3 0.9 0.6 0.9 3.5 1.1 1.1 0.0 1.5 2.5 2.3 1.6 0.0 1.1 2.3 0.0 2.7 1.0 0.4 2.5 1.8 1.8 0.0 0.8 0.8 4.1 0.0 1.3 0.2 8.7 3.4 2.6 0.3 2.0 2.5 0.2 0.1 0.0 2.0 2.6 0.1 1.1 2.6 1.7 0.3 3.1 0.7 2.7 0.5 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636019-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "PC-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 5.8 5.0 2.5 1.8 2.3 0.6 5.5 1.8 3.0 7.4 1.2 7.4 2.3 7.0 1.7 6.2 6.6 1.5 6.0 2.6 2.7 5.2 5.7 5.2 2.3 2.2 2.1 8.5 5.4 2.8 5.9 1.8 2.5 5.9 2.0 1.7 6.0 1.3 7.2 7.8 6.4 2.1 1.5 6.8 5.4 7.2 2.7 2.1 5.2 1.8 1.9 7.6 6.5 2.3 3.0 6.9 2.6 2.5 4.1 8.0 2.5 2.9 3.8 4.7 3.3 2.4 2.5 1.8 3.6 6.5 3.2 1.9 3.0 1.9 3.7 5.1 2.3 7.5 7.3 2.2 3.2 1.7 2.1 3.3 3.8 2.0 8.7 5.1 3.3 4.9 6.1 3.3 3.4 6.6 5.8 2.4 3.4 3.7 18.3 4.0 2.3 2.8 2.6 4.0 6.4 6.2 11.9 2.4 4.0 2.6 5.4 5.2 1.5 4.4 1.5 1.8 2.4 1.9 2.3 2.8 3.2 2.8 3.6 1.1 0.2 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.4 0.2 0.5 0.5 0.4 0.2 2.5 2.3 1.8 3.0 2.6 2.7 2.2 2.1 2.5 1.5 2.7 2.3 4.6 6.4 3.9 3.9 5.8 1.7 3.1 1.6 7.4 5.9 4.4 4.2 10.3 7.2 1.5 7.3 6.2 5.9 4.7 5.8 3.9 5.9 5.4 3.0 8.1 5.8 5.4 9.9 7.5 3.8 6.0 5.6 4.6 5.0 1.3 9.2 7.1 6.6 5.8 15.2 5.3 5.3 2.0 6.6 2.4 4.5 8.4 4.6 3.6 4.7 8.3 7.2 7.2 5.5 5.4 4.4 2.3 13.9 2.8 4.5 5.4 3.9 1.3 7.0 19.7 8.2 5.1 10.8 13.9 6.2 2.6 4.8 5.8 5.8 5.2 1.7 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 5.6 6.6 4.4 3.4 4.1 7.9 4.7 4.7 6.6 5.5 1.7 5.6 4.4 6.9 0.7 6.4 4.6 2.3 5.7 4.5 3.2 4.4 4.8 4.4 2.6 5.1 3.6 3.8 3.9 2.3 4.9 3.6 4.8 6.3 1.3 0.8 4.6 2.4 6.1 7.3 4.8 3.4 3.2 6.0 4.8 7.5 4.0 3.0 4.1 1.7 1.6 6.2 5.2 4.0 5.2 17.2 3.8 9.4 3.9 4.1 13.0 14.6 10.3 7.1 5.9 8.0 7.0 8.3 11.2 8.4 4.5 9.2 2.6 7.8 1.8 10.6 11.1 5.1 11.4 12.8 4.8 8.2 12.3 5.1 3.2 12.1 2.4 2.3 5.1 8.9 9.7 4.9 12.8 17.2 17.3 17.2 13.6 3.6 14.4 22.4 28.5 12.0 3.7 11.2 13.3 15.7 9.3 12.5 4.7 1.5 9.6 11.5 8.9 17.5 7.2 13.4 6.2 8.4 15.1 12.1 11.7 8.3 11.4 8.7 4.2 7.9 11.1 3.9 7.3 4.3 3.2 6.7 6.2 3.0 3.4 4.4 1.5 7.8 3.4 3.3 3.5 5.1 4.4 4.1 4.7 6.6 4.5 3.2 5.1 3.6 4.8 3.2 4.0 4.0 3.4 0.0 3.6 3.6 4.6 8.4 2.4 5.3 7.4 3.5 4.5 3.7 0.6 4.3 3.8 0.0 0.0 6.5 5.9 6.3 7.9 8.9 44.7 3.8 4.7 4.3 4.8 4.6 3.7 4.8 11.4 6.4 4.1 8.1 4.5 4.7 3.6 2.8 6.8 11.8 3.7 3.7 4.1 3.8 7.1 15.3 6.2 9.3 3.6 2.8 5.5 5.1 12.3 1.0 4.2 7.5 4.9 15.1 4.5 4.0 7.5 5.8 1.7 2.1 0.0 9.0 5.5 5.9 12.8 8.8 8.8 7.0 7.4 5.0 4.6 2.2 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 7.1 5.4 6.6 5.3 6.5 3.0 7.4 6.6 7.4 10.8 5.0 7.7 4.0 8.9 3.6 6.0 10.1 3.0 5.4 6.2 6.6 9.9 3.4 6.2 7.3 7.1 6.6 11.7 7.1 2.9 7.1 2.9 6.7 9.4 3.8 2.9 5.8 4.0 6.4 7.0 9.2 4.5 6.1 12.8 6.6 6.6 6.8 4.0 8.3 3.3 6.4 8.1 7.8 8.0 3.5 3.5 5.7 4.1 3.7 6.9 5.3 2.1 1.1 5.0 2.2 5.6 6.5 11.9 5.5 3.5 1.1 2.3 4.0 4.3 2.2 3.3 3.5 7.6 8.7 1.1 8.5 5.1 9.2 7.4 8.7 4.5 5.5 3.1 3.4 4.2 6.2 6.0 4.2 7.6 7.6 7.8 12.8 8.1 4.7 1.6 0.5 10.6 5.6 5.8 4.5 9.5 8.5 4.0 6.0 3.0 4.4 10.1 5.0 4.0 0.9 2.1 4.9 9.1 6.2 0.1 5.6 1.8 8.7 0.1 0.4 0.1 1.0 0.7 0.8 0.7 0.6 0.6 0.4 1.3 0.8 0.7 0.1 0.5 1.7 0.9 0.4 0.4 6.6 6.5 6.6 7.4 6.2 6.6 7.1 6.6 6.7 6.1 6.8 8.0 6.7 3.2 2.7 5.5 6.1 2.5 2.5 4.6 1.8 13.3 7.5 7.6 2.2 7.2 3.2 0.0 10.4 3.0 6.1 3.4 3.9 2.1 5.3 3.2 7.9 4.3 3.6 1.7 5.7 2.7 2.0 7.0 7.1 6.2 0.0 6.4 5.0 6.6 4.2 6.7 6.3 4.7 4.1 7.9 4.6 5.0 8.7 3.9 5.4 11.2 5.2 3.8 8.2 4.0 8.5 3.0 1.6 5.7 3.9 4.0 3.0 1.1 5.5 8.8 13.1 7.4 5.0 16.3 6.9 3.6 3.0 1.1 5.0 6.9 4.3 2.4 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585769 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004010 Approved Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Cytosol "HPA004010: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favorable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 5.2 5.7 5.7 4.9 6.4 3.1 6.1 9.1 8.3 10.9 2.9 8.1 8.4 9.6 5.4 6.2 8.8 4.4 5.6 5.6 6.2 8.2 5.8 5.8 5.5 6.1 4.7 11.0 8.3 5.7 9.5 3.6 4.8 10.2 4.7 6.5 8.2 5.1 6.0 7.4 8.2 4.2 2.6 7.6 7.5 3.3 6.3 4.4 8.0 3.6 3.9 9.0 8.5 9.8 5.7 0.5 5.4 7.1 6.5 7.2 1.7 4.9 4.3 5.0 3.7 7.5 8.9 5.9 5.6 4.7 0.3 8.0 0.1 3.2 2.9 4.0 1.4 7.2 17.4 1.8 4.8 0.6 11.8 4.8 6.7 3.3 3.1 4.2 5.3 1.0 6.9 7.1 4.6 9.8 7.3 6.7 3.0 2.2 3.2 18.8 6.1 2.9 4.6 5.8 14.7 10.4 4.0 5.0 3.0 3.2 6.3 6.1 8.1 1.9 5.2 4.4 0.4 0.9 3.3 2.4 6.3 4.3 8.1 2.8 1.1 0.4 0.9 0.6 0.9 2.7 1.1 0.7 0.8 1.1 1.3 1.0 1.9 1.3 2.4 2.3 1.5 0.5 5.7 6.4 9.1 8.3 5.6 6.2 6.1 4.7 4.8 2.6 6.3 9.8 5.3 0.0 3.4 11.1 5.3 1.0 7.6 3.4 6.8 10.7 4.1 2.4 1.8 4.3 2.5 7.3 20.9 1.3 14.3 4.7 5.9 3.9 0.1 3.5 11.1 7.1 12.0 3.4 14.1 3.7 1.1 5.2 3.6 4.5 0.0 14.8 3.6 3.5 2.6 13.5 13.6 5.2 0.0 5.0 3.1 0.8 13.4 3.3 5.4 6.5 6.0 5.8 15.5 6.6 11.4 4.2 8.1 13.2 1.4 7.0 6.6 2.4 4.0 12.0 0.0 6.2 4.6 5.3 3.1 3.1 2.6 0.8 4.7 6.8 7.4 5.1 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649417-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 10.3 6.6 7.2 5.2 8.2 5.2 10.1 6.8 7.7 14.6 5.3 9.7 2.9 11.0 4.4 11.8 9.6 3.6 7.7 6.8 7.9 9.0 6.7 6.9 6.4 7.7 7.4 10.4 7.2 4.2 7.5 4.7 7.6 8.9 4.2 3.3 9.5 4.4 7.8 11.1 7.9 5.5 8.1 8.1 6.9 6.1 7.6 5.5 8.5 3.9 6.0 11.6 11.3 9.1 13.5 9.1 8.9 8.1 19.2 17.4 11.3 17.0 16.3 11.5 11.0 9.2 6.8 10.4 19.7 10.4 24.7 11.2 15.9 10.9 18.6 14.3 13.7 21.6 10.3 10.7 16.2 35.4 8.3 17.2 10.0 15.3 13.4 11.4 13.7 16.4 20.2 13.3 17.6 5.1 20.9 9.2 13.5 11.0 16.5 16.6 19.7 12.0 18.7 25.2 8.6 5.6 13.3 20.3 19.3 9.3 9.0 8.9 15.6 14.8 10.0 12.5 24.7 8.5 9.3 28.2 3.4 22.0 13.1 0.6 0.7 0.1 1.8 0.7 2.0 1.9 1.6 2.0 1.2 2.4 2.0 2.0 0.1 1.8 0.7 2.1 1.8 0.8 7.2 8.2 6.8 7.7 6.8 7.9 7.7 7.4 7.6 8.1 7.6 9.1 22.0 16.0 22.5 22.5 20.3 16.2 14.4 12.5 13.1 31.8 10.6 9.9 17.6 11.5 38.0 31.3 33.3 9.0 21.0 25.6 3.9 11.9 4.2 15.5 47.4 20.9 9.5 8.4 40.4 8.8 13.7 22.2 6.1 16.1 27.8 22.4 14.3 10.6 7.5 15.2 30.0 20.9 16.2 13.5 7.4 3.8 13.4 9.1 7.2 22.5 11.0 17.6 27.8 34.2 45.3 12.2 11.6 12.8 11.1 11.1 15.5 6.3 18.0 38.8 19.7 22.4 20.7 35.8 21.6 14.0 16.3 2.7 20.1 25.8 20.5 10.8